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Abstract 
African trypanosomiasis is a neglected tropical disease affecting both animals 
and humans in sub-Saharan Africa.  The disease is caused bythe protozoan 
parasite Trypanosoma brucei, which is transmitted by the tsetse fly (Glossina 
sp.) vector.  In animals, infection leads to severe muscle atrophy and anaemia 
resulting in significant production and economic losses.  In humans, infection 
leads to both neurological and cardiac dysfunction and can be fatal if untreated.  
While the neurological-related pathogenesis is well studied, and indeed is 
responsible for the colloquial name “Sleeping Sickness”, the cardiac 
pathogenesis remains unknown.  Previous studies interpreted cardiac dysfunction 
as being due to immune/inflammatory responses.  However, recent work 
examining the parasite’s interaction with the blood brain barrier, the traversal 
of which is important for development of neurological signs, has identified direct 
immune/inflammatory independent mechanisms involving calcium (Ca2+) 
signalling.  The current study exposed isolated ventricular cardiomyocytes and 
adult rat hearts to T. brucei to test whether trypanosomes can alter Ca2+ 
signalling and cardiac function independent of a systemic immune/inflammatory 
response. 
Using a high-throughput method of observing spontaneous contractile activity in 
isolated cardiomyocytes, we were able to determine that the presence of T. b. 
brucei parasites resulted in more cardiomyocytes exhibiting spontaneous 
contractile events.  Moreover, when the parasites were removed by careful 
centrifugation, the culture supernatant had the same effect.  Confocal Ca2+ 
imaging identified an increase in the frequency of arrhythmogenic spontaneous 
diastolic sarcoplasmic reticulum (SR)-mediated Ca2+ release (Ca2+ waves).  
Studies utilising specific inhibitors, recombinant protein and RNA interference all 
demonstrated that this altered SR function was due to cathepsin-L; a cysteine 
protease produced by T. brucei (TbCatL).  Experiments utilising a Langendorff 
perfusion method revealed that trypanosome culture supernatant could induce 
ventricular premature contractions in 50% of a cohort of ex vivo whole rat 
hearts. 
Mechanistic experiments were performed on single isolated cardiomyocytes 
stimulated at 1.0 Hz and perfused first with control media followed by 
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trypanosome culture supernatant.  The protocol utilised triple caffeine 
applications: (i) prior to stimulation to empty the SR of Ca2+, (ii) after perfusion 
with control media and after supernatant to determine the SR Ca2+ content and 
sarcolemmal extrusion of Ca2+ following each solution.  Results were normalised 
to a parallel set of cardiomyocytes perfused with control media only as time 
controls.  These experiments revealed a 10-15% increase in SR Ca2+ reuptake by 
the SR Ca2+ ATPase (SERCA) but a reduced SR Ca2+ content suggesting a 
concomitant increase in SR-mediated Ca2+ leak.  This conclusion was supported 
by the data demonstrating that TbCatL increased Ca2+ wave frequency.  These 
effects were abolished by autocamtide-2-related inhibitory peptide (AIP), 
highlighting a role for Ca2+/calmodulin kinase II (CaMKII) in the TbCatL action on 
SR function.  When cytosolic diastolic Ca2+ was measured in cardiomyocytes with 
SR function inhibited by ryanodine and thapsigargin, trypanosome supernatant 
prevented a decline in cytosolic diastolic Ca2+ that was observed in control 
media.  AIP did not abolish this effect suggesting that TbCatL may raise diastolic 
Ca2+ that could activate CaMKII leading to the observed effects. 
These data demonstrated for the first time that African trypanosomes alter 
cardiac function independent of a systemic immune response via a mechanism 
involving extracellular cathepsin-L-mediated changes in SR function. 
Utilising the same (culture adapted and monomorphic) strain of T. brucei as the 
in vitro experiments, Lister 427, in a rat model of infection we found no 
significant increase in the arrhythmia frequency as measured by a 15 min 
electrocardiogram (ECG).  However, when hearts were removed and Langendorff 
perfused with the addition of isoproterenol the arrhythmia frequency was 
increased.  When the pleomorphic strain T. b. brucei TREU 927 was used in rats 
with continuous ECG recording from biopotential telemetry there was a 
significant increase in arrhythmia frequency in the infected rats.  When hearts 
were removed and Langendorff perfused with isoproterenol there was a similar 
increase in arrhythmia frequency as observed with the 427 infected hearts.  This 
suggests that a cardiac dysfunction phenotype is present during trypanosome 
infections in an animal model providing the basis for future therapeutic work. 
The relationship between arrhythmogenic SR-mediated Ca2+ release and TbCatL 
has parallels with endogenous extracellular cathepsin-L (CatL).  It has been 
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demonstrated that a basal level of CatL is necessary for normal cardiac function.  
However, in coronary heart disease (CHD) CatL levels are increased in the serum 
of patients correlating with the severity of disease.  The effects of raised CatL 
on cardiac function remain unknown.  Work in our lab has identified that ex vivo 
Langendorff perfused hearts that have undergone a 30 min period of ischaemia 
followed by 90 min reperfusion show greater CatL activity in coronary effluent 
than hearts perfused without ischaemia.  In addition, preliminary data collected 
in this thesis suggest that human patients that have suffered a myocardial 
infarction and have undergone reperfusion via percutaneous coronary 
intervention (PCI) showed higher CatL levels in post-reperfusion serum samples 
compared to pre-reperfusion serum.  When severity of heart function in patients 
(measured as left ventricular volume at systole and diastole, ejection fraction, 
infarct size and area at risk) was assessed by magnetic resonance imaging (MRI) 
in a preliminary study, there was a positive correlation with serum CatL levels.  
Using recombinant CatL on isolated rat ventricular cardiomyocytes it was found 
that the SR Ca2+ content and the stimulated Ca2+ transient were significantly 
reduced in a concentration dependent manner.  This suggests a CatL dependent 
SR dysfunction.  This conclusion was supported by an increase in Ca2+ wave 
frequency measured by confocal Ca2+ imaging in isolated cardiomyocytes. 
The work in this thesis demonstrates a role for both mammalian-derived and 
exogenous extracellular cathepsin-L proteases in arrhythmogenic SR-mediated 
Ca2+ release.    
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Definitions/Abbreviations 
[Ca2+]i Intracellular calcium ion concentration 
[Ca2+]o Extracellular calcium ion concentration 
[Ca2+]SR Sarcoplasmic reticulum calcium ion concentration 
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AC Adenylyl cyclase (forms cAMP from AMP) 
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β Change in fluorescence between zero and saturating [Ca2+] at 
380 nm 
BBB Blood brain barrier 
BCA Bicinchoninic acid 
BSA Bovine serum albumin 
CA074 L-3-trans-(propylcarbamyl)oxirane-2-carbonyl)-L-isoleucyl-L-
proline (Cathepsin B inhibitor) 
Ca2+ Calcium ion 
CAA0225 (2S,3S)-oxirane-2,3-dicarboxylic acid 2-[((S)-1-benzylcarbamoyl-
2-phenyl-ethyl)-amide] 3-{[2-(4-hydroxy-phenyl)-ethyl]-amide} 
(Cathepsin L inhibitor 
CaCl2 Calcium chloride 
CaM Calmodulin 
CaMKII Calcium calmodulin kinase II 
cAMP 3'-5'-cyclic adenosine monophosphate 
CatL Cathepsin-L 
CATT Card agglutination test for trypanosomiasis 
CBSS Carter’s balanced salt solution 
CCD Charge coupled device 
cDNA Complementary DNA 
CHD Coronary heart disease 
CICR Calcium induced calcium release 
CNS Central nervous system 
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CO2 Carbon dioxide 
CPVT Catecholaminergic polymorphic ventricular tachycardia 
CSF Cerebrospinal fluid 
Ct Cycle threshold 
CysC Cystatin C 
Δ Change in … 
d[Ca2+]i/dtmax Maximum rate of [Ca2+]i rise 
d[Ca2+]i/dtmin Maximum rate of [Ca2+]i decline 
DAD Delayed after depolarisation 
DNA Deoxyribonucleic acid 
dNTP DNA bases (A, adenine; C, cytosine; G, guanine; T, thymine) 
dsRNA Double stranded ribonucleic acid 
DTT Dithiothreitol 
E-64 (1S,2S)-2-(((S)-1-((4-Guanidinobutyl)amino)-4-methyl-1-
oxopentan-2-yl)carbamoyl)cyclopropanecarboxylic acid (Protease 
inhibitor) 
EAD Early after depolarisation 
ECa Equilibrium potential of calcium ion 
ECC Excitation contraction coupling 
ECG Electrocardiogram 
ECM Extracellular matrix 
EDTA Ethylene diamine tetraacetic acid 
EGTA Ethylene glycol tetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
Em Membrane potential 
ENa Equilibrium potential of sodium ion 
F/F0 Fluorescence over minimum fluorescence 
FKBP FK-506 binding protein 
Fluo-3 Calcium ion binding fluorophore 
Fura-2 Ratiometric calcium ion binding fluorophore 
Fura-4F Ratiometric calcium binding fluorophore 
g Gravity, force unit 
g Grams, mass unit 
GJNH Golden Jubilee National Hospital 
GPCR G-protein coupled receptor 
GPI Glycophosphatidylinositol 
GTP Guanosine triphosphate 
H+ Hydrogen ion (proton) 
H0 Null hypothesis 
H1 Test hypothesis 
H-89 N-[2-(p-bromocinnamylamino)ethyl]-5-iso-quinolinesulphonamide 
(PKA inhibitor) 
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HAT Human African trypanosomiasis 
HBMEC Human brain microvascular endothelial cell 
HCl Hydrochloric acid 
HCO3- Bicarbonate 
HEPES 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid 
HF Heart failure 
HMI-9 Trypanosome growth media 
hr Hour, time unit 
Hz Hertz, frequency unit 
I/R Ischaemia/reperfusion 
IC50 Concentration of compound at which there is 50% inhibition of 
target 
ICa Calcium ion current 
ICa L L-type calcium ion current 
ICa T T-type calcium ion current 
If Funny current 
IFNγ Interferon gamma 
IgG Immunoglobulin G 
IK1 Inwardly rectifying potassium ion current 
IKr Rapid outwardly rectifying potassium ion current 
IKs Slow outwardly rectifying potassium ion current 
IKto Transient outward potassium ion current  
IKur Ultra-rapid outwardly rectifying potassium ion current 
IL-1 Interleukin 1 
IL-10 Interleukin 10 
IMDM Iscove’s modified Dulbecco’s medium 
INa Sodium ion current 
INa/Ca Sodium/calcium ion exchanger current 
IP3 Inositol triphosphate 
IP3R Inositol triphosphate receptor 
ISO Isoproterenol 
JTV519 1,4-benzothiazepine based calcium ion channel blocking drug 
K+ Potassium ion 
K11777 N-methyl-piperazine-Phe-homoPhe-vinylsulfone-phenyl 
(Cathepsin L inhibitor) 
KCl Potassium chloride 
Kd Dissociation constant 
kDa Kilo Dalton, protein mass 
Km Affinity constant 
KSERCA SERCA activity 
L Litre, volume unit 
L/L0 Length over minimum length 
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λ Wavelength 
LAMP Loop-mediated isothermal amplification of DNA 
LASER Light amplification by stimulated emission radiation 
Leu Leucine (amino acid) 
LSCM LASER scanning confocal microscopy 
LTCC L-type calcium channel 
M Molar, concentration unit 
MES 2-(N-morpholino)ethanesulfonic acid 
MgCl2.6H2O Magnesium chloride hexahydrate 
MgSO4.7H2O Magnesium sulphate heptahydrate 
MI Myocardial infarction 
MIKH Modified isolation Krebs-Henseleit solution 
min Minute, time unit 
ml Millilitre, volume unit 
MLCK Myosin light chain kinase 
MLP Muscle LIM protein 
MPTP Mitochondrial permeability transition pore 
MRI Magnetic resonance imaging 
mRNA Messenger ribonucleic acid 
ms Millisecond, time unit 
mV Millivolt, potential difference unit 
NA Numerical aperture, lens curvature unit 
Na+ Sodium ion 
NaCl Sodium chloride 
NaH2PO4 Sodium dihydrogen orthophosphate 
NaHCO3 Sodium bicarbonate 
NaOAc Sodium acetate 
NaOH Sodium hydroxide 
NCX Sodium/calcium ion exchanger 
NECT Nifurtimox-eflornithine combination therapy 
nM Nanomolar, concentration unit 
NO Nitric oxide 
NTC No template control 
NT-proBNP N-terminal prohormone of brain natriuretic peptide 
O2 Oxygen gas 
°C Degrees Celsius, temperature unit 
P Probability 
pA Picoampere, current unit 
PAR-2 Protease activate receptor 2 
PCI Percutaneous coronary intervention 
PCR Polymerase chain reaction 
Phe Phenylalanine (amino acid) 
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PKA Protein kinase A 
PKC Protein kinase C 
PLB Phospholamban 
PLC Phospholipase C 
PMCA Plasma membrane calcium ion ATPase pump 
PMT Photo multiplier tube 
Po Open probability 
P-R Time interval from beginning of ECG P wave to beginning of Q 
PTx Pertussis sensitive toxin 
QRS Time interval from beginning of Q to end of S wave of ECG 
qRT-PCR Quantitative real-time polymerase chain reaction 
QT Time interval from beginning of Q to end of T wave on ECG 
QT50 Time interval from beginning of Q to 50% return to baseline of T 
wave on ECG 
QT90 Time interval from beginning of Q to 90% return to baseline of T 
wave on ECG 
QTc Time interval from beginning of Q to end of T wave on ECG 
corrected for heart rate 
RCF Relative centrifugal force 
RISK Reperfusion injury salvage kinase 
Rmax Fluorescence ratio at saturatingly high [Ca2+]i 
rmCatL Recombinant mouse cathepsin-L 
Rmin Fluorescence ratio at minimal [Ca2+]i 
Rn Normalised fluorescence of reporter dye (quantitative real-time 
polymerase chain reaction) 
RNA Ribonucleic acid 
RNAi Ribonucleic acid interference 
RNS Reactive nitrogen species 
ROS Reactive oxygen species 
RQ Relative quantity 
RT Reverse transcriptase 
RyR Ryanodine receptor 
s Second, time unit 
SA Sino-atrial 
SAPO Specified Animal Pathogens (Scotland) Order 
SEM Standard error of the mean 
Ser Serine (amino acid) 
SERCA Sarco (endo)plasmic reticulum calcium ion ATPase channel 
siRNA Small interfering ribonucleic acid 
SN Supernatant 
SR Sarcoplasmic reticulum 
ssRNA Single stranded ribonucleic acid 
25 
 
Stage I Haemolymphatic stage of trypanosomiasis 
Stage II Meningoencephalitic stage of trypanosomiasis 
STEMI ST elevated myocardial infarction 
τ Constant of decay (time taken to decay to 1/e) 
T. b. brucei 
GVR35 
Strain of Trypanosoma brucei brucei 
T. b. brucei 
Lister 427 
Strain of Trypanosoma brucei brucei 
T. b. brucei 
TREU 927 
Strain of Trypanosoma brucei brucei 
T. b. 
rhodesiense 
IL1825 
Strain of Trypanosoma brucei rhodesiense 
TbCatB Trypanosoma brucei derived cathepsin B 
TbCatL Trypanosoma brucei derived cathepsin L 
TbCatL Trypanosoma brucei derived cathepsin L gene 
TcoCatB Trypanosoma congolense derived cathepsin B 
TcoCatL Trypanosoma congolense derived cathepsin L 
TcrCatB Trypanosoma cruzi derived cathepsin B 
TcrCatL Trypanosoma cruzi derived cathepsin L 
Θ Half the angle of the collection cone of a lens 
Thr Threonine (amino acid) 
TJ Tight junction 
TLF Trypanosome lytic factor 
Tm Melting point – temperature at which dsDNA denatures into two 
separate strands of DNA 
TnC Troponin C 
TNFα Tumour necrosis factor α 
TnI Troponin I 
TRIS tris(hydroxymethyl)aminomethane 
TSF Trypomastigote soluble fraction 
T-tubule Transverse tubule 
µL Microlitre, volume unit 
µM Micromolar, concentration unit 
µm Micrometre, length unit 
VF Ventricular fibrillation 
VPC Ventricular premature complex 
VSG Variable surface glycoprotein 
VT Ventricular tachycardia 
WHO World health organisation 
WO Washout 
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1.1 Introduction 
In a multicellular organism it is important to deliver oxygen and nutrients to all 
the cells of all the tissues and organs of the organism that cannot be achieved by 
diffusion alone.  The nutrient rich media or blood must be delivered somehow to 
an organism’s tissues.  The solution of millions of years of evolution is a 
muscular pump pushing blood through a circulatory system.  In mammals this is 
achieved by the four-chambered muscular heart.  The heart is a syncytium of 
contractile cells that under normal circumstances work together to contract 
synchronously to deliver the vital nutrient and oxygen rich blood to the tissues.  
In order for this to happen a series of events occur from electrical depolarisation 
of pacing cells spreading to the contractile cells resulting in mechanical work 
and the heart beat.  This is achieved by a secondary messenger of calcium ions 
(Ca2+).  A series of channels and pumps within the contractile cells or 
cardiomyocytes enables the continual cycling of Ca2+ from the extracellular 
space into the cardiomyocyte, induction of Ca2+ release from intracellular 
stores, activation of the contractile myofilaments within the cardiomyocyte that 
constitutes the shortening of the cell or systole.  The Ca2+ is then recycled in the 
same quantities in an elegant balance of fluxes back into the intracellular store 
and the extracellular space by channels and pumps constituting the relaxation of 
the cell or diastole.  This cycle must continue without fatigue for the duration of 
the organism’s life with the ability to adapt to the ever changing environment an 
animal encounters from rest and relaxation to emergency activity when chasing 
prey or escaping predators. 
When this delicate balance of Ca2+ fluxes goes astray, the result can be 
disastrous with dysynchrony of the heart beat as arrhythmias and failure of 
contraction.  This leads to failure of the pump and insufficient delivery of blood 
to the tissues.  There are many known causes of disruption to the Ca2+ flux 
balance of the cardiomyocyte and heart as a whole but equally many unknown 
and in hitherto unexplored potential sources of Ca2+ signalling dysfunction.  One 
such unexplored source is African trypanosomiasis which will be investigated in 
this thesis.  This work has also led to interesting parallels in known causes of 
Ca2+ signalling dysfunction such as ischaemia/reperfusion (I/R) injury, which will 
also be explored.  This chapter will discuss the literature in the context of 
African trypanosomiasis, and also with respect to Ca2+ handling dynamics in I/R 
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injury and heart failure.  The following chapters will investigate the role of a 
potential common factor – the cysteine protease cathepsin-L. 
1.2 What is Trypanosomiasis? 
Trypanosomiasis is a vector-borne parasitic disease caused by kinetoplastid 
protozoa of the genus Trypanosoma spp.  There are multiple trypanosome 
species causing different diseases in different hosts transmitted by insect 
vectors throughout the tropical world.  In sub-Saharan Africa, multiple species of 
trypanosome cause disease in animals, (Animal African trypanosomiasis (AAT); 
‘Nagana’) and humans (Human African trypanosomiasis (HAT); ‘Sleeping 
Sickness’).  HAT is caused by two subspecies of T. brucei transmitted by tsetse 
flies of the genus Glossina.  Specifically, they are T. b. rhodesiense causing East 
African HAT and T. b. gambiense type I and II causing West African HAT.  The 
main species causing AAT in cattle and other ruminants are T. vivax, T. 
congolense and T. brucei causing severe muscle wastage, anaemia and loss of 
productivity(1).   T. b. brucei also causes severe disease in equines and canines 
with T. simiae causing high mortality in pigs(1).  In latin America T. cruzi, 
transmitted by triatomine insects, is maintained in >100 species of mammalian 
hosts a reservoir (2).  T. cruzi is transmitted to humans by the triatomine 
vectors(3) causing Chagas disease characterised by dilated cardiomyopathy and 
arrhythmias discovered by Carlos Chagas in 1909(4).  In Asia T. evansi causes 
‘Surra’ a wasting disease in camels, water buffalo and horses.  T. evansi and the 
equine infective relative T. equiperdum are T. brucei derivatives that are 
mechanically or sexually transmitted no longer requiring the tsetse vector due to 
partial or complete loss of the kinetoplast(5).  Much of the focus of this thesis 
will be on T. b. brucei as a model for HAT.  However, animal infections should 
not be ignored as they have significant economic impact in sub-Saharan Africa 
with an estimated 48 million cattle infected with losses of $1-1.2 billion 
annually(6;7).  Cattle are not only important for meat and milk, but are also have 
impact on livelihoods in poor areas of Africa as a means of traction where 
mechanical farm equipment is too expensive or cannot be maintained(6).   
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1.2.1 Lifecycle of Trypanosoma spp. 
Trypanosomes are transmitted by blood-feeding tsetse flies of the genus 
Glossina.  There are about 30 different species and subspecies of tsetse broadly 
categorised into three groups with different habitat predilections with different 
abilities to transmit  different species and strains of trypanosome(8).  Tsetse flies 
are viviparous, i.e. produce a fully developed live larva, which burrows into the 
soil, pupates and emerges as an adult fly one month later.  The fly becomes 
infected when it takes a blood meal from an infected mammalian host (Figure 
1.1).  Short-stumpy bloodstream form trypomastigote parasites taken into the 
fly’s digestive tract undergo several differentiation steps involving metabolic 
and anatomical changes(9) to become procyclic trypomastigotes during the 
following 3-5 weeks(10).  The procyclics then leave the fly’s midgut, transform 
into epimastigotes and migrate to the salivary gland.  In the salivary gland the 
epimastigotes transform into infectious metacyclic trypomastigotes.  When the 
infected tsetse fly bites a susceptible individual the metacyclics are injected 
into the host.  There they transform into long-slender bloodstream form 
trypomastigotes and are carried in the mammalian host’s bloodstream to other 
sites such as lymph nodes, spleen, liver, heart, eyes and endocrine organs in 
what is known as the haemolymphatic or stage I disease(10).  The long-slender 
bloodstream forms multiply by binary fission.  In density-dependent manner a 
proportion of the long-slender trypomastigotes terminally differentiate into 
short-stumpy trypomastigotes(11) and can be transmitted to more tsetse flies 
when they take a blood meal and ingest the short-stumpy bloodstream form 
trypomastigotes(12) perpetuating the cycle.   
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Figure 1.2: Schematic representation of bloodstream form T. brucei from International Laboratory 
for Research on Animal Diseases with permission(14). 
 
1.2.3 How do Trypanosomes Survive in the Host? 
1.2.3.1 Variable Surface Glycoprotein 
Trypanosomes are surrounded by a variable surface glycoprotein (VSG) coat that 
protects against complement-mediated lysis.  T. brucei has >1000 VSG genes of 
which only one at a time are expressed from one of multiple telomeric VSG 
expression sites.  The mammalian host’s immune system eventually recognises 
and mounts an effective immune response against the predominant VSG variants 
leading to antibody-mediated lysis of the trypanosomes.  However, 
trypanosomes will continually switch VSG expression to produce unique VSG 
proteins that the host’s antibody response will not recognise.  In this way an 
infection can last many years(15-17).  The continual switching of VSG coats makes 
development of an effective vaccine for HAT and AAT almost impossible(18). 
1.2.3.2 Resistance 
Wild animals have developed tolerance of trypanosome infections as have the 
indigenous Bos taurus derived breeds of cattle (N’dama).  Bos indicus (Zebu) 
derived breeds of cattle remain susceptible(19).  In the case of HAT there is a 
continual evolutionary battle between host and parasite.  While T. brucei and 
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other trypanosome species are infective to many mammalian species, usually 
only T. b. gambiense and T. b. rhodesiense are infective to humans.  This is due 
to trypanosome lytic factors (TLFs), which are present in normal human serum 
and destroy trypanosomes infective to animals(20-22).   
1.2.4 What are the Clinical Features of Trypanosomiasis? 
1.2.4.1 Animal African Trypanosomiasis 
AAT occurs in livestock throughout the tsetse belt of Africa (Figure 1.3).  The 
host-parasite interaction produces extensive immune-mediated pathology and 
severe anaemia(23), including cardiac involvement with perimyocarditis observed 
in both field(24;25) and experimental infections(26-28).  Clinically infected animals 
lose condition, become weak and unproductive often resulting in death.  All 
aspects of production are affected including fertility, milk yields, growth and 
work output.  Therefore treatment and control strategies need to incorporate 
AAT in addition to HAT to improve the socio-economic situation as well as 
physical health of at risk communities.  
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Figure 1.3: Tsetse Belt in Africa. 
Natural habitat regions of the trypanosome vector tsetse flies (Glossina spp.) are shown in green.  
The areas left for cattle rearing are shown in blue. 
1.2.4.2 Human African Trypanosomiasis 
Historically HAT has had epidemics and resurgences over the last century.  At 
the turn of the 20th century it was estimated that many hundreds of thousands of 
people were killed(8).  However, in the first half of the 20th century strong 
measures were taken including cull of the animal reservoir and destruction of 
the tsetse habitat combined with advances in insect vector control which led to 
a reduction in the reported cases by the 1960s(8).  Unfortunately factors such as 
war, famine and socio-economic instability led to reduced surveillance and 
vector control resulting in a resurgence of the disease by the late 1990s.  The 
World Health Organisation (WHO) estimated there were over 300,000 cases in 
1998(29).  This resurgence led to a concerted effort by WHO and local 
governments to improve human case detection and treatment and better vector 
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control(10).  As a result WHO now reports that the reported number of human 
cases in Africa were 9875 in 2009, 7139 in 2010 and 6743 in 2011(30).  The 
changing pattern of reported HAT cases from 2009 to 2011 shows a favourable 
picture of the epidemiological situation in Africa (Figure 1.4); however these 
figures should be taken with caution.  It is estimated that there may be as many 
as 10 times more cases that go unreported.  One study in particular noted that in 
Uganda, 2005 that  T. b. rhodesiense cases were underestimated by a factor of 
12(31).  Therefore, despite encouraging statistics, it is increasingly important to 
maintain a high level of surveillance, treatment and control in endemic 
countries to prevent a possible resurgence of the disease.  Approximately 70 
million people are still at risk of infection(32).  Finding new drug targets will aid 
in the WHO’s goal of eradication by 2020 by improving treatment administration 
and response, reducing drug resistance and reducing cost. 
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Figure 1.4: WHO reported cases of HAT. 
The black ‘border’ indicates the division between T. b. gambiense and T. b. rhodesiense.  Uganda 
can have infections of both species of trypanosome(33). 
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Traditionally HAT disease is described in two stages, the early haemolymphatic 
stage (Stage I) and the late meningoencephalitic stage (Stage II), the latter being 
characterised by central nervous system (CNS) invasion{Bucheton, 2011 385 /id}.  
Without treatment HAT is often fatal(35;36), however there are reports of 
untreated cases of T. b. gambiense being cleared from hosts or developing a 
long-lasting serological response without symptoms(37-40).  T. b. gambiense 
accounts for at least 96% of HAT cases(41) and has a chronic progressive course 
typically lasting around 3 years(38), although there have been reports of 
recrudescence after decades(42) and more acute progressions of disease as 
well(43;44).  T. b. rhodesiense typically has a much more acute course with death 
occurring within weeks or months(36).   
Stage I clinical signs are usually non-specific with an onset typically 1-3 weeks 
following the tsetse bite.  The signs include headache, malaise, arthralgia, 
weight loss, fatigue and intermittent fever(10;45).  Often patients presenting with 
these signs are mis-diagnosed with malaria(10).  Progression begins to manifest as 
lymphadenopathy, splenomegaly, hepatomegaly; cardiac signs including 
myocarditis, perimyocarditis and congestive heart failure; ophthalmological signs 
such as iritis, keratitis and conjunctivitis; endocrine dysfunction and fertility 
problems(8;10).   
The intermittent periods of fever can last up to a week separated by intervals of 
several days to months(46).  These episodes correspond to a type I inflammatory 
reaction associated with macrophage activation, interferon γ, tumour necrosis 
factor α (TNFα), reactive oxygen species (ROS) and nitric oxide (NO)(8).  The 
immune/inflammatory reaction controls parasitaemia levels and tissue invasion 
but itself can have damaging consequences(47).  The host can also mount type II 
immune reactions which consists of interleukin-10 (IL-10) production than can 
have anti-inflammatory properties(47).   
Stage II disease is characterised by sleep disturbances giving HAT its colloquial 
name ‘Sleeping Sickness’(48).  The disease disrupts the circadian rhythm of the 
sleep/wake cycle resulting in a fragmented sleep pattern rather than a true 
inversion of sleep(49).  Other neurological signs include; tremors, fasciculations, 
motor weakness, limb paralysis and abnormal movement.  These disorders are 
rarely seen during Stage I and increase in frequency with the duration of the 
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disease(45;50).  Psychiatric symptoms such as irritability, psychotic reactions, 
aggressive behaviour, or inactivity with apathy can dominate the clinical 
picture(50).  Death occurs from the progression of neurological signs, 
inflammation and multiple organ failure(10). 
1.2.4.3 Cardiac Abnormalities in HAT 
Cardiac involvement is frequently seen in patients with T. b. gambiense 
infection.  Signs are evident on the electrocardiogram (ECG) as corrected QT 
(QTc) prolongation (an indicator of the time taken for ventricular depolarisation 
and repolarisation), repolarisation changes and low voltage(51-54).  Blum et al. 
(2007) reported prolongation of QTc, repolarisation changes and low voltage 
were observed in 50% of stage I patients and up to 71% of stage II HAT 
patients(51).  Palpitations (arrhythmic heart beats) were reported in 18% of  T. b. 
gambiense infected individuals compared with non-infected controls reporting 
5% of individuals with palpitations(51).   QTc prolongation carries an increased 
risk for ventricular arrhythmia and sudden cardiac death(55).  These ECG changes 
have been attributed to perimyocarditis without myocardial necrosis as 
demonstrated by negative troponin measurements(51;55-58).  In T. b. rhodesiense 
infections perimyocarditis can be more severe(59;60).  Post mortem examination 
of animals(26-28) and humans(56;57) revealed that trypanosomes infiltrate the 
myocardium leading to a mononuclear inflammatory response and fibrosis, which 
may progress to heart failure.  Adams et al. (1986) found in a study of 16 HAT 
deaths from T. b. gambiense that two were a result of pulmonary oedema from 
cardiac failure(56).  Bertrand et al. (1973) identified inflammation of the 
conduction system of the heart in 70% of 100 patients examined(57), however 
conduction problems were uncommon despite this finding.  Two studies assessing 
atrio-ventricular (AV) block identified type I AV block in 3.7% and 14% of patients 
examined(61;62), type II AV block in 1% and 2.5% respectively(61;62), and type III AV 
block was found in one patient described in a case report(63).  Enlargement of 
the cardiac silhouette of >50% of the thoracic diameter on radiographic 
examination has been reported in 40 (34%) of 118 patients(61) and 14 (24%) of 59 
HAT patients(64).  Whether the enlargement was due to true cardiomegaly or if it 
was pericardial effusion was not examined in these studies(61;64).  
Echocardiography findings are not commonly looked for, however one study 
identified right-ventricular dilatation in 16 (64%) of 25 HAT patients and 
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pericardial effusion in three (12%) individuals(64).  Blum et al. (2007) assessed 
troponin and NT-proBNP (N-terminal prohormone of brain natriuretic peptide) as 
indicators of systolic cardiac function in HAT patients(51).  The troponin levels, an 
indicator of myocardial damage and necrosis, were within the normal range.  
NT-proBNP, an indicator of excessive myocardial stretching, was significantly 
higher in patients than in non-infected controls (p<0.001)(51).  The ejection 
fraction was predicted by using suggested gender and age specific criteria for 
NT-proBNP(65).  An ejection fraction of <40% was predicted in 14 (24%) of 59 
patients suggesting consistent with left-ventricular systolic dysfunction(51).  
While the cardiac abnormalities reported in the literature can be attributed to 
inflammation and fibrosis, recent evidence has shown direct effects of 
trypanosomes and their secreted factors within in vitro blood brain barrier (BBB) 
models(66-69).  Whether African trypanosomes and their secreted products can 
have a direct effect on the myocardium has not been explored and will therefore 
be investigated in this thesis. 
1.2.5 How is HAT Diagnosed? 
Due to the non-specific clinical signs of HAT the mainstay of diagnosis is by 
laboratory examination of blood and/or cerebrospinal fluid (CSF)(70;71).  A three-
stage programme is used in current control strategies for HAT surveillance; 
screening, diagnostic confirmation and staging(8). 
1.2.5.1 Screening 
The most efficient and low cost method available is the card agglutination test 
for trypanosomiasis (CATT), however this is only available for HAT caused by T. 
b. gambiense(10).  The test was developed in the 1970s and can be performed on 
serum, capillary blood from a finger prick or blood from impregnated filter 
papers(72-74).  CATT is reported to have a sensitivity of 87-98% and specificity of 
93-95%(75-78) making it an effective tool for screening large numbers of 
individuals.  However, due to the test not being 100% sensitive, individuals with 
suggestive clinical features such as a tsetse bit ‘chancre’ further examination is 
warranted even in the case of a negative CATT(8). 
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1.2.5.2 Diagnostic Confirmation 
Microscopic examination of the blood and/or lymph node aspirates is required 
for confirmation (Figure 1.5).  Lymph node aspiration is commonly from the 
cervical lymph nodes and has a sensitivity of 40-80% depending on the parasite 
strain and stage of disease(79).  The test is more sensitive during Stage I 
disease(79).  Examination of blood films has a low sensitivity so concentration 
techniques such as centrifugation are routinely performed(80).  Diagnosis using 
the DNA Polymerase Chain Reaction (PCR) is becomingly an increasingly accurate 
tool with reported sensitivity of 99% and specificity of 97.7% in a systematic 
review of 16 studies(81).  Unfortunately PCR is not generally an available option 
in the field.  An attractive alternative is loop-mediated isothermal amplification 
of DNA (LAMP) which has been developed for both T. b. rhodesiense and T. b. 
gambiense(82-84).  LAMP has the benefit that DNA can be amplified with high 
specificity rapidly under isothermal conditions with simple incubators.  The DNA 
amplification can be monitored either spectrophotometrically or with the naked 
eye without the use of expensive dyes. 
 
Figure 1.5: Photomicrograph of Giemsa stained T. b. gambiense. 
Blood smear from patient with African trypanosomiasis. Image approved for reproduction by 
Centers for Disease Control and Prevention. 
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1.2.5.3 Staging 
Treatment of HAT depends heavily on the stage of disease as the drugs for Stage 
II disease are required to enter the CNS and are often highly toxic (see below).  
Therefore, diagnostic staging by examination of CSF via lumbar puncture is 
considered essential before Stage II drugs are administered(85).  The current WHO 
definition of Stage II disease is when there are >5 leukocytes.µL-1 CSF, 
trypanosomes or protein content of >370 mg.L-1(29).  Many use the >5 
leukocytes.µL-1 CSF guideline, however uncertainty surrounds the cohort of 
patients that have 6-20 leukocytes.µL-1 CSF as they may have variable signs of 
neuroinflammation and variable responses to first-line treatments(8;85;86).  
Microscopic finding of trypanosomes is unequivocal for diagnosis but a PCR 
positive on CSF is controversial as patients that have achieved a successful 
resolution of Stage I disease may still have a positive PCR result(87;88).  CNS 
staging is still a controversial area with a lack of a gold standard with which to 
compare new methodologies(10).  However new markers are being tested such as 
chemokines and acute phase proteins(10). 
1.2.5.4  T. b. rhodesiense 
Unfortunately there is no serological screening test for T. b. rhodesiense yet.  
Current strategies consist of clinical signs and history of exposure.  However, 
parasitological examination is often more straightforward as parasitaemias are 
higher than for  T. b. gambiense(8).  As a result WHO launched an initiative in 
2006 in collaboration with the Foundation for Innovative Diagnostics (FIND) to 
improve diagnosis and staging of HAT cause by both  T. b. rhodesiense and  T. b. 
gambiense(89).   
1.2.6 What are the Current Treatment Strategies? 
As HAT has two stages, the haemolymphatic stage and the meningoencephalitic 
stage, the treatment strategies must be adapted accordingly.  Stage II is 
characterised by individual parasites crossing the blood brain barrier (BBB) 
therefore drugs to treat Stage II must be able to cross the BBB.  
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1.2.6.1 Pentamidine 
Pentamidine is the drug of choice for Stage I West African HAT.  It can be given 
intramuscularly for one week or as an intravenous infusion(8).  The drug is usually 
effective for early stage disease, but has the potential complications of 
hyperglycaemia or hypoglycaemia, prolongation of the QT interval on the ECG, 
hypotension, and gastrointestinal features(8;10) (Table 1.1).  Pentamidine is less 
effective for intermediate stage disease (10-20 leukocytes.µL-1 CSF) (section 
1.2.5.3)(90-92) with up to 48% treatment failure in one study(92). 
1.2.6.2 Suramin 
Suramin is used for Stage I East African HAT but avoided for West African HAT 
due to increased prevalence of Onchocerca spp. which are very effectively killed 
by Suramin increasing the risk of severe allergic responses in patients(8).  
Recommended dosing regimens are complex lasting up to 30 days.  Potential 
adverse reactions are frequent but often mild and reversible such as 
nephrotoxicity and peripheral neuropathy.  Acute and late hypersensitivity 
reactions can occur, so a lower test dose is trialled before treatment(8) (Table 
1.1). 
1.2.6.3 Melarsoprol 
Melarsoprol, an organoarsenic compound, is the most widely used treatment for 
Stage II East African HAT and West African where eflornithine is unavailable.  
Treatment regimens differ depending on the parasite subspecies (Table 1.1).  
Adverse reactions are frequent and can be life-threatening.  The most important 
is an encephalopathic syndrome which occurs in an average of 4.7% of patients 
with  T. b. gambiense infections and 8.0% of patients with  T. b. rhodesiense 
infections, with fatality rates of 44% and 57% respectively(93;94).  Other adverse 
reactions are skin reactions such as pruritus and maculopapular eruptions, 
peripheral neuropathies, cardiac arrhythmias(93) and thrombophlebitis if 
injection technique is poor(8).  In several areas up to 30% treatment failures have 
been reported suggesting emerging resistance in which a P2 adenosine 
transporter is implicated(95). 
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1.2.6.4 Eflornithine 
Eflornithine, an ornithine decarboxylase inhibitor, has been made widely 
available to patients thanks to efforts from WHO and pharmaceutical 
companies(10).  It is used in combination with the drug nifurtimox, nifurtimox-
eflornithine combination therapy (NECT)(10).  Mortality from eflornithine is 
significantly less than from melarsoprol with 1 (0.7%) out of 143 vs. 3 (2.1%) out 
of 144 patients dying from treatment(96).  Eflornithine is now recommended as 
the first-line treatment for Stage II West African HAT(97-99), but not for East 
African HAT as  T. b. rhodesiense is innately less susceptible to the drug than  T. 
b. gambiense(100).  Unfortunately eflornithine has a short half-life meaning that 4 
intravenous infusions must be given daily making it awkward to administer in 
rural public treatment facilities (Table 1.1).  Adverse reactions included 
cytotoxicity leading to anaemia, leukopaenia and thrombocytopaenia (25-50%), 
gastrointestinal signs (10-39%) and convulsions (7%)(101). 
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Table 1.1: Standard treatment options for HAT and main adverse reactions. 
Drug Stage Route of 
Application 
Dosing Adverse Reactions 
Trypanosoma brucei gambiense 
Pentamidine* First Intramuscular 4 mg.kg-1 q 24 h 
for 7 days 
Hypoglycaemia, injection site 
pain, diarrhoea, nausea, 
vomiting, prolongation of QT 
Eflornithine Second Intravenous 
(30 min 
infusion) 
100 mg.kg-1 q 6 h 
for 14 days 
Diarrhoea, nausea, vomiting, 
convulsions, anaemia, 
leukopaenia, 
thrombocytopaenia 
Melarsoprol† Second Intravenous 2.2 mg.kg-1 q 24 h 
for 10 days 
Encephalopathic syndromes, 
pruritus, peripheral 
neuropathies, 
thrombophlebitis 
Trypanosoma brucei rhodesiense 
Suramin* First Intravenous Test dose 4-5 
mg.kg-1 day 1, then 
20 mg.kg-1 q 7 days 
for 5 weeks (max 
dose 1g per 
injection) 
Hypersensitivity reactions 
(acute and late), 
albuminuria, cylinduria, 
haematuria, peripheral 
neuropathy 
Melarsoprol* Second Intravenous 3.6 mg.kg-1 q 7 
days for 3 weeks 
(max dose 180 mg 
per injection) 
Encephalopathic syndromes, 
pruritus, peripheral 
neuropathies, 
thrombophlebitis 
*  Endemic countries: according to national legislature or guidelines  
 † Only where eflornithine is not available or where melarsoprol is first-line treatment.  
Reproduced with permission from Brun et al. 2010(8)  
1.2.7 How do Trypanosomes Cross the Blood Brain Barrier 
1.2.7.1 Blood Brain Barrier 
Much of the severity of HAT and the eventual death of a sufferer stems from the 
parasite crossing the BBB.  The BBB serves to maintain a constant internal 
environment vital for CNS function by strictly regulating the passage of 
molecules across blood vessels(102;103).  The BBB consists of multiple layers; the 
endothelial cells of the vasculature, endothelial basement membrane, 
parenchymal basement membrane and foot processes of the astrocytes of the 
brain parenchyma(104) (Figure 1.6).   
Chapter 1  General Introduction 44 
 
 
Figure 1.6: Schematic drawing of the layers of the blood brain barrier. 
Trypanosomes cross from the lumen of the vessel between the tight junctions of the endothelial 
cells and across the endothelial basement membrane into the perivascular space.  They can then 
cross the parenchymal basement membrane and between the foot processes of the astrocytes that 
make up the astrocyte glia limitans and enter the brain parenchyma. 
1.2.7.2 Parasite Proteases and the BBB 
In order to enter tissues or individual cells many parasites produce and secrete 
proteases to facilitate their passage across the skin, epithelial cell layers or 
plasma membranes(105-108).  Therefore it is possible that T. brucei spp. could 
produce and secrete proteases to facilitate traversal of the BBB.  Indeed, this 
appears to be the case, as studies have identified that trypanosomes express 
phosphatases on their external surface and can release cysteine proteases and 
metallo-proteases(67;109-111).  Further work by Grab and colleagues have identified 
using in vitro BBB models that cysteine proteases, specifically the cathepsin-L 
like cysteine protease (TbCatL) is necessary for traversal of their BBB 
models(66;112-114).  RNA interference of TbCatL in  T. b. brucei led to infected 
mice surviving 60 days longer with a 50% reduced ability of the parasites to cross 
the BBB(112).  Human infective trypanosomes such as T. b. rhodesiense have a 
much greater efficiency of traversal of the BBB model consisting of a monolayer 
of human brain microvascular endothelial cells (HBMECs) crossing paracellularly 
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without disruption of the barrier measured by transendothelial resistance(67).  It 
was found that T. b. rhodesiense had higher levels and activity of TbCatL and 
therefore may be the critical factor in BBB traversal(69).  Nikolskaia et al. (2006) 
were able to inhibit traversal of the HBMEC model with a cathepsin-L specific 
inhibitor, K11777 (N-methyl-piperazine-Phe-homoPhe-vinylsulfone-benzene) but 
not a cathepsin-B specific inhibitor, CA074 (L-3-trans-(propylcarbamyl)oxirane-2-
carbonyl)-L-isoleucyl-L-proline)(69).  Interestingly, incubation of T. b. brucei in 
media from T. b. rhodesiense with the HBMEC model enhanced traversal(69).  
They also showed the comparative contributions of protease activity in the 
different subspecies of T. brucei (Figure 1.7) as measured by a fluorometric 
activity assay with the fluorescent substrate Z-Phe-Arg-AMC (this technique was 
also used in this thesis and is described in detail in General Methods).  They 
showed that T. b. rhodesiense possessed approximately 8-fold more active 
cysteine proteases than T. b. brucei (Figure 1.7A). The cysteine protease 
inhibitors E-64 and K11777 decreased peptidase activity by 94%, showing that 
they were detecting mainly the activity of papain-like cysteine proteases.  In 
contrast, CA074 led only to a 25% decrease in the overall activity of 
bloodstream-form lysates, suggesting that TbCatB is a minor component in these 
lysates.  Analysis of bloodstream-form secretion products (supernatants) showed 
that T. b. rhodesiense secreted 10-fold more active cysteine proteases (85% 
inhibition with E-64) than did T. b. brucei (30% inhibition with E-64; Figure 
1.7B).  No inhibition was observed using CA074, suggesting that the bloodstream-
form trypanosomes secrete TbCatL but not TbCatB.  To further characterise 
TbCatL expression by T. b. gambiense, T. b. rhodesiense, and T. b. brucei, they 
conducted Western blots on lysed parasites to confirm that T. b. gambiense and  
T. b. rhodesiense expressed higher levels of TbCatL than T. b. brucei (Figure 
1.7C)(69).  However, a band is still clearly visible for T. b. brucei indicating it can 
produce TbCatL albeit in lower quantities.  It has also been shown in another 
study that T. b. brucei is capable of crossing HBMECs(67). 
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Figure 1.7: Cysteine protease activity from T. brucei spp. 
(A) Protease maximal rate of activity from lysates of T. b. rhodesiense (Tbr) and T. b. brucei (Tbb).  
Incubated with DMSO vehicle, E-64 to differentiate serine protease activity, CA074 to discriminate 
between TbCatB activity and K11777 to discriminate between TbCatL activity.  (B) As in (A) but 
with culture media supernatants.  (C) Western blot of T. b. gambiense (Tbg), T. b. rhodesiense 
(Tbr) and T. b. brucei (Tbb) lysates equivalent to 2 x106 parasites incubated for 30 min with 5 mM 
DTT and 20 µM APC336 label with anti-biotin antibody. Figure from Nikolskaia et al. (2006) with 
permission.   
1.2.7.3 Trypanosomes Induce Ca2+ Oscillations in HBMECs 
How does TbCatL enable trypanosomes to cross the BBB?  Nikolskaia et al. (2006) 
demonstrated effectively that trypanosomes induce intracellular Ca2+ fluxes 
within the endothelial cells of their BBB model(69) (Figure 1.8).  HBMECs were 
loaded with Fura-2AM (section 2.6.4 for details on Ca2+ sensitive fluorophores) 
and the 340/380 nm excitation wavelength ratio measured.  Their initial 
interpretation was that the trypanosomes induced the intracellular Ca2+ 
concentration ([Ca2+]i) via mechanical stimulation(67) based on the findings of 
Paemeleire et al. 1999 who found that mechanical stimulation of rat cortical 
capillary endothelial cells induced Ca2+ waves(115).  However when the 
experiments were repeated but with the culture supernatants the [Ca2+]i 
oscillations were also induced(69).  Use of the cathepsin-L inhibitor K11777 
abolished the [Ca2+]i oscillations which was interpreted as TbCatL inducing the 
Ca2+ changes(69).  In conjunction with the Grab group’s previous work(67) it 
appears that the parasites secrete the cysteine protease TbCatL, which induces 
Tbr 
Tbb 
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[Ca2+]i oscillations in HBMECs and allows the parasites to traverse the monolayer 
paracellularly.   
 
Figure 1.8: Ca2+ oscillations of HBMECs. 
Time-lapse images of [Ca2+]i changes in HBMECs measured as the 340/380 nm ratio in Fura 2-AM 
loaded cells.  Figure panel from Nikolskaia et al. (2006) with permission.   
Interestingly, induction of changes in [Ca2+]i by T. cruzi by its cathepsin-L like 
cysteine protease, historically referred to as cruzipain in the literature but more 
recently referred to as TcrCatL, is required for intracellular invasion(116;117).  In 
the case of T. cruzi the TcrCatL activates G-protein coupled receptors (GPCRs) 
which in turn raise [Ca2+]i leading to synaptotagmin VII-dependent lysosome 
migration.  The lysosomes fuse to the parasite attachment site which precedes 
the formation of the parasitophorous vacuole required for cell entry(118;119).  In 
the case of T. brucei spp., which is extracellular, secreted/excreted TbCatL 
appears to activate the GPCR protease-activated receptor 2 (PAR-2) in 
endothelial cells(66).  This in turn raises [Ca2+]i which is thought to increase the 
permeability of the BBB through the effects of phospholipase C (PLC) and protein 
kinase C (PKC)(66).  These effects are hypothesised to act on cytoskeletal 
components resulting in cell retraction and loosening of the tight junctions from 
calmodulin (CaM) activation of myosin light chain kinase (MLCK)(66) (Figure 1.9). 
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Figure 1.9: Proposed model for African trypanosome-induced BBB dysfunction 
It is proposed that TbCatL (aka brucipain) triggers GPCRs such as PAR-2 via Gαq activation 
leading to PLC-mediated Ca2+ release from intracellular stores.  The increase in [Ca2+]i leads to 
calmodulin (CaM) activation of myosin light chain kinase (MLCK) potentially leading to cytoskeletal 
changes and barrier dysfunction.  Ca2+ independent activation of cytoskeleton mediated by Ras-
superfamily GTPases (i.e. RhoA) is also possible via p63RhoGEF.  Parasite and/or host-derived 
proteases may also contribute by degrading or altering adherens junction (AJ) and tight junction 
(TJ) proteins.  Figure from Grab et al. (2009) with permission(66). 
Independent of the parasite effects, the host response may also contribute to 
BBB traversal through processes such as the neuroinflammatory response(120;121).  
There is a fine balance between pro-inflammatory cytokines such as IFN-γ, IL-1 
and TNFα, and counter-inflammatory cytokines such as IL-10(122).  A role for 
cytokines in determining entry of trypanosomes into the CNS was provided by a 
study in knockout mice where the gene for IFN-γ had been disrupted(123).  
Following systemic infection, it was found that trypanosomes accumulated in the 
perivascular regions (Figure 1.6), unable to traverse between the endothelial 
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and the parenchymal basement membranes(123).  These findings suggested that 
lymphocyte-derived IFN-γ is required for trypanosome traversal across cerebral 
blood vessels although it is unclear how at present.  
1.2.8 Trypanosome Cysteine Proteases 
Trypanosomes exhibit protease activity to enable them to carry out regulatory 
functions and to infect hosts(124).  There are several families of cysteine protease 
activity; Clan CA family C2 (calpains) and Clan CD families C13 (GPI:protein 
transamidase), C14 (metacaspase) and C50 (separase) involved in regulatory 
processes within the trypanosome cells(125).  The primary focus in this thesis is 
the Clan CA family C1, papain-like cysteine proteases or the cathepsins.  
Cysteine protease activity very similar to that of the mammalian cathepsin-L was 
identified and localised to the endo-lysosomal system of trypanosomes(126-128).  
The expression of the cathepsin-L-like proteases is developmentally regulated 
among the different life-cycle stages of trypanosome species.  For example, in 
T. brucei spp. greater expression of a cathepsin-L-like cysteine protease is found 
in the bloodstream short-stumpy insect infective stage than the bloodstream 
long slender form or the insect procyclic stage(129;130).  Genes for cathepsin-L-like 
proteases have been described in T. brucei spp.(131;132) and T. cruzi(133), as well 
as T. congolense(134) (a causative agent of AAT).  In addition cathepsin-B-like 
proteases have been described in T. brucei spp.(135), T. cruzi(136;137) and T. 
congolense(138).  From the Tritryp genome resource database 
(www.tritrypdb.org) there are 11 annotated copies of the TbCatL gene in the 
genomes of all species and strains of T. brucei, with no amino acid sequence 
differences; although trypanosomes are diploid and the consensus genome 
sequences are haploid so allelic differences cannot be formally ruled out(139). 
1.2.8.1 Cysteine Protease Activities of Trypanosomes. 
1.2.8.1.1 Trypanosoma brucei spp. 
Cathepsin-L-like protease activity for  T. b. brucei and  T. b. rhodesiense is used 
for degradation of anti-VSG IgG(124), lysosomal protein trafficking(140), 
trypanosome replication(141) and BBB traversal(66;69).  The cathepsin-B-like 
activity is involved in protein turnover in lysosomes(135), transferring 
degradation(142) and cytokinesis(112).  The involvement of Clan CA cysteine 
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proteases in so many cellular processes of parasites makes them attractive 
targets for drug and vaccine development. 
1.2.8.1.2 T. congolense 
T. congolense cathepsin-L activity (TcoCatL) is involved in trypanotolerance in 
cattle(143-146).  Indeed TcoCatL (aka congopain) is being investigated as a vaccine 
target for AAT due to its conserved nature in comparison with VSGs(147) 
Cathepsin-B-like activity (TcoCatB) is involved in degradation of endocytosed 
proteins(138).   
1.2.8.1.3 T. cruzi  
The activities of the T. cruzi cathepsin-L-like cysteine protease (TcrCatL) is 
grouped into two categories; TcrCatL1 and TcrCatL2.  TcrCatL is involved in 
metacyclogenesis, host cell invasion, host cell signalling, amastigote 
survival/nutrition, generation of kinins, inflammation and antigen presentation 
summarised in a review by Caffrey et al. (2011)(124).  The function of cathepsin-
B-like activity (TcrCatB) has yet to be determined.     
In the fight against African trypanosomiasis many of the unique features of 
trypanosomes make attractive targets for new drug development.  This thesis 
will focus on the cathepsin-L like cysteine protease TbCatL secreted/excreted by 
African trypanosomes and its role in altering intra-cardiomyocyte Ca2+ dynamics 
and cardiac function.  Understanding how TbCatL affects Ca2+ signalling may 
yield a potential avenue of treatment that could prevent not only cardiac 
abnormalities but also BBB traversal and limit the disease to Stage I where 
current drug regimens carry less risk.  
1.3 Ca2+ and the Heart 
1.3.1 The Heart  
The synchronous beat of the heart is achieved by the process of excitation-
contraction coupling (ECC), which is the process by which electrical stimulation 
is transformed to mechanical work performed by the muscle. 
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1.3.2 The Cardiomyocyte 
The heart is made up of many different cell types including 
fibroblasts/fibrocytes, endothelial cells, immune cells etc. but the cells that 
give the heart its contractile ability are the cardiomyocytes.  Cardiomyocytes 
are discrete striated cells.  The striations correspond with the light and dark I 
and A bands of the myofilaments made up from the contractile proteins actin 
and myosin.  The darker A band is the overlapping region of the two proteins 
where cross-bridges are formed during the contractile cycle of the muscle.  The I 
band consists of the thinner actin filaments anchored at the Z-line.  The plasma 
membrane (sarcolemma) of cardiomyocytes has invaginations called transverse 
tubules (T-tubules) that are electrically continuous with the sarcolemma.  A 
complex web-like organelle called the sarcoplasmic reticulum (SR) extends 
throughout the cytoplasm.  In close approximation (15-20 nm)(148) with the T-
tubules terminal cisternae form the junctional SR.  There can be unattached 
expansions of SR termed corbular SR.  The remainder of the SR is network SR.  A 
high density of mitochondria provides the energy for cross-bridge cycling (Figure 
1.10).  An understanding of the structure of the cardiomyocyte is important 
when understanding the events that must transpire from the electrical 
depolarisation or action potential to the contraction of the cardiomyocyte and 
the whole heart.    
 
Figure 1.10: Ultrastructure of the cardiomyocyte. 
Figure redrawn and adapted from Katz (2001)(149) with permission. 
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1.3.3 The Cardiac Action Potential 
The cardiac action potential (AP) varies in form depending on the cell type.  
However it broadly fits five phases: 
 Phase 0 – Rapid upstroke 
 Phase 1 – Repolarisation 
 Phase 2 – Plateau 
 Phase 3 – Late repolarisation 
 Phase 4 – Resting membrane potential/Depolarisation (pacemaker cells) 
In the ventricular cardiomyocyte these phases can be easily identified (Figure 
1.11).  When stimulated by the passive current spread from an adjacent 
electrically coupled cardiomyocyte Na+ channels are activated such that the Na+ 
current INa exceeds the transient outward K+ current (IKto).  The activation of Na+ 
channels brings about further activation in a positive feedback loop such that 
there is a rapid upstroke of depolarisation or Phase 0 (200 V.s-1) to 
approximately 35-50 mV(148).  The end of Phase 0 occurs when Na+ channels 
inactivate.  Inward and outward currents are balanced.  Phase 1 is mostly due to 
IKto due to its fast nature leading to the notch which is much more prominent in 
rodents compared to rabbits and humans(148).  Phase 2 or the plateau phase is a 
state of balance brought about by inward Ca2+ current (ICa) through the L-type 
Ca2+ channel (LTCC) and outward current by delayed K+ rectifier currents (IKs, IKr, 
IKur) (slow, rapid and ultra-rapid)(148).  Phase 3 is when repolarisation accelerates 
due to increased IKs, IKr, IKur and inactivation of LTCCs.  The LTCC is inactivated 
both by voltage and Ca2+-dependent means, though the Ca2+-dependent means is 
predominant via CaM binding(150-152).  Phase 4 for ventricular cardiomyocytes is 
maintenance of the resting membrane potential at -80-90 mV predominantly due 
to inward rectifier K+ currents such as IK1 (148).  
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Figure 1.11: Ventricular cardiomyocyte action potential. 
 
The heart unlike other tissues requires no central nervous system input.  If the 
heart were to be removed and be provided with oxygen and nutrients it would 
continue to beat.  This is achieved by pacemaker cells within the sino-atrial 
node located in the right atrium.  Pacemaker cells have a naturally drifting 
membrane potential (Em) that slowly returns toward zero due to declining 
outward K+ currents and increased inward If, INa/Ca, ICa T, ICa L and INa(148) (Figure 
1.12).  Once threshold is reached (≈-40 mV) the L-type Ca2+ channels activate 
and depolarise the cell.  All cardiac cells have some degree of pacemaker ability 
but in the normal situation there is a hierarchy of pacemakers defined by the 
rate at which the cells depolarise.  Cells of the SA node are usually fastest 
followed by the AV node, Purkinje cells and finally the cardiomyocytes 
themselves.  The funny current (If) (so-called because it is activated by 
hyperpolarisation as opposed to depolarisation) seems to plays a more significant 
role in the pacemaker ability of other cell types such as the Purkinje fibres 
rather than the SA node, although this is controversial(148). 
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Figure 1.12: Sino-atrial node pacemaker action potential. 
 
Although the heart does not require nervous input to beat it is innervated by the 
sympathetic and parasympathetic nervous systems to modulate the heart rate.  
Sympathetic stimulation results in release of noradrenaline that binds to β-
adrenergic receptors triggering a cascade of cyclic adenosine monophosphate 
(cAMP) mediated affects that serve to increase the rate and force of 
contraction.  One of the main effects is modulation of LTCC activity increasing 
the Ca2+ influx(153) the main component of the pacemaker Phase 0. Conversely 
parasympathetic stimulation via the vagus nerve releases acetylcholine which 
binds to muscarinic receptors which act to decrease cAMP and the slope of the 
pacemaker Phase 0 thereby slowing the heart rate. 
1.3.4 The Electrocardiogram 
The wave of depolarisation initiated at the SA node spreads across the atria to 
the atrio-ventricular (AV) node and then through the conduction system to the 
ventricles.  The ventricles and atria are electrically isolated from one another 
apart from via the AV node.  The depolarisation spreads through the bundle 
branches and through the myocardium (Figure 1.13).  This wave of 
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depolarisation can be recorded as an average electrical potential or the 
electrocardiogram (ECG). 
 
Figure 1.13: Schematic of the conduction system of the heart. 
 
Essentially the heart can be thought of as an electrical dipole much like a 
battery with a positive and negative terminal due to the electrical connectivity 
of the heart through gap-junctions(154).  The ECG leads placed on an individual 
act as a voltmeter.  Beginning with rest there is no net charge as all 
cardiomyocytes will be at their resting membrane potential.  As the AP begins 
usually starting with the pacemaker cells of the SA node a wave of 
depolarisation spreads through the atria(148).  This is a spread from the right 
atrium where the negative electrode is toward the left where the positive 
electrode is so manifests as a positive deflection called the P-wave.  Once the 
atria are depolarised the net change is zero so the ECG trace returns to zero.  
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The next phase is early depolarisation of the ventricles representing the change 
in voltage as the depolarisation spreads across the septum from the left to the 
right so manifests as a negative deflection called the Q-wave.  Then the 
ventricular myocardium depolarises from endocardium to epicardium.  The net 
depolarisation from all dipoles across the myocardium is leftward thus positive 
called the R-wave.  The wave of depolarisation ceases so the trace returns to 
baseline, sometimes with a negative deflection called the S-wave.  
Repolarisation then progresses across the myocardium from epicardium to 
endocardium producing the T-wave (Figure 1.14). 
 
Figure 1.14: The ECG in relation to cardiac polarity (taken from rat). 
Starting top left, depolarisation of the atria is from (-) to (+) therefore positive deflection and 
manifests as the P-wave.  Depolarisation spreads through the conduction system with a net 
change away from (+) manifesting as a negative Q-wave.  Ventricular depolarisation spreads from 
the endocardium to the epicardium with a net voltage change toward (+) as the R-wave.  The S-
wave occurs when there is some voltage change toward (-).  Finally ventricular repolarisation 
occurs as the T-wave.  This can be in either direction depending on the positioning of the leads and 
the position of the heart in the thorax. 
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1.4 Excitation-Contraction Coupling 
At the single cell level the depolarisation of the plasma membrane (sarcolemma) 
spreads through the cardiomyocyte via invaginations called transverse tubules 
(T-tubules).  The distribution of ion channels in the surface sarcolemma differ 
from that of the T-tubules such that the density of Na+ and K+ channels 
responsible for the polarity shifts of the AP are increased(155;156).  The 
depolarisation of the sarcolemma activates the L-type Ca2+ channels which are 
present at a >4 times density in the T-tubules than at the surface(157), this allows 
Ca2+ to enter the cardiomyocyte from the extracellular space(158).  T-type Ca2+ 
channels are not thought to play a significant role in ventricular cardiomyocytes 
in contrast with pacemaker cells(159).  The difference in channel distribution 
reflects the importance of Ca2+ in the generation of cardiomyocyte contractile 
function from the AP.  Indeed, it has been known since the late 19th Century that 
Ca2+ was vital for the heart beat.  Sydney Ringer identified that a frog heart 
ceased to beat when Ca2+ was accidentally removed from perfusion solution(160-
163).  For clarity, the Ca2+ dynamics will be considered for contraction (systole) 
and relaxation (diastole) separately.   The Ca2+ dynamics during systole are 
discussed first (Figure 1.15). 
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1.4.1 Systole 
 
Figure 1.15: Ca2+ dynamics during systole. 
An AP depolarises the sarcolemma and T-tubule activating the voltage-gated LTCC.  Extracellular 
Ca2+ enters through the LTCC before the channel is inactivated by Ca2+ preventing overload.  The 
relatively small amount of Ca2+ that enters activates the RyR triggering release of Ca2+ from the SR 
into the cytosol and binding to the myofilaments causing contraction. 
1.4.1.1 Ca2+ Influx Through the L-Type Ca2+ Channel 
Spatially the T-tubule and terminal cisternae of the intracellular Ca2+ store the 
sarcoplasmic reticulum (SR) are in close apposition in a spaced termed the 
dyadic cleft which can be <1.5 x 105 nm3 in volume(164).  Within these junctional 
spaces are LTCCs on the T-tubule surface and Ca2+ release channels also called 
ryanodine receptors (RyRs) on the SR cisternae membranes(165).  The RyRs are so-
called due to their affinity for the plant alkaloid ryanodine and consist of four 
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560 kDa monomers making the total tetrameric protein the largest yet identified 
at >2000 kDa(166).  In cardiac muscle the arrangement of LTCCs and RyRs is in the 
region of 10-25 LTCCs to 100-200 RyRs(167;168) constituting the ‘couplon’(169), 
although some studies suggest the couplon is smaller with 10-40 RyRs(170-174).  In 
truth it is probably variable(175).  When the LTCCs open upon the change in 
voltage from the AP the local [Ca2+]i rises sharply (<1 ms) in the dyadic cleft to 
10-20 µM free Ca2+(159).  The exact quantity of Ca2+ influx is dependent on many 
factors, species being the main one.  In the rabbit it has been shown Ca2+ entry 
via ICa through the LTCC during the AP is approximately 12 µM, which may even 
be as low as 6 µM due to Ca2+ inactivation of the LTCC(176).  Other studies suggest 
a value of 21 µM for rabbit and 14 µM for rat using voltage clamp(177).  The 
quantity of total Ca2+ required for myofilament activation for a normal 
ventricular twitch has been calculated as approximately 60-70 µM under steady 
state conditions(178).  Taking into account the Ca2+ buffering of the cytosol of 
assumed to be 100:1 (bound:free Ca2+) this would be an increase to 600 nM from 
150 nM free Ca2+(148).  Therefore, an influx of 14-21 µM total Ca2+ (140-210 nM 
free Ca2+) would be insufficient to produce a contraction of normal magnitude 
(~40% of maximum(179)) of the cardiomyocyte due to the small quantity, 
buffering and diffusion of Ca2+(180) (Figure 1.16).  Indeed, a total [Ca2+]i of 20 µM 
would give a contraction force of ~2% of maximum (Figure 1.16).  
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Figure 1.16: Ca2+ requirements for contractile activation. 
Ca2+ requirements for contractile activation based on diastolic [Ca2+]i = 150 nM and total cytosolic 
buffering = 244/(1+673/[Ca2+]i)-28.  This includes TnC, myosin, SERCA, calmodulin, ATP, creatine 
phosphate and sarcolemmal sites.  (Inset) Force is shown as a function of free [Ca2+]i. Force = 
100/(1+n).  Taken from Bers (2000) with permission(179).  
1.4.1.2 Ca2+ Induced Ca2+ Release from the SR 
During the 1970s and 1980s Fabiato demonstrated in experiments where the 
sarcolemma was carefully removed from canine Purkinje cells that the 
additional Ca2+ required came from the SR(180-184).  Removal of the sarcolemma 
and T-tubules allows the [Ca2+]i to equilibrate with [Ca2+] of the solution the cell 
is bathed in.  By altering the [Ca2+] of the bathing solutions it was possible to 
identify that application of increasing amounts of trigger Ca2+ resulted in a 
greater release of Ca2+ from the SR.  A solution with [Ca2+] of 100 nM allowed 
accumulation of Ca2+ in the SR.  Changing the solution [Ca2+] to 250 nM for 30 ms 
induced a release of Ca2+ from the SR of 1.7 µM and contraction of the 
cardiomyocyte.  Interestingly, when [Ca2+] increased to 10 µM and applied for 
150 ms the peak SR Ca2+ release was reduced to 1.2 µM and a smaller 
contraction(184).  This suggests that high [Ca2+] inactivates SR Ca2+ release i.e. 
there is a peak activating concentration before a decline beyond that 
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concentration producing a bell curve of activation when tension is plotted 
against [Ca2+].  In addition to a concentration effect, there was also a time-
dependent effect.  Fabiato (1985) tested different trigger Ca2+ activation times 
of 1, 5, 10, 20 and 50 ms with increasing [Ca2+].  It was found that the longer 
trigger times resulted in reduced tension i.e. reducing the peak of the bell-
shaped curve(184).  Thus, this work by Fabiato suggests that a small Ca2+ influx of 
~250 nM induces Ca2+ release from the SR amplifying the original trigger Ca2+ 
such that contraction occur.  Moreover, an increase in the trigger [Ca2+] leads to 
an increase in the [Ca2+] amplification and subsequent contraction of the 
cardiomyocyte i.e. it is of a graded nature. However, beyond the optimal [Ca2+] 
~10 µM there is an inactivating effect producing the characteristic bell curve.  
Interestingly, one of the main hallmarks of ECC is the Em dependent bell-shaped 
curve for ICa, change in [Ca2+]i and contraction performed in intact 
cardiomyocytes(148;185-189).  The fact that there is such a close relationship with 
the change in Em and ICa, contraction and Δ[Ca2+]i (Figure 1.17) suggests that ICa, 
contraction and Δ[Ca2+]i are themselves closely associated.  It has been 
demonstrated that a change in ICa leads to the change in [Ca2+]i, which then 
leads to the change in contraction.  This explains the observation of 40% 
contraction despite a Ca2+ influx that would only normally produce a 2% of 
maximum contraction, and that when extracellular Ca2+ is manipulated there is a 
change in amplification.  Therefore the LTCC trigger activates the release of the 
SR Ca2+ store which supports a theory of Ca2+ induced Ca2+ release (CICR) in the 
heart. 
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Figure 1.17: Voltage dependence of ICa, Ca2+ transient amplitude, contraction and charge 
movement in isolated guinea-pig ventricular cardiomyocytes. 
ICa and Ca2+ transient amplitude data from Beuckelmann & Wier (1988)(185), charge movement from 
Hadley & Lederer (1991)(190) and contraction from Bers (2001)(148).  All data were normalised to 
their respective maxima.  Figure from Bers (2001)(148). 
Thus, the relatively small rapid Ca2+ influx through the LTCC is enough to 
activate the RyRs releasing Ca2+ from the SR(159) (CICR).  If Ca2+ activates the 
RyR, what prevents a positive feedback loop?  The LTCC follows the Em 
dependent bell-shaped curve as mentioned (Figure 1.17) demonstrating that 
higher ICa from the LTCC does not result in a runaway release of SR Ca2+.  Fabiato 
(1985) proposed that the RyR had two binding sites with different affinities and 
association constants(184).  The initial trigger Ca2+ would bind with lower affinity 
but rapid onset resulting in SR Ca2+ release.  The second inhibitory site would 
have a higher affinity for Ca2+ but a slower onset thereby inactivating the RyR a 
short time after influx, potentially explaining the reduced contraction at longer 
stimulation times(184).  This was shown not to be the case when intact 
cardiomyocytes were studied, in fact contraction increased at higher [Ca2+] in 
experiments using flash photolysis of caged Ca2+(191).  Cannell et al. (1987) found 
that if cardiomyocytes were rapidly repolarised during the rising phase of the 
Ca2+ transient the peak was reduced(187).  If there is a second inhibitory binding 
site on the RyR then in order to reconcile the findings of Cannell et al. the 
quantity of Ca2+ influx through the LTCC in the short time taken to deactivate 
the LTCCs must be increased for RyR inactivation to occur.  However, they 
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calculated that the repolarisation of -24 mV to -54 mV would only increase Ca2+ 
influx by 20% according to the increased electrochemical gradient(159).  A 
potential of -54 mV is the same potential at which the fast Na+ channels 
inactivate marking the end of the effective refractory period therefore making 
the cardiomyocyte vulnerable to an early after depolarisation (covered in more 
detail in section 1.6.2.2) potentially leading to an arrhythmia(192).  So if Fabiato’s 
suggestion that there was sufficient influx during the repolarisation to inactivate 
CICR(184) was correct then Ca2+ could not be released and arrhythmic contractions 
could not occur.  However, Cannell et al. observed that Ca2+ influx due to the 
electrochemical gradient upon repolarisation was not sufficient to explain the 
reduction in Ca2+ transient peak they observed(187) so another theory of 
inactivation is likely. 
1.4.1.3 Local Control of CICR 
1.4.1.3.1 Historical Models 
Traditionally researchers had perceived the Ca2+ in the cardiomyocyte to be in a 
‘common pool’ i.e. the SR is recharged by and releases into the same space.  
Unfortunately, a common pool model of CICR cannot amplify trigger Ca2+ and 
still be able to prevent positive feedback.  This is because experimental 
evidence shows that when the cardiomyocyte is repolarised during the release 
phase (159) thereby inactivating the LTCC trigger, the Ca2+ transient peak is 
reduced.  If a common pool model were true then the Ca2+ released would be 
expected to continue the release process, i.e. the process would be autonomous 
but this is not the case.  Therefore, to attempt to establish a mathematical 
model of CICR, Stern (1992) looked at the ultrastructure of the cardiomyocyte 
and compared it to that of skeletal muscle(165).   Due to the fact that the LTCC 
and RyR were in direct apposition in skeletal muscle(193) Stern considered local 
control theories(194).  The first type was a synaptic type model where one LTCC is 
apposed with one RyR.  In a synapse model the control could occur either; by 
random inactivation of the RyR and the local Ca2+ diffuses away; or by Ca2+ 
dependent inactivation of RyR and the local Ca2+ diffuses away.  However, while 
this model permits the amplification of Ca2+, it requires high conductance of the 
RyR for [Ca2+]i to rise sufficiently to induce contraction(194).  The second model 
Stern tried was one where one LTCC could activate several RyRs, the ‘cluster-
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bomb model’.  This is a model where one LTCC can recruit a cluster of RyRs 
allowing for a graded response with amplification of the initial trigger Ca2+.   
1.4.1.3.2 Experimental Evidence 
Experimental evidence for a localised SR Ca2+ release came from Cheng et al. 
(1993) in the form of local spontaneous Ca2+ release events of 200 nM amplitude, 
2 µm diameter and 25 ms half-time decay termed ‘Ca2+ sparks’(195).  Ca2+ sparks 
occur randomly at a low frequency of ~100.s-1 independent of Ca2+ influx at rest 
but several thousand can be synchronised by ICa through the LTCC which 
summates in time and space to form the stimulated Ca2+ transient(148).  Due to 
the randomness of RyR opening at rest the process is best thought of in terms of 
stochastic probabilities.  For example, at 10 µM [Ca2+] within the dyadic cleft 
there is less than one free Ca2+ ion available (0.04) with 15 membrane-bound to 
activate a RyR within a 15 nm radius (dimension of the cleft)(148). In these terms 
the RyR activation is described in terms of open probability (Po).  It was initially 
proposed that a Ca2+ spark was the Ca2+ release event of a single RyR as the 
individual Ca2+ flux of a Ca2+ spark was calculated as 2 x 10-17 mol.s-1 (4 pA)(196), 
but appears to actually be from a cluster of 6-20 RyRs which would support the 
cluster-bomb model(148).    
1.4.1.3.3 How Does Local Control Work? 
Local control of Ca2+ sparks comes from the theory that Ca2+ release from a 
cluster of RyRs or ‘couplon’ is effectively an all-or-none phenomenon(194) so the 
release within a cluster can be regenerative.  However, the physical distance 
between clusters and the requirement for high local [Ca2+] to stimulate a cluster 
prevents them from activating one another as the released Ca2+ from 
neighbouring clusters will have diffused away.  Therefore the Ca2+ release is 
limited to local regions of the cardiomyocyte and does not normally propagate 
i.e. the spatial and temporal characteristics of stochastic RyR opening prevent 
the general propagating regeneration of a common pool model.   The gradation 
of response that was observed by Cannell et al. (1987)(187) can be explained by 
increases in Ca2+ influx recruiting more clusters of RyRs than by altering the 
amount of Ca2+ released from a cluster.  That way, as mentioned above, the Ca2+ 
sparks from each cluster summate synchronously brought about by depolarisation 
of the sarcolemma during an AP. 
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1.4.1.3.4 Amplification of Ca2+ 
The amplification of Ca2+ to 200-400 µM which can diffuse to the 
myofilaments(159) is a function of the fractional SR Ca2+ release which is 
dependent on both trigger Ca2+ and the SR Ca2+ content(197-199).  During a normal 
cardiomyocyte contraction the fractional release of the SR is 43 and 55% of its 
Ca2+ in rabbit and rat respectively(197;198).  This fractional release changes in 
response to altered trigger Ca2+ reflecting the graded nature of CICR(198).  
Interestingly, when the SR Ca2+ is altered and reduced to ~50% of normal the 
fractional release becomes effectively nil(199) i.e. ICa cannot trigger CICR.  This 
could be due to an altered Ca2+ sensitivity of the RyR within the SR serving to 
prevent further depletion and allow refilling of the SR(148).  This may indeed be a 
mechanism of terminating normal SR Ca2+ release to prevent a positive feedback 
loop.  When SR Ca2+ content is increased the fractional release elicited is 
increased sharply suggesting a Ca2+ sensitising effect of the RyR within the SR.  
This may explain increased spontaneous release of Ca2+ in the case of SR Ca2+ 
overload (discussed in section 1.6).     
1.4.1.3.5 Prevention of Positive Feedback 
How does local control prevent positive feedback?  There are 3 possibilities; i) 
local depletion of the SR Ca2+, ii) inactivation of the RyR and iii) stochastic 
attrition(194;200;201).  Stochastic attrition means that if the LTCC and the RyRs of 
the associated couplon happen to be closed (channels have a finite probability of 
closing at any given time) at the same moment, then local [Ca2+]i would fall to 
levels such that Ca2+ release from the SR is stopped.  In a synapse model this 
would be quite likely, but for a cluster-bomb model would be harder to achieve 
as both the LTCC and all the RyRs of the cluster would have to be closed at a 
given time.  SR Ca2+ depletion as a mechanism by which positive feedback is 
prevented can be tested with ryanodine or caffeine.  These drugs act to induce 
Ca2+ release from the SR.  When Cheng et al. (1993) and Satoh et al. (1997) 
performed these experiments, they found that there were long-lasting local 
elevations in [Ca2+]i which did not decline over time(195;202).  If SR Ca2+ depletion 
was the mechanism then on the time-scale of a Ca2+ spark (~25 ms) one would 
expect a decrease in [Ca2+]i to prevent regeneration of Ca2+ release, but the 
work of Cheng and Satoh shows [Ca2+]i elevations lasting >200 ms(195;202).  This 
was confirmed by Sham et al. (1998) who found that early LTCC openings 
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produced events called Ca2+ spikes but that prolonged openings of the LTCC 
could not reactivate SR Ca2+ release(200).  These results argue against SR Ca2+ 
depletion as the prolonged LTCC opening should have elicited a response as the 
SR was not prevented from refilling.  The results also argue against stochastic 
attrition as there is a finite probability of channel opening as well as closing so 
prolonged LTCC opening should have elicited a response if this were the case.  
Therefore some form of inactivation is more likely.  Fabiato (1985) proposed 
that positive feedback of CICR was prevented by a second inactivating Ca2+ 
binding site on the RyR(184) i.e. Ca2+ dependent activation.  However this was 
shown not to be the case with intact cardiomyocytes(191).  The work of Sham et 
al. (1998) with Ca2+ spikes demonstrated a use-dependent inactivation due to 
the failure of prolonged LTCC openings to induce SR Ca2+ release.  These 
experiments used a high concentration of EGTA (4 mM) to produce the Ca2+ 
spikes.  The problems that could arise are; i) additional Ca2+ buffering may 
decrease the ability of RyR to trigger neighbouring RyRs, ii) reduce local [Ca2+]i 
around RyRs, which may either reduce local activation or limit inactivation, and 
iii) cytosolic Ca2+ buffering may decrease SERCA uptake of Ca2+ leading to SR Ca2+ 
depletion(148).  There is probably a combination of factors affecting termination 
of SR Ca2+ release.  Wang et al. (2001) showed a coupling fidelity between SR 
Ca2+ depletion and RyR inactivation of 0.71 at first trigger but dropping to 0.30 
following a second stimulation at the same site(203).  This suggests a use-
dependent inactivation. 
1.4.1.3.6 A Likely Model? 
Each of the above proposed models have evidence against them.  Sobie et al. 
(2002) devised another theory supported by experimental data(204).  Anatomical 
observations suggest that RyR clusters are arranged in arrays with touching 
vertices with an accessory protein located at each vertex called FK-506 binding 
protein (FKBP)(205;206).  Therefore Sobie et al. (2002) proposed the ‘sticky cluster’ 
model where FKBP and RyR are coupled allowing for simultaneous 
openings/closings of RyRs within clusters(207).  In this model the coupling can be 
defined by a co-operativity factor with a maximum of 1 and <1 being reduced 
coupling that prolongs the duration of Ca2+sparks i.e. lower co-operativity results 
in less efficient termination of Ca2+ sparks.  Increases in local and SR [Ca2+] does 
not affect duration but the frequency of Ca2+ sparks (in a non-linear fashion).  
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These observations are seen with a RyR cluster size of 50(204).  In this model 
inactivation or adaptation of the RyRs is not required with the coupling of FKBP 
although the model does not specifically rule it out.  Stochastic attrition, 
however, is intrinsic to this model and together with SR Ca2+ regulation of RyR 
and co-operativity with FKBP provides a model that stands up to the 
experimental data.      
1.4.1.4 Activation of the Myofilaments 
Once the RyRs have been activated and [Ca2+]i rises Ca2+ can bind to troponin C 
(TnC), part of the thin filament regulatory complex (Figure 1.18).  After Ca2+ 
binding TnC binds more strongly to troponin I (TnI) which pulls TnI from its actin 
binding site.  The troponin/tropomyosin complex rolls deeper into the groove of 
the actin filament revealing the myosin binding domains of the actin filament.  
The myosin heads then attach forming a cross-bridge utilising the myosin ATPase 
to convert the chemical energy held within adenosine triphosphate (ATP) into 
mechanical energy. At rest, myosin is complexed with ATP or in a rapidly 
equilibrated state with adenosine diphosphate (ADP) and the inorganic 
phosphate (Pi) so ATP is technically hydrolysed but the energy has not been 
utilised yet(208;209).   As [Ca2+]i rises the myosin-ADP-Pi complex interacts with 
actin as the troponin/tropomyosin complex rolls from the binding site releasing 
the Pi rapidly utilising the energy.  The actin-myosin complex further pushes the 
troponin/tropomyosin complex into the actin groove which facilitates myosin 
binding at neighbouring TnC sites.  The actin-myosin complex passes through two 
more energy state with ADP bound encompassing the ‘power stroke’ or myosin 
head rotation.  Actin affinity increases through these steps until ADP dissociates.  
Under normal [ATP]i the actin-myosin complex binds ATP readily  inducing 
dissociation of actin from myosin.  The cycle continues until [Ca2+]i declines.   
Without ATP the cross-bridges remain firmly attached in the state of rigor(148).  
The Ca2+-force interaction is reciprocal because cross-bridge binding and force 
generation enhance the affinity of Ca2+ binding to TnC which slows Ca2+ 
dissociation prolonging the active state. 
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Figure 1.18: Ca2+ activation of the myofilaments. 
Ca2+ binds to troponin C (TnC; blue) causing it to bind more strongly to troponin I (TnI; red).  The 
troponin/tropomyosin complex (black/green) rolls into the actin (grey) groove revealing the binding 
site for myosin (orange).  Binding of myosin further pushes the troponin/tropomyosin complex into 
the groove facilitating neighbouring myosin heads to bind (co-operative activation).  Figure from 
Bers (2008)(159) with permission.  
1.4.1.5 Inositol 1,4,5-Triphosphate Receptors 
While RyRs are the primary Ca2+ release channel in the SR there are also inositol 
1,4,5-triphosphate receptors (IP3Rs).  These are similar to RyRs in that they are 
large tetrameric intracellular Ca2+ release channels located in the SR membrane 
that are activated by Ca2+(210).  However, IP3Rs require IP3 in addition to Ca2+ to 
be activated, therefore making them subject to the control of extracellular 
ligands that engage phospholipase C-activating sarcolemmal receptors such as 
GPCRs and tyrosine kinase(210).  IP3Rs are less abundant than RyRs (<1:50-100 of 
RyRs)(211) but recent work shows they play a role in ECC(212).  IP3 signalling has 
been known about in ventricular cardiomyocytes for nearly 30 years(213) but 
purely as augmentation of RyR Ca2+ signalling(214).  Signore et al. (2013) 
demonstrate a new mechanism that regulates ECC via ion channels and NCX 
resulting in depolarised resting membrane potential and prolongation of the 
AP(212).  Therefore Ca2+ release from the IP3R doesn’t appear to affect 
contraction but can enhance Ca2+ transients via ion flux modulation.  They found 
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that inhibition of RyRs had no effect on IP3R AP modulation but intracellular Ca2+ 
buffering did(212).  This suggests the existence of IP3 signalling domains distinct 
from the dyadic cleft(215).  The precedent for this is IP3-dependent perinuclear 
Ca2+ signalling involved in excitation-transcription coupling as evidenced from 
imaging, immunofluorescence studies and electron microscopy(216-218). 
The relative quantities of IP3 and IP3Rs are much lower than other tissues(219) and 
in relation to RyRs in the heart(220) such that it is unlikely to have a significant 
effect on [Ca2+]i.  Instead, it is more likely that any effect IP3Rs have is local.  
Roderick and Knollmann (2013) suggest that Ca2+ released from adjacent IP3Rs 
may “prime” the RyR for activation by LTCC Ca2+ influx and potentially decrease 
the cytosolic Ca2+ buffering in the vicinity of the dyad(215).  Sigmore et al. (2013) 
also demonstrate activation of NCX the inward currents of which may explain the 
prolonged AP they observed(212).  There was no depletion of intracellular Ca2+ so 
other channels must be affected in addition to NCX.  This has potential as a 
source of arrhythmia generation as a previous study examining the Fas ligand 
causing IP3-mediated AP prolongation and depolarised resting membrane 
potential resulted in an increased arrhythmia frequency(221).  Arrhythmias are 
discussed in a later section. 
1.4.2 Diastole 
For the cardiomyocyte to relax again and allow the whole heart to relax and fill 
with blood before the next contraction, a series of events must occur to 
dissociate the Ca2+ from the myofilaments and recycle the Ca2+ from the cytosol 
back to the SR.  Several mechanisms exist and there are species differences in 
terms of the proportion of Ca2+ removed from the cytosol by each mechanism.  
Figure 1.19 shows that during diastole Ca2+ is removed from the cytosol 
predominantly by reuptake to the SR by the sarco (endo)plasmic reticulum 
ATPase pump (SERCA) but also by sarcolemmal extrusion by the Na+/Ca2+ 
exchanger (NCX)(158).  Other mechanisms of Ca2+ removal such as the 
sarcolemmal (plasma membrane) Ca2+ ATPase pump (PMCA) and the 
mitochondrial Ca2+ uniporter account for <25% of Ca2+ extrusion(222;223).  One 
study demonstrated that the time constant of decay (τ) for the PMCA was longer 
at 13.0 s in rat and 10.4 s in rabbit than either SERCA at 0.18 s and 0.29 s 
respectively or NCX at 1.73 s and 1.0 s so would have little effect in the normal 
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heart beat(224).  In the rat 92% of Ca2+ removal is due to SERCA and 7% due to NCX 
vs. 70% and 28% respectively in rabbit ventricular cardiomyocytes(224).  Human 
cardiomyocytes have similar Ca2+ handling properties to rabbits with SERCA 
contributing 63% and NCX contributing 37% Ca2+ removal in normal human 
cardiomyocytes(225). 
 
Figure 1.19: Ca2+ dynamics during diastole. 
Ca2+ dissociates from the myofilaments and is removed from the cytosol via two main routes, 
sarcolemmal extrusion by the Na+/Ca2+ exchanger and back into the SR by the SR Ca2+ ATPase 
pump (SERCA).  There is some Ca2+ extrusion by the plasma membrane Ca2+ ATPase (PMCA) 
and into the mitochondria but this is less than 25%. 
1.4.2.1 Relaxation of the Myofilaments 
The myofilaments remain active after [Ca2+]i has decreased prolonging the active 
state of contraction i.e. a lag between decline in [Ca2+]i and relaxation(159).   
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Bers (2008) suggests that increased Ca2+ affinity for TnC as a result of cross-
bridge binding during contraction and slowed dissociation explains the lag 
between [Ca2+]i and myofilament relaxation(159).  Evidence in support of this is 
that acceleration in [Ca2+]i accelerates relaxation proportionately whereas 
protein kinase A (PKA) dependent TnI phosphorylation (which accelerates TnC 
Ca2+ dissociation without altering [Ca2+]i decline) has a much weaker lusitropic 
effect(226).  Altering TnC Ca2+ dissociation has been shown to influence 
relaxation(226-229) therefore there is a dynamic interplay between Ca2+ binding, 
cross-bridge co-operativity  and myofilament deactivation.  Once the [Ca2+]i has 
decreased the myosin remains in complex with ATP in the technically hydrolysed 
state (myosin-ADP-Pi) ready for the release of Ca2+ during the next cycle.   
1.4.2.2 SR Ca2+ Re-uptake 
The main route for Ca2+ to leave the cytosol is via re-uptake to the SR.  This is 
achieved by the sarco (endo)plasmic reticulum Ca2+ ATPase pump (SERCA).  
SERCA is a member of the P-type ion transporting ATPases.  The SERCA protein in 
cardiac muscle and slow twitch skeletal muscle is SERCA2a which has 4 fewer 
amino acids than the fast twitch skeletal muscle counterpart SERCA1a(230;231).  
The general structure of SERCA consists of a cytoplasmic nucleotide binding 
domain where ATP binds to provide the energy for the pump action with the 
phosphorylation site at aspartate-351, a β strand domain and a hinge 
region(232;233).  There are 10 membrane spanning domains (M1 - M10), 5 of which 
have cytoplasmic helical stalks.  Ca2+ binds with high affinity (Km < 1 µM) to the 
cytoplasmic side of the pump.  The Ca2+ is bound to M4-M6 and M8 possibly 
forming a channel(234;235).  The terminal phosphate of the bound ATP is 
transferred to aspartate-351 inducing the transition state of occlusion where 
Ca2+ cannot be released either side.  The phosphorylation causes a transition 
from the E1 form of the protein to E2 which has a much lower Ca2+ affinity (~ 1 
mM) thereby releasing the Ca2+ against a concentration gradient into the SR(148).  
In E2 form protons are taken up and the aspartate-351 is dephosphorylated 
causing the protein to transition to a second occluded state.  ATP binds to the 
nucleotide binding domain restoring the protein to the E1 state releasing the 
protons ready to accept Ca2+ for the next cycle (Figure 1.20).  It has been 
calculated that the likely range of SERCA concentration is 15-75 µM depending 
on species with rats having up 100 µM and rabbits about 19 µM(236).  With an 
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estimated turnover of 10-15 ions.pump-1.s-1 in dog and guinea-pig(237;238) and ~4 
fold lower affinity for Ca2+ than SERCA1a(237) each pump would only have to cycle 
once to remove 50 µM Ca2+ from the cytosol(148). 
 
Figure 1.20: SERCA Ca2+ transport. 
Starting from top left, two Ca2+ ions bind with high affinity (< 1 µM).  Bound ATP is used to 
phosphorylate aspartate-351 altering the protein conformation from E1 state so that the Ca2+ ions 
are occluded.  The protein undergoes further conformational change to E2 and releases the Ca2+ 
ions due to the reduced affinity (~ 1 mM).  Protons are carried to reverse the conformational 
change from E2 to E1.   
1.4.2.3 SERCA Regulation 
In contrast with skeletal muscle, cardiac SERCA is regulated by the protein 
phospholamban (PLB)(239).  PLB exists as a homopentamer (22 kDa; from five 6080 
Da monomers).  Each monomer consists of a hydrophilic cytosolic domain and 
hydrophobic transmembrane α-helix(240).  PLB is an endogenous inhibitor of 
SERCA acting to decrease Ca2+ transport and ATPase activity by reducing the 
affinity of SERCA for Ca2+(241;242).  This essentially shifts the Ca2+ re-uptake curve 
to the right.  PLB can be phosphorylated at either/both of two residues; serine-
16 by protein kinase A (PKA)(239;240;243) and/or at threonine-17 by Ca2+/Calmodulin 
Kinase II (CaMKII)(244;245).  This changes the conformation of PLB causing it to 
dissociate from SERCA which restores the higher Ca2+ affinity thereby increasing 
Ca2+ uptake to the SR (Figure 1.21). 
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Figure 1.21: Schematic of PLB-SERCA Interaction. 
PLB can exist as the monomer or the pentamer with a dissociation constant Kd1.  Monomeric PLB 
binds to SERCA with a dissociation constant Kd2.  Heterdimeric PLB-SERCA inhibits the ATPase 
but phosphorylation of PLB or Ca2+ binding to the pump can remove the inhibition. Figure from 
Kimura et al. (1997)(246) with permission. 
1.4.2.4 Sarcolemmal Extrusion of Ca2+ by Na+/Ca2+ Exchange 
 After SR re-uptake the next main contributor to reduce [Ca2+]i during diastole is 
the Na+/Ca2+ exchanger (NCX).  NCX is a ~110 kDa 938 amino acid protein with 9 
transmembrane domains and a 550 amino acid cytoplasmic loop between the 5th 
and 6th transmembrane domains(247;248).  The cytoplasmic loop does not appear to 
be necessary for Na+ or Ca2+ transport(249) but does appear to be involved in 
allosteric regulation by Ca2+(250;251).  The NCX exchanges 3 Na+ for 1 Ca2+ resulting 
in an electrogenic current (INa/Ca) which can act in either direction and 
contributes to the cardiac AP (Figure 1.11 &Figure 1.12).  The direction NCX acts 
depends on Em following a driving force equal to Em – ENa/Ca (where ENa/Ca = 3ENa – 
2ECa with ENa and ECa being the respective equilibrium potentials)(252).  Extrusion 
of Ca2+ is referred to as forward mode and removes the same [Ca2+] that entered 
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the cardiomyocyte via the LTCC during systole in order to maintain balance(253).  
Extrusion of Ca2+ occurs as a single Ca2+ ion binds to the E1 state NCX on the 
cytoplasmic side.  This induces a conformational change through which NCX 
changes to the E2 state facing outward.  The Ca2+ is released and three 
extracellular Na+ ions can bind the E2 NCX.  This induces a conformational 
change back to E1 releasing the Na+ inside the cardiomyocyte cytoplasm{Hilgemann, 
1991 757 /id} (Figure 1.22). 
 
Figure 1.22: NCX Ca2+ transport in forward mode. 
Starting from top left, a high [Ca2+]i results in one Ca2+ ion binding to NCX causing a conformational 
change to the occluded form and then further change to the E2 conformation facing the exterior of 
the cardiomyocyte.  The Ca2+ is released and 3 Na+ ions bind before a conformational change to an 
occluded state followed by return to E1 occurs.  The Na+ ions are released and Ca2+ can bind 
again.  Figure drawn from description by Hilgeman et al. (1991){Hilgemann, 1991 757 /id}.   
Reverse mode NCX will bring Ca2+ into the cytoplasm and is governed by high 
[Na+]i shifting Em to more positive values than the equilibrium potential(252).  This 
will occur normally during depolarisation of the AP but only for a short time (<1 
ms) before Ca2+ influx through the LTCC activates CICR and [Ca2+]i rises switching 
NCX back to forward mode(159).  There are species differences in [Na+]i which 
determines the extent of Ca2+ extrusion by NCX.  Rats for example have a higher 
resting [Na+]i so Na+ influx with concomitant Ca2+ extrusion by NCX has less drive 
meaning SERCA competes more effectively to reduced [Ca2+]i thereby loading the 
SR at rest.  This can be readily seen in resting rat cardiomyocytes as increased 
spontaneous contractile activity as the SR Ca2+ is higher which increases the 
sensitivity and Po of the RyR(199).  In the rabbit and human [Na+]i is lower such 
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that the Ca2+ extrusion has a greater drive due to a higher differential 
concentration thereby increasing Ca2+ extrusion.  SERCA competes relatively less 
effectively so the SR Ca2+ will have a tendency to decrease at rest(252).  
1.4.2.5 Other Ca2+ Removal Mechanisms 
There are two other sources of Ca2+ removal from the cytosol; the sarcolemmal 
(plasma membrane) Ca2+ ATPase (PMCA) and the mitochondrial Ca2+ uniporter.  
The PMCA is a P-type ATPase like SERCA so it utilises the energy from ATP to 
transport ions.  The PMCA can be stimulated by PKA and calmodulin(255;256) 
enhancing both Vmax and Km.  However, during normal Ca2+ transients the 
transport rate is <1µM.s-1 so would take about 60 s to produce relaxation by 
itself(257).  When compared with the LTCC (300 µM.s-1), RyR (1000 µM.s-1), SERCA 
(200 µM.s-1) and NCX (30 µM.s-1) the transport of PMCA seems to be less 
important(148).  Its purpose is more likely to be a longer term Ca2+ balance. 
Mitochondrial transport in terms of ECC is also of limited importance as 
experiments by Bassani et al. (1992) demonstrated that inhibition of SERCA and 
NCX resulting in relaxation occurring over tens of seconds(257).  However Ca2+ 
fluxes may still be important in terms of mitochondrial function. 
1.5 β-Adrenergic Stimulation 
During situations of physiological or pathological stress the body responds with 
increased sympathetic tone leading to release of catecholamines such as 
adrenaline and noradrenaline.  These ligands bind the adrenergic receptors 
including β1 receptors in the heart.  The β receptors are large 7 transmembrane 
proteins with a ligand binding domain on the extracellular side and the 
cytoplasmic C-terminal attached to GTP-binding protein (G-protein) (Figure 
1.23A).  Activation of the receptor results in dissociation of the α subunit which 
stimulates adenylyl cyclase (AC) to produce cyclic AMP (cAMP).  Cyclic AMP 
activates PKA (and CaMKII potentially through PKA(258)) which phosphorylates; i) 
troponin I in the myofilaments acting to decrease sensitivity thereby improving 
lusitropy during diastole, ii) LTCC(153) increasing ICa, iii) PLB by PKA at serine-
16(239;240;243) (and by CaMKII at threonine-17(240;244;245)) decreasing SERCA 
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inhibition, iv) RyR increasing Po(259) (Figure 1.23A).  These changes all serve to 
increase the inotropy and chronotropy of the heart(148).   
 
Figure 1.23: β-adrenergic signalling in the cardiomyocyte. 
(A) Non-failing myocardium – β stimulation activates PKA which phosphorylates PLB disinhibiting 
SERCA, RyR increasing Po, LTCC increasing Ca2+ influx and desensitises the myofilaments 
facilitating increased lusitropy.  (B) Failing myocardium – proposed sequence of events from 
prolonged β-adrenergic exposure, PKA hyperphosphorylates RyR increasing Po such that Ca2+ 
leaks at rest spontaneously, SERCA activity is downregulated and NCX is upregulated depleting 
the SR.  Figure from Brum et al. (2006)(260) with permission. 
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1.6 Abnormal Ca2+ Dynamics and Arrhythmias 
Diseases of the heart can affect Ca2+ dynamics via alteration of RyRs, associated 
proteins, spatial organisation of couplons, RyR Ca2+ sensitivity, SR Ca2+ content 
and Ca2+ leak(222).  In the normal situation CICR occurs as Ca2+ influx through the 
LTCC triggers Ca2+ release from the RyR as described above.  The Ca2+ release 
from an individual couplon or Ca2+ release unit is termed a Ca2+ spark(195) which 
will occur simultaneously across all couplons within the cardiomyocyte leading to 
a synchronous rise in [Ca2+]i and contraction of the cell.  Under certain 
circumstances, SR-mediated spontaneous Ca2+ release without a LTCC trigger can 
occur.  In this case, the SR-mediated Ca2+ release is not synchronised by an AP 
throughout the T-tubules and results in an asynchronous propagating rise in 
[Ca2+]i and wave of contraction.  This event is called a Ca2+ wave(261).  
1.6.1 Ca2+ Waves  
Some types of arrhythmias can be traced back to abnormalities of Ca2+ handling, 
specifically Ca2+ waves when the SR is overloaded with Ca2+(262;263).  The Ca2+ 
waves occur when spontaneous Ca2+ sparks leak from the SR at a sufficient 
quantity (~100 s-1) to trigger neighbouring couplons(261).  Spontaneous Ca2+ 
release from the SR can be thought of in terms of a “threshold theory”(264).  
When the SR [Ca2+] reaches threshold spontaneous Ca2+ release occurs, either 
from increasing the Po of the RyR(265) or the magnitude of the Ca2+ sparks(195).  
The normal SR threshold can be reached sooner by either increasing Ca2+ influx 
or decreasing Ca2+ efflux which will also elevate [Ca2+]i thereby increasing the 
drive for NCX.  The influx of Na+ being electrogenic can trigger a delayed after 
depolarisation (DAD) which, if large enough, can trigger an AP.  The SR Ca2+ 
release threshold depends on the properties of the RyR.  If the Po is increased, 
then the threshold is effectively lowered as a smaller [Ca2+] will trigger a release 
of Ca2+.  Experimentally the Po can be increased (and threshold reduced) by 
caffeine(266) whereas tetracaine has the opposite effect (reducing Po and 
increasing the threshold)(267).  As would be expected of a Ca2+ stimulated 
receptor, RyR Po is increased by higher SR and intracellular [Ca2+](268;269).  
Stimulation with a β-adrenergic agonist can elevate Ca2+ influx via PKA-mediated 
phosphorylation of the LTCC(153) which will lead to an increased SR Ca2+ content.   
Likewise, the SR content can be increased by decreasing NCX action by raising 
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[Na+]i through inhibition of the Na+/K+ ATPase with cardiac glycosides(270).  
Alteration of RyR properties can occur pathologically altering its Ca2+ sensitivity.  
For example, in the disease catecholamine polymorphic ventricular tachycardia 
(CPVT) there is a mutation in the RyR(271;272) which increases Po in response to 
PKA-mediated phosphorylation beyond the normal level(273).  CPVT can also occur 
from mutations in the calsequestrin gene (CASQ2)(274) and a triadin mutation has 
been reported(275).  In the case of heart failure, there are reports of 
hyperphosphorylation of the RyR resulting in dissociation of FKBP12.6(276).  
FKBP12.6 acts as a diastolic inhibitor of RyR reducing Po and aberrant Ca2+ 
release i.e. stabilising the closed state of the channel(276). However, in heart 
failure this hypothesis remains controversial as phosphorylation of the RyR in 
different models of heart failure is inconsistent(277-280).  SERCA may also play a 
role in the generation of Ca2+ waves.  The obvious effect is increased SERCA 
activity brought about by phosphorylation of PLB from β-adrenergic 
stimulation(239;240;243) and disinhibition leads to a greater quantity of Ca2+ being 
pumped into the SR(192).  However, SERCA can also have an opposite effect by 
decreasing Ca2+ wave propagation(281;282) as the Ca2+ must diffuse through the 
cytoplasm from release site to release site past network SR containing SERCA i.e. 
SERCA is uptaking the released Ca2+ before it reaches the next release site(192). 
1.6.2  Progression to Arrhythmias 
1.6.2.1 Delayed After Depolarisations 
Spontaneous Ca2+ release can lead to the generation of an “aftercontraction” or 
escape beat.   At the single cell level, for an arrhythmic contraction to occur 
there is the generation of a transient inward current(283) which can lead to a 
second depolarisation of the cardiomyocyte occurring after the primary SA 
nodal-derived AP.  This is called a delayed afterdepolarisation (DAD).  This has 
been shown to correlate with SR Ca2+ overload under voltage-clamp 
conditions(284).  The inward current has been shown to be initiated by the 
presence of Ca2+ at the inner surface of the sarcolemma from Ca2+ release from 
SR overload(270;285).  An electrogenic Ca2+ triggered sarcolemmal ion transporter is 
the NCX and the transient inward current has been attributed to inward NCX 
current(286).  The inward current, if large enough can reach threshold and 
depolarise the cell to trigger an AP(287).  However, the whole heart is a syncytium 
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of electrically coupled cells via connexin-43 gap-junctions(154).  Any inward 
current occurring in one cell would be diluted across the coupled cells therefore 
many cells would have to exhibit a DAD simultaneously in order for an ectopic 
beat to occur(192).  Winslow et al. (1993) used an atrial model comprising an 
array of 512 x 512 cardiomyocytes which suggested as many as 1,000 would be 
needed for an ectopic beat(288). 
1.6.2.2 Early After Depolarisations 
Ca2+ waves can also be implicated in other kinds of arrhythmogenic disturbances 
such as spatially discordant alternans (SDA), repolarisation changes and early 
after depolarisations (EADs)(289).  EADs can occur when AP duration is prolonged 
which allows the L-type Ca2+ current to recover during the plateau phase of the 
AP(286).  This enables a second upstroke to occur.  Unlike DADs which are 
mediated through the NCX, EADs are likely to be mediated through the L-type 
channels as Em has not sufficiently repolarised to allow Na+ channels to have 
recovered from inactivation.  EADs are thought to be involved in arrhythmias 
with prolongation of the electrocardiographic QT interval, although this is 
difficult to test as it would require AP recording in intact hearts(286).  Yet studies 
have shown that EADs appear to be synchronous events and not wave 
phenomena as seen in DADs which appear to show spatially heterogeneous Ca2+ 
increases(290;291).   
1.6.2.3 Treatment Strategies 
There are three ways to target arrhythmias from Ca2+ waves; i) abolish the Ca2+ 
waves, ii) prevent Ca2+ waves producing a DAD (or EAD), iii) stop the DAD 
producing an ectopic beat.  Preventing ectopic beats from DADs has been 
attempted with the local anaesthetics encainide and flecainide that reduce the 
excitability of the sarcolemma.  Unfortunately they were shown to have 
dangerous adverse effects including sudden death(292).  Preventing Ca2+ waves 
from producing DADs would require inhibition of NCX to prevent the electrogenic 
influx of Na+ but this could have unwanted effects in terms of Ca2+ handling and 
may end up causing more Ca2+ waves as SERCA will no longer have competition 
and could overload the SR with Ca2+(293).  With regard to abolishing Ca2+ waves 
there are two approaches; prevent the SR Ca2+ overload that produces the 
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waves, or prevent the waves occurring despite Ca2+ overload.  Preventing SR Ca2+ 
overload can be achieved by reducing the [Na+]i thus increasing NCX mediated 
Ca2+ efflux.  Local anaesthetics such as lidocaine and mexiletine inhibit the 
tetrodotoxin sensitive Na+ channel thereby decreasing [Na+]i resulting in 
increased Ca2+ efflux activity by NCX(294).  This must be carefully balanced so as 
not to cause a DAD via increased NCX activity.  Prevention of Ca2+ waves without 
altering SR Ca2+ overload which would be best achieved by targeting the RyR and 
reducing Po effectively increasing the SR Ca2+ release threshold but without 
altering systolic Ca2+ release(192).  The RyR is regulated by FKBP12.6 during 
diastole preventing Ca2+ leak.  The drug JTV519 (K201) has been suggested to 
increase FKBP12.6 binding decreasing the RyR Po and has been shown to 
decrease occurrence of ventricular arrhythmias(273).  However, other studies 
propose no effect on FKBP12.6 binding from use of JTV519, although Ca2+ wave 
frequency is reduced(295;296).  The local anaesthetic tetracaine has also been 
shown to reduce RyR Po(297) and increase the SR Ca2+ release threshold(267).  It was 
shown to abolish Ca2+ waves in cardiomyocytes subjected to Ca2+ overload by 
excessive β-adrenergic stimulation(298).  Unfortunately tetracaine would be an 
inappropriate drug as it has antagonistic effects at Na+ channels required for 
APs; however a compound with more target specificity may be an attractive 
option.  
1.6.3 Ca2+ Handling in Heart Failure 
Heart failure (HF) is a disease state with weakening of myocardial contractility 
ultimately resulting in deterioration of ventricular pump function.  This can 
occur following a severe myocardial insult such as a myocardial infarction (MI) 
where large areas of the myocardium have a reduced blood supply due to 
narrowing or blockage of the coronary arteries resulting in ischaemia.   The 
remaining viable tissue can be taxed beyond its means and begin to fail.  The 
characteristic cardiomyocyte features of HF are reduced systolic Ca2+ transient 
amplitude and prolonged Ca2+ transient duration(299-302) with a concomitant 
reduction in the SR Ca2+ content(303-306).  The reduction in SR Ca2+ is thought to be 
due to an increase in diastolic Ca2+ leak from the SR from the RyR(299) but could 
equally be due to reduced SERCA activity or protein levels and increased NCX 
activity.  Reduced SERCA activity thereby reducing Ca2+ re-uptake to the SR 
during diastole could occur from reduction in SERCA expression as described by 
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Mercadier et al. (1990) in human heart failure(307) or by reduced activity due to 
increased inhibition by PLB(308).  In human heart failure it has been shown that 
there is decreased phosphorylation of PLB at the PKA phosphorylated serine-16 
residue(309) and that the same is true in a rat model of heart failure(310).  Current 
thinking is that CaMKII plays a role a role in heart failure through altered 
phosphorylation of PLB at the threonine-17 residue phosphorylated by 
CaMKII(311).  Increased NCX activity is thought to play a role in heart failure(312-
315), acting as increased competition for SERCA thereby reducing SR Ca2+ content, 
however these changes are inconsistent(302).  Another potential reduction in Ca2+ 
release is a reduced trigger Ca2+ from the LTCC.  Indeed, it has been found that 
LTCC number has been reduced in HF(316).  However, another study shows that 
the activity of LTCCs increases(317) which reflects an increase in β-adrenergic-
mediated phosphorylation of LTCCs(318).  What seems to be widely accepted 
though is diastolic Ca2+ leak from the SR(319-323), but the mechanism by which the 
leak occurs remains open to debate(276;277;324).  There is some evidence to suggest 
that hyperphosphorylation of the RyR at the CaMKII site Ser2815 can result in an 
increase in diastolic Ca2+ leak(280;319), while the others propose PKA-mediated 
hyperphosphorylation of the RyR resulting in dissociation of the regulatory 
protein FKBP12.6(276;324).  Figure 1.23B shows the proposed changes present in 
heart failure.  Many of the changes are a result of a chronic β-adrenergic 
stimulation leading to a refractory state where further stimulation has no effect 
therefore patients will be unable to adapt to an increase in cardiac workload(325).  
1.6.4 Ischaemia/Reperfusion Injury 
Coronary heart disease (CHD) is the leading cause of death worldwide with an 
estimated 7 million deaths annually(326).  The disease is a narrowing and eventual 
blockage of the coronary arteries that supply the myocardium with blood.  The 
result of blockage is myocardial infarction (MI) creating a region of ischaemia 
distal to the obstruction.  Currently the most effective strategy for reducing the 
size of the infarct and improving clinical outcome is early reperfusion with use 
of thrombolytic therapy or percutaneous coronary intervention (PCI)(327).  PCI is a 
surgical procedure where a balloon is inserted into the blocked/narrowed 
coronary artery via a remote vessel, often a femoral or radial artery, and 
inflated to open the lumen of the affected coronary artery and restore blood 
flow to the ischaemic myocardium.  Unfortunately the process of restoring blood 
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flow can itself be damaging – termed myocardial reperfusion injury.  The injury 
results in death of cardiomyocytes that were viable immediately prior to 
reperfusion(328).  Myocardial reperfusion injury consists of four types of 
dysfunction.  The first is myocardial stunning, a persistent mechanical 
dysfunction despite no irreversible damage and restoration of normal coronary 
flow(329).  This phenomenon is usually reversible days to weeks after the initial 
insult.  The second type is the no-flow phenomenon where there is microvascular 
damage preventing restoration of blood flow to the affected region(330).  The 
third type is reperfusion arrhythmia brought about by Ca2+ overload and 
modulation of the Ca2+ handling proteins such as LTCC, RyR, SERCA and NCX(331-
337) as discussed in section 1.6.1.  The fourth type of cardiac dysfunction is 
termed lethal reperfusion injury(327).  There are multiple contributing factors; 
oxygen, Ca2+ and pH paradoxes and inflammation.  Oxygen paradox is where 
reperfusion of the ischaemic tissue results in oxidative stress and release of 
reactive oxygen species (ROS) and myocardial enzymes(338) including 
cathepsins(339;340).  Ca2+ paradox occurs when intracellular Ca2+ rises secondary to 
sarcolemmal damage and ROS effects inhibiting SERCA(341-344) and increasing Po of 
the RyR(341;345-347).  The increase in Ca2+ can overload the cardiomyocyte leading 
to a state of hypercontracture and can overload the mitochondria leading to 
opening of the mitochondrial permeability transition pore (MPTP)(328) which 
causes cell death by uncoupling of oxidative phosphorylation and ATP 
production.  The pH paradox happens when rapid reperfusion washes out the 
lactic acid from anaerobic respiration leading to activation of the Na+/H+ 
exchanger and Na+/HCO3- symporter overwhelming the cell’s pH buffering 
capacity(348), which can depress force of contraction, raise diastolic [Ca2+]i(148).  
Finally inflammation; the infarct zone attracts neutrophils during the first 24 
hours causing vascular plugging, release of degradative enzymes such as cysteine 
proteases and ROS(349) (Figure 1.24). 
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Figure 1.24: Mediators of Reperfusion Injury 
During ischaemia several biochemical and metabolic processes contribute to injury.  Mitochondrial 
re-energisation (purple), generation of ROS (orange), [Ca2+]i overload (green), rapid restoration of 
pH (blue) and inflammation (red) all interact to mediate cardiomyocyte death through the opening 
of the MPTP causing hypercontracture of the cardiomyocyte.  Reproduced with permission from 
Yellon and Hausenloy (2007)(327), copyright Massachusetts Medical Society.  
1.6.4.1 Treatment Strategies 
Previous attempts at targeting individual mediators of lethal reperfusion injury 
have produced inconsistent results that have not translated to clinical studies, 
which have been extensively reviewed in Yellon and Hausenloy (2007)(327).  The 
current thinking is to target multiple mediators to achieve a synergistic effect.  
For example, ischaemic post-conditioning targets several mediators and has 
been shown to reduce myocardial injury in a clinical study of patients with acute 
Chapter 1  General Introduction 84 
 
MI undergoing PCI(350).    Ischaemic post-conditioning was identified by Zhao et 
al. (2003) who reduced infarct size from 47% to 11% after a 45 min period of 
ischaemia in dogs.  This was achieved by inducing three 30 s cycles of ischaemia 
during reperfusion(351).  Post-conditioning acts to reduce oxidative stress, Ca2+ 
overload, improve endothelial cell function, reduce cardiomyocyte apoptosis, 
reduce neutrophil accumulation(352) as well as delaying the restoration of normal 
pH(353).  In addition, post-conditioning also activates the reperfusion injury 
salvage kinase (RISK) pathway(354) and inhibits MPTP opening(355).  Preconditioning 
is a similar phenomenon whereby infarct size can be reduced by initiating 
transient periods of ischaemia before the sustained ischaemic event and appears 
to act in a similar way as post-conditioning(356).  Several studies have tested 
post-ischaemic conditioning and reduced infarct size by up to 36% with improved 
coronary blood flow(350;357;358).  The disadvantage of post-ischaemic conditioning 
is that it requires surgical intervention and so is only available to patients with 
acute MI undergoing PCI.  Therefore, pharmacologically targeting the mediators 
recruited by post-conditioning or indeed others that activate the RISK pathway 
or inhibit MPTP opening would be attractive targets.  Hausenloy and Yellon have 
shown that agents that activate phosphatidylinositol-3-OH kinase (PI3K)-Akt and 
p42/p44 extracellular signal-regulated kinases (Erk 1/2) have reduced infarct 
sizes by up to 50%(354;356).  Other strategies examined have been atrial natriuretic 
peptide before PCI which reduced infarct size by 15% and improved ejection 
fraction by 5% but had no effect on mortality(359), glucagon-like peptide 1 which 
reduced infarct size by up to 45%(360), erythropoietin which reduced infarct size 
by 42%(361) and atorvastatin which reduced infarct size by 48%(362).  Inhibition of 
the MPTP has been investigated and shown that with cyclosporine or sanglifehrin 
A (MPTP inhibitors) that infarct sizes can be reduced by 50%(363).  The role of 
degradative enzymes such as the cysteine proteases were investigated in the 
1980s by Bolli and colleagues which showed that the cysteine proteases could 
play a role in acute MI but that general proteolysis was not the method by which 
they acted based on the technique they used(364).  However they acknowledge 
that their technique of measuring tyrosine release is not specific enough to 
detect selective proteolysis of particular proteins(364).  They did however identify 
proteases that could have a role in acute MI through specific inhibition with 
leupeptin, pepstatin and antipain, specifically cathepsins A, B, D, L and H. A 
second study by the same group examined infarct size after ischaemia with 
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protease inhibition but found no significant change(365).  However, recent 
evidence has emerged that suggest proteases and their inhibition do have a 
significant role in ischaemia/reperfusion injury in the brain following 
stroke(366;367).   
1.6.5 Endogenous Cathepsins 
The maintenance of a healthy organism requires controlled biosynthesis, 
maturation, function and terminal breakdown of proteins.  Proteolytic enzymes 
contribute to these processes by cleaving peptide bonds resulting in the target 
protein’s destruction, maturation or modulation of its biological activities(368).  
These proteolytic enzymes are broadly categorised as matrix metalloproteinases 
(MMPs) and cathepsins, derived from the Greek word kathépsin meaning to 
digest or boil down first identified in the 1920s(369).  The cathepsins can be 
classified according to substrate specificity; serine cathepsins (A and G), aspartic 
cathepsins (D and E) and cysteine cathepsins (B, C, F, H, L, K, O, S, W, V and 
X)(370), which are the primary focus of this thesis.  The cathepsins were shown to 
be localised within acidic intracellular organelles such as lysosomes and 
endosomes where their primary function was to break down unwanted 
proteins(371-374).   
1.6.5.1 Cathepsins in the Whole Body 
Recent studies reveal a much wider role for cathepsins in health such as antigen 
presentation in the immune system(375), collagen turnover in bone and 
cartilage(376;377) and neuropeptide and hormone processing(378;379).  A list of 
currently known cysteine cathepsins and their physiological functions is 
presented in Table 1.2 from Brix et al. (2008)(380).  Recent work has also shown a 
wider range of active locations and pH for cathepsins such as secretory 
vesicles(381;382), the cytosol(383-385), and the nucleus(386;387) each of which are 
shown in Table 1.2.  
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Table 1.2: Clan C1A cysteine proteases. 
Name Tissue Expression Function pH 
Cathepsin B Ubiquitous Lysosomal, extracellular; 
proteolytic processing of amyloid 
precursor protein, tumour invasion 
and metastasis 
pH 4-6 
(optimal), 
pH 7 (stable) 
Cathepsin C Ubiquitous Lysosomal; activates granulocyte 
serine proteases, factor XIII 
neuraminidases 
pH 6 
(optimal), 
pH 4-7.5 
(stable) 
Cathepsin F Heart, skeletal 
muscle, brain, testis, 
ovary 
Lysosomal; role in tumour invasion 
and metastasis 
pH 5.2-6.8 
(optimal), 
pH 4.5-7.2 
(stable) 
Cathepsin H Brain, kidney, liver; 
inflamed tonsil 
Lysosomal; invariant chain (Ii) 
degradation 
pH 6.8 
(optimal), 
pH 5-8 
(stable) 
Cathepsin K Predominantly in 
bone (osteoclasts); 
present in most 
epithelial tissues 
Lysosomal, extracellular; 
osteoclastic bone resorption; 
fibrinogen and ECM degradation 
pH 6 
(optimal), 
pH 4-8 
(stable) 
Cathepsin L Ubiquitous Lysosomal, extracellular, nuclear 
(truncated); antigen presentation, 
Ii degradation, cell cycle 
regulation  
pH 6 
(optimal), 
pH 4-7 
(stable) 
Cathepsin S Alveolar 
macrophages, 
spleen, testis, 
epithelial cells; CD4+ 
T-cells  
Lysosomal, extracellular; Ii 
degradation, artherogenesis, 
antigen presentation, 
angiogenesis, elastinolytic activity 
pH 6 
(optimal), 
pH 4.5-8 
(stable) 
Cathepsin V (L2) Predominantly in 
thymus, testis; 
present in brain, 
corneal epithelium, 
skin 
Lysosomal; antigen presentation, Ii 
degradation 
pH 5.7 
(optimal), 
pH 4-7.2 
(stable) 
Cathepsin W Spleen, natural killer 
and cytotoxic T-cells 
Immune response, regulation of T-
cell cytotoxic activity 
Not reported 
Cathepsin X Widely expressed; 
ubiquitous in primary 
tumours 
Lysosomal; non-proteolytic in cell 
adhesion 
Not reported 
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Moreover, the cysteine cathepsins have been shown to have roles in various 
disease processes such as cancer(388), obesity(389-391), rheumatoid arthritis(392;393) 
as well as cardiovascular diseases such as atherosclerosis(394-399) and 
cardiomyopathy(400-402) demonstrated in both animal models and human cases.  
For example, in cancer, cathepsins B, F, H, K, L, V, S and X have been shown to 
be overexpressed in many carcinomata and frequently associated with a poor 
prognosis(403-408).  In the case of obesity and type II diabetes, deletions of 
cathepsins K or L have been shown to limit obesity, and cathepsin S has been 
shown to be increased in both clinical cases of type II diabetes and in diabetes-
prone mice(391;409-411).  The cathepsins B, L, K and S are reported to be involved in 
rheumatoid arthritis and osteoarthritis as levels of these cathepsins are 
increased within the synovial fluid of patients with these conditions(368). 
1.6.5.2 Cathepsins and the Cardiovascular System 
As well as cancer and metabolic diseases such as diabetes, cysteine cathepsins 
also play a role in cardiovascular disease.  For example, cathepsins B, L and S 
have been shown to be increased in atherosclerotic lesions of mice(412).  
Moreover, cathepsins K and S were found to be overexpressed in human 
atherosclerotic lesions(398), and more recently, cathepsin L protein expression 
has also been shown to be increased in atherosclerotic lesions with a 
concomitant increase in circulating serum levels(413).  Cathepsins also play a role 
in restenosis and neointima formation following PCI(414).  Cathepsins contribute 
to extracellular matrix (ECM) remodelling as part of their protease activity(414), 
which suggests a possible role in remodelling diseases such as restenosis and 
neointima formation.  In a rabbit model of balloon injury (a method of PCI where 
inflation of a balloon inserted into the coronary vessel via the femoral artery 
restores the lumen of the occluded artery), cathepsin S mRNA and protein 
expression were increased(415).  A similar study in rats utilising a carotid balloon 
injury showed increased mRNA and protein expression of both cathepsins S and 
K(416).  By their ECM remodelling activity, cathepsins also play a role in aneurysm 
formation.  When human patients with abdominal aortic aneurysm were assessed 
it was found that the lesion showed increased protein expression of cathepsins K 
and S with a concomitant decrease in the natural cathepsin inhibitor, cystatin 
C(417).  Moreover, further studies have demonstrated increased proteolytic 
activity of cathepsins B and L in the wall of the aneurysm and associated 
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thrombus(418-420).  In the same study by Liu J et al. (2006) that examined serum 
cathepsin-L (CatL) levels in patients with atherosclerosis, raised serum levels of 
CatL were also found in patients with aneurysm(413). 
1.6.5.3 Cathepsins in the Heart 
Within the heart, cysteine cathepsins are expressed in all cell types (Figure 
1.25).  The upshot of this is that cysteine cathepsins have multiple roles in 
cardiac disease.  A study by Cheng et al. (2006) showed that cathepsins B, S and 
K mRNA and protein expression were increased in hypertrophic and failing 
myocardium in the Dahl salt-sensitive rat model of hypertension(421).  Moreover, 
when immunohistochemistry for cathepsins K and S was performed on the 
myocardium from the same rats, there was increased staining in cardiomyocytes, 
intra-coronary smooth muscle cells and macrophages compared to normal 
control myocardium(421).  When the hypertensive rats were treated with the 
broad spectrum cysteine protease inhibitor E-64 (trans-epoxysuccinyl-L-
leucylamido-(4-guanido) butane) or a CatS specific inhibitor, elastinolytic 
activity in the myocardium was blunted(421;422).  Cysteine cathepsins also play a 
role in cardiomyopathy.  Further studies by Cheng et al. (2012) have observed 
increased mRNA expression of cathepsins B, L, S and/or K in both dilated and 
hypertrophic cardiomyopathy in human disease(423).  
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Figure 1.25: The cathepsin cysteine proteases expressed in cardiovascular cells. 
(A) Macroscopy of whole heart.  (B) Microscopy of the myocardium, scale bar = 50 µm. Cats = 
cathepsins; CFC = cardiac myofibroblast; CMC = cardiomyocyte; SMC = smooth muscle cell; and 
EC = endothelial cell.  Figure from Cheng et al. (2012) with permission(423). 
Although other cathepsins have been studied in cardiovascular disease such as B, 
K and S(423), CatL is gaining interest.  CatL is a ubiquitously expressed 
homoeostatic enzyme involved in many disease processes(368).  Within the heart 
it is known that a basal level appears to be necessary, as a CatL knockout mouse 
model shows a dilated cardiomyopathy phenotype(402).  It also seems to play a 
role in cardiovascular disease involved in remodelling post-infarction(424) and 
atherosclerosis(413) and appears to be increased in the serum of individuals with 
coronary heart disease(425;426).  However, the consequences of raised serum 
levels remain unclear as do the potential mechanisms of action.  What has been 
shown, in the case of coronary artery disease, is a positive correlation of serum 
CatL levels and severity of disease(425).  Specifically, there were three findings; i) 
patients with unstable angina pectoris had higher serum CatL levels than those 
with stable angina pectoris, ii) of patients with acute coronary artery disease, 
those with acute MI had higher CatL serum levels than those with unstable 
angina pectoris, iii) patients with previous chronic MI had the highest serum CatL 
of all(425).  Furthermore, there is a strong correlation between percentage of 
stenosis of the left anterior descending coronary and serum CatL levels in 
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individual patients(413).  A recent study by Liu A et al. (2013) investigated the 
role of CatB in myocardial infarction(427).  In that study rats were subjected to 
left anterior descending coronary artery ligation followed by intraperitoneal 
administration of the CatB specific inhibitor CA074Me at a dose of 10 mg.kg.day-1 
or equivalent volume of vehicle for 4 weeks.  They found the treated rats 
demonstrated smaller decreases in cardiac function, decreased cardiomyocyte 
hypertrophy and decreased fibrosis(427).  In addition, the serine cathepsin CatA 
and the aspartic cathepsin CatD have also been shown to be released and have 
increased proteolytic activity in hearts that have undergone 
ischaemia/reperfusion both experimentally and clinically(368;428-431).   
1.6.5.4 Cathepsin-L  
Among the cysteine cathepsins, the most extensively described in health and 
disease is CatL(423).  As with the other cathepsins (Table 1.2), CatL is normally 
located within the lysosome with an optimal activity at pH 5.5-6.0(372) but is 
active at neutral pH(380).  It has been demonstrated that in transgenic CatL 
knock-out mice that there is accumulation of material within enlarged lysosomes 
with ventricular dilatation and impaired cardiac contraction(401;402).  Therefore, 
these data suggest that a basal level of CatL is essential for maintenance of 
normal cardiac structure and function.  Recent work has shown that cathepsins, 
including CatL, can be released/secreted into the extracellular space and have 
proteolytic activity resulting in ECM remodelling(368).  Moreover, as discussed 
above, serum levels of CatL have been shown to be increased with coronary 
heart disease(413;425;426).  Yet, despite this evidence, the consequences of raised 
serum levels of CatL remain unknown.  A study by Sun et al. (2011) induced MI 
utilising a permanent coronary artery ligation technique in CatL deficient 
transgenic mice(424).  Induction of MI in the complete absence of CatL in all cell 
types increased infarct size at day 14 post-MI.  Sun et al. (2011) suggested that 
this was caused by a reduced level of blood/bone marrow derived cell 
mobilisation to the site of injury to aid cardiac repair (due to their reduced 
ability to remodel the ECM to enable mobilisation)(424).  They also suggested that 
absence of CatL led to a reduced level of myofibroblasts and circulating 
fibroblasts, which would normally limit infarct dilatation(424).  In another study 
by the same group, Sun et al. (2013) also demonstrated that in CatL deficient 
mice that had undergone aortic banding, to increase afterload thereby inducing 
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left ventricular hypertrophy, had significantly worse systolic and diastolic 
function as well as reduced survival(432).  They suggested that CatL lysosomal 
protein degradation and activation of autophagy ameliorated the hypertrophic 
response to the aortic banding(432).  It is important to recognise that in both 
these studies transgenic mice with a complete CatL deficiency from conception 
were used.  A deficiency from conception in all cell types will result in complex 
compensatory biochemical changes and alterations in cellular structure 
(specifically lysosomal structure), and is highly likely to lead to different 
responses to induction of MI or aortic banding.  The recognition of potential 
compensatory effects becomes apparent when considering reducing the effects 
of CatL as a potential treatment for disease.  When the effect of 
pharmacologically inhibiting CatL in other body systems as opposed to transgenic 
knock-out has been investigated, the inhibitors cause only a partial and 
temporary deficiency and may therefore result in a different response(433).  
Overall, these observations suggest that whilst a complete CatL deficiency is 
deleterious to cardiac function, excess CatL may also be harmful, especially 
given the correlation of serum CatL levels and severity of disease in patients 
with coronary heart disease.  
1.7 Overall Aims 
The overall aims of this thesis are to: 
1. Identify whether trypanosomes can have a direct effect on Ca2+ handling 
in ventricular cardiomyocytes via a secreted/excreted factor. 
2. Identify the potential mechanism by which the trypanosomes can exert 
their effects and whether it is the same mechanism involved in Ca2+ 
signalling within HBMECs. 
3. Characterise the Ca2+ handling disturbances in isolated ventricular 
cardiomyocytes. 
4. Develop an in vivo model with which the cardiac phenotype of a 
trypanosome infection can be investigated. 
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5. Investigate the parallels/differences between the Ca2+ handling effects of 
trypanosome derived cathepsin-L and mammalian derived cathepsin-L.
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2.1 Trypanosome Culture and Supernatant Preparation 
2.1.1 Axenic Culture of Trypanosoma brucei brucei 
Cultures of Trypanosoma brucei brucei strain Lister 427 were maintained 
axenically in logarithmic growth phase from cryo-preserved stabilates (section 
2.1.2) in a modified version of HMI-9 media which is widely used to culture 
mammalian bloodstream form trypanosomes(434;435).  The composition of the 
modified HMI-9 media was: IMDM (Iscove’s Modified Dulbecco’s Medium with 
Glutamax (Life Technologies)) supplemented with; βBCPT (0.05 mM 
bathocuprinone disulphonic acid, 1.5 mM L-cysteine, 2 mM sodium pyruvate, 
0.16 mM thymidine, 0.2 mM β-mercaptoethanol), 1 mM hypoxanthine, 1.4 mM 
glucose, 0.125 mM adenosine, 0.125 mM guanosine, 30 μg.mL-1 kanamycin, 10 
u.mL-1 penicillin, 10 u.mL-1 streptomycin and 1 mg.mL-1 methyl cellulose.  
Parasites were cultured in the modified HMI-9 supplemented with 20% v/v Serum 
Plus®, (a serum supplement containing Foetal Bovine Serum (SAFC Biosciences)) 
in a humid incubator at 37 °C, 5% CO2 (in air).  Trypanosome cultures were 
maintained in 25 cm2 vented top tissue culture flasks to ensure adequate 
diffusion of CO2 into the media for appropriate pH buffering at ~pH 7.4 due to 36 
mM sodium bicarbonate (NaHCO3) and 25 mM HEPES within the IMDM 
(Invitrogen).  Phenol red within the media enabled visualisation of correct pH 
balance of the cultures.  Counting of parasites was done in quadruplicate using 
an improved Neubauer Haemocytometer (Figure 2.1) and new trypanosome 
cultures in modified HMI-9 were seeded and maintained to achieve a 
concentration of 5.0 x 105 parasites.mL-1 for experimentation.  Parasite cultures 
typically achieved a doubling time of 8 hr.  For example, if a 10 mL culture of 
5.0 x 105 parasites.mL-1 was required in 48 hr and the doubling time was 8 hr 
(determined from up to once daily haemocytometer counts), then the number of 
doubling times in 48 hr will be 6 (48 hr/8 hr).  From a desired concentration of 
5.0 x 105 parasites.mL-1 this would be a seeding concentration of 7.8 x 103 
parasites.mL-1 ((5.0 x 105)/26).  If the concentration of parasites in the seeding 
culture is 5.0 x 105 parasites.mL-1 then the volume of seeding culture required to 
achieve 5.0 x 105 parasites.mL-1 in 48 hr would be 15.6 µL.mL-1 (7.8 x 103/5.0 x 
105).  Therefore, for a 10 mL culture 156 µL of seeding culture would need to be 
added to 10 mL modified HMI-9.  The fresh trypanosome culture will then act as 
the seeding culture for the next fresh culture in 48 hr etc.  Cultures were 
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maintained in this fashion for up to 4 weeks or until the culture failed to 
grow/parasites died. 
 
Figure 2.1:  Counting trypanosomes with a Neubauer Improved Haemocytometer. 
Cartoon representation of the haemocytometer grid viewed with through a standard light 
microscope.  Trypanosomes were counted in each primary square to make the quadruplicate 
count.  Cells crossing left-hand and upper borders were counted (black dots), cells crossing right-
hand and bottom borders were not (light grey dots). (Figure from open source). 
2.1.2 Stabilate Preparation 
A stock of parasites was preserved in cryo-storage (stabilates) for the purposes 
of new trypanosome cultures in case of culture contamination or overgrowth.  
Trypanosomes were cultured to a concentration of ~5.0 x 105 parasites.mL-1.  
Modified HMI-9 media without added antimicrobials, with 10% glycerol added as 
a cryo-protectant was prepared as stabilate media.  Trypanosome cultures in 
modified HMI-9 were centrifuged at a relative centrifugal force (RCF) of 857 g 
for 10 min and the supernatant carefully aspirated.  The remaining pellet of 
parasite cells was gently resuspended in stabilate media to a concentration of 
5.0 x 105 parasites.mL-1.  The resuspended parasite culture was placed in 1 mL 
aliquots into cryo-tubes and labelled appropriately.  The cryo-tubes were frozen 
slowly in an insulated container with isopropyl alcohol in an outer layer in a -80 
ºC freezer for 24 hr.  This method prevents the formation of large ice crystals 
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that could disrupt and kill the cells.  The frozen stabilates were then removed 
and stored in liquid nitrogen until required. 
2.1.3 Stabilate Thawing 
When a new culture of trypanosomes was required modified HMI-9 media with 
40% Serum Plus® (and antimicrobials) was pre-warmed to 37 ºC in the incubator.  
The extra Serum Plus® provides additional metabolic support for the freshly 
thawed trypanosomes.  An aliquot of stabilate was gently warmed by hand and 
added by pipette to 4 mL modified HMI-9 with 40% Serum Plus® without 
agitation.  The trypanosome culture in modified HMI-9 with 40% Serum Plus® was 
monitored and counted daily, and reseeded as appropriate.  After 72 hrs the 
trypanosomes were transferred to modified HMI-9 with 20% Serum Plus®, and 
were maintained as described in 2.1.1. 
2.1.4 Preparation of Live Trypanosomes for Experimentation 
Modified HMi-9 as in section 2.1.1 (hereafter referred to as control media) 
containing live trypanosome cultures at a concentration of ~5.0 x 105 
parasites.mL-1 was decanted from the tissue culture flask into an appropriately 
sized centrifuge tube.  The pH of the cultures and control media were checked 
using a pH meter.  The pH was maintained by the 25 mM HEPES, 36 mM NaHCO3 
within the IMDM of the modified HMI-9 and 5% CO2 within the incubator and was 
measured as pH 7.40 ± 0.02, but if >0.02 different then the pH of the control 
media was adjusted to match the trypanosome culture with sodium hydroxide 
(NaOH) or hydrochloric acid (HCl) as appropriate.  The living parasites were then 
incubated with isolated adult rat left ventricular cardiomyocytes. 
2.1.5 Preparation of Supernatant 
Cultures of trypanosomes as above were counted (section 2.1.1) and carefully 
aspirated from the tissue culture flasks into sterile centrifuge tubes.  
Supernatant was prepared by centrifugation of cultured trypanosomes at 857 g 
for 10 min.  A low RCF was used to avoid causing cell lysis and the liberation of 
intracellular proteins.  The supernatant was carefully aspirated using a pipette 
filler into a fresh centrifuge tube, the remaining pellet of cells was either 
discarded into 3% trigene disinfectant, or used for stabilate preparation (section 
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2.1.2).  To ensure there was no contamination with live trypanosomes, 
supernatant was further filtered using a 0.2 μm syringe filter (Sartorius Stedim).  
Control media was treated in an identical manner to the supernatant 
(centrifuged and filtered). The supernatants were temperature matched and pH 
adjusted to the control HMI-9 batch used for each experiment (section 2.1.4). 
2.2 Trypanosome Infections – In Vivo ECG Acquisition 
2.2.1  T. b. brucei Lister 427 Infection Model 
2.2.1.1 Preparation of Trypanosomes 
Trypanosoma brucei brucei Lister 427 were grown in mice to adapt them to in 
vivo conditions.  This step was performed by Mrs. Anne-Marie Donachie, a 
technician from the Wellcome Trust Centre for Molecular Parasitology, 
University of Glasgow.  The parasites were grown in the mice for 2-3 days with 
daily venepuncture to check parasitaemia levels.  When parasites were 
detectable the mice were sacrificed and blood collected in heparin.  A sample of 
the blood was counted with a Neubauer improved haemocytometer in triplicate 
(section 2.1.1).  The parasites were diluted under sterile conditions to 1.0 x 105 
parasites in a 200 µL volume of  Carter’s balanced salt solution (CBSS; 25 mM 
HEPES, 120 mM NaCl, 5.4 mM KCl, 0.55 mM CaCl2, 0.4 mM MgSO4, 5.6 mM Na2PO4  
and 11.1 mM glucose, pH 7.4).     
2.2.1.2 ECG Acquisition 
Adult male Wistar rats (250-300 g) were allowed a 7 day acclimatisation period 
upon delivery to the biological services unit.  Animals were kept at the 
Cardiovascular Research Unit, University of Glasgow in a dedicated room 
licensed under the Specified Animal Pathogens (Scotland) Order 2009 (SAPO).  
Rats were anaesthetised by inhalation of isoflurane gas at 4-5% delivered in 1-1.5 
L.min-1 oxygen in an induction box.  The rats were removed from the box when 
there was loss of the righting reflex.  The animals were maintained on isoflurane 
delivered via facemask.  The gas was reduced based on assessment of the 
animals’ vital parameters to a final plane of anaesthesia at 1-1.5% in 1 L.min-1 
O2.  The ECG was recorded via the placement of intradermal electrodes.  The 
placement sites on the rat were caudal aspects of the left and right carpi and 
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the medial aspects of left and right crura.  The sites were cleaned with 
chlorhexidine as were the electrode tips.  Appropriate earthing and positioning 
was used to minimise signal noise.  To ensure reproducibility for the same rats 
and between rats, all animals were positioned identically based on an outline 
drawn on a corkboard.  Electrodes were placed in the same manner (Figure 
2.2A). The ECG was recorded for 15 min with an IWX228 bioamplifier (iWorx, 
USA).  Rats were then infected with 1.0 x 105 parasites in a 200 µL 
intraperitoneal injection, control rats were injected with 200 µL CBSS.  The ECG 
was recorded for a further 15 min following the injection before rats were 
recovered. 
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Figure 2.2: Photographs of the infected rat ECG acquisition. 
(A) Rat anaesthetised and in position within the “black outline” drawn on the corkboard.  ECG leads 
are placed in a lead II format (blue lead negative, green lead positive, grey lead earth/ground).  
Leads are taped down to minimise noise.  The corkboard is coated in clear plastic to facilitate easy 
cleaning. (B) Computer and ECG acquisition equipment.  An earthing lead connects the device to 
ground via a plumbed basin.   
2.2.1.3 Health Monitoring and Parasitaemia Checks 
Infection with T. brucei Lister 427 can cause anaemia, weight loss and 
immunosuppression.  Eventually the parasitaemia becomes fulminant, which is 
fatal if allowed to persist.  Parasitaemia was measured daily.  A drop of blood 
was obtained by a small puncture of the lateral tail vein.  The blood was 
expressed on to a glass slide and viewed with a 40x objective lens on a standard 
light microscope.  The slide was examined and the number of parasites counted 
and compared to the description of Herbert and Lumsden (1976)(436) (Figure 2.3).   
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Figure 2.3: Chart and tables for estimating trypanosome parasitaemia. 
Circles are the view down a 40x objective lens at blood films at different quantities of parasite.  The 
numbers are the anti-log of the parasitaemia .mL-1.  For fewer parasites a greater quantity of fields 
must be analysed – numbers are given in the tables.  Fewer than 1 x 105.4 parasites.mL-1 are not 
detectable from blood films. (Figure from Herbert and Lumsden (1976)(436).  
In addition, general clinical parameters were checked – adverse effects were 
recognised as lassitude persisting beyond 72 hours, or weight loss equal or 
greater than 25%, extreme pallor, hypothermia, sunken eyes, hunched posture, 
and staring coat, or where the parasitaemia exceeds 5.0 x 108 parasites.mL-1 for 
more than 2 consecutive days.  In these cases animals were withdrawn from the 
study and humanely euthanized.   
2.2.1.4 Terminal Data 
Infected and control animals were anaesthetised again after 4 days and the ECGs 
were repeated.  Animals were sacrificed and the lungs, liver and spleen 
weighed.  The hearts were removed and Langendorff perfused (section 2.5).  
The pseudo-ECG was recorded for a 15 min steady state period followed by the 
addition of 100 nM ISO and the ECG recorded for 15 min.  The concentration of 
ISO was increased 10 x every 15 min to 100 µM.   
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2.2.1.5 Data Analysis 
ECG data were collected using the IWX228 bioamplifier and LabScribe 2 software 
(iWorx) at a sampling rate of 2,000 Hz.  The ECG from the last min of each 15 
min period was averaged using the advanced ECG analysis module of the 
programme and exported to Origin6.1 (OriginLab) for QT interval measurement 
(section 2.5.4.1).  The entire traces were assessed for arrhythmic events 
according to the Lambeth Conventions(437) (section 2.5.4.2). 
2.2.2  T. b. brucei TREU 927 Infection Model 
2.2.2.1 Trypanosome Preparation 
A limitation of T. brucei Lister 427 is that it follows a logarithmic growth curve 
in vivo until the death of the infected host, therefore, the T. brucei brucei TREU 
927 strain was used.  The 927 parasites were prepared as described for 427 
(section 2.2.1.1) by Anne-Marie Donachie.  Blood taken from infected mice was 
examined and the parasites counted with a haemocytometer. 
2.2.2.2 Telemetry Probe Implantation 
One of the main limitations of the 427 infection model with 15 min ECG 
recordings is that isolated arrhythmic events may be missed.  To counteract this 
problem, continuous ECG recordings were made using a CA-F40 biopotential 
telemetry implant (Data Sciences International). 
2.2.2.3 Animals 
Male Wistar rats aged 8-10 weeks were acquired from a licensed commercial 
breeder in the UK (Harlan Laboratories, UK).  Animals were housed in pairs for a 
minimum of 7 days before use to allow an acclimatisation period.  Thereafter 
animals were housed individually in order for the telemetry receiver plates to 
receive only one signal.  Animals were housed in isolated accommodation under 
the SAPO licence as required for animals with trypanosome infections.  They 
were given free access to water and food pellets. 
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2.2.2.4 Theatre Preparation 
Telemetry probes were implantated under a surgical procedure (Figure 2.4).  
The animals were intended to be recovered from the procedure so operations 
were performed under aseptic conditions as much as practicable.  The surgical 
area was prepared with the appropriate equipment required for the procedure 
(Figure 2.4(i)).  The telemetry probe can be re-used between animals.  The 
leads of the probe were sealed with sutures to prevent solutions from tracking 
up the electrode wires into the transmitter.  The device was soaked in enzyme 
(Tergazyme®, Alconox, Inc. USA) to degrade biological material adhering to the 
device and leads for ≥5 h.  The device was rinsed in water and then soaked in a 
cold sterilising solution consisting of peracetic acid (0.9-1.1%), hydrogen 
peroxide (<1.0%) and acetic acid (4.9-5.5%) (Actril®, Minntech BV, Netherlands) 
for ≥5 h.  The device was rinsed with sterile saline and stored in sterile saline 
sufficient to completely cover the device for up to 24 hours if to be implanted 
(Figure 2.4(i)).  Devices not required for implantation were stored dry and 
sterilised when required.  The surgical area was disinfected with chlorhexidine 
gluconate spray (Ecolab, UK) and covered with a sterilised drape.  A heating pad 
to keep animals warm was covered in another sterile drape.  Surgical 
instruments were autoclaved at 134 ºC prior to surgery and decontaminated 
between procedures (if more than one was performed) using a hot-bead 
steriliser (Germinator 500, SouthPointe Surgical Supply, USA).  Animals were 
placed in a warming box immediately after regaining consciousness to provide a 
warm environment to recover in (Figure 2.4(ii)).  Oxygen and anaesthetic agent 
were checked and filled as necessary. 
2.2.2.5 Anaesthesia and Preparation of Animals 
Rats were collected and weighed.  Animals were anaesthetised using an 
inhalational vs. injectable agent for the greater control and least cardio-
respiratory depressive effects of anaesthetic agents(438).  The inhalational 
anaesthetic used was isoflurane (Isoflo, Abbot Laboratories, USA) delivered in 
100% O2.  Animals were anaesthetised by placing them in a pre-filled induction 
box as shown in Figure 2.4(iii).  Once there was a demonstrable loss of righting 
reflex animals were moved to facemask on 4% isoflurane at 1.5 L.min-1.  Fur was 
clipped with electric clippers over the thoracic region of the dorsum (Figure 
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2.4(iv)) and on the ventrum over the right pectoral and xyphoid (Figure 2.4(v)).  
The clipped areas of skin were cleaned with warmed 10% surgical skin 
disinfectant (Hibiscrub, Ecolab Ltd) and gauze swabs (Figure 2.4(v-vi)).  The 
animal was moved to the surgical table and positioned in ventral recumbency 
(Figure 2.4(vii)) on the heated pad to maintain the animal’s temperature.  Peri-
operative analgesia of 5 mg.kg-1 carprofen (Rimadyl, Pfizer Animal Health) was 
administered with 5 mL of 0.9% sterile saline subcutaneously (Figure 2.4(viii)) to 
maintain fluid balance under anaesthesia. 
2.2.2.6 Surgical Procedure 
The animal was placed in ventral recumbency and maintained with isoflurane 
and 100% O2 via facemask throughout the procedure.  Depth of anaesthesia was 
monitored by measuring the respiratory rate and testing the pedal pain 
withdrawal reflex and the isoflurane % altered accordingly from initial induction 
at 4.0-4.5% to a stable surgical plane of anaesthesia of 1.5-2.0%.  A sterile drape 
with cut window was draped over the animal.  A 25 mm horizontal incision was 
made with a scalpel blade toward the caudal edge of the clipped area of skin, 
mid thoracic region (Figure 2.4(ix)).  This allowed the telemetry probe to be 
inserted over the back without impeding the animal’s normal behaviour once 
recovered.  The subcutaneous fascia was bluntly dissected with scissors (Figure 
2.4(x) to create a pocket large enough to accommodate the probe.  The probe 
was orientated with anchor points dorsal and leads caudal (Figure 2.4(xi)) and 
then inserted into the pocket (Figure 2.4(xii)).  The probe was anchored with 1.5 
metric nylon suture (W319, Johnson & Johnson) through the skin and anchor 
points on the probe (Figure 2.4(xiii)).  A saline soaked sterile swab was placed 
over the surgical site and the animal was rotated carefully into dorsal 
recumbency to expose the ventral sites (Figure 2.4 (xiv)).  Starting with the 
xyphoid site a 10 mm incision was made with a scalpel blade and subcutaneous 
fascia bluntly dissected (Figure 2.4(xv)).  A tract was dissected carefully 
subcutaneously around the thorax with scissors toward the right of the animal to 
allow the positive lead marked red by the manufacturer of the probe to be 
passed (Figure 2.4(xvi)).  A haemostat was carefully passed through the tract 
and the scissors removed (Figure 2.4(xvii)).  The appropriate biopotential lead 
was grasped with the tip of the haemostat and pulled through to the xyphoid 
(Figure 2.4(xviii-xix)).  A length of the silicone sheath of the biopotential lead 
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was carefully removed to expose a length of the wire.  Figure 2.4(xix) shows the 
lead pulled through and exposed wire after removal of a length of the red 
silicone.  Using a 21-gauge needle a small tract was created through the 
underlying muscle for the exposed wire to pass through (Figure 2.4(xx)).  The 
exposed wire is in direct contact with the muscle so will return an electrical 
signal to the transmitter.  The removed silicone insulation was replaced over the 
exposed end not in the muscle to insulate against interference and noise and 
sutured into place with 1.5 metric nylon (Figure 2.4(xxi)).  An additional suture 
was place proximal to the wire insertion for further anchoring.  The ventral skin 
incision was closed with 1.5 metric polyglactan 910 (Vicryl, W9386, Johnson & 
Johnson, UK) in a simple continuous pattern (Figure 2.4(xxii)).  The procedure 
was repeated passing to the left of the animal for the negative electrode over 
the right pectoral to prevent the leads crossing over one another and potentially 
introducing noise to the signal (Figure 2.4(xxiii-xxiv)).  The animal was returned 
to ventral recumbency.  The leads were coiled and tucked into the pocket with 
the probe and positioned to minimise discomfort to the animal (Figure 2.4(xxv)).  
The skin was closed in a simple continuous pattern with 1.5 metric polyglactan 
910.  The gaseous anaesthesia was reduced to 0% during closing and the animal 
allowed to recover on 100% O2 followed by room air until pedal withdrawal and 
palpebral reflexes had returned.  The animal was then placed in the warm box 
to come round to full consciousness (Figure 2.4(xxvii)).  Rats were monitored 
daily for signs of discomfort and wound healing and cleanliness.  No follow-up 
analgesia was necessary as rats were comfortable and displaying normal 
behaviour (Figure 2.4(xxviii)). 
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Figure 2.4: Photographs of the steps of the telemetry probe implantation procedure. 
 
2.2.2.7 Trypanosome Infection 
Rats were allowed to recover from surgery for 7 days and then were infected as 
described for the 427 model (section 2.2.1.2).  Infection was with 1.0 x 105 T. 
brucei TREU 927 in 200 µL CBSS via intraperitoneal injection.  Control rats were 
injected with the same volume of CBSS.  Rats were monitored as described 
above (section 2.2.1.3). 
2.2.2.8 Data Acquisition and Analysis 
Cages with implanted rats were placed onto receiver pads.  The implanted 
probes were activated magnetically.  Telemetry signals were relayed via a data 
exchange matrix to the computer loaded with the acquisition software 
Dataquest™ OpenART v4.2 (Data Sciences International).  Raw ECG data was 
collected continuously at 2,000 Hz sampling frequency for 2 weeks and saved 
daily.  Files were exported to Ponemah v4.8 (Data Sciences International) for 
analysis.  The probes have a battery life of 6 months when in continuous use.  
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ECGs were recorded continuously for the duration of the model.  ECGs were 
assessed for arrhythmia frequency and QT intervals as described later (section 
0). 
 
2.3 Ventricular Cardiomyocyte Isolation 
2.3.1 Isolation of Adult Rat Left Ventricular Cardiomyocytes 
Adult male Wistar rats (250-300 g) were humanely euthanized in accordance 
with Schedule 1 of the UK Animal (Scientific Procedures) Act 1986, Directive 
2010/63/EU of the European Parliament and the ethical review panel of the 
University of Glasgow.  Rats were first concussed followed by immediate cervical 
dislocation.  Complete severance of the spinal cord was confirmed by manual 
palpation.  The rat was placed in dorsal recumbency and the heart removed by 
thoracotomy (Figure 2.5A) into ice-cold isolation buffer.  The heart was gently 
squeezed to express blood from the ventricles and placed in a second beaker of 
isolation buffer.  The isolation buffer used was a modified isolation Krebs-
Henseleit (MIKH) solution.  The composition of MIKH was as follows (in mM): NaCl 
(120), KCl (5.4), HEPES (20), NaH2PO4 (0.52), MgCl26H2O (3.5), Taurine (20), 
Creatine (10), Glucose (11.1), pH was adjusted to 7.4 at 37 ºC with NaOH.  The 
inclusion of taurine has been suggested to protect the isolated cells from Ca2+ 
overload during Ca2+ paradox(439;440).  The washed heart was finely dissected to 
remove extraneous tissue and clear the area around the aorta.  The heart was 
cannulated via the aorta in retrograde Langendorff perfusion as shown in Figure 
2.5B and C.  It is important that the cannula stops short of the aortic valve so 
that the perfusion pressure closes the aortic valve and pushes the perfusion 
solution into the coronary vessels (Figure 2.6).  The aorta was tied to the 
cannula with a 1.5 metric nylon suture (Pearsall’s Ltd) using a surgeon’s knot 
(defined as 2 throws, 1 turn and 1 throw before tying) to ensure a tight locking 
knot.  Successful cannulation was confirmed by the perfusate leaving the heart 
becoming transiently sanguineous and the coronary vessels becoming clear.  
Hearts were perfused at a rate of 7 mL.min-1 with MIKH for a period of 5 min to 
ensure complete clearing of blood from the myocardium and coronary 
circulation.   
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Figure 2.5: Photographs of rat heart removal and cannulation. 
(A) Thoracotomy of the rat with ribcage reflected to show thoracic and proximal abdominal organs 
in situ.  (B) Langendorff isolation set up with cannulated heart.  The heart is perfused in retrograde 
Langendorff perfusion with MIKH warmed to 37 ºC in the water bath and by the heat exchange 
column.  Perfusion is maintained by constant flow perfusion pump calibrated to deliver 7 mL.min-1.  
MIKH containing 0.5% BSA is in a separate reservoir with a 3-way tap to switch between solutions.  
(C) Close-up of cannulated heart tied in place with clear perfusate indicating successful perfusion 
of the coronary vessels. 
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Figure 2.6: Langendorff perfusion of the heart. 
The aorta is transected between the heart base and aortic arch to leave a straight cut (dashed 
line).  The cannula is inserted through the aortic opening, marked as the black ellipse, but care 
taken not to push through the aortic valve (labelled).  When perfusion solution is pumped through 
the cannula the perfusion pressure closes the aortic valve as the afterload would during diastole in 
vivo.  The perfusion pressure therefore pushes the solution into the coronary vasculature, indicated 
by the blue arrows, to supplement the excised heart with the Krebs-Henseleit solution.    
Following the clearance of blood hearts were perfused with MIKH with 0.83 
mg.mL-1 collagenase I (Worthington Biochemical Corporation) and 0.1 mg.mL-1 
protease XIV (Sigma-Aldrich) at the same flow rate for 8-12 min depending on 
particular enzyme requirements to get the best quality and yield of 
cardiomyocytes.  Optimisation experiments were performed as detailed below 
when a new batch of enzyme was purchased.  The collagenase is activated by 
the protease and digests the extracellular matrix of the heart to liberate 
individual cells.  After perfusion with enzyme the hearts were perfused for 6.5 
min with MIKH containing 0.5% bovine serum albumin (BSA).  The BSA provides 
substrate and stops continued digestion of the tissue.  Any minor leakiness of 
cardiomyocyte membranes can also be sealed by the BSA(441) and prevent influx 
of extracellular Ca2+ that can cause a hypercontractile state in the 
cardiomyocyte.  The ventricles were cut from the cannula and the right ventricle 
separated and discarded.  The left ventricular free wall and the interventricular 
septum were cut into strips and gently mixed to yield a single cell suspension in 
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MIKH containing 0.5% BSA.  The Ca2+ in solution ([Ca2+]o) was raised in this 
suspension via stepwise increments of 100 µM until 1.0 mM was reached to guard 
against Ca2+ paradox(439).  Ca2+ paradox occurs when Ca2+ is removed, such as in 
the case of enzymatic digestion, and monovalent cations such as Na+ enter the 
cardiomyocyte down the electrochemical gradient(439).  If [Ca2+]o is returned to 
physiological concentration (1.8 mM) immediately, then Ca2+ can enter the cell 
suddenly down its concentration gradient and kill the cell.  By restoring [Ca2+] 
gradually, the ion concentrations are able to equilibrate without killing the 
cell(439).  Cells were viewed on the light microscope for yield, quality and 
viability.  Cell morphology appropriate for experimentation was the torpedo-like 
rod shape, striations and clear sarcolemma (membrane).  Ball shaped cells were 
hypercontracted cells following an influx of Ca2+ through a damaged 
sarcolemma(442) (Figure 2.7). This protocol is an amalgam of multiple techniques 
described in the literature, reviewed in Louch et al. (2011), that have been 
found to be optimal for this set-up(443).  The protocol was fully characterised for 
each enzyme batch used.   
 
Figure 2.7: Photomicrographs of isolated cardiomyocytes. 
(A) View of isolated rat left ventricular cardiomyocytes with 10x objective lens.  Rod shaped cells 
are viable contractile cells.  Ball shaped cells are hypercontracted cardiomyocytes following influx 
of extracellular Ca2+.  These cells are not viable. (B) View of single cardiomyocyte with 40x 
objective lens showing striations, intact sarcolemma and straight ends.  Lower left of same image 
shows a hypercontracted cardiomyocyte. 
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Isolated cells were assessed for total yield, percentage of viable rod shaped cells 
(Figure 2.7) and percentage of cells exhibiting spontaneous contractile activity.  
Viability counts were performed at 0 and 1.0 mM Ca2+ and again in the 1.0 mM 
Ca2+ after 2 hr.  When a new batch of enzyme was purchased, similar 
experiments were performed to ensure optimisation and consistency of the 
percentage rods achieved between batches. 
2.3.2 Isolation of Adult Rabbit Left Ventricular Cardiomyocytes 
Isolation of rabbit cardiomyocytes was performed by Mrs. Aileen Rankin, a 
technician in Prof. Godfrey Smith’s lab; a similar protocol to adult rat 
cardiomyocyte isolation.  Adult New Zealand White rabbits (2-2.5 kg) were given 
an intravenous injection of 500 U heparin and an overdose of sodium 
pentobarbitone (100 mg.kg-1).  Hearts were rapidly excised as described for the 
rat and cannulated in retrograde Langendorff perfusion via the aorta.  The 
cannulated hearts were perfused with 150 mL of MIKH of the same composition 
as in 2.3.1 at a rate of 25 mL.min-1 (37 ºC) to rinse away blood and reduce 
probability of clot formation.  The MIKH was supplemented with 1.4 mg.mL-1 
collagenase I and 0.1 mg.mL-1 protease XIV and perfused for ≈7 min.  Hearts 
were then perfused with MIKH containing 0.1% BSA for ≈6 min to provide 
substrate for superfluous enzyme and seal up cardiomyocyte membranes to 
prevent hypercontraction and cell death.  Hearts were cut down and the atria 
removed.  The experiments presented in this thesis used cardiomyocytes from 
the left ventricle.  The left ventricles were cut into strips and mixed in 20 mL 
0.1% BSA MIKH with 0.125 mM CaCl2 in a culture flask for 30-60 min.  The cells 
were allowed to settle and the supernatant removed.  The cells were then 
resuspended in 0.1% BSA MIKH with 0.25 mM CaCl2 and the process repeated.  
This was done again for 0.5 and 1.0 mM CaCl2.  The gradual increase in [Ca2+] 
was performed to protect the cells from Ca2+ paradox(439) (section 2.3.1). 
2.4 Cardiomyocyte Spontaneous Contractile Activity 
Measurements 
Isolated rat left ventricular cardiomyocytes (section 2.3.1) were incubated at 
room temperature for 30 min with live trypanosome culture at a concentration 
of ~5.0 x 105 parasites.mL-1 or control media (i.e. modified HMI-9 prepared the 
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same way but without parasites) in a ratio of 1:3; cells (~1.0 x 105 
cardiomyocytes in 1 mL MIKH at 1.0 mM Ca2+) : culture/media (3 mL).  The ratio 
of 1:3 was calculated to achieve a physiological [Ca2+]o based upon the [Ca2+] of 
the IMDM of the media (section 2.1.1) reported by the manufacturer as 1.97 mM.  
Following incubation the cardiomyocytes were loaded onto a glass cover slip in a 
tissue bath (Cell Microcontrols) and viewed on an inverting light microscope 
(Nikon) with a 10x 0.25 Numerical Aperture (NA) lens.  A quantity of 10-15 rod 
shaped cardiomyocytes per field over 10 fields was viewed for 1 min per field 
and the number of cells exhibiting at least one spontaneous contractile event 
recorded. 
A further cohort of cardiomyocytes were incubated at room temperature for 30 
min in control media or trypanosome culture supernatant prepared as previously 
described (section 2.1.5).  The filter size of 0.2 µm meant parasite 
secretory/excretory products would remain in the media.  The ratios were 1:3 as 
with live trypanosomes above.  Cardiomyocyte spontaneous contractions were 
recorded and expressed a percentage of total cells as above. 
2.5 Langendorff Perfusion of ex vivo Whole Rat Hearts 
2.5.1 Principles of Langendorff Perfusion 
As described above (section 2.3.1), the principle of Langendorff perfusion is to 
supply an excised heart with its oxygenation and nutrient requirements.  This is 
achieved via cannulation of the aorta taking care not to advance beyond the 
aortic valve (Figure 2.6).  The mock extracellular solution containing oxygen and 
glucose is then perfused down the aorta against the closed valve thus forced by 
the pressure of the column of fluid in the aorta and perfusion apparatus into the 
coronary vessels to supply the myocardium.  The mock extracellular solution is 
removed via coronary veins to the right atrium.  The chambers of the heart 
remain essentially “dry”.  This technique was devised by Oscar Langendorff in 
1895(444).  Langendorff perfusion offers many advantages: simplicity of 
preparation, low cost, reproducibility and isolation from other physiological 
systems and exocrine control such as sympathetic tone(445).  It must also be 
considered the potential limitations; heart function is deteriorating with time (5-
10% deterioration of contractile and chronotropic function per hour)(445;446). 
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2.5.1.1 Constant Flow vs. Constant Perfusion Pressure 
There are two modes of perfusion used for the Langendorff technique.  
Langendorff himself used a constant perfusion pressure system with a sealed 
pressurised chamber with manometer(444).  The simplest way of maintaining a 
constant perfusion pressure is with a set height of a column of fluid such as 
positioning of the reservoir a known height above the preparation thus using 
gravity to maintain the pressure.  The disadvantage of using gravity fed 
perfusion pressure is the volume of fluid required.  To reduce the fluid required 
there are negative feedback pressure control loop peristaltic pump systems 
available(447).  Constant pressure systems are useful when reliance of coronary 
tone auto-regulation is required and if a regional ischaemia is performed, i.e. 
ligation of part of the vascular bed where constant flow would result in 
increased pressure in the remaining vasculature(445).  Constant flow systems 
simply rely upon a peristaltic pump to deliver the perfusate and are useful if for 
studying function when no vascular interventions such as regional coronary 
occlusions are required that with constant flow can increase the pressure and 
alter potentially damage tissue causing artefactual changes.  For this thesis, the 
constant flow system was used as no vascular interventions were required 
because only the ECG was measured. 
2.5.1.2 Measuring Physiological Parameters 
2.5.1.2.1 Electrocardiogram 
The Langendorff technique lends itself well for measurement of the 
electrocardiogram (ECG) due to excellent access to the epicardium.  Electrodes 
can be placed in a tissue bath surrounding the heart to measure the ECG with 
placement of the negative electrode adjacent to the right atrium and the 
positive electrode adjacent to the left ventricular free wall.  Data acquired can 
be used to measure common ECG parameters such as PR interval, QRS duration 
and QT interval as well as identifying occurrence of arrhythmic events.   
2.5.1.3 Potential Problems 
To limit preparation failure and ensure high quality, repeatable data it is 
important to consider the potential problems that can arise and minimise them. 
Chapter 3  The Effects of Trypanosoma brucei  116 
 
2.5.1.3.1 Temperature 
Maintenance of a physiological temperature throughout the experiment is 
important.  Variations in temperature can affect myocardial contractility and 
heart rate in the steady state(446;448;449).  Temperature can also have effects of 
myocardial viability following ischaemia/reperfusion models where lower 
temperatures can have a cardioprotective effect(450-454).  The heart has a large 
surface-to-volume ratio making radiant heat loss a large problem.  This can be 
minimised by: warming the perfusate to physiological temperatures, use of a 
heat exchange column to minimise radiation of heat from the perfusate before it 
enters the heart, submersion of the cannulated heart in an organ bath or 
exposure to a radiant heat source.  In the case of an ischaemia/reperfusion 
model where perfusion is interrupted partially (regional ischaemia) or totally 
(global ischaemia) then non-perfusion sources of heat must be considered. 
2.5.1.3.2 Perfusion Flow Rate 
The perfusion flow and pressure must be maintained throughout the experiment.  
Restrictions in flow can occur in diameter changes of the tubing from one region 
of the system to another, potential blockages in the coronary vessels (air emboli 
or thrombi) or experimental interventions.  Therefore it is important to measure 
the coronary flow from the heart.  The simplest way to achieve this is to collect 
the coronary effluent for a fixed period of time and measure the quantity of 
fluid collected. 
2.5.1.3.3 Maintenance of equipment 
One of the most common reasons for preparation failure is microbial 
contamination of the perfusion system(445).  This can be minimised by the design 
of the system limiting the number of connectors and avoiding side branches 
where stagnant fluid can collect.  The apparatus must be thoroughly cleaned 
before and after use with heated (>80 ºC) double-distilled water to ensure 
adequate removal of bacterial substrates such as glucose.  Periodic (2 weekly) 
deep cleaning with Decon 90, ethanol or 10% HCl can be employed.  In our 
system a second heat exchange coil can be used while the other is being deep 
cleaned.  Plastic tubing is periodically replaced as necessary particularly in the 
case of use of trypanosome supernatant and media where the media is ideal for 
bacterial growth. 
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2.5.2 System Design and Implementation 
The system used in our laboratory consists of two reservoirs containing perfusion 
solution, which are kept at 37 ºC in a water bath (Figure 2.8).  A three-way stop-
cock allows switching between the reservoirs so that a drug may be added to one 
and a control reservoir remains.  A peristaltic pump set to a constant flow rate 
(dependent on experimental requirements) delivers perfusion solution via a heat 
exchange column and bubble trap to the cannulated heart.  Although care is 
taken to avoid any air in the system, the bubble trap serves as a secondary 
measure to ensure no air enters the heart potentially causing an air embolus and 
damage to the myocardium.  The heart is cannulated to a 3 mm outer diameter 
cannula (Harvard Apparatus) via the aorta.  Care is taken to ensure the cannula 
does not pass the aortic valve.  A small incision is made in the right ventricular 
outflow tract to allow free drainage of coronary effluent and prevent 
development of back-pressure.  The heart is submerged into a heat-jacketed 
organ bath to maintain temperature of the preparation. 
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Figure 2.8: Langendorff system. 
The heart is cannulated via the aorta and perfused.  To maintain temperature the perfusion solution 
reservoir is kept in a water bath set to 37 ºC and the supply to the heart passed through a heat 
exchange column.  The heart is submerged in a heated organ bath.  Perfusion solution is delivered 
via a peristaltic perfusion pump set to a constant flow rate.  Two reservoirs with a tap to switch 
enable specific quantities of drug or different solutions to be perfused during an experimental 
protocol.  The figure shows a magnified portion with the heart.  ECG electrodes can be suspended 
in the organ bath in close proximity with the heart top record the ECG.  A water-filled polyethylene 
balloon can be affixed to a cannula and inserted into the left ventricle via the left atrium if required.  
A haemostat valve would enable a solid-state catheter to be inserted without introduction of air and 
simultaneous fine control of balloon inflation, but was not conducted for this study.  
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2.5.3 Exclusion Criteria 
Inclusion and exclusion criteria are useful when considering consistency and 
reproducibility.  Keeping to a short as time as possible from animal sacrifice to 
cannulation is important to minimise myocardial damage or 
preconditioning(455;456).  In the rat a time of <3 min is acceptable(455).  High flow 
rates in a constant pressure system (or low perfusion pressures) are indicative of 
damage to the aorta or damage to the aortic valve.  If flow rates are low or 
perfusion pressures high this can be an indicator of an obstruction; either 
obstruction of the coronary ostia by inappropriate cannulation or an embolus of 
air or particulate matter.  Highly arrhythmic hearts could be inadequately 
perfused.  It is good practice to set exclusion criteria during a steady state 
period.  The table below shows exclusion criteria for commonly used 
mammals(445) those of the rat were adopted for this thesis:  
Table 2.1: Exclusion criteria for Langendorff perfusion of mice, rats and rabbits 
Parameter Mouse Rat Rabbit 
Time to perfusion (min) >4 >3 >3 
Arrhythmia Duration (min) >3 >3 >3 
Heart rate (beats per min) <320 or >620 <70 or >400 <150 or >190 
 
2.5.4 Data Analysis 
2.5.4.1 Electrocardiography 
The ECG (or pseudo-ECG since this is no longer a living animal) can be measured 
by placement of electrodes in close approximation with the epicardium over the 
right atrium and left ventricle.  The resulting change in voltage or ECG (section 
1.3.4 for details on the ECG) was recorded with an iWorks/CBS systems 
bioamplifier.  ECG parameters that can be measured are: PR interval, QRS 
duration and QT intervals (Figure 2.9).  Parameters were measured manually as 
recommended by the AHA/ACCF/HRS recommendations for standardisation and 
interpretation of the electrocardiogram(457).  QT length, determined by the end 
of the T wave at the isoelectric point or by intersection of the tangent of the 
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steepest part of the T wave with the isoelectric point(457), was measured.  The 
QT interval was also measured at 90% repolarisation(458) (QT90) and at 50% 
repolarisation(459) (QT50), so as to have a clearly defined end point.  QT intervals 
were corrected for heart rate using the Framingham method(460): 
QTc = QT + 0.154x(1-RR) 
 
Figure 2.9: Measurable ECG parameters. 
Example rat ECG with the parameters of PR interval, QRS duration and QT intervals highlighted.  
For this thesis the QT90 and QT50 were also measured by taking the 90% and 50% repolarisation 
points of the T wave respectively to reproducibly determine an end point of T.  
2.5.4.2 Arrhythmia Classifications 
To maintain consistency and enable comparison with available literature 
arrhythmias were classified according to the Lambeth Conventions(437).  
Specifically, ventricular premature complexes (VPCs) were defined as discrete 
and identifiable premature QRS complexes (premature in relation to the P 
wave).  Bigeminy, defined as alternating P-QRS, VPC, is classed as a distinct 
variant of VPC.  Runs of 2-3 VPCs were defined as salvos, >4 as ventricular 
tachycardia (VT).  Ventricular fibrillation (VF) was defined as a signal from which 
individual QRS complexes cannot be distinguished and a rate cannot be 
measured.  Occurrence of VPCs as defined was counted and expressed as the 
number of events per min.  The VPC is premature in relation to the P wave and 
has an identifiable QRS shape although wider (Figure 2.10).  
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Figure 2.10: ECG recording of a rat heart with VPC. 
Example recording from a rat heart in Langendorff perfusion.  The trace shows and example of a 
premature complex in relation to the P wave.  The complex resembles a QRS but is wide and 
bizarre. 
2.6 Measuring Intracellular Calcium 
2.6.1 Ca2+ Fluorophores for LASER-Scanning Confocal 
Microscopy 
In order to measure intracellular Ca2+ dynamics with LASER-Scanning Confocal 
Microscopy (LSCM), a suitable probe is required.  The conventional method is to 
use a Ca2+ sensitive fluorescent indicator or fluorophore(461), an excitable 
molecule with an affinity for the molecule or ion of interest; Ca2+ in the case of 
the work presented in this thesis.  Numerous fluorophores have been 
developed(462).  They have different Ca2+ affinities and excitation/emission 
spectra such as the non-ratiometric rhod and fluo dyes(462) and the ratiometric 
indo and fura dyes(463).  The principle of fluorescence imaging is that the 
fluorescent molecule is loaded into cells and bind to the molecule/ion of 
interest.  The fluorophore contains electrons that are excitable at a specific 
energy or wavelength.  The cells are then subjected to electromagnetic 
radiation at that excitation wavelength.  High energy photons at the excitation 
wavelength (energy) of the fluorophore are absorbed and elevate the electrons 
from their ground state to a higher energy level.  After a time in the order of the 
nanosecond range(464) the electrons fall to their original ground state after 
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internal conversion releasing photons of lower energy or wavelength than the 
original photon (Figure 2.11). 
 
 
Figure 2.11: Schematic of fluorescence 
High energy photons excite electrons of the fluorophore from the ground state to the higher energy 
excited state.  Internal conversion de-excites the electrons without emitting radiation, this takes ≈ 
10-14 – 10-10s before the electron returns to its ground state by emission of another photon, this time 
at a lower energy.  Imaging techniques can be used to excite fluorophores at one wavelength and 
collect emission light at a longer wavelength. 
For LSCM (section 2.7), a fluorophore excitable at an operational wavelength is 
needed.  The LSCM has an argon-LASER that operates in the blue region of the 
electromagnetic spectrum, specifically an optimum wavelength of 488 nm(465).  
Ca2+ sensitive fluorophores have been developed that excite at this wavelength 
such as fluo-3(462). 
Excited State 
Ground State 
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Figure 2.12: Emission spectrum for fluo-3 
Emission spectra for different global intracellular concentrations of Ca2+ ([Ca2+]i).  Concentrations 
marked in red are expected values for systolic and diastolic [Ca2+]i (466) making fluo-3 a good choice 
for intracellular Ca2+ imaging. (Figure from Invitrogen) 
Fluo-3 makes an ideal choice at normal global intracellular concentrations of 
Ca2+ ([Ca2+]i) as ~1.0µM, the expected [Ca2+]i  during systole(466), and 100 nM, the 
expected [Ca2+]i  for diastole(466).  Both fluorescence levels for systolic and 
diastolic [Ca2+]i are represented and a sufficient distance apart to give good 
resolution (Figure 2.12).  The optimal sensitivity of the fluorophore is most 
reliable at [Ca2+] closest to the dissociation constant (Kd)(467) which has been 
reported as 558 ± 14 nM in the case of fluo-3 in cardiomyocytes(468).  Lower 
affinity indicators can be used for higher expected [Ca2+]i without saturation(461). 
2.6.2 Loading Cardiomyocytes with Fluorophore 
It is necessary for the fluorophore to be able to enter the cell to measure [Ca2+]i.  
This can be achieved by methods such as microinjection, diffusion from patch-
clamp pipettes and ester loading(469).  Most fluorophores are cell impermeable so 
they can be modified with acetoxymethyl esters (AM) which results in an 
uncharged molecule which is cell permeable(470;471).  Once the AM fluorophore is 
within the cell, esterases cleave the AM moiety and the impermeable indicator 
remains inside the cell. 
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2.6.3 Disadvantages of Ca2+ Sensitive Fluorophores 
2.6.3.1 Ca2+ Buffering 
When using fluorophores it is important to consider disadvantages.  Since Ca2+ 
sensitive fluorophores function by binding Ca2+, high concentrations of the 
fluorophores can alter the Ca2+ buffering of the cell(472).  For experiments 
presented in this thesis the manufacturer’s recommended concentration of 5 µM 
of fluo-3 was used which should not significantly affect buffering for these 
experiments(473).  
2.6.3.2 Cytotoxicity 
Other disadvantages to be aware of are that some fluorophores can be cytotoxic 
resulting in inhibition of proliferation in some cell types(469).  However, the 
cardiomyocytes used in the studies presented here were not used for any other 
purpose following imaging.   
2.6.3.3 Photobleaching 
Excessive illumination of the fluorophores can lead to bleaching and production 
of Ca2+ insensitive forms of the fluorophores(474).  It is therefore important to 
reduce illumination to a level that limits photobleaching but maintains an 
adequate signal to noise ratio.  Signals from non-ratiometric dyes are more 
sensitive to the artefact of photobleaching than signals from ratiometric dyes, as 
a ratio of two wavelengths can control for bleaching(469).  However, ratiometric 
indicators can have the problem that photobleaching of the two excitation of 
emission wavelength maxima can occur at different rates(474).  For the LSCM 
experiments presented in this thesis the LASER power output was kept to 15%.  
For both LSCM and epifluorescence experiments the protocol length was kept as 
short as possible and freshly loaded cells used frequently to limit any 
photobleaching artefact. 
2.6.3.4 Compartmentalisation 
A particular problem of the fluorophores, especially AM loaded indicators, is 
compartmentalisation.  The indicators when bound to AM ester can not only 
easily cross the plasma membrane of cells but also cross organelle membranes 
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within the cell.  The indicator will be present at different concentrations within 
the organelles compared to cytosol(469).  There are many differences between 
cell type, loading conditions and type of indicator.  To try to limit 
compartmentalisation for these experiments loading temperature was kept at 
room temperature(475) and loading time was kept to 10 min. 
2.6.3.5 Dye leakage 
Over time the fluorophores can leak from the cells into the extracellular 
medium.  The leakage can be suppressed by low/room temperature(476-478) so the 
indicators were loaded at room temperature and LSCM experiments performed 
at room temperature. 
2.6.3.6 Differential Pathlength and Dye Loading 
Non-ratiometric indicators in particular are subject to the effect of differential 
pathlength and dye loading.  Differences in cellular morphology can cause 
heterogeneity in dye loading.  Emitted photons from different regions of the cell 
have different “paths” to the detector and therefore have different levels of 
quenching (Figure 2.13).  This can lead to apparent differences in [Ca2+]i, which 
are artefacts.  The simplest way to correct for this phenomenon is to ratio the 
raw fluorescence signal (F) with the baseline (F0)(479).  This method will only 
work if the cell does not change position.  In the case of contracting 
cardiomyocytes this is difficult, since the ends of the cell move.  To limit this, in 
the analysis for F/F0 ratio was calculated from a 20 pixel band adjacent to Ca2+ 
wave initiation point with the cell(296).  Alternatively, a ratiometric indicator can 
be used, which controls for movement and differential dye loads.  In the case of 
Fura dyes, there are two excitation wavelength maxima from which the ratio 
between the two is calculated.  Any changes of pathlength or dye loading 
happen to the dye and so both wavelengths will be affected equally so the ratio 
will not change.  Unfortunately there are no available ratiometric indicators 
with an appropriate excitation/emission spectrum for use with an argon LASER 
for LASER-scanning confocal microscopy. 
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Figure 2.13: Diagram of differences in resting fluorescence signals due to different path lengths. 
Differences in cell morphology can lead to alterations of fluorescence quenching from photons 
following different pathlengths.  This can lead to artefacts in [Ca2+]i assessment if the ratio of F/F0 is 
not taken.  
2.6.4 Ratiometric Ca2+ Fluorophores for Epifluorescence 
Microscopy 
To measure the stimulated Ca2+ transient Fura-2 and Fura-4 were used.  In 
contrast with Fluo-3, the Fura dyes are ratiometric.  Ratiometric dyes can either 
have two excitation (Fura) or two emission wavelength maxima (Indo)(463).  The 
major advantage of using a ratiometric dye is that differential pathlength 
(Figure 2.13) and differences in dye loading are corrected for.  In the case of 
Fura dyes there are two peaks of excitation at 340 nm and 380 nm for Ca2+ 
bound and unbound, respectively, and emission at 510nm (Figure 2.14 Figure 
2.15).  When Ca2+ is released from the sarcoplasmic reticulum (SR) during systole 
[Ca2+]i it binds to fluorophore in the cytosol and is excited by 340 nm light.  
During diastole, when Ca2+ is taken back up into the SR, the [Ca2+]i drops below 
the Kd and Ca2+ dissociates from the dye.  The unbound dye is excited by 380 nm 
light so the 340 nm signal reduces and the 380 nm signal increases.  When the 
ratio of 340/380 nm is calculated the transient rises and falls with the release 
and reuptake of Ca2+.  As with the Fluo dyes there are different Fura dyes with 
different affinities.  For greater resolution at lower [Ca2+]i, such as diastolic 
[Ca2+]i, or low amplitude Ca2+ waves a higher affinity dye is more useful, such as 
Fura-2 with a Kd of 181 ± 52 nM(480).  For higher [Ca2+]i a lower affinity dye such 
as Fura-4F with a Kd of 1.16 ± 0.016 µM is more useful(480). 
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Figure 2.14: Emission spectrum for Fura-2. 
Emission spectra for different global intracellular concentrations of Ca2+ ([Ca2+]i).  In contrast with 
Fluo-3 the spectrum has two excitation peaks for Ca2+ bound dye (green arrow) and unbound dye 
(purple arrow). Concentrations marked in red are expected values for systolic and diastolic 
[Ca2+]i(466) making fura-2 a good choice for intracellular Ca2+ imaging closer to diastolic or minimum 
[Ca2+]i. (Figure from Invitrogen). 
 
 
Figure 2.15: Emission spectrum for Fura-4F. 
Emission spectra for different global intracellular concentrations of Ca2+ ([Ca2+]i).  The two 
excitation peaks for Ca2+ bound dye (green arrow) and unbound dye (purple arrow) are shown. 
Concentrations marked in red are expected values for systolic and diastolic [Ca2+]i(466) making fura-
4F a good choice for intracellular Ca2+ imaging closer to systolic or peak [Ca2+]i. (Figure from 
Invitrogen).  
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2.7 Imaging Ca2+ with LASER-Scanning Confocal 
Microscopy 
2.7.1 Principles of Image Collection 
Adult rat left ventricular cardiomyocytes were loaded with Fluo-3AM, excitable 
at 488 nm.  Once excited the emitted photons are >515 nm.  The confocal 
microscope has an Argon LASER with peak radiation intensity at 488 nm(465).  The 
LASER light at the excitation wavelength is passed through a series of 
dichromatic mirrors, which reflect wavelengths shorter than the determined 
wavelength and allow longer wavelength light through.  The excitation LASER 
light is reflected through scanning mirrors that continually rotate through the x 
and y dimensions in an arc.  This allows the user to set the scan dimensions and 
scan the whole specimen or specific regions.  The directed excitation light is 
focussed onto the specimen through the objective lens of the microscope (Figure 
2.16A).  Emitted light from the excited fluorophore within the specimen is 
collected through the objective lens and de-scanned by the rotating scan mirror 
i.e. allowing the emitted light to return on the excitation path to the 
dichromatic mirrors.  The light then passes through the dichromatic mirrors as it 
is now a lower energy and longer wavelength and hits the photo detector, in this 
case a photo multiplier tube (PMT).  A pinhole allows only light from the in-focus 
focal plane of the specimen; all other focal plane light is blocked (Figure 2.16B).  
As out of focus emission light is rejected, only fluorescence from the focal plane 
is detected so the interfering fluorescence from the rest of the cell is 
eliminated.  This allows for a much better estimation of fluorescence, thus 
[Ca2+]i, in the area of interest.  
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Figure 2.16: Principles of LASER-scanning confocal microscopy 
(A) Excitation of fluorophore within the cell.  The LASER emits light at the excitation wavelength 
(488 nm) passed through a series of dichromatic mirrors (one shown for simplicity).  The scanning 
mirror directs the beam through x and y axes to scan the specimen.  (B) The dichromatic mirrors 
reflect wavelengths shorter than the determined wavelength and allow longer wavelengths through.  
Emitted light at a longer wavelength (>515 nm from Fluo-3) passes through the dichromatic mirror.  
A pinhole at the photo detector allows only light from the plane of focus through to the detector to 
give a more accurate estimation of dye fluorescence without interference from other focal depths. 
2.7.2 Spatial and Temporal Resolution 
Since the image is generated by scanning a LASER across the specimen point by 
point it takes a period of time, so the whole cell is never imaged at any one 
time.  This presents a problem when trying to capture relatively short-lived 
events such as spontaneous releases of Ca2+.  Conventional images generated are 
512 x 512 pixel arrays.  The typical speed of scan is 500 lines per second so a 
5122 array takes approximately 1s to acquire.  This time can be reduced by 
reducing the area scanned or bi-directional scanning.  The spatial resolution is 
less straight forward due to the effects of diffraction.  Due to the diffraction of 
light a point source of light cannot be imaged as a single intense point, instead it 
has an intense peak with peaks and troughs of intensity rippling outward, called 
the Airy disc.  The resolution of the image can be determined from the 
wavelength of the light and the numerical aperture (NA) of the lens.  A lens with 
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higher NA has greater light capturing efficiency(481) and is defined by half the 
angle of the collection cone (θ) and the refractive index of the immersion 
medium (n) to give: NA = nsinθ.  The x-y resolution can then be calculated using 
the Rayleigh/Abbe formula(482): 
 r = 0.61λ/NA 
where r is the radius of the Airy disc between intensity peak and first zero.  
Images for this thesis were collected using a Zeiss LSM 510 with a 63x 1.2 NA 
water immersion lens.  Therefore we can calculate the size of the Airy disc and 
x-y resolution at 515 nm as 0.52 µm.  In the z dimension or axial resolution the 
formula is(482): 
r = 2λ/nsin2θ 
using the same λ and NA we get a z resolution of 0.72 µm.  The pinhole aperture 
was set to 1.0 Airy unit to improve axial resolution.  This ensures that only the 
first order maxima of the diffraction pattern are accepted into the photo 
detector.  If the pinhole aperture were set to >1.0 Airy unit then second order or 
greater maxima of the diffraction pattern would be allowed through leading to 
loss of resolution.  The trade-off by reducing the light permitted through is a loss 
of image brightness.  
2.7.3 Image Acquisition 
The depth of scan for confocal imaging systems at visible wavelengths is up to 40 
µm, beyond this spherical aberration is a problem i.e. the image becomes 
distorted by the surface geometry of the lens(483).  This is suitable for isolated 
ventricular cardiomyocytes having a typical depth of ~20 µm.  Ca2+ waves can 
occur at frequencies greater than the scan time and so be missed or only 
partially resolved if LSCM scanning speed is 1 frame.s-1.  Therefore Ca2+ wave 
imaging in this thesis was performed using a different technique.  The scan area 
was reduced to a single line which the LASER scans back and forth.  This 
technique is referred to as line-scanning.  Each scan progresses across the region 
of interest selected by the user to give length across the cell in the x dimension.  
Each pass of the LASER adds a line of pixels in the y dimension to give time 
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producing a “waterfall” image.  Each pixel in the images produced equates to 
0.27 µm in x and 3.07 ms in y.  The scanning LASER line was orientated parallel 
with the long axis of the cell (Figure 2.17A) and placed approximately 
equidistant between the outer edge of the cell and the nucleus/nuclei to ensure 
the nuclear area was not included in the scan line and alter the fluorescence 
signal(296).   
 
Figure 2.17: Line-scan confocal imaging. 
(A) Isolated cardiomyocyte loaded with Fluo-3 dye.  The yellow line indicates the scan dimension 
selected by the user.  Care is taken to ensure the nucleus (green ellipse) is not included in the scan 
line.  (B) The same cell imaged in standard light transmission mode with the scan line denoted by 
the dotted line.  Note that the nucleus is not clearly visible.  (C) Section of a waterfall image 
showing a Ca2+ wave in progress with distance across the cell in the x dimension and time in the y 
dimension.  The cell is typically scanned for 1min which equates to 30,000 scans. 
2.7.4 Image Analysis 
Images were acquired using the Zeiss LSM 510 imaging system and software.  
Waterfall images were exported to ImageJ (National Institutes of Health, USA) 
and converted to greyscale TIFF files.  These files were de-compressed in Paint 
Shop Pro 5 (Corel) where wave velocity was calculated by measuring the 
difference in pixel co-ordinates between initiation point and end point of each 
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wave and calculating the wave propagation gradient.  Uncompressed TIFF files 
were processed in a programme written by Dr. Francis Burton (Nbands) that 
measures the mean fluorescence output from a 20 pixel band defined by the 
user.  This output file was imported into the graph analysis software Origin6.1 
(OriginLab).  The baseline fluorescence F0 was measured from each trace and 
applied to the raw data to give the F/F0.  Data are expressed as the ratio of 
F/F0. 
2.8 Imaging Ca2+ with Ratiometric Epifluorescence 
Imaging 
2.8.1 Principles of Epifluorescence Microscopy 
Essentially the technique is very similar to LSCM.  The Ca2+ fluorophores used in 
these experiments was ratiometric, i.e. difference wavelengths of excitation 
depending on whether the dye Ca2+ bound or not (section 2.6.4).  For the 
experiments in this thesis Fura-2 and Fura-4F were used.  Both have excitation 
wavelengths of 340 nm and 380 nm (Ca2+ bound and unbound) so the confocal 
LASER source is not appropriate.  Therefore the fluorophore was excited with a 
mercury vapour arc lamp with a spinning wheel monochromator (Cairn 
Research).  Within the unit a diffraction grating splits the white light into its 
constituent wavelengths.  A spinning disc of excitation filters switches rapidly 
between the two excitation wavelengths alternating between 340 nm and 380 
nm at a rate of 250 Hz.  A dichromatic mirror reflects the excitation light 
through the objective to illuminate and excite the fluorophore epifluorescently 
in the specimen on the microscope stage.  The emitted light at a longer 
wavelength of 510 nm is allowed to pass through the dichromatic mirror to be 
detected by the PMT (Figure 2.18). 
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Figure 2.18: Epifluorescence imaging. 
Multispectral light is emitted by the mercury vapour arc lamp.  Collimating mirrors reflect the light 
onto a diffraction grating which splits the light into its component wavelengths.  These are then 
collimated and pass through an excitation wavelength filter.  The user can define the wavelengths 
with many filters in the monochromator unit.  For excitation of Fura dyes excitation wavelengths of 
340 nm and 380 nm (ultraviolet – shown in blue and purple) were required.  A spinning wheel 
enables rapid switching between the two wavelengths.  The dichromatic mirrors (one shown for 
simplicity) reflect light of wavelengths shorter than the user selected wavelength through the 
objective lens of the microscope to illuminate the specimen epifluorescently and excite the 
fluorophore.  Emitted light (at 510 nm) (shown in green) is collected by the objective lens and 
passes through the dichromatic mirrors which allow light of longer wavelengths than selected 
through to the PMT photo detector.   
In contrast with LSCM light from the whole specimen is collected from different 
focal planes rather than a single point.  In these experiments we are interested 
in the global change in [Ca2+]i so the resolution of a single scanning point is not 
necessary. 
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2.8.2 Data Acquisition and Analysis 
Isolated cardiomyocytes were loaded with 5 µM Fura-2AM or Fura-4F-AM for 
10min.  The cells were then diluted with test solution (see individual chapter 
methods for details) and incubated for 30 min.  This step allowed de-
esterification of the fluorophore as well as incubating the cells with test 
solution.  Cardiomyocytes were then loaded into a tissue bath (Cell 
Microcontrols) and superfused with test solutions at 37 ºC by gravity fed 
perfusion pen with active pump outflow.  Cells were field stimulated with 2.0 ms 
duration voltage pulses delivered through parallel platinum wires (stimulation 
voltage set to 1.5 times the threshold).  The stimulation simulates the action 
potential that depolarizes the sarcolemma leading to the Ca2+ release and 
reuptake cycle (section 1.4).  When the Fura dye is excited (section 2.6.4), the 
output signal is detected sequentially for each excitation wavelength by the 
PMT.  The output signal is sent to an oscilloscope for visualisation of the signals 
and an analogue to digital converter (Axon Instruments).  The signal is sampled 
at 5000 Hz to generate a trace for each excitation wavelength using Clampex 
10.3 (Axon) and the ratio 340/380 calculated online.  The ratio trace is the 
change is fluorescence corrected for movement artefact, differential dye-
loading and differential pathlengths (section 2.6.4.).  From the ratio trace it is 
possible to calculate [Ca2+]i using the following(463): 
[Ca2+] = Kd x β(R – RMin)/(RMax – R) 
Kd is the dissociation constant of the dye.  β is the relative change in 
fluorescence between zero and saturating [Ca2+] at 380 nm.  R is the ratio signal.  
RMin is the minimum ratio before stimulation, which was reduced by 10% to 
account for the higher diastolic [Ca2+]I in rat cardiomyocytes.  RMax is the 
saturation fluorescence achieved by killing the cell with a sharp micropipette at 
the end of the protocol to release Ca2+ bound dye to give maximum signal.  RMin 
and RMax were determined for each cell. β was measured by Dr. Chris Loughrey 
when the system was set-up and calibrated.  For Fura-2 Kdβ = 1.2 x10-6 and for 
Fura-4F Kdβ = 2.8 x10-6. 
Data were plotted in Origin6.1 (OriginLab) and converted to [Ca2+], which is the 
Ca2+ transient.  Average transients were calculated using macros written by Prof. 
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Godfrey Smith, University of Glasgow.  Differentiation plots and exponential 
decay functions were calculated using the software’s own functions. 
2.9 Dissection of T. brucei Mechanism 
2.9.1 Specific Protease Inhibitors 
T. brucei secretes a cathepsin-L-like cysteine protease that induces Ca2+ 
signalling in the endothelial cells of a blood brain barrier model(69).  Given the 
importance of Ca2+ signalling in excitation-contraction coupling of the heart it 
was prudent to test if a cysteine protease could be affecting Ca2+ in 
cardiomyocytes.  The cysteine protease activity of T. brucei  consists of two 
cysteine proteases TbCatL and TbCatB(112) so specific protease inhibitors for 
TbCatL and TbCatB were tested.  K11777 (N-methyl-piperazine-Phe-homoPhe-
vinylsulfone-phenyl) has been developed and used against the cathepsin-L-like 
cysteine protease of the related parasite T. cruzi(484;485) and TbCatL(69).  Figure 
2.19 shows the chemical structure and irreversible binding of K11777 to the 
active site of TbCatL.  By blocking the active site of TbCatL, it is unable to act 
as a protease and cleave proteins.  The reported IC50 of K11777 is 0.06 µM(484) so 
K11777 was added in excess at a concentration of 10 µM to control media and 
supernatant and spontaneous contractile events in cardiomyocytes measured as 
described above (section 2.4). 
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Figure 2.19: Structure and binding of K11777. 
(A) Structural representation of K11777 shows the interacting domains, P1, P1’, P2 and P3. (B) 
Representation of K11777 in the active site of TbCatL.  The hydrophobic regions in light green are 
pockets for the interacting domains of K11777 appropriately labelled.  The dark green area shows 
where the polar residues of TbCatL interact with the ligand forming a non-polar C-C bond. (Figure 
adapted from Kerr et al. (2009)(485). 
CA074 (L-3-trans-(propylcarbamyl)oxirane-2-carbonyl)-L-isoleucyl-L-proline) has 
been used to inhibit TbCatB(69;486).  Figure 2.20 shows the chemical structure and 
irreversible binding to the active site of TbCatB blocking its protease action.  
CA074 has an IC50 of 2.24 nM(487), and was added to control media and 
supernatant at a concentration of 10 µM and a population assay performed as 
described above (section 2.4).  
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Figure 2.20: Structure and binding of CA074. 
(A) Structural representation of CA074. (B) (left) Representation of CA074 in the active site of 
TbCatB.  The hydrophobic regions in purple are pockets for the interacting domains of CA074.  (B) 
(right) CA074 interactions with residues in the active site of CA074. (Figure adapted from Kerr et al. 
(2010)(486). 
2.9.2 Recombinant T. brucei Cathepsin-L 
2.9.2.1 Manufacture of T. brucei Cathepsin-L 
Recombinant TbCatL was kindly donated by Dr. Ana-Paula C. A. Lima of Instituto 
de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro and 
Prof. James H. McKerrow, University of California San Francisco Medical School.  
Recombinant TbCatL was stored at-80 ºC and activated with the reducing agent 
dithiothreitol (DTT) (concentration determined by enzyme activity assay 
described below) prior to each use. 
2.9.2.2 Recombinant TbCatL Activity Assays 
The activity of the recombinant TbCatL can be measured by the cleavage of a 
fluorogenic substrate and subsequent measurement of the fluorescence on a 
spectrophotometer.  The fluorogenic peptidyl substrate benzyloxycarbonyl-
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phenylalanyl-arginine-7-amido-4-methyl-coumarin (Z-FR-AMC) has been used to 
test activity in TbCatL and shown to be effective with 120 M substrate converted 
by 1 M TbCatL min-1 with a peak activity at pH 5.0(129).  The substrate Z-leucine-
arginine-AMC (Z-LR-AMC) was also effective at converting 130 M.min-1 at pH 
6.0(129). TbCatL recognises the phenylalanyl-arginine residue of the substrate and 
cleaves the fluorogenic AMC moiety.  In a spectrophotometer (Wallac Envision) 
reaction wells in a black background light-absorbent 96 well plate (Corning) are 
exposed to light at the excitation wavelength of 360 nm (Figure 2.21).  Light at 
the emission wavelength of 480 nm is detected by a photo multiplier tube and 
recorded as arbitrary units of fluorescence (section 2.6.1 for details on 
fluorescence).   
 
Figure 2.21: Schematic of a fluorogenic activity assay. 
Z-FR-AMC substrate is not fluorescent until cleaved.  TbCatL recognises the phenylalanyl-arginine 
(FR) residues and cleaves the fluorescent 7-amido-4-methyl-coumarin (AMC) moiety.  Excitation 
light at 360 nm excites the AMC which emits at 480 nm.  The change in fluorescence from baseline 
is an indicator of enzyme activity.  
Using a similar method to that described in Caffrey et al. (2001)(129), 
recombinant TbCatL was diluted to 0.1 µg.mL-1 in assay buffer (0.1 M NaOAc pH 
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5.5 plus DTT at 0.1, 0.5, 1.0 and 2.0 mM).  Enzyme in assay buffer or assay 
buffer without enzyme as a blank control (100 µL) was added to 20 µM 
fluorogenic substrate in the 100 µL of assay buffer in triplicate in a 96 well black 
plate, and measured in a spectrophotometer at 37 ºC at excitation and emission 
frequencies of 360 and 480 nm for 30 min.  The relative fluorescence of the 
blank control with the appropriate concentration of DTT was subtracted and 
plotted as arbitrary relative fluorescence units (Figure 2.22A(i)).  The mean 
activity curves were differentiated to give the peak rate of conversion.  DTT at 
1.0 and 2.0 mM showed the maximal activity of the enzyme; (218 vs. 2278 vs. 
5040 vs. 6548 vs. 6560 units.s-1; 0 vs. 0.1 vs. 0.5 vs. 1.0 vs. 2.0 mM DTT; Figure 
2.22A(ii)). 
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Figure 2.22: Activity assays and cardiomyocyte population assay to test activating quantity of DTT 
for TbCatL. 
(A) (i) Activity assay with 0.1 µg.mL-1 TbCatL in 0.1 M NaOAc and 20 µM fluorogenic substrate Z-
FR-AMC at 0, 0.1, 0.5, 1.0 and 2.0 mM DTT.  Data are plotted as mean ± SEM curves (n=3) of 
arbitrary relative fluorescence units. (ii) Maximum rate of conversion of substrate by 0.1 µg.mL-1 
TbCatL as fluorescence units.s-1 by differentiation of the curves in (i).  (B) Population assay of adult 
rat left ventricular cardiomyocytes in media with different concentrations of DTT.  Data are 
expressed as mean ± SEM. n = number of cells from (isolations).  Statistics were performed by 
multiple linear regression analysis and P≤0.05 considered significant. 
2.9.2.3 Assessment of DTT Effects on Cardiomyocyte Spontaneous 
Contractile Events 
A cohort of cardiomyocyte population assays was performed with different 
concentrations of DTT to test that concentrations of DTT necessary for 
recombinant CatL activation did not have a significant effect on spontaneous 
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Ca2+ release.  Briefly, cardiomyocytes were prepared as above (section 2.3.1) 
and incubated with control media (section 2.1.1) with 0.5, 1.0 and 2.0 mM DTT.  
Cells were loaded into a tissue bath and viewed through a 10x objective lens and 
10 fields of ~10 rod-shaped cardiomyocytes were viewed for 1 min per field.  
The numbers of cells showing spontaneous contractile events per min were 
recorded and expressed as percentage change over media control.  Trypanosome 
culture supernatant was tested alongside as a positive control for differential 
contractility when compared to DTT.  Supernatant showed a significant increase 
over control as expected (Chapter 3) (100 ± 4.1 vs. 129.3 ± 4.1%; control (n = 
1051 cells from 8 hearts) vs. Supernatant (n = 1232 cells from 8 hearts; P<0.05).  
DTT had no significant effect compared to control; (109.0 ± 4.7, vs. 94.9 ± 14.8 
vs. 102.4 ± 16.3%, 2 mM DTT (n = 1013 cells from 8 hearts) vs. 1 mM DTT (n = 874 
cells from 7 hearts) vs. 0.5 mM DTT (n = 852 cells from 7 hearts); P>0.05 when 
compared to control media; Figure 2.22B).  When compared to supernatant 
there was still a significant difference (P = 0.05).  Therefore an activating 
concentration of 2.0 mM DTT results in maximal recombinant TbCatL activation 
without having a significant effect on the cardiomyocytes. 
2.9.2.4 Recombinant TbCatL in Cardiomyocyte Spontaneous Contractile 
Event Measurements 
Recombinant TbCatL was prepared by adding at a dilution factor of 1:50 (volume 
of 8 µL) to 300 µL control media (as described in section 2.1), 100 µL of 
cardiomyocytes in MIKH and 4 µL of 0.1 M DTT giving a final concentration of 2 
mM DTT.  The 1:50 dilution of TbCatL gave a final concentration of 2 nM TbCatL 
as used in Caffrey et al. (2001)(129).  The solution was incubated at room 
temperature for a period of 30 min to allow the DTT to activate the TbCatL and 
for the cardiomyocytes to be exposed to the active TbCatL, as with the 
supernatant and control media experiments described above (section 2.4).  The 
percentage of cardiomyocytes exhibiting at least one spontaneous contractile 
event min-1 was measured.  
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2.9.3 RNA Interference of T. brucei Cathepsin-L 
2.9.3.1 RNA Interference  
RNA interference (RNAi) was performed in Trypanosoma brucei brucei 2T1 (a cell 
line derived from bloodstream form Lister 427)(488).  The trypanosomes were 
transfected with the plasmid pTL107 (an extrachromosomal circular piece of 
DNA from which genes of interest may be expressed), which was derived from 
the commercial plasmid pGL2084, a Gateway® (Invitrogen) modified version of 
the plasmid pRPaisl(489).  The pTL107 plasmid contains a tetracycline inducible 
stem-loop RNAi cassette and target region of the gene of interest, TbCatL.  The 
target region of the TbCatL gene contained in pTL107 corresponded to 
nucleotides 409-986 of the open reading frame, with the following 
oligonucleotides used to generate the TbCatL gene construct; forward 5’-GGG 
GAC AAG TTT GTA CAA AAA AGC AGG CTG CAG TGA CCC CAG TGA AGG A-3’ and 
reverse 5’-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTA GAC ATT GGT TTG 
TGC CCT T-3’.  Trypanosomes containing this construct were kindly 
manufactured and provided for use in this study by Nathaniel Jones, University 
of Glasgow.  The trypanosomes containing the plasmid were selectively 
maintained in culture with modified HMI-9 by addition of 2.5 µg.mL-1 hygromycin 
and 0.5 µg.mL-1 phleomycin as the RNAi plasmid had resistance genes to these 
antimicrobials so that successful transfectants can be selectively maintained.  
Addition of 1.0 µg.mL-1 tetracycline induced the transcription of the RNAi 
cassette providing a dsRNA stem in the stem-loop construct homologous to 
TbCatL.  RNAi induction was performed in two independent biological 
duplicates.  Using two independent clones controlled for replication of 
phenotype upon RNAi induction over two independent transfection events i.e. 
the phenotype observed was not a random effect of the transfection, but due to 
inducible interference of TbCatL. 
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Figure 2.23: The RNAi pathway in Trypanosomatids 
The mechanism by which dsRNA (or dsRNA in the stem of stem-loop constructs) is recognised and 
cleaved into 25 nucleotide segments is governed by the RNase III-related enzyme Dicer.  The 
small interfering RNA (siRNA) fragments are unwound to form single-stranded RNAs (ssRNA) by 
RNase-H-containing protein that belongs to the argonaute (AGO1) family or Slicer.  The ssRNAs 
display sequences recognised by the messenger RNA (mRNA) transcribed from the gene of 
interest which are then specifically targeted and degraded before translation. (Redrawn from 
Balana-Fouce and Reguera(490)).   
The parasite’s inherent RNAi system recognises the double-stranded RNA (dsRNA) 
via the recently characterised RNase III-related enzyme Dicer(491), which then 
degrades dsRNA into small interfering RNAs (siRNA) 25 nucleotides in length.   A 
second enzyme belonging to the argonaute (AGO) family (‘slicer’) recognises and 
binds the siRNA, unwinds it to form single-stranded RNA (ssRNA), which then 
binds to homologous sequences in the messenger RNA of the gene of interest, 
TbCatL in this case.  The TbCatL mRNA is then degraded by the trypanosomes’ 
inherent degradation mechanisms (Figure 2.23)(490). 
Chapter 3  The Effects of Trypanosoma brucei  144 
 
2.9.3.2 Growth Curves 
The RNAi specificity and degree of TbCatL knockdown was tested in the two 
independent biological duplicates.  RNAi was induced with 1 µg.mL-1 tetracycline 
and growth curves performed on induced vs. uninduced cultures in triplicate for 
the two biological duplicates.  Cultures for growth curves were initiated with 1.0 
x 105 parasites.mL-1 in modified HMI-9 with the addition of hygromycin and 
phleomycin as above.  The cultures were counted in triplicate with an improved 
Neubauer haemocytometer (section 2.1.1) at 24, 48 and 72 hr time points post-
induction.  The cultures were reseeded every 24 hrs as a 1:10 dilution into fresh 
modified HMI-9 media with added antimicrobials to ensure a sufficient quantity 
of parasites to count accurately without overgrowth of the culture.  It has been 
shown that TbCatL is essential for growth of the parasite(492) so successful 
induction of RNAi should manifest as a negative growth phenotype.   
2.9.3.3 Real time Quantitative PCR to Confirm Inhibition of TbCatL 
Expression 
During RNA interference the mRNA for the gene of interest becomes degraded 
(Figure 2.23).  In order to test the efficiency of the RNAi it is possible to 
indirectly measure the amount of mRNA by using the quantitative Real-Time 
Polymerase Chain Reaction (qRT-PCR).  RNA cannot serve as a template for PCR 
as the technique only works on double stranded DNA.  Therefore, the mRNA 
must be converted to double-stranded complementary DNA (cDNA) by a method 
called reverse transcription.  The qRT-PCR is then performed on the cDNA. 
2.9.3.3.1 RNA Extraction 
The process of RNA extraction is complicated by the presence of ribonuclease 
enzymes (RNases) which are ubiquitous in the environment on skin of the user 
and often the laboratory bench and can rapidly degrade a sample.  To minimise 
the risk of degradation the work area was cleaned with 70% ethanol and use of 
RNaseZap™ (Ambion), which destroys environmental RNases.  Gloves and 
equipment (e.g. pipettes) were treated with RNaseZap.  Tubes and pipette tips 
certified as RNase/DNase free were used throughout the extraction protocol.  
RNA was extracted from parallel cultures (section 2.9.3.2) grown to 5.0 x 105 
parasites.mL-1 in 10 mL culture (5.0 x106 parasites) using the RNeasy® (QIAgen) 
kit.  Parasites were pelleted by centrifugation at 1,500 g for 10 min.  The cells 
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were lysed with a buffer containing guanidine-isothiocyanate and β-
mercaptoethanol, which disrupts the cell membranes releasing the cellular 
contents into the lysate and inactivates RNases that could degrade the RNA.  The 
lysate was homogenised by passing ≥5x through a 23-guage needle.  One volume 
of 70% ethanol was added to the lysate and mixed by pipetting.  The ethanol 
provides the appropriate conditions for RNA binding in the next step.  The 
ethanol/lysate mixture was added 700 µL at a time to a spin-column with an RNA 
binding silica membrane and centrifuged for 15 s at ≥8,000 g.  The column was 
retained and the flow-through discarded.  The column was then washed with 
proprietary buffers (RWT and RPE) designed to support RNA binding and wash out 
contaminants such as intracellular proteins.  A final centrifugation step dried the 
column removing any remaining ethanol.  The dry column was then placed in a 
sterile RNase free collection tube and 30 µL RNase free water added to the 
column and centrifuged for 1 min at 8,000 g.  The water neutralises the pH and 
reduces the RNA-binding affinity to the membrane thus eluting the RNA(493).  RNA 
quantity was measured by absorbance of 220-320 nm wavelength light in a 
microvolume spectrophotometer (Nanodrop ND-1000, Thermo Scientific).  The 
relationship of concentration of nucleic acid and absorbance is linear (Beer-
Lambert Law), which therefore enables a readout on-screen of the RNA 
concentration in the sample as ng.µL-1. 
2.9.3.3.2 Synthesis of cDNA  
For qRT-PCR the RNA must be transcribed to its complementary DNA (cDNA).  
This is initiated by an oligonucleotide primer of poly-thymine (oligo-dT primers) 
that binds to the polyadenylated tail of the mRNA.  The primers then direct the 
reverse transcriptase (RT) to synthesise a single strand of cDNA using dNTPs 
(adenine (A), thymine (T), cytosine (C) and guanine (G)).  This forms an 
mRNA/DNA hybrid.  To make the cDNA double-stranded the mRNA is degraded 
which is achieved by RNase H.  The remaining single-stranded DNA forms a 
hairpin loop due to hydrophobic interactions and serves as the primer for the 
second complementary strand by a DNA-dependent DNA polymerase (Figure 
2.24). 
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Figure 2.24: Synthesis of cDNA by reverse transcription. 
Oligo-dT primers recognise and bind to poly-adenylated tail of mRNA.  Reverse transcriptase 
transcribes the mRNA into complimentary strand of DNA.  RNase H degrades the mRNA and the 
remaining ssDNA acts as primer for DNA polymerase to synthesise the remaining strand to 
produce dsDNA complimentary to the original mRNA in the sample.   
For preparation of cDNA, approximately 1.0 µg of total RNA was treated with 
DNaseI (TURBO DNase (Ambion)) to remove any contaminating genomic DNA.  
Samples were incubated in a reaction volume of 25 µL (containing 2.5 µL of 10x 
enzyme buffer and 1 µL DNase) for 25 min at 37 ºC.  Following the incubation, 
2.5 µL of a DNase inhibitor was added to stop the reaction.  
Reverse transcription was carried out using the Omniscript RT kit (Qiagen) with 
5.0 μM of each oligo dT primer (QIAgen).  The kit contains the reverse 
transcriptase (RT), dNTPs and an enzyme buffer containing Mg2+ for optimal 
enzyme activity.  The Omniscript RT kit performs three functions: i) RNA-
dependent reverse transcription to form the first cDNA strand from the mRNA, ii) 
RNase H activity to degrade the mRNA and iii) DNA dependent polymerase to 
synthesise dsDNA from the ssDNA.  An additional RNase inhibitor (RNase-Out 
(Invitrogen) was added to protect samples (Table 2.2), which according to the 
manufacturer does not affect the RNase H capability of the Omniscript RT.  A 
parallel reaction was carried out without RT to confirm successful cDNA 
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synthesis and rule-out genomic DNA contamination.  This process creates cDNA 
for all mRNA in the sample.   
To measure the gene of interest PCR must be performed. 
Table 2.2: Reverse Transcription Reaction Components 
Component Volume (per reaction) Final Concentration 
10x RT Buffer 5.0 µL 1x 
dNTP mix (5 mM each) 5.0 µL 0.5 mM per dNTP 
Oligo-dT primer (10 mM) 5.0 µL 1 µM 
RNaseOut (10 units.µL-1) 2.5 µL 25 units 
Reverse Transcriptase 2.5 µL 10 units 
RNase free H2O Variable* To final volume of 50 µL 
RNA (1µg) Variable* 1 µg  
TOTAL 50 µL  
* Variable depending on concentration of RNA in sample.  Final volume made up with RNase free 
H2O. 
2.9.3.3.3 Quantitative RT-PCR 
The Polymerase Chain Reaction (PCR) works by taking a small quantity of target 
DNA and amplifying it to detectable quantities.  The amplification is a three step 
process: first by denaturing the dsDNA through heating (~90-98 ºC) to break the 
DNA into separate strands.  Secondly, short DNA sequences (primers), designed 
by the user, complementary to flanking regions of the gene of interest then 
anneal to the single strands when the temperature is reduced to 50-65 ºC.  
Thirdly, the samples are heated to 72-80 ºC to allow the DNA polymerase to 
synthesise complementary strands from added nucleotide bases (adenine, 
thymine, cytosine and guanine (dNTPs) directed by the primers.  The process is 
repeated 30-40 times, each step doubling the quantity of DNA for the gene of 
interest (Figure 2.25).  The requirements for a PCR reaction are: 
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Table 2.3: Components and functions of a PCR reaction. 
Component Function 
Buffer Maintains reaction mix at appropriate pH and provides Mg2+ 
for polymerase activity. 
Deoxynucleotide 
Triphosphates (dNTPs) 
Provide energy and nucleotides for the synthesis of DNA.  
Quantities are balanced to reduce mismatch errors. 
Specific Primers Short DNA sequences (20-30 nucleotides) that bind to 
complementary DNA sequences flanking the gene of interest 
and provide an initiation point for the polymerase to act 
Polymerase Heat stable enzyme that adds the complementary dNTP to 
the DNA template (A binds with T vv. C binds with G vv.)  
Template dsDNA Sample to be amplified 
 
When setting up the PCR heat cycler several stages must be programmed: 
1. Initiation: The reaction is heated to 90-98 ºC and held for up to 10 min.  
This step is required for full denaturation of the DNA. 
2. Denaturation: The reaction is heated to 90-98 ºC for up to 1 min to 
disrupt the hydrogen bonds between the complementary bases of the two 
DNA strands to separate them. 
3. Annealing: The reaction is cooled to 50-65 ºC for up to 1 min to allow the 
primers to bind to their complementary sequences on the ssDNA 
template.  The DNA polymerase then binds to the primer-template hybrid. 
4. Elongation: The reaction is heated to 72-80 ºC (for time determined by 
the length of sequence to be amplified).  The polymerase synthesises a 
new strand by adding dNTPs to the template strand in the 5’-3’ direction 
of the new strand (3’-5’ of the template) 
5. Cycle Repeats: Steps 2-4 are repeated 30-40 times to amplify the DNA 
product 
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6. Final Elongation: A final longer elongation step of up to 15min may be 
added to ensure any remaining ssDNA is completely extended. 
7. Final Hold: If further analysis is to be performed on the sample they can 
be held on the cycler plate at 4 ºC. 
Over the course of the 30-40 cycles the reaction goes through 3 phases.  The 
first phase is the exponential phase where there are sufficient reagents to 
amplify all the available templates in the annealing/elongation steps.  Beyond 
approximately cycle 15 the reaction enters the linear phase where reagents are 
diminishing.  The final phase is the plateau phase where all reagents have been 
consumed and no more products can be synthesised.  With conventional PCR the 
product is analysed at the end of the reaction so, depending on cycle number, is 
likely to be in the plateau phase.  Real-time PCR has the advantage of measuring 
the increase in product over the course of the reaction using fluorophore probes 
so determining the point at which the plateau is reached. 
For the PCR conducted in this thesis only qRT-PCR was performed.  The principle 
of qRT-PCR is that a DNA binding fluorophore fluoresces when bound and excited 
in the cycler unit so that the relative quantity of DNA can be measured.  There 
are several methods available; the SYBR green was employed in this thesis.  The 
SYBR green fluorophore binds to the minor groove of dsDNA.  As the reaction 
progresses more dsDNA is present so more dye is in a bound state and excitable. 
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Figure 2.25: Amplification of template DNA by PCR: 
Schematic of PCR showing (1) denaturation of DNA at 90-98 ºC, (2) annealing at 50-65 ºC and (3) 
elongation at 72-80 ºC. Black “ladders” represent template DNA to which blue primers anneal and 
green synthesised DNA elongates by DNA polymerase (blue ellipses).  The synthesised DNA is 
used as further template in the next cycle to amplify exponentially over the course of the reaction.  
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Samples and reagents were thawed and kept on ice.  Reactions were prepared in 
a laminar flow hood to minimise aerosol contamination and personal protective 
equipment was worn to prevent user contamination of samples.  Synthesised 
cDNA was diluted 1:5 with RNase/DNase free H2O to increase volume and 
decrease pipetting error and 100ng of cDNA (2 µL) per reaction well used.  The 
oligonucleotide primers used were designed by Dr. Liam Morrison, University of 
Glasgow and were: TbCatL forward 5’-TCT CGG ATA TGA CAC GTG AAG AGT-3’ 
and reverse 5’-TCT GCG CAG CTG CAA AGT-3’.  To offset individual reaction 
error from differing starting quantities of DNA the TbCatL product must be 
normalised to an endogenous control gene that is unlikely to be altered in 
quantity by the addition of the RNAi plasmid.  This allows small differences to be 
detected in gene expression as any over/under expression due simply to 
different starting template quantities will also be evident in the endogenous 
control gene.  Therefore, by using a stable endogenous control gene small 
changes in template concentration will also affect the endogenous gene by the 
same amount and so be removed when normalised.  As a result and subtle 
variations in the gene of interest without any change to endogenous gene can be 
accepted with greater confidence.  For example, if hypothetical samples A and B 
have different gene expressions, B is higher say, without an endogenous control 
it is not known whether B is truly higher, or if B had a higher starting quantity of 
template DNA.  But if a set of primers for an endogenous control gene is used on 
aliquots from the same samples and that control gene is stable under the 
experimental manipulation, i.e. RNAi in this case won’t alter its expression, then 
if B did have a greater starting concentration the endogenous control gene will 
also be increased.  So if the situation arose where B was actually increased and 
there was a higher concentration of template then the endogenous control 
would be raised but by a smaller amount than B.  Therefore when B was 
normalised sample B with endogenous primers the true change would become 
evident.  This does not control for pipetting error because each well on the plate 
is unique so triplicates of each sample and primer set should be performed, i.e. 
samples A and B need to be run in triplicate for both target gene primers and 
endogenous control primers, so 6 wells for each sample, 3 with target gene 
primers and 3 with endogenous control primers.  GPI-8 is a ubiquitously 
expressed transamidase that adds glycophosphatidylinositol (GPI) anchors to cell 
surface proteins(494), and was used as the endogenous control.  The primers 
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were: forward 5’-CGA AGC GCA TTT GGA TAG-3’ and reverse 5’-ACG GCG TGA 
TGA CAG TGA AG-3’. 
RT-PCRs were carried out in triplicate per individual sample, to control for 
pipetting error, on a 7500 Real-Time PCR system (Applied Biosystems), using 
approximately 100 ng cDNA, 1 x Power Sybr green master mix (Applied 
Biosystems) and 4.0 μM of the respective oligonucleotide primers, in a final 
reaction volume of 25 μL per well. The SYBR green mix contains the reporter 
fluorophore that binds to the dsDNA and reports the quantity, AmpliTaq Gold 
DNA polymerase, dNTPs and a ROX dye that is used to offset non-PCR related 
fluorescence.  The ROX dye is a passive reference dye, i.e. it does not change 
fluorescence during PCR, therefore is used as a control for potential changes in 
fluorescence due to non-PCR factors such as instrumentation variability, well 
volume and pipetting error.  The samples run were 3 separate cultures each of 
induced RNAi (1 µg.mL-1 tetracycline) and uninduced RNAi (no tetracycline) for 
both biological duplicates (STL 349 and STL 350).  Each was duplicated again 
with GPI-8 primers as endogenous normalisation control.  In parallel samples 
without template DNA (no template controls (NTCs) were also run as a control 
for contamination.  These are wells with identical components of primer and 
SYBR mix but no template DNA so that if any signal should be detected, there is 
cross-contamination of target DNA in the reaction components and the final 
result not be accepted. The samples and master mix of primers and SYBR mix 
were added to a 96-well plate and covered with an adhesive optical film to 
minimise sample evaporation.  Cycle conditions were; 10 min heat-activation of 
the polymerase, then 40 cycles of 95 ºC for 10min and 60 ºC for 1 min for 
denaturation and annealing/elongation.   
2.9.3.3.4 Melting Curve Analysis 
A melting curve analysis step was added to the protocol to test for non-specific 
contaminating DNA.  SYBR green binds to all dsDNA in a sample, not only the 
target DNA.  To ensure that minimal non-specific contaminating DNA is included 
in the fluorescence signal a melting curve step is added to the protocol.  This 
step is performed after the final cycle where the samples are heated slowly from 
60 ºC up to 95 ºC causing the DNA to denature while collecting fluorescence.  
The melting point (Tm) is the temperature at which the dsDNA denatures into 
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two separate strands of ssDNA.  Different lengths and base compositions of DNA 
will have different Tm so if the sample is purely from the amplification of the 
target DNA with the specific primer set the melting curve analysis should have 
one distinct peak (Figure 2.26B).  If there is contaminating DNA or excessive 
primer-dimer formation (primers annealing to themselves) the melting curve will 
have multiple peaks.  For this thesis samples were checked in this way and no 
contamination was detected. 
2.9.3.3.5 Amplification Curve Analysis  
The principal of quantifying a target gene with qRT-PCR is determining the point 
at which the fluorescence signal reaches a detectable threshold (Ct).  The level 
of fluorescence is directly proportional to the quantity of DNA in the sample.  
The cycler machine software automatically normalises the fluorescence against 
the non-PCR background fluorescence detected by the reference dye which 
controls for sample evaporation and pipetting error.  The reference dye used by 
the Applied Biosystems 7500 machine is ROX.  The normalised fluorescence of 
the reporter (Rn) is not detectable for the initial cycles of the reaction as the 
quantity of DNA is still too low.  This level of unchanging fluorescence before the 
DNA has reached sufficient concentration is referred to as the baseline 
fluorescence.  The machine software automatically selects and subtracts this 
baseline from Rn to give the change in fluorescence ΔRn.  Once the quantity of 
DNA reaches sufficient levels the fluorescence is detectable and increases.  The 
point at which this occurs, or the cycle number it occurs, is the cycle threshold 
(Ct) (Figure 2.26A).  Although this can be manually determined by the user, for 
the purposes of this thesis, the Ct detection threshold was set automatically by 
the Applied Biosystems software.  The Ct value determines the quantification of 
the DNA i.e. the more DNA template you begin with the earlier fluorescence 
becomes detectable.  Therefore Ct is inversely proportional to DNA quantity. 
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Figure 2.26: Amplification plot and melting curve examples. 
(A) Amplification plot example showing two hypothetical samples and a no template control (NTC).  
The threshold has been set in the exponential phase of the reaction.  The Ct is the cycle number at 
which normalised fluorescence reaches the threshold. (B) Melting curve analysis example for the 
same hypothetical samples.  One major peak is visible so there is no contaminating DNA or primer-
dimer formation. (Figure adapted from www.medscape.com). 
The relative gene expression was measured for the induced RNAi cultures 
compared to uninduced cultures.  Relative gene expression was calculated using 
the comparative Ct method or 2-ΔΔCt method(495): 
Threshold 
Ct 
A 
B 
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Fold change = 2-ΔΔCt 
Where ΔΔCt = [(Ct target gene – Ct reference gene)SAMPLE A – (Ct target gene – Ct 
reference gene)SAMPLE B].  For Ct values the mean of triplicates is used.  This 
method was appropriate since the starting cultures were from the same seeding 
culture. 
An example calculation is shown: 
      [ENDO] TbCatL 
  
TbCatL    
CT 
GPI‐8     
CT  CT           CT           
2‐CT 
(RQ) 
   18.89 21.142     
   18.825 21.883     
   18.829 21.532     
350 
Uninduced 
MEAN  18.85 21.52 ‐2.67 0.00  1.00 
SEM  0.02 0.21        
 
      [ENDO] TbCatL 
  
TbCatL    
CT 
GPI‐8     
CT  CT           CT          
2‐CT 
(RQ) 
   22.584 21.291     
   22.299 21.854     
   22.414 21.511     
350 Induced 
MEAN  22.43 21.55 0.88 3.55  0.09 
SEM  0.08 0.16        
Figure 2.27: Sample calculations using 2-∆∆Ct method. 
Data acquired with the Applied Biosystems 7500 was imported into Excel (Microsoft).  The mean Ct 
was calculated for the triplicates.  First change in Ct (∆Ct) was calculated and then change in Ct 
compared to uninduced culture (∆∆Ct).  To get relative quantity ∆∆Ct was raised to the negative 
power.   
2.10 Statistical Analysis  
2.10.1 Student’s Two-Sample T-Test 
When only two incubation solutions were tested a two-sample Student’s T-Test 
was the appropriate statistical test.  The dependent variable was percentage of 
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cells exhibiting spontaneous contractile activity.  Any two groups were incubated 
in solutions separately and are therefore independent of one another.  The 
distribution of percentages in the two groups was checked to be normally 
distributed (Figure 2.28).  
The null hypothesis (H0) was that the two means were equal, the test hypothesis 
(H1) was that they were not.  The t statistic is determined by the difference 
between the means divided by the variability or standard error of the mean 
(SEM).  If the difference in the two group means is greater than the SEM then the 
t statistic is large and there is evidence to reject H0.  Standard statistical tables 
generate a probability or P value that H0 is not rejected incorrectly (Type I 
error) or accepted incorrectly (Type II error).  A P value of <0.05 has been used 
as acceptance criteria for H1 in this thesis. 
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Figure 2.28:  Normality distribution plots for media and supernatant. 
(A) Histogram of frequency of observations of % cells exhibiting spontaneous contractile activity 
with normal distribution curve in control media. (B) Histogram and normal distribution curve for cells 
incubated in supernatant.  The data are independent, continuous and follow the assumption of 
normality making a two-sample Student’s T-test appropriate.  
2.10.2 Student’s Paired T-Test 
When two dependent groups are compared to one another, for example, Chapter 
4 presents some data from individual cells perfused with media followed by 
supernatant (section 4.2.3); a paired t-test was used.  Normality was checked 
for data as described in 2.10.1 and P<0.05 used as acceptance of H1 criteria. 
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2.10.3 ANOVA and Multiple Linear Regression 
When more than two groups were compared a multiple linear regression of 
categorical variables was used.  The dependent variable was the percentage of 
cells exhibiting spontaneous contractile activity within the 1 min observation 
period.  The categorical predictors were the different solutions they were 
incubated in.  Using an experiment discussed in section 3.3.8 as an example the 
solutions compared were control media vs. wild type trypanosome supernatant 
vs. uninduced RNAi supernatant vs. induced RNAi supernatant.  The ANOVA 
question is normally, is the mean percentage of cells showing spontaneous 
contractile activity the same for all incubation solutions?  The model is: 
Table 2.4: Formulae for ANOVA statistical analysis 
Control Media (M) y = meanM + error 
WT Supernatant (S) y = meanS + error 
Uninduced RNAi Supernatant (U) y = meanU + error 
Induced RNAi Supernatant (I) y = meanI + error 
 
However, the disadvantage is that this method introduces error for each 
comparison.  A more robust method is to make the comparisons simultaneously 
using a multiple linear regression and minimise the sum of squared deviations 
i.e. the error.  The categorical predictors remain the same as does the response 
variable, however “dummy” indicators are created and all compared to the 
control group, in this example control media. 
Table 2.5: Formulae for dummy indicators for each incubation solution 
WT Supernatant X1 = 1 for cells incubated in WT SN, 0 otherwise 
Uninduced RNAi Supernatant X2 = 1 for cells incubated in media U SN, 0 otherwise 
Induced RNAi Supernatant X3 = 1 for cells incubated in media I SN, 0 otherwise 
 
The model becomes (m = mean): 
y = mM + (mS – mM)X1 + (mU – mM)X2 + (mI – mM)X3 + error 
y = β0 + β1X1 + β2X2 + β3X3 + error 
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The data must be normally distributed which is checked by the plotting of 
residuals i.e. the difference between the observed data and the expected data.  
The data are normally distributed if residuals are spread evenly about the graph 
of expected cumulative probability vs. observed cumulative probability (Figure 
2.29). 
  
Figure 2.29: Residual plot for RNAi example data. 
The plot of residuals tests the distribution of data for normality.  The data lie evenly spread and 
close to the expected cumulative probability therefore the data are normally distributed.  
Multiple linear regression analyses were performed using SPSS 19 (IBM) software.  
The software produces summary tables of the statistical analyses shown below 
for the example data.  A P value is produced for the whole dataset acquired by 
ANOVA testing whether the means are different or not, which in this case is 
=0.001.  Comparisons were made to control media referred to as “constant” in 
the table.  The linear regression returns P values for each comparison showing 
significance for the wild-type supernatant and the uninduced RNAi supernatant, 
i.e. sufficient evidence to reject H0 (means are the same) for wild-type 
supernatant and uninduced RNAi supernatant but not for induced RNAi 
supernatant (Figure 2.30).  
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Figure 2.30: Output tables for RNAi example data from SPSS software. 
The first table is the ANOVA analysis output returning a significance value for general difference 
between means.  Wild-type supernatant (SN), uninduced RNAi supernatant (SN349un) and 
induced RNAi (SN349i) are compared to control media (constant).  The second table using the 
same nomenclature produces columns for difference in mean (B) with SEM to return a t statistic 
and P value.    
  
 
ANOVAb 
Model Sum of Squares df Mean Square F Sig.
1 Regression 3152.730 3 1050.910 8.031 .001a
Residual 3140.485 24 130.854   
Total 6293.215 27    
a. Predictors: (Constant), SN349un, SN349i, SN 
b. Dependent Variable: % Cells waving 
 
 
 
Coefficientsa 
Model 
Unstandardized Coefficients 
Standardized 
Coefficients 
t Sig. B Std. Error Beta 
1 (Constant) 100.000 4.324  23.129 .000
SN 22.129 6.114 .639 3.619 .001
SN349i -3.036 6.114 -.088 -.497 .624
SN349un 16.229 6.114 .469 2.654 .014
a. Dependent Variable: % Cells waving 
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3 CHAPTER 3 – The Effects of Trypanosoma 
brucei on Isolated Cardiomyocytes and Whole 
Hearts 
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3.1 Introduction 
3.1.1 African Trypanosomiasis 
Human African Trypanosomiasis (HAT or Sleeping Sickness) is a neglected disease 
caused by blood-borne protozoan parasites of the genus Trypanosoma. The 
parasites are transmitted to hosts by the tsetse fly (Glossina spp.) when it bites 
and takes a blood meal.  There are two forms; East African, caused by 
Trypanosoma brucei rhodesiense, and West African, caused by Trypanosoma 
brucei gambiense.  HAT is classically described as a chronic disease 
characterised by two stages{Bucheton, 2011 385 /id}.  The first being the haemo-
lymphatic stage and the second being the meningo-encephalitic stage 
characterised by sleep disturbances(45;48) giving it the colloquial name of 
“Sleeping Sickness”.  Stage I disease with  T. b. gambiense infection is variable 
with some reports describing acute progression(43;44) while more commonly 
progression tends to be months to years(38).  Although HAT is described as fatal if 
left untreated for  T. b. gambiense(35) and  T. b. rhodesiense(36), there are 
reports of untreated cases of  T. b. gambiense being cleared from hosts or 
developing a long-lasting serological response without symptoms(37-40).  T. brucei 
infection of livestock also impacts upon human health through loss of 
productivity and mortality(7) , which has a significant impact on the economic 
development of sub-Saharan Africa.  In humans, the West African form is by far 
the most common accounting for 96% of cases(41).  The World Health Organisation 
(WHO) have listed the reported number of human cases in Africa as 9875 in 
2009, 7139 in 2010 and 6743 in 2011(30).   Approximately 70 million people are 
thought to still be at risk in 36 sub-Saharan African countries(32)  as well as an 
estimated 48 million cattle with losses of $1-1.2 billion annually(6). 
3.1.2 Cardiac Involvement in HAT 
The second stage of HAT typically manifests as neurological disturbances(8) and, 
often overlooked, cardiac alterations(51) perceived by patients as palpitations.  
Post mortem examination of animals(26-28) and humans(56;57) revealed that 
trypanosomes infiltrate the myocardium leading to a mononuclear inflammatory 
response, fibrosis and heart failure.  When the electrical activity of the heart is 
measured using an electrocardiogram (ECG), abnormalities such as prolongation 
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of corrected QT (QTc), repolarisation changes and low voltage have been seen in 
50% of stage I and up to 71% of stage II HAT patients(51).  Palpitations are also 
reported in 18% of patients compared to 5% in controls(51). The current paradigm 
is that this is associated with inflammation and/or treatment.   
3.1.3 Trypanosome Secreted Factor Affects Ca2+ Signalling in a 
Blood Brain Barrier Model 
In a blood brain barrier (BBB) model it has been identified that a secreted factor 
is required for crossing the BBB, which then results in the neurological 
disturbances seen in clinical HAT(69).  The study reported that the factor induced 
a spontaneous rise in Ca2+ within the endothelial cells that constitute the model.  
They proceeded to further characterise the factor as a cysteine protease  whose 
effect could be abrogated with a cathepsin L specific inhibitor (K11777) but not 
with a cathepsin B specific inhibitor (CA074)(69).  
3.1.4 Ca2+ in the Cardiomyocyte 
Sarcoplasmic reticulum (SR)-mediated Ca2+ release, during the process of 
excitation-contraction coupling, leads to cardiomyocyte and whole heart 
contraction (systole).  Cardiomyocytes relax (diastole) by lowering intracellular 
Ca2+ concentration ([Ca2+]i) predominantly by SR-mediated Ca2+ uptake via the 
sarco (endo)plasmic reticulum Ca2+ ATPase (SERCA) pump but also sarcolemmal 
extrusion via the sodium/calcium exchanger (NCX)(158).  Under certain 
circumstances (e.g. heart failure), SR-mediated Ca2+ release can also occur 
spontaneously in the absence of electrical excitation in the form of propagating 
Ca2+ waves(261).  These events are linked to impaired contraction, abnormal 
electrical activity, ventricular premature complexes (which can cause 
palpitations) and the triggering of fatal arrhythmias(192).  
If a cysteine protease secreted from African trypanosomes can induce 
spontaneous Ca2+ release within a BBB in vitro model it may also alter [Ca2+]i 
dynamics in cardiomyocytes via induction of Ca2+ waves potentially leading to 
subsequent propagation that causes ventricular premature complexes or 
palpitations. 
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3.1.5 Aims  
The literature reports the presence of trypanosomes within the myocardium of 
the host, which may lead to a mononuclear inflammatory cell infiltrate(26;57;496).  
It has been postulated by Morrison et al. (1981)(26) that trypanosomes could 
release substances that affect the myocardium without an inflammatory 
component. This is in reference to a study by Galvao-Castro et al. (1978)(497) 
where trypanosomes were found within the myocardium without an 
inflammatory cell infiltrate in mice, which had been sublethally irradiated to 
immunocompromise the host mice.  It is possible therefore that African 
trypanosomes could lead to abnormalities in cardiomyocyte [Ca2+]i dynamics 
independent of a systemic immune response. 
The aims of this chapter are to: (i) establish if trypanosomes can have a direct 
effect on cardiomyocyte function independent of an immune response; (ii) 
identify how the trypanosomes can have that effect and whether it is the same 
factor identified as being necessary for BBB traversal; and (iii) determine if 
trypanosomes can have a direct effect on whole heart function independent of 
an immune response.   
Chapter 3  The Effects of Trypanosoma brucei  165 
 
3.2 Methods 
3.2.1 Adult Cardiomyocyte Isolation 
Left ventricular cardiomyocytes were isolated from adult male Wistar rats (250-
300 g) as described in section 2.3.1.  Briefly, the rats were euthanized and the 
hearts removed and perfused via the aorta in Langendorff perfusion.   The hearts 
were enzymatic ally digested with a collagenase and protease mix dissolved in 
MIKH (for composition see section 2.3.1) followed by MIKH with BSA.  The [Ca2+]o 
was then increased from 0 mM to 1.0 mM incrementally by 100 µm every 5 min.  
The cardiomyocytes were then re-suspended in MIKH containing no BSA with a 
[Ca2+]o of 1.8 mM.  
3.2.2 Preparation of Trypanosomes, Media and Supernatant 
Populations of Trypanosoma brucei brucei strain Lister 427 were maintained 
axenically in logarithmic growth phase in a modified version of the HMI-9 
medium which is widely used to culture mammalian bloodstream form 
trypanosomes(434). The modified HMI-9 composition is detailed in section 2.1.1.  
Briefly, (i) control media and (ii) supernatant were prepared identically as 
described in section 2.1.5.  Every supernatant batch prepared was temperature 
matched and pH adjusted to the control media batch used for each experiment, 
the pH was 7.40 ± 0.02 at 37 °C. 
3.2.3 Light Microscopy-Based Spontaneous Contractile Activity 
Measurements 
Cardiomyocytes were incubated for 30 min in either supernatant or control 
media and then placed onto a cell bath containing the incubation solution.  10 
separate fields containing approximately 10-15 cardiomyocytes were then 
imaged using a light microscope with a x20 objective lens and charge-coupled 
device (CCD) camera for 1 min per field.  For each experimental test solution, 
individual cells were marked on screen once a single spontaneous contractile 
event occurred within that cell during the 1 min time period.  Mean data was 
then collated from the 10 fields as a percentage of cells which had at least one 
wave within a 1 min time period.  The percentage change of cardiomyocytes 
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exhibiting contractile events was calculated as the percentage increase over the 
level of contractile events in control media which was set as 100%.  
3.2.4 Confocal Fluorescence-Based [Ca2+]i Measurements 
Intact isolated cardiomyocytes suspended in MIKH with a [Ca2+]o of 1.8 mM 
(section 3.2.1) were loaded with a Ca2+ sensitive fluorophore (5.0 μM Fluo-3AM, 
(Biotium Inc., Hayward, CA)) by incubation for ~10 min. The MIKH was then 
removed and the cells re-suspended in fresh 1.8 mM [Ca2+]o mixed 1:4 with 
media or supernatant and incubated for 30 min.  The incubation also served to 
ensure complete de-esterification of the fluorophore. Cardiomyocytes were 
allowed to settle on a coverslip, placed on a bath (Cell Microcontrols, Norfolk, 
VA).  Cardiomyocytes were then superfused with control media or supernatant 
by perfusion pen fed from solution reservoirs by gravity with an active suction 
outflow.  The cells were field stimulated with 2.0 ms duration voltage pulses 
delivered through parallel platinum wires (stimulation voltage set to 1.5 times 
the threshold) at a frequency of 1.0 Hz for a period of 45 s.  Superfusion was 
maintained but stimulation was stopped and the cell allowed to rest for a 
further 45 s before rapid application of a 10 mM bolus of caffeine for 20 s to 
assess the SR Ca2+ content(498).  Confocal line-scan images of the cardiomyocytes 
were recorded using a LSM 510 confocal system (Zeiss).  Fluo-3 was excited at 
488 nm (Ar LASER) and measured >515 nm using epifluorescence optics of an 
inverted microscope with a 63X/1.2 NA water-immersion objective lens.  
Fluorescence was acquired in line-scan mode at 3.07 ms.line-1 (1 line = 512 
pixels); pixel dimension was 0.27 m.  The scanning LASER line was orientated 
parallel with the long axis of the cell and placed approximately equidistant 
between the outer edge of the cell and the nucleus/nuclei to ensure the nuclear 
area was not included in the scan line(296).  Fluorescence data were expressed as 
a ratio of the quiescent fluorescence (F/F0).  F/F0 measurements were 
calculated from a 60 s period of line scan trace adjacent to the point of event 
initiation in order to limit movement artefact(296).  The Kd of Fluo-3 is reported 
as 558 ± 15 nM (n=6) in intact cardiomyocytes(468). 
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3.2.5 Field Stimulation and Fluorescence-Based [Ca2+]i 
Measurements  
Intact cardiomyocytes in MIKH with a [Ca2+]o of 1.8 mM (section 3.2.1) were 
loaded with a ratiometric Ca2+ sensitive dye.  Fura-4FAM (Invitrogen) has greater 
sensitivity at peak systolic cytosolic Ca2+ with a published Kd of 1.16 ± 0.016 µM 
Ca2+ and Fura-2AM (Biotium Inc., Hayward, CA) has greater sensitivity to detect 
diastolic cytosolic Ca2+ with a published Kd of 0.18 ± 0.05 µM Ca2+(480).  Cells in 
MIKH were incubated with Fura-4F-AM for 10 min to allow the dye to cross the 
cell membrane.  Cells were then diluted 1 in 4 in control media or supernatant 
at room temperature for 30 min.  The cardiomyocytes were allowed to settle on 
a coverslip, placed on a bath (Cell Microcontrols, Norfolk, VA) and superfused 
with control media/supernatant as described in section 3.3.4, at 37 °C.  Cells 
were field stimulated with 2.0 ms duration voltage pulses delivered through 
parallel platinum wires (stimulation voltage set to 1.5 times the threshold).  
After superfusion with control media or supernatant, the SR Ca2+ content was 
determined by rapid application of 10 mM caffeine.  Stimulation was stopped at 
the application of the caffeine.  The fluorophore fluorescence ratio (340/380 nm 
excitation; R340/380nm) was measured using a spinning wheel spectrophotometer 
(Cairn Research Ltd; sampling rate of 5000 Hz) through epifluorescence optics of 
a x40/1.3 NA oil immersion lens (Nikon) and data were analysed offline.  The 
mean fluorophore fluorescence ratio was obtained by averaging 10 steady state 
transients (Origin).   
3.2.6 RNA Interference of Trypanosoma brucei cathepsin L 
3.2.6.1 Preparation of RNAi clones  
Trypanosoma brucei brucei 2T1 (a bloodstream form cell line derived from the 
Lister 427 strain) was transfected with pGl2084; a Gateway® (Invitrogen, U.K.) 
modified version of the plasmid pRPaisl(499).  The pRPaisl plasmid has a 
tetracycline inducible stem-loop RNAi cassette(488).  The target region of the 
Trypanosoma brucei cathepsin-L gene (TbCatL) was from nucleotides 409-986 of 
the open reading frame, with the following oligonucleotides used to generate 
the construct; forward 5’-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTG CAG 
TGA CCC CAG TGA AGG A-3’ and reverse 5’-GGG GAC CAC TTT GTA CAA GAA 
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AGC TGG GTA GAC ATT GGT TTG TGC CCT T-3’(489).  The cells containing the 
plasmid were selectively maintained in culture by addition of 2.5 µg.mL-1 
hygromycin and 0.5 µg.mL-1 phleomycin.  The transfection and generation of two 
independent TbCatL RNAi clones was carried out by Nathaniel Jones of the 
Wellcome Trust Centre for Molecular Parasitology. 
3.2.6.2 Growth Curves to Assess Phenotype of RNAi  
RNAi was induced with 1 µg.mL-1 tetracycline and growth curves performed on 
induced vs. uninduced cultures in triplicate for the two biological duplicates.  
Cultures for growth curves were initiated with 1.0 x 105 parasites.mL-1 and were 
counted in triplicate with an improved Neubauer haemocytometer as described 
earlier (section 3.2.2) at 24, 48 and 72 h timepoints post-induction.   
3.2.6.3 RT-PCR to Confirm Inhibition of TbCatL Expression 
RNA was extracted from cultures grown in parallel using the RNeasy® kit 
(QIAgen).  For preparation of cDNA, approximately 1 g of total RNA was treated 
with TURBO DNase (Ambion) according to the manufacturer’s protocol. The 
reverse transcription was carried out using Omniscript RT kit (Qiagen) with 5 M 
oligo dT primers.  Real-Time PCRs were carried out in triplicate per individual 
sample on a 7500 Real-Time PCR system (Applied Biosystems), using 
approximately 100 ng cDNA, 1 x Power SYBR green master mix (Applied 
Biosystems) and 4 M of the respective oligonucleotide primers, in a final 
reaction volume of 25 L. The oligonucleotide primers used were: TbCatL 
forward 5’-TCT CGG ATA TGA CAC GTG AAG AGT-3’ and reverse 5’-TCT GCG CAG 
CTG CAA AGT-3’, with GPI-8 as the constitutively expressed endogenous control; 
forward 5’-CGA AGC GCA TTT GGA TAG-3’ and reverse 5’-ACG GCG TGA TGA 
CAG TGA AG-3’.  Specificity of knock-down was confirmed by analysis of T. 
brucei cathepsin B (TbCatB) gene expression on the same samples using TbCatB 
primers; forward 5’- TCC CAG CAG CTT CGA TTC C-3’ and reverse 5’- GCG GAC 
TGA TCT GCA ATT TGT-3’.  Relative gene expression was calculated using 
previously described methods(495). 
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3.2.7 Langendorff Perfusion of Ex Vivo Adult Rat Hearts 
Adult male Wistar rat hearts were excised and cannulated via the aorta and 
initially perfused in Tyrodes solution; 116 mM NaCl, 20 mM NaHCO3, 0.4 mM 
Na2HPO4, 1.0 mM MgSO4-7H2O and 4.0 mM KCl.  D-glucose was added on the 
same day as intended use to a final concentration of 11 mM.  The solution was 
bubbled with 95% O2 / 5% CO2 for 15-20 min to oxygenate and buffer before 
CaCl2 was added to a concentration of 1.8 mM.  Hearts were cannulated via the 
aorta and perfused with Tyrodes at 10 mL.min-1 to clean out the blood from the 
coronary vasculature.  Hearts were then perfused for 10 min in control media to 
achieve a steady state, followed by either control media for time-controls or 
supernatant (10 min) and then washout with control media (10 min).  Solutions 
were maintained at 37 °C gassed with 100% O2 mixture (pH at 7.4).  Constant 
flow was used (10 mL.min-1).  The ex vivo Langendorff perfused heart was ideal 
for these experiments because it enabled the translation of single cell data to 
the whole organ in the absence of the immune/inflammatory response that 
would be apparent in vivo.  Pseudo-ECG was recorded (iworx) and the mean 
number of ventricular premature complexes (VPCs) was obtained from the 5 min 
at the end of each section of the protocol to ensure data was analysed from 
steady state.  The ECG was also analysed for QT interval, the last 1 min of each 
section of steady state ECG trace was averaged using LabScribe2 (iWorx) and 
measured manually as recommended by the AHA/ACCF/HRS recommendations 
for standardisation and interpretation of the electrocardiogram(457).  QT length, 
determined by the end of the T wave at the isoelectric point or by intersection 
of the tangent of the steepest part of the T wave with the isoelectric point(457), 
was measured.  The QT interval was also measured at 90% repolarisation(458) 
(QT90) and at 50% repolarisation(459) (QT50), so as to have a clearly defined end 
point (Figure 3.9B), for media and supernatant.  These data (n = 12) were 
normalised to time control hearts that were perfused only with media for the 
duration of the experiment (n = 6).  QT intervals were corrected for heart rate 
using the Framingham method(460): 
 
QTc = QT + 0.154x(1-RR) 
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3.2.8 Statistical Analysis 
Data are expressed as mean ± SEM.  For Ca2+ transient amplitude and Ca2+ wave 
parameters comparisons were performed by applying the paired Student’s t-test.  
ANOVA statistics were used in cases of multiple comparisons.  Multiple linear 
regression analysis was used to compare nominal categorical data with 
continuous variables.  Normality was assessed by plotting of residuals.  
Differences were considered significant when P<0.05.   
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3.3 Results 
3.3.1 Trypanosomes Increase Ca2+ Wave Frequency in 
Cardiomyocytes   
To study whether bloodstream form trypanosomes could have a direct effect on 
cardiomyocytes independent of a systemic immune response, spontaneous 
contractile events were measured.  Isolated cardiomyocytes were incubated for 
30 min with either: modified HMI-9(434) culture media containing approximately 
5.0 x 105 parasites.mL-1, supernatant derived from parasite culture, or control 
media.  The incubated cells were then observed.  Cardiomyocytes exhibiting 
spontaneous contractile events were noted and expressed as percentages of 
total cardiomyocytes examined.  When incubated with live trypanosome culture 
the percentage of cells waving significantly increased to 145% of media levels 
(52.11 ± 1.64% vs. 75.38 ± 5.26% cardiomyocytes exhibiting at least one 
spontaneous contractile event.min-1; control media vs. live trypanosomes; 
P<0.001; Figure 3.1B).  To determine whether the effect on cardiomyocyte 
waving was potentially due to an excreted/secreted factor the populations of 
cardiomyocytes were incubated for 30 min with trypanosome culture 
supernatant. Cells incubated with supernatant showed a significant increase of 
130% in the percentage of cells waving (52.11 ± 1.64% vs. 67.47 ± 1.92% 
cardiomyocytes exhibiting at least one spontaneous contractile event.min-1; 
control media vs. supernatant; P<0.001; Figure 3.1B).    
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Figure 3.1: Mean percentage of cells waving. 
(A) Photomicrograph of an isolated rat cardiomyocyte incubated Trypanosoma brucei brucei (grey 
arrow heads). (B) Mean % ± SEM of isolated cardiomyocytes exhibiting ≥1 spontaneous contractile 
event.min-1 in media, live trypanosomes or supernatant (n = cardiomyocytes with number of hearts 
in parentheses).  Statistical analysis was performed by ANOVA with P < 0.05 considered 
significant.  
3.3.2 Contractile Event Frequency Increase Abolished by Heating 
To determine if the supernatant effect was potentially due to a 
secreted/excreted protein (or peptide), a separate set of experiments was 
performed in the group by Elspeth Elliott.  Cardiomyocytes were incubated in 
supernatant heated to >80 ºC as well as control media and untreated 
supernatant.  Data shown are percentage change of cardiomyocytes exhibiting at 
least one spontaneous contractile event over control media.  Untreated 
supernatant showed the same effects as in Figure 3.1 (100 ± 2.68% vs. 133.3 ± 
2.88% ; control media vs. supernatant; P<0.001; Figure 3.2).   When supernatant 
was heat treated the percentage change returned to control levels (100 ± 2.68% 
vs. 105.6 ± 3.86%; control media vs. boiled supernatant; P>0.05; Figure 3.2). 
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Figure 3.2:  Percentage change in cells exhibiting spontaneous contractile events in heated 
supernatant. 
Mean ± SEM percentage change in cells showing contractile activity over control media set to 
100%. Cardiomyocytes were incubated in control media (n=107 cells), trypanosome culture 
supernatant (n=527 cells) or supernatant that had been heated to >80 ºC (n=612 cells) for 30 min.  
Populations of cells were counted for number of cells exhibiting spontaneous contractile events for 
1 min.  Statistical significance was determined by ANOVA and P<0.05 take to be significant. 
3.3.3 Ca2+ Wave Velocity and Frequency are Increased by 
Trypanosome Culture Supernatant 
To characterise the intra-cardiomyocyte [Ca2+]i dynamics underpinning the 
spontaneous contractile events (Figure 3.1), confocal imaging was performed 
(Figure 3.3).  Cells were loaded with Fluo-3 and incubated in media or 
supernatant as above and then superfused with the incubation solution with field 
stimulation at a frequency of 1.0 Hz for 45 s followed by a post-train rest period 
of 45 s (Figure 3.3A).  Line-scan mode was utilised to produce images of time(x) 
vs. distance(y) across the cardiomyocyte (Figure 3.3B(i & ii)).  This revealed that 
the spontaneous contractile events (denoted by an inward deflection in the y-
axis of the image, Figure 3.3C) were preceded by a rise of fluorescence and 
therefore [Ca2+]i, which propagated from one region of the cell to the other 
(Figure 3.3B (i & ii)).  These events were characteristic of spontaneous SR-
mediated Ca2+ release (Ca2+ waves).  Ca2+ wave frequency in cardiomyocytes 
incubated with supernatant was increased to 243% of media levels (0.07 ± 0.02 
vs. 0.17 ± 0.03 waves.s-1; media vs. supernatant; P<0.05; (Figure 3.3B(iii))). Ca2+ 
wave velocity, calculated as Ca2+ wave propagation gradient (Figure 3.3C(i & ii)), 
was increased in supernatant to 107% of media (110.2 ± 2.2 vs. 118.4 ±1 .7 
µm.s1; media vs. supernatant; P<0.05; (Figure 3.3C(iii))). This data was acquired 
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in conjunction with Mrs. Amanda Panissidi, a veterinary undergraduate on a 
summer project under my supervision. 
 
Figure 3.3: Confocal imaging of spontaneous contractile events using Fluo-3AM loaded 
cardiomyocytes.   
Confocal analysis of Ca2+ waves and the caffeine-induced Ca2+ transients (an indication of SR 
Ca2+) content derived from administration of 10 mM caffeine. (A) Protocol used for cardiomyocytes 
perfused with either control media or supernatant.  The blue bracket denotes the part of the 
protocol corresponding to images in Panel B. (B) Top panel (i & ii) shows confocal line-scan 
images of intracellular regions of isolated cardiomyocytes in both control media (i) and supernatant 
(ii). Below panel is the respective line profile trace taken from a 20 pixel region (denoted by 2 
yellow lines in top image). Panel (iii) Mean ± SEM for Ca2+ wave frequency in control media (n=18) 
and supernatant (n=21). (C) Individual representative Ca2+ waves taken for (i) control media and (ii) 
supernatant with (iii) mean ± SEM Ca2+ wave velocity in media (n=53 waves from 18 cells) and 
supernatant (n=158 waves from 21 cells). Mean data were compared using a two-sample Student’s 
T test, P<0.05 was taken to be significant. 
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3.3.4 Supernatant Increases the Rate of Stimulated Ca2+ Transient 
Decline  
Experiments so far have examined diastolic Ca2+ release.  Therefore experiments 
with electrically stimulated cardiomyocytes were required to examine systolic 
Ca2+ release.  Cardiomyocytes were loaded with Fura-4F followed by incubation 
in control media or supernatant for 30 min and then superfused with the same 
solution and stimulated at 1.0 Hz as shown in Figure 3.4.  The Ca2+ transient 
amplitude was not significantly altered, (0.91 ± 0.10 vs. 1.00 ± 0.09 µM; control 
media (n=10) vs. supernatant (n=14); P>0.05; Figure 3.4B(iv)).  The maximum 
rate of Ca2+ transient rise d[Ca2+]i/dtMax was not significantly altered either, 
(77.9 ± 7.7 vs. 76.1 ± 9.1 µM.s-1; control media vs. supernatant; P>0.05; Figure 
3.4B(v)).  The maximum rate of Ca2+ transient fall d[Ca2+]i /dtMin tended to be 
faster in supernatant, (6.6 ± 0.84 vs. 8.9 ± 0.90 µM.s-1; control media vs. 
supernatant; P=0.086; Figure 3.4B(vi)), although not statistically significant.  
However, when the rate constant of transient decay is analysed there is a 
significant increase; (11.3 ± 1.06 vs. 15.7 ± 1.41 s-1; control media vs. 
supernatant; P<0.05; Figure 3.4B(vii)).  These data show a faster Ca2+ transient 
decline.  To determine whether the increased rate of decline was due to 
increased SERCA activity or increased sarcolemmal efflux, a 10 mM bolus of 
caffeine was rapidly applied.  The amplitude of the caffeine-induced Ca2+ 
transient indicates SR Ca2+ content as the caffeine opens the RyR releasing the 
Ca2+ stored within the SR.  The decay indicates sarcolemmal extrusion, which is 
predominantly NCX  function(224), since the SR is effectively open so the activity 
of SERCA is no longer acting to remove Ca2+.  The caffeine-induced Ca2+ transient 
amplitude was not significantly altered (1.12 ± 0.95 vs. 1.08 ± 0.95; control 
media vs. supernatant; P>0.05; Figure 3.4C(ii)), nor is the rate constant of 
decay, (1.19 ± 0.06 vs. 1.22 ± 0.07 s-1; control media vs. supernatant; P>0.05; 
Figure 3.4C(iii)).   
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Figure 3.4: Stimulated (1.0 Hz) epifluorescent imaging of Ca2+ transients with Fura-4F AM 
(A) Protocol used in epifluorescence Ca2+ measurements. (B) (i)  Average trace from last 12 
transients in media (n=10; grey) or supernatant (n=14; black).  (Inset) normalised traces overlaid.  
(B) Mean ± SEM for (ii) peak [Ca2+]i, (iii) minimum [Ca2+]i, (iv) Ca2+ transient amplitude, (v) 
maximum rate of Ca2+ transient rise (d[Ca2+]i/dtmax), (vi) maximum rate of Ca2+ transient fall 
(d[Ca2+]i/dtmin) and (vii) rate constant of decay (s-1).  (C)  Example traces of caffeine-induced Ca2+ 
transient in cells superfused with media (n=10) and supernatant (n=14).  (i) Mean data for caffeine-
induced Ca2+ transient amplitude and (ii) caffeine transient rate constant of decay.  Statistical 
comparisons were made using a two-sample Student’s T test, P<0.05 was considered significant.  
3.3.5 The Effects of Supernatant on the stimulated Ca2+ Transient 
During β-adrenergic Stimulation  
3.3.5.1 Effects on the Stimulated Calcium Transient 
The sympathetic nervous system and β-adrenergic signalling pathway are 
activated in response to both physiological and pathophysiological stresses.  To 
examine the effects of supernatant under β-adrenergic stimulation, 
isoproterenol was added (ISO; 100 nM) (Figure 3.5A).  Under these conditions 
there was no significant difference in peak [Ca2+]i, (1.71 ± 0.16 vs. 1.89 ± 0.11 
µM; control media (n=13) vs. supernatant (n=13); P>0.05; Figure 3.5C(i)), or 
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amplitude, (1.52 ± 0.15 vs. 1.67 ± 0.10 µM; control media vs. supernatant; 
P>0.05; Figure 3.5C(iii)), of the Ca2+ transient.  However, the diastolic or 
minimum [Ca2+]i was significantly increased in supernatant, (195 ± 10.1 vs. 224 ± 
6.5 nM; control media vs. supernatant; P<0.05; Figure 3.5C(ii)).  The maximum 
rate of Ca2+ transient rise was not altered by supernatant, (157 ± 17.2 vs. 150 ± 
13.1 µM.s-1; control media vs. supernatant; P>0.05, Figure 3.5C(iv)).  In contrast 
to the cohort of cardiomyocytes perfused without the addition of ISO (Figure 
3.4), there was a significant increase of 130% of control levels in maximum rate 
of Ca2+ transient fall, (16.0 ± 1.72 vs. 21.4 ± 1.98 µM.s-1; control media vs. 
supernatant; P<0.05; Figure 3.5C(v)).  This latter result is confirmed by the 
significant increase in rate constant of decay by supernatant to 126% of control 
levels, (16.5±1.34 vs. 20.9±1.31 s-1; control media vs. supernatant; P<0.05; 
Figure 3.5C(vi)), higher than the cohort of cardiomyocytes not treated with ISO 
(Figure 3.4). 
3.3.5.2 Effects on Spontaneous Ca2+ Release 
Diastolic Ca2+ waves became apparent (Figure 3.5A and B) in supernatant.  When 
counted, (Figure 3.5D(i)), Ca2+ wave frequency increases in supernatant over 
time. The Ca2+ wave frequency increased by 840% of control levels, (0.031 ± 
0.013 vs. 0.26 ± 0.087 waves.s-1; control media vs. supernatant; P<0.05; Figure 
3.5D(ii)).  The diastolic wave amplitude was also increased by supernatant to 
633% of control levels, (9.44 ± 6.42 vs. 59.74 ± 20.98nM; control vs. supernatant; 
P<0.05; Figure 3.5D(iii)).  These data are consistent with the findings in the 
confocal studies (Figure 3.3), which also demonstrated that supernatant 
increased the Ca2+ wave induction propensity. 
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Figure 3.5: Stimulated (1.0 Hz) epifluorescent imaging of Ca2+ transients with 100 nM isoproterenol 
(ISO).   
(A) Protocol with 100 nM isoproterenol.  (B) Average trace from last 12 transients of representative 
cells superfused with media (n=13) or supernatant (n=13). (Inset) normalised traces overlaid.  (C(i-
vi) Mean ± SEM data for Ca2+ transient parameters.  (D(i))  Number of diastolic Ca2+ releases 
during superfusion of supernatant (black) normalised to control (grey). (ii) Mean ± SEM Ca2+ wave 
frequency (ii) Ca2+ wave amplitude. Statistical comparisons were performed between control and 
supernatant groups using a two-sample Student’s T test, P<0.05 was considered significant. 
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3.3.6 Ca2+ Waves are Reduced by Cathepsin-L Inhibition but not 
Cathepsin-B Inhibition 
Nikolskaia et al. (2006) reported that the candidate factor allowing BBB 
traversal by induction of cytosolic Ca2+ rises in HBMECs was the cathepsin-L like 
cysteine protease referred to as Trypanosoma brucei Cathepsin-L (TbCatL)(69).  
T. brucei expresses two related Clan CA, Family C1 cysteine proteases; TbCatL 
and TbCatB(112;500).  Given these previous data, cardiomyocytes were incubated 
with or without the specific TbCatL inhibitor K11777(69) (10 µM) and spontaneous 
contractile events assessed within 1 min as in Figure 3.1.  Supernatant increased 
the percentage change of contractile events to 137% of media levels (100.0 vs. 
137.5 ± 5.4% cardiomyocytes with contractile events relative to control media; 
control media vs. supernatant; P<0.001; Figure 3.6A).  K11777 inhibited this 
effect (96.8 ± 5.4 vs. 95.8 ± 2.5% cardiomyocytes with contractile events relative 
to control media; control media + K11777 vs. supernatant + K11777; P>0.05; 
Figure 3.6A).  When repeated with CA074 (10µM; TbCatB-specific inhibitor) the 
percentage increase of cardiomyocytes producing contractile events was 
maintained (103.8 ± 4.0 vs. 127.4 ± 6.4% cardiomyocytes with contractile events 
relative to control media; control media + CA074 vs. supernatant + CA074; 
P<0.001; Figure 3.6A).  These data suggest that the increase in spontaneous 
contractile events can be prevented by application of a CatL specific inhibitor 
(but not by a CatB specific inhibitor), and therefore could be mediated by 
TbCatL.   
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Figure 3.6: Percentage change in spontaneous contractile events with inhibitors and recombinant 
protein. 
Mean % change ± SEM in contractile events over media levels in isolated cardiomyocytes.  (A)  
Specific cathepsin inhibitors. Inhibitors used were; cathepsin L inhibitor K11777 and cathepsin B 
inhibitor CA074.  Inhibitors were added to media as controls.    (B)  Recombinant T. brucei 
cathepsin L. (2 nM and 2 mM dithiothreitol). The control was with appropriate vehicle. P values 
were calculated by multiple linear regression on raw data with P<0.05 considered significant. n = 
number of cells from number of isolations in parentheses. 
3.3.7 Recombinant TbCatL Increases Ca2+ Wave Frequency 
When a recombinant TbCatL (rTbCatL) was added to media at a concentration of 
2nM as shown to be the quantity produced by T. brucei by Caffrey et al. 
(2001)(129) the % increase of cardiomyocytes exhibiting contractile events over 
media was significantly greater than control vehicle (106.9 ± 3.7 vs. 120.8 ± 
7.1%; control media vs. rTbCatL; P<0.05; Figure 3.6B).  This confirms that 
TbCatL is having a direct effect on the cardiomyocytes. 
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3.3.8 Ca2+ Waves are Reduced by RNA Interference of TbCatL 
To confirm that it is TbCatL produced by the parasites that increases Ca2+ waves 
in cardiomyocytes observed in Figure 3.1, we used two independent  T. b. brucei 
clones with RNAi inducible knockdown of TbCatL(489).  Growth curves were 
performed on uninduced trypanosome cultures and cultures induced with 
tetracycline (Figure 3.7A).  TbCatL is essential for survival of the parasite(127) so 
successful induction of RNAi will result in a significant growth curve reduction.  
In both independent clones there was a significant reduction in parasite numbers 
at 48 h (6.84 ± 0.07 vs. 5.78 ± 0.05 log10 parasites.mL-1 for clone STL349 and 6.85 
± 0.03 vs. 6.19 ± 0.11 log10 parasites.mL-1 for clone STL350; uninduced vs. 
induced; P<0.005; Figure 3.7A).  The reduction was even greater at 72 h (7.81 ± 
0.08 vs. 5.68 ± 0.03 log10 parasites.mL-1 for STL349 and 7.88 ± 0.03 vs. 6.27 ± 
0.13 log10 parasites.mL-1 for STL350; uninduced vs. induced; P<0.0005; Figure 
3.7A).  Quantitative RT-PCR on cDNA manufactured from cultures at the 24 h 
time-point using both TbCatB and TbCatL primers shows that there was 
successful induction of RNAi and significantly reduced TbCatL (0.15 ± 0.02 for 
STL349 and 0.095 ± 0.005 for STL350 relative quantitation to uninduced cultures 
(n=3); P<0.05; Figure 3.7B(i)) without significant reduction of TbCatB (1.92 ± 
0.34 for STL349 and 1.79 ± 0.30 relative quantitation to uninduced culture (n=3); 
P>0.05; Figure 3.7B(ii)).  
When cardiomyocytes are incubated with the supernatant from T. brucei STL349 
(Figure 3.7C) the percentage increase in cardiomyocytes exhibiting spontaneous 
contractile events in 1 min over control media when RNAi is induced was 
significantly reduced compared to the same clone when uninduced (97.0 ± 5.1 
vs. 116.2 ± 5.0%; induced vs. uninduced; P<0.05; Figure 3.7C(i)).  The same is 
true for STL350 (102.0 ± 5.7 vs. 116.5 ± 5.6%; induced vs. uninduced; P<0.05; 
Figure 3.7C(ii)).  These data show that the percentage change in contractile 
events over media control was significantly reduced when TbCatL was selectively 
knocked down. 
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Figure 3.7: RNA interference (RNAi) of T. brucei cathepsin L (TbCatL).   
(A) Growth curves of biological duplicates (STL 349 and STL 350) with inducible TbCatL RNAi.  (B)  
Relative gene expression for (i) TbCatL and (ii) TbCatB compared to uninduced culture in triplicate 
cultures for STL349 (n=3) and STL350 (n=3).  (C(i)) Mean ± SEM % change for spontaneous 
contractile events in cardiomyocytes for STL349. Media (n=747(7)), 427 supernatant (n= 817(7)), 
uninduced RNAi supernatant (n=858(7)) and induced RNAi supernatant (n=841(7)). (ii) Mean ± 
SEM % change for spontaneous contractile events in cardiomyocytes for STL350. Media 
(n=1018(11)), 427 supernatant (n= 1427(12)), uninduced RNAi supernatant (n=1597(12)) and 
induced RNAi supernatant (n=1564(12)). n = number of cells from number of isolations in 
parentheses. 
3.3.9 Supernatant Can Cause Arrhythmic Events in Whole Hearts 
As arrhythmias have been reported in some patients with HAT(51) experiments 
were performed with ex vivo Langendorff perfused whole rat hearts.  By 
removing the heart from the animal the immune/inflammatory response is no 
longer a factor and the direct effects of trypanosome culture supernatant on the 
heart can be observed.  The pseudo-ECG was recorded with pellet electrodes 
within an organ bath.  Hearts were perfused for 10 min in media to achieve a 
steady state followed by 10 min with either media for time controls or culture 
supernatant and then another 10 min of washout with media (Figure 3.8A).  The 
pseudo-ECG was examined for arrhythmic events as determined by the Lambeth 
Conventions(437), and described in section 2.5.4.2, during the last 5 min of each 
section of the protocol.  Example ECGs are shown in Figure 3.8B for (i) control 
and (ii) supernatant with ventricular premature complex (VPC).  When the 
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arrhythmia frequency for each individual heart is plotted, all of the hearts that 
show an increase in arrhythmia frequency during the 2nd 10 min are in the 
supernatant perfusion group. During washout 83% of the hearts show a reduction 
in arrhythmia frequency (Figure 3.8C).  The mean is shown by the grey broken 
line with error bars representing SEM.  There was no significant difference in 
mean ± SEM of the arrhythmia frequency between the different time periods of 
the protocol in the time control group (n=6); (0.40 ± 0.28 min-1 vs. 0.33 ± 0.19 
min-1 vs. 0.53 ± 0.27 min-1; 1st 10min vs. 2nd 10min vs. 3rd 10min; P<0.05).  
However, in the group of hearts perfused with supernatant during the 2nd 10min 
(n=12) there was a significant increase in arrhythmia frequency, which then 
reduced during the washout period (0.60 ± 0.26 min-1 vs. 5.15 ± 2.49 min-1; 
P<0.05; vs. 1.36 ± 0.73 min-1; P=0.07).  There was no significant difference 
between steady state and washout in the supernatant perfused group (Figure 
3.8D(i)).   
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Figure 3.8 ECG data from ex vivo perfused rat hearts. 
(A) Langendorff perfusion protocol.  (B) Typical pseudo-ECG recordings (C) Number of arrhythmic 
events per minute in individual hearts.  Time control hearts (n=6) (grey) on the left and supernatant 
exposed hearts (n=12) (black) on the right. The mean is shown with the dashed line, error bars 
indicate SEM. (D) (i) Mean ± SEM of ventricular premature complexes per min for all time controls 
and supernatant perfused hearts during steady state in media (1st 10min), switch to media or 
supernatant (2nd 10min) and media washout (WO) (3rd 10min).  (ii) Mean ± SEM for responder 
hearts in media, media or supernatant, and washout with media. 
3.3.10 Arrhythmic Events Occurred in a Proportion of Hearts  
While the mean data of all the hearts shows an increase in arrhythmia frequency 
in the group of hearts perfused with supernatant, when examined further only a 
proportion (50%) exhibited an increase in arrhythmic events.   When time 
controls vs. only these ‘responders’ are assessed (Figure 3.8D(ii)) there is no 
difference during the steady state period (0.40 ± 0.28 min-1 vs. 0.70 ± 0.37 min-1;  
time control (n=6) vs. supernatant perfused responder (n=6); P>0.05).  During 
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the second 10 min period the responders showed a significant increase in 
arrhythmia frequency (0.33 ± 0.19 min-1 vs. 10.03 ± 4.20 min-1; P<0.05).  There 
was no significant difference between the washout periods (0.53 ± 0.27 vs. 2.03 
± 1.29; P>0.05).   
3.3.11 QT Interval Was Not Affected 
The ECGs collected for arrhythmia analysis (Figure 3.8) were also analysed for 
QT interval.  It has been reported in the literature that ECGs from patients with 
HAT have a prolongation of the QT interval(51), which had been attributed to 
inflammation.  Given the direct effects of supernatant on cardiomyocyte Ca2+ 
handling and arrhythmia frequency in whole hearts it was examined whether 
supernatant could prolong the QT interval.  There was no statistical difference 
in the QT interval; (0.070 ± 0.005 vs. 0.074 ± 0.004 s; control media vs. 
supernatant; P>0.05), QT90 (0.058 ± 0.004 vs. 0.063 ± 0.003 s; control media vs. 
supernatant; P>0.05), or QT50 (0.044 ± 0.004 vs. 0.047 ± 0.004; control media vs. 
supernatant; P>0.05; Figure 3.9C(i-iii)).  When QT was corrected for heart rate 
between individuals there was no statistical difference either for QTc (0.187 ± 
0.005 vs. 0.194 ± 0.005s; control media vs. supernatant; P>0.05), QT90 (0.175 ± 
0.003 vs. 0.177 ± 0.003s; control media vs. supernatant; P>0.05), or QT50 (0.161 
± 0.003 vs. 0.160 ± 0.003; control media vs. supernatant; P>0.05; Figure 3.9D(i-
iii)).  There was no difference in heart rate (mean ± SEM) between media (282 ± 
17 bpm) or supernatant (278 ± 12 bpm) perfused hearts. 
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Figure 3.9: QT intervals from ex vivo whole rat hearts perfused with media and supernatant. 
(A)  Protocol, blue brackets indicate period of protocol from which average ECGs were obtained.  
(B) Representative ECG complex showing how QT (red), QT90 (blue) and QT50 (green) were 
measured. (C) Mean ± SEM for (i) QT, (ii) QT90 and (iii) QT50. (D) Mean ± SEM for (i) QT, (ii) QT90 
and (iii) QT50 corrected for heart rate using the Framingham method.  Data were normalised to time 
matched controls perfused with media throughout the protocol.    
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3.4 Discussion 
3.4.1 Trypanosomes Increase Ca2+ Wave Frequency in 
Cardiomyocytes   
Classically, the clinical focus on HAT has been the neuropsychiatric disturbances.  
However cardiac involvement has been reported(58), but has usually been 
attributed to inflammation(51).  In fact the traditional thinking behind much of 
the pathology of trypanosomiasis has been that it is a result of the 
immune/inflammatory response to invasion of the tissues by the parasite, 
extensively documented in both animals(26-28) and humans(56;57).   Therefore, 
inflammation was thought to be the mediator for the parasites traversing the 
BBB via disruption of the basement membrane leading to the classical CNS 
effects(501).  However later work has shown that the parasites can cross the BBB 
without disruption of the tight junctional proteins between the endothelial 
cells(502). Nikolskaia et al. (2006) demonstrated that T. brucei spp. secrete a 
factor that induces Ca2+ oscillations in human brain microvascular endothelial 
cells (HBMECs)(69).  The hypothesis tested in the current study was that, like the 
HBMECs, trypanosomes could have an effect on cardiomyocytes without an 
immune/inflammatory component.  The results demonstrated in the first part of 
this current study show that isolated adult rat left ventricular cardiomyocytes 
show increased spontaneous contractile activity.  This can be related to altered 
Ca2+ signalling within the cardiomyocyte.  Nikolskaia et al. (2006) postulated 
that the changes in [Ca2+]i  they observed could be due to mechanical 
stimulation by actively swimming parasites, which they subsequently ruled out 
by removing the live parasites from the culture medium, and yet continued to 
observe the same effect(69).  The data presented in this thesis show the increase 
in spontaneous contractions was still apparent when cardiomyocytes were 
incubated in supernatant supporting the evidence presented in Nikolskaia et al. 
(2006)(69).  Further results shown here (Figure 3.2) demonstrate that heat 
treatment of supernatant abrogates the observed effects, suggesting the 
responsible factor is a heat labile excreted/secreted factor.  Particular care was 
taken in preparation of the supernatant to ensure the trypanosomes were not 
lysed, therefore ruling out an intracellular protein released upon parasite death. 
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3.4.2 Ca2+ Wave Velocity and Frequency are Increased by 
Trypanosome Culture Supernatant 
Spontaneous contractions in cardiomyocytes arise from an asynchronous, 
spontaneous release of Ca2+ from the SR, termed a Ca2+ wave(261).  By loading 
cardiomyocytes with Ca2+ sensitive fluorophores it was possible to image the rise 
and fall of cytosolic Ca2+ in response to incubation with the supernatant.  The 
images obtained enabled the spontaneous Ca2+ waves to be further characterised 
to enable inferences on possible mechanisms to be drawn.  As observed in the 
population assay (Figure 3.1), an increased frequency of Ca2+ waves was 
observed in cardiomyocytes incubated with supernatant.  Increased Ca2+ wave 
frequency can occur when individual Ca2+ release events (Ca2+ sparks) trigger 
further release of Ca2+ from the SR through CICR(148).  An increased Ca2+ wave 
frequency is determined by the time taken to reach SR Ca2+ threshold(192).  
SERCA stimulation by a direct or indirect effect of a factor in supernatant would 
increase the rate of accumulation of Ca2+ within the SR and hence decrease the 
time between spontaneous events(192;503).  This may have clinical repercussions as 
increased Ca2+ wave frequency is likely to increase the propensity for whole 
heart arrhythmias(192).   
The velocity of Ca2+ wave propagation is an indicator of cluster to cluster RyR 
activation determined by RyR sensitivity, both dyadic and luminal, and 
refractoriness(222;261;504).  The results reported in this current study show a 
significant increase in velocity of Ca2+ waves present within cells incubated in 
supernatant.  O’Neill et al. (2004) has shown that Ca2+ wave velocity was related 
to SERCA activity and therefore the observed increase in velocity observed in the 
current study may be an expected additional effect of enhanced SERCA 
activity(503).  However, it is acknowledged that the relationship between SERCA 
activity and Ca2+ wave characteristics is complex(505).  
3.4.3 Supernatant Increases the Rate of Stimulated Ca2+ Transient 
Decline  
Experiments were performed on cohorts of cardiomyocytes that were incubated 
and superfused with media or supernatant and field stimulated at 1.0 Hz.  The 
cells were loaded with Fura-4F and the rise and fall in cytosolic Ca2+ measured.  
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The main finding was an enhanced rate of transient decline.  SERCA activity 
(KSERCA) was estimated by measuring the rate constant of decay of the 
electrically stimulated Ca2+ transient.  However, since Ca2+ is removed from the 
cytosol by reuptake into the SR by SERCA and extrusion by NCX(158), an increase 
in rate constant could have sarcolemmal efflux contributions.  Although SERCA 
and NCX are not the only mechanisms involved Ca2+ removal during relaxation, 
the sarcolemmal Ca2+ ATPase pump and mitochondrial Ca2+ uptake contribute 
minimally, accounting for <25% of Ca2+ extrusion(222;223) and occurring over a 
much slower time course than either SERCA or NCX(224).  In the rat 92% of Ca2+ 
removal is due to SERCA and 7% due to NCX vs. 70% and 28% respectively in 
rabbit left ventricular cardiomyocytes(224).  In humans, the Ca2+ removal 
contributions have been reported as 63% due to SERCA and 32% due to NCX(225), 
therefore more similar to rabbit.  If a high concentration caffeine bolus is 
rapidly applied to the cell, as well as being an indicator of [Ca2+]SR, the rate 
constant of decay of the caffeine-induced Ca2+ transient can indicate potential 
alterations in NCX with a much smaller component due to the other mechanisms.  
When the rate constant of decay of the caffeine-induced Ca2+ transient was 
measured there was no statistically significant difference.  This suggests no 
significant alteration of extracellular extrusion, although the NCX current was 
not directly measured.  It can be inferred that the logical explanation for an 
increased rate of Ca2+ transient decline is an increased KSERCA.  This can be 
measured as in Bode et al. (2011) by subtracting the rate constant of decay of 
the electrically stimulated Ca2+ transient from that of the caffeine-induced Ca2+ 
transient(506) which gives a significant increase in KSERCA of 143% (10.1 ± 1.10 vs. 
14.5 ± 1.39s-1; control vs. supernatant; P<0.05).  This compares well with the 
increase of 139% (11.3 ± 1.06 vs. 15.7 ± 1.41s-1; P<0.05) when using the rate 
constant of decay for the electrically stimulated transient alone.  Since KSERCA is 
increased it would be expected that there would be a concomitant increase in 
the caffeine-induced transient amplitude reflecting a higher [Ca2+]SR yet this was 
not found.  The possible mechanisms underlying these findings form the basis for 
the next chapter. 
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3.4.4 The Effects of Supernatant on the Stimulated Ca2+ Transient 
During β-adrenergic Stimulation  
Cohorts of cardiomyocytes were treated as above but with the addition of 100 
nM isoproterenol (ISO).  β-adrenergic agonists such as ISO bind to the G-protein 
coupled β-adrenergic receptor which then stimulates adenylyl cyclase elevating 
cyclic AMP which activates protein kinase A (PKA).  PKA, among other functions, 
phosphorylates the RyR which may increase its sensitivity and also 
phosphorylates the Ser16 residue on phospholamban (PLB), an inhibitory protein 
of SERCA(148).  Another kinase also plays a role in the β-adrenergic cascade, Ca2+ 
calmodulin kinase II (CaMKII) through activation by PKA and directly from β-
adrenergic stimulation(258).  Importantly, CaMKII also has phosphorylation sites on 
the RyR and Thr17 on PLB.  Between stimulation pulses, diastolic release events 
of Ca2+ can be observed in cells incubated and superfused with supernatant in 
the presence of ISO.  The rate constant of stimulated transient decline is also 
greater than without ISO as would be expected(507).  The fact that these effects 
are not present in the control media suggests the effects of the secreted factor 
on SR functions are enhanced by β-adrenergic stimulation.     
3.4.5 Ca2+ Waves are Reduced by Cathepsin-L Inhibition but not 
Cathepsin-B Inhibition 
The cysteine protease activity of trypanosomes comprise of TbCatL and 
TbCatB(492).  Nikolskaia et al. (2006) demonstrated that TbCatL activity was 
responsible for the Ca2+ rises in HBMECs enabling traversal of their in vitro BBB 
model.  They found that the cathepsin-L specific inhibitor K11777 abrogated the 
parasite traversal of the model but not the cathepsin-B specific inhibitor 
CA074(69).  Given the role of Ca2+ rises in the HBMEC model and the key role of 
Ca2+ in E-C coupling, K11777 and CA074 were applied to cohorts of 
cardiomyocytes that were then examined utilising spontaneous contractile 
activity assays (section 3.2.3).  The addition of CA074 to cardiomyocytes did not 
alter the supernatant effect on spontaneous contractile activity of cells.  When 
K11777 was applied to cardiomyocytes incubated in supernatant, the number of 
cardiomyocytes exhibiting spontaneous contractile activity was reduced to the 
same level observed in control media.  This result supports the hypothesis that it 
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is the cathepsin-L-like cysteine protease TbCatL that could be causing an 
increase in waves.     
American trypanosomiasis (aka Chagas Disease), caused by Trypanosoma cruzi, is 
characterised by significant cardiac pathology.  Interestingly, a study by Barr et 
al. (1996) demonstrated a protease within the trypomastigote soluble fraction 
(TSF) that induces Ca2+ transients in canine cardiomyocytes(508).  The protease 
has since been shown to be an orthologous protease to TbCatL(509).  The result 
described by Barr et al. (1996) was that Ca2+ release was independent of an 
inward L-type Ca2+ current and due to SR Ca 2+ release mediated by a pertussis 
toxin (PTx) sensitive g-protein coupled receptor(508).  The data presented in this 
chapter interpreted in context of the literature would suggest that TbCatL may 
activate a g-protein coupled receptor, causing activation of a secondary 
messenger, which then leads to spontaneous release of Ca2+ from the SR.  Future 
work in the laboratory will aim to elucidate the sarcolemmal target for TbCatL.  
3.4.6 Recombinant Cathepsin-L Increases Ca2+ Wave Frequency 
The increase of Ca2+ waves has been abrogated by application of a cathepsin-L 
inhibitor which suggests an association of TbCatL and increased spontaneous Ca2+ 
release.  To support this finding a cohort of spontaneous contractile activity 
assays was performed with recombinant TbCatL.  These experiments showed the 
expected response of increased numbers of cells exhibiting Ca2+ waves.  This 
suggests that it is TbCatL that is having a direct effect on spontaneous 
contractile activity of cardiomyocytes. 
3.4.7 Ca2+ Waves are Reduced by RNA Interference of TbCatL 
The use of recombinant TbCatL shows a gain of function effect, but to prove 
that TbCatL is definitively the responsible factor experiments were performed to 
show a loss of function phenotype.  TbCatL is essential for parasite survival(492) 
meaning that a complete gene knockout is not possible, so an inducible RNA 
interference (RNAi) approach was employed.  Two independent clones of T. b. 
brucei were transfected with an inducible RNAi construct of the Trypanosoma 
brucei cathepsin-L (TbCatL) gene.  Growth curves were performed to test 
efficacy of the RNAi which showed the expected defect in growth associated 
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with knockdown of an essential gene(492).  Quantitative PCR confirmed successful 
knockdown of TbCatL with additional PCR using TbCatB specific primers to 
ensure specificity of knockdown.  When cardiomyocytes were incubated with 
supernatant from the induced cultures the number of cardiomyocytes exhibiting 
Ca2+ waves was reduced to the levels observed on control media.  To confirm it 
wasn’t a result of the transfection process on the trypanosomes, cardiomyocytes 
were also incubated in supernatant from uninduced cultures, which showed the 
same increase in Ca2+ waves as wild-type T. b. brucei.   
These results demonstrate by three independent methods that TbCatL is 
increasing the number of cardiomyocytes that exhibit Ca2+ waves.  These 
experiments were all performed in isolated cardiomyocytes, thereby removing 
the immune/inflammatory response.  These data demonstrate for the first time 
a direct effect by secreted TbCatL on the Ca2+ dynamics of cardiomyocytes 
independent of an immune/inflammatory response.  These findings also have 
implications in terms of treatment.  Current HAT drugs are difficult to 
administer in the field and cause severe toxic side effects in 5-10% of cases with 
an average case fatality rate of 50%(510).  Inhibitors of cysteine proteases are 
currently being tested as novel trypanocides(492) but may also have a beneficial 
effect not only in limiting BBB traversal but potentially also cardiac dysfunction.  
3.4.8 Supernatant Can Cause Arrhythmic Events in Whole Hearts 
The literature reports ECG abnormalities and patient descriptions of arrhythmic 
disturbances or palpitations(45;51-54) in cases of HAT.  Most notably are ventricular 
premature complexes (VPCs) and a prolonged QT interval.  To explain the 
clinical ECG findings in light of the evidence presented in this study the role of 
Ca2+ waves in arrhythmic heart disease has been considered.  Ca2+ waves have 
been implicated in a number of arrhythmias such as delayed after 
depolarisations (DADs) and early after depolarisations (EADs)(222).     
The data in this chapter shows a significant increase in ventricular arrhythmias, 
specifically VPCs, in ex vivo intact hearts.  These hearts are removed from an 
immune/inflammatory component so this is a direct effect from the 
trypanosome supernatant.  Given the increase in Ca2+ waves observed, the faster 
decline of stimulated transient and the known relationship of Ca2+ release and 
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subsequent efflux by NCX(192) it is reasonable to suggest that the increase in Ca2+ 
waves within ventricular cardiomyocytes is linked to an increased frequency of 
DADs brought about by the electrogenic potential of NCX.  The result is very 
similar to the response to β-adrenergic stimulation.  In the presence of increased 
β-adrenergic stimulation there is increased phosphorylation of phospholamban, 
which reduces the inhibition on SERCA.  The reduced inhibition of SERCA allows 
more Ca2+ to be taken up into the SR during diastole.  Since sarcolemmal 
extrusion (via NCX) and SR reuptake (via SERCA) are the main Ca2+ removal 
mechanisms, they compete for the same diastolic pool of Ca2+ so there is less 
time for NCX to extrude Ca2+ in the presence of enhanced SERCA activity.  
Increased β-adrenergic stimulation also increases Ca2+ influx via stimulation of 
the L-type Ca2+ channel, which will raise diastolic [Ca2+]i thereby increasing the 
diastolic pool of Ca2+ from which SERCA draws resulting in Ca2+ overload of the 
SR.  SR Ca2+ overload would in turn, result in more diastolic Ca2+ waves resulting 
in a greater need for Ca2+ extrusion by NCX leading to more influx of Na+ 
increasing the likelihood of action potential threshold being reached.  The action 
potentials rather than the Ca2+ waves could then propagate from cell to cell 
through gap junctions(154) potentially setting up an arrhythmogenic focus within 
the ventricular myocardium leading to the VPCs observed in this study and in the 
field(51).   
Ca2+ waves can also be linked to EADs(289) and EADs are associated with prolonged 
QT intervals(286) which have been found in HAT patients(51).  However, there was 
no statistically significant difference in QT intervals of hearts perfused with 
control media vs. supernatant (Figure 3.9) or when corrected for heart rate 
using the Framingham method.  These findings suggest that the observed QT 
alterations clinically(51) are less likely to be an acute effect but a more longer 
term effect which was attributed by Blum et al. (2007) to be a result of 
associated myocarditis(51).  QT is prolonged in myocarditis because the 
infiltration of inflammatory cells disrupts the myocardial tissue and can alter the 
electrical conductivity of the heart leading to alterations of depolarisation and 
repolarisation(27;57).  It is possible that in vivo there may be a synergistic effect 
on the myocardium of the direct effects of TbCatL with inflammation. 
When patients with Chagasic cardiomyopathy were examined, a prolonged QT 
interval was found(511).  When investigated utilising mouse models of T. cruzi 
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infection, a similar prolongation of QT was also found, which correlated with the 
histopathological findings of infiltrating lymphocytes and macrophages(512).  This 
could be the case for HAT but in vivo infection models would be required; these 
are presented and discussed in Chapter 5. 
3.4.9 Arrhythmic Events Occurred in a Proportion of Hearts  
Since Ca2+ waves have a low probability (<0.13) of propagating cell to cell(154) 
and DAD amplitude is diminished over a greater number of cells(192), multiple 
adjoining cells would be required to initiate an ectopic beat.  In an atrial 
mathematical model it was identified that 1000 cells would be required in a grid 
of 512 x 512 to initiate an ectopic beat(288).  The data in this chapter suggests 
that TbCatL can induce Ca2+ waves in 67.47% ± 1.92 of cells, therefore a 
proportion of hearts may be expected not to exhibit arrhythmias as a sufficient 
number of adjacent cells would not be waving.  Only a proportion of hearts 
perfused with supernatant showed increased numbers of VPCs whereas none of 
the controls did.  This evidence is supported by clinical field data that shows 
only a proportion of individuals show ECG abnormalities (71%) and palpitations 
(18%)(51). 
3.5 Conclusions 
The data presented in this chapter demonstrates for the first time that T. b. 
brucei can cause direct effects on isolated rat left ventricular cardiomyocytes 
and ex vivo intact whole rat hearts independent of an immune/inflammatory 
response.  How the trypanosomes have this effect is through the action of a 
cathepsin-L like cysteine protease, TbCatL.  A possible mechanism of action is 
that TbCatL acts in a similar way to β-adrenergic stimulation by altering the 
sensitivity of the RyR to Ca2+, and increasing Ca2+ reuptake into the SR by 
increased SERCA activity.  However, this still needs to be investigated further 
and is discussed in Chapter 4.   
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4 CHAPTER 4 – Investigating the Mechanisms of 
Arrhythmogenic Sarcoplasmic Reticulum-
Mediated Ca2+ Release Caused by Trypanosoma 
brucei   
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4.1 Introduction 
4.1.1 Trypanosomes and Intracellular Ca2+ 
The classical major effects of second stage Human African Trypanosomiasis 
(HAT) are the neuropsychiatric disturbances that give the disease its colloquial 
name of “Sleeping Sickness”.  This occurs when the parasites cross the blood 
brain barrier (BBB)(68).  Grab et al. (2004) showed that blood stream form 
trypanosomes induced oscillatory changes in [Ca2+]i within endothelial cells of 
the an in vitro blood brain barrier model which enabled the parasites to cross 
the endothelial monolayer paracellularly(67).  Nikolskaia et al. (2006) 
subsequently demonstrated that the oscillatory changes in [Ca2+]i were caused by 
a cathepsin-L-like cysteine protease (TbCatL)(69).  Grab et al. (2009) later 
postulated the membrane target leading to the oscillatory changes in [Ca2+]i to 
be the g-protein coupled receptor (GPCR) protease activated receptor 2 (PAR-
2)(66).  Interestingly, the related parasite Trypanosoma cruzi, the cause of 
American trypanosomiasis (Chagas Disease) which has notable cardiac 
pathology(513), also produces a protease that induces [Ca2+]i fluctuations in range 
of mammalian cells(514) and cardiomyocytes(508).  These changes in [Ca2+]i are 
associated with host cell invasion as inhibition of Ca2+ transients in host cells 
prevents invasion(515;516).  The changes in [Ca2+]i induced by T. cruzi  were shown 
to be sensitive to inhibition of the pertussis toxin sensitive GPCR(508).  This 
suggests a putative role for Ca2+ in the host cell invasion for T. cruzi.  With 
regard to T. b. brucei it is clear that it can also induce changes in [Ca2+]i in host 
cells such as endothelial cells in vitro.   The novel data presented in the 
preceding chapter demonstrates that Trypanosoma brucei brucei also has an 
effect on spontaneous Ca2+ release in cardiomyocytes.   
4.1.2   African Trypanosomes and [Ca2+]i in the Heart 
As discussed in the preceding chapter recent studies have identified clinical 
manifestations of cardiac pathology such as palpitations and prolonged QTc 
intervals(51) in patients with HAT.  In post-mortem examinations of infected 
humans(56;57) and experimentally infected animals(26-28) there has been significant 
cardiac pathology with the presence of trypanosomes in the myocardium with or 
without inflammatory cell infiltrates(26;497).  The results presented in the 
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preceding chapter demonstrate that trypanosome supernatant increases 
spontaneous Ca2+ release and may also increase ventricular arrhythmia 
frequency in ex vivo rat hearts.  This would suggest that the observed cardiac 
clinical signs in HAT may be related to altered intracellular Ca2+ handling 
induced by TbCatL.  The mechanisms at the level of the SR underlying the 
increase in propensity for spontaneous Ca2+ release in cardiomyocytes induced by 
T. brucei remain unknown and are the focus of this chapter. 
4.1.3 Mechanisms to Explore 
The conclusion that TbCatL causes abnormal SR-mediated Ca2+ release as a result 
of stimulation of SERCA needs to be substantiated.  Firstly, the only evidence for 
this conclusion is an accelerated decline of the Ca2+ transient in supernatant 
perfused cardiomyocytes.  If increased spontaneous Ca2+ release was a result of 
increased SERCA activity, the SR Ca2+ content may be expected to be higher.  
Therefore, paired experiments with the same cardiomyocyte being perfused with 
media followed by supernatant were performed to improve the accuracy and 
reliability of the epifluorescence SR Ca2+ content experiments.  Secondly, 
whether cathepsin-L can lead to altered [Ca2+]i independent of SR Ca2+ release 
and uptake is unknown.  Therefore experiments assessing the diastolic [Ca2+]i 
with SR ATPase and RyR inhibitors were conducted.  Thirdly, alteration of the 
Ca2+ transient decline could be associated with altered myofilament Ca2+ 
responsiveness(148;517), therefore cardiomyocyte length measurements were 
performed in parallel with the epifluorescence Ca2+ measurements to assess 
myofilament Ca2+ sensitivity.  Fourthly, evidence on how the extracellular 
cathepsin-L targets intracellular SERCA is an important question to try to 
answer.  The dual increase of spontaneous Ca2+ release in the form of Ca2+ waves 
and increased SERCA activity suggest that Protein Kinase A (PKA) and/or 
Ca2+/calmodulin Kinase II (CaMKII) may be possible targets(148).  Therefore the 
spontaneous contractile event experiments were performed with PKA and CaMKII 
specific inhibitors.   
4.1.4 Aims of the Chapter 
It is clear that trypanosome supernatant can have a direct affect on 
cardiomyocyte Ca2+ dynamics but the host cell SR-related mechanisms remain 
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unclear.  The primary aim of this chapter is to explore the potential SR-related 
mechanisms by which TbCatL could be eliciting its effects on Ca2+ handling and 
whether CaMKII and/or PKA are potential mediators of the observed effects on 
SR function.    
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4.2 Methods 
4.2.1 Adult Rat Cardiomyocyte Isolation 
Adult rat left ventricular cardiomyocytes were isolated from male Wistar rats as 
described in section 2.3.1.  Briefly, hearts were removed and enzymatically 
digested with collagenase to break down the connective tissue.  Isolated 
cardiomyocytes were prepared as described in in section 2.3.1.  The 
cardiomyocytes were suspended in MIKH containing no BSA with a [Ca2+]o of 1.8 
mM.  
4.2.2 Preparation of Control Media and Supernatant 
Control media and supernatant were prepared as described in section 2.1.5.  
These solutions were then loaded into a gravity fed perfusion system for delivery 
to isolated cardiomyocytes via a perfusion pen at 37 ºC.   
4.2.3 Normal Extracellular Ca2+ Epifluorescence Measurements 
The isolated cardiomyocytes in 1.8 mM Ca2+ MIKH from above were loaded with 5 
µM of the ratiometric Ca2+ fluorophore Fura-4F-AM (Invitrogen) by incubation for 
10 min at room temperature.  The cardiomyocytes were resuspended in 1.8 mM 
Ca2+ MIKH and incubated for 30 min at room temperature for de-esterification.  
Cardiomyocytes were loaded into a tissue bath (Cell Microcontrols) and allowed 
to settle onto a coverslip.  Cardiomyocytes were superfused with normally 
prepared control media or supernatant at 37 ºC by gravity fed perfusion pen with 
active pump outflow.  Cardiomyocytes were field stimulated (1.0 Hz, 2.0 ms 
duration, stimulation voltage set to 1.5 x threshold) and perfused firstly with 
control media (60 s) followed by supernatant (60 s).  Caffeine (10 mM, 20 s; 
without field stimulation) was applied before the protocol, after perfusion with 
media and after supernatant.  The three caffeine boluses and two solution 
changes were all performed in the same isolated cardiomyocyte thus enabling 
accurate paired assessment of SR Ca2+ content between media and supernatant.  
Parallel experiments were performed with media for both 60 s periods as time-
controls.  The results obtained with supernatant were normalised to these time-
controls.  The Fura-4F fluorescence ratio (340/380 nm excitation; R340/380nm) was 
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measured with a spinning wheel spectrophotometer (Cairn Research Ltd) at a 
sampling rate of 5,000 Hz.  [Ca2+]i was calculated from R340/380nm as described in 
General Methods.  Mean Ca2+ transients were calculated by averaging 12 steady 
state transients using Origin (OriginLab). 
4.2.4 Low Extracellular Ca2+ Epifluorescence Measurements 
Cardiomyocytes were prepared as described above, but [Ca2+]o was increased 
only to 0.5 mM.  The intact cardiomyocytes were then resuspended in MIKH with 
0.5 mM Ca2+ and loaded with 5 µM Fura-4F-AM for 10 min.  Cells were de-
esterified in 0.5 mM Ca2+ MIKH for 30 min before being allowed to settle on a 
cover slip within a tissue bath as described above (section 4.2.4).  Superfusate 
solutions of control media and supernatant were made with [Ca2+]o of 0.5 mM by 
diluting 1 in 4 with 0 mM Ca2+ MIKH.  A test experiment assessing the percentage 
change in cell exhibiting spontaneous contractile events as performed in Chapter 
3 was conducted to examine whether a 1 in 4 diluted supernatant still showed an 
increase in cells exhibiting spontaneous contractile events compared to 1 in 4 
diluted media.  Cells incubated in 1 in 4 diluted supernatant with 0.5 mM [Ca2+]o 
showed a significant increase in contractile events of 300%; (10.33 ± 5.23% vs. 
31.05 ± 6.16% cardiomyocytes exhibiting at least one spontaneous contractile 
event.min-1; control media vs. supernatant; P<0.05; Figure 4.1).  This was 
comparable with the increase in supernatant observed at 1.8 mM [Ca2+]o; (52.11 
± 1.64% vs. 67.47 ± 1.92% cardiomyocytes exhibiting at least one spontaneous 
contractile event.min-1; control media vs. supernatant; P<0.001; Figure 3.1).  
Therefore low [Ca2+]o were performed with a 1 in 4 diluted control media or 
supernatant. 
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Figure 4.1: Spontaneous contractile events in low and normal [Ca2+]o. 
Mean % ± SEM of isolated rat left ventricular cardiomyocytes exhibiting ≥1 spontaneous contractile 
event.min-1 in media and supernatant at 1.8 mM [Ca2+]o and 0.5 mM [Ca2+]o. n = number of 
cardiomyocytes. 
Cardiomyocytes were superfused with the 1 in 4 diluted control media or 
supernatant at 37 ºC with field stimulation as above (section 4.2.3) using the 
same protocol of media (60 s) followed by supernatant (60 s) with three caffeine 
boluses; before protocol, after media and after supernatant.  Results were 
normalised to time-controls. 
4.2.5 First Post-Caffeine Ca2+ Transient Analysis 
As an indicator of Ca2+ influx via the L-type Ca2+ channel (LTCC), the amplitude 
of the first Ca2+ transient following the application of caffeine (10 mM) was 
measured.  The SR is essentially empty of Ca2+ following the application of 
caffeine so the [Ca2+]i will predominately come from what enters through the 
sarcolemma via the LTCC(518).   
4.2.6 Fractional Shortening Measurements 
In parallel with normal 1.8 mM [Ca2+]o epifluorescence measurements cell length 
was also measured.  Edge detection software (Ionoptix) was used to measure the 
change in length of field stimulated (1.0 Hz) isolated cardiomyocytes.  The 
change in length was plotted as a ratio over the diastolic cell length immediately 
before stimulation (L/L0).  Fractional shortening was calculated as the 
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percentage reduction from L0.  To assess changes in myofilament Ca2+ sensitivity 
cell length was plotted against [Ca2+]i during diastole. 
4.2.7 Epifluorescence Measurements of Diastolic [Ca2+]i During 
SR Inhibition 
Fura-2-AM loaded cardiomyocytes were incubated with 1.0 µM thapsigargin 
(Merckmillipore) and 1.0 µM ryanodine (Merckmillipore) for 30 min to inhibit SR 
function.  The cardiomyocytes were then superfused with control media for 1 
min followed by perfusion with supernatant (or media for time-controls) for 4 
min in the continued presence of 1.0 µM thapsigargin and ryanodine.  Changes in 
diastolic [Ca2+]i were assessed using the spinning wheel spectrophotometer as 
above (section 4.2.3). 
4.2.8 Spontaneous Contractile Event Measurement in Isolated 
Cardiomyocytes With H-89 and AIP 
Isolated cardiomyocytes were incubated at a dilution of 1 in 4 with control 
media or supernatant (cells in MIKH:control media/supernatant) for 30 min with 
or without the PKA inhibitor H-89 (N-[2-(p-bromocinnamylamino)ethyl]-5-iso-
quinolinesulphonamide) (Sigma-Aldrich) at a concentration of 10 µM(153;519).  For 
experiments with the CaMKII inhibitor AIP (autocamtide-2 related inhibitory 
peptide) (Merckmillipore) cardiomyocytes were plated in 35mm petri dishes 
(Corning) at a density of 25-50 cells.cm-2 for 60 min(320).  To improve AIP loading 
a myristoylated form was used that has greater cell permeability.  
Cardiomyocytes were viewed under a light microscope and charged-couple 
device (CCD) camera at 20 x magnification enabling observation of ≥10 
cardiomyocytes per field of view.  Individual cardiomyocytes exhibiting at least 
one spontaneous contractile event within 1 min were noted and expressed as the 
percentage of the total examined cardiomyocyte number.  This process was 
repeated over 10 fields and mean data reported. 
4.2.9 Epifluorescence Measurements with CaMKII Inhibition 
Epifluorescence measurements at physiological (1.8 mM) [Ca2+]o in field 
stimulated (1.0 Hz) cardiomyocytes with Fura-4F were performed with the 
CaMKII inhibitor AIP.  Diastolic [Ca2+]i measurements in unstimulated 
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cardiomyocytes with Fura-2AM were also conducted with AIP.  Cells were 
prepared by incubating in petri dishes with AIP for 60 min as above (section 
4.2.8).  The protocols applied in sections 4.2.3 and 4.2.7 were performed in 
separate cohorts of cells and analysed as described. 
4.2.10 Statistical Analysis 
Data are expressed as mean ± SEM.  Paired experiments were normalised to 
time-controls performed in parallel.  Statistical comparisons were made by a 
paired Student’s T-test on the raw data.  Two-sample Student’s T-tests were 
performed on percentage changes over controls.  A significance level of P<0.05 
was considered significant. 
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4.3 Results 
4.3.1 Supernatant Increased the Decay Rate Constant of the 
Stimulated Ca2+ Transient 
The experiments conducted in Chapter 3 were with two separate groups of 
cardiomyocytes at 1.8 mM [Ca2+]o incubated for 30 min.  The data presented in 
that chapter demonstrated an increase in the decay rate constant but no 
statistically significant difference in the amplitude of the caffeine-induced Ca2+ 
transient (albeit with a tendency towards being lower in supernatant; Figure 
3.4).  Although using a 30 min incubation period ensured that the supernatant 
had sufficient time to act, it was not possible to perform paired experiments 
which reduced the sensitivity of the experiments; in particular the peak of the 
caffeine-induced Ca2+ transient.  It also prevented ascertaining whether the 
supernatant could have acute effects. In order to address these issues, paired 
experiments without prior incubation were performed.  Cardiomyocytes were 
perfused for 60 s with media followed by 60 s with supernatant (or media for 
time-controls) (Figure 4.2A).  Results in supernatant were normalised to the 
time-controls.   
4.3.1.1 Physiological [Ca2+]o (1.8 mM) 
Mean data ± SEM was obtained from average Ca2+ transients from the last 12 Ca2+ 
transients in media and supernatant  (Figure 4.2B).  The maximum [Ca2+]i was 
not significantly altered by supernatant; (662.4 ± 56.0 vs. 657.5 ± 55.6 nM; 
control media vs. supernatant; P>0.05; Figure 4.2C(i)), nor was the minimum 
[Ca2+]i significantly altered; (160.6 ± 5.3 vs. 165.7 ± 5.5 nM; control media vs. 
supernatant; P>0.05; Figure 4.2C(i)).  Therefore, the stimulated Ca2+ transient 
amplitude was also not significantly altered by supernatant; (501.8 ± 56.6 vs. 
490.1 ± 55.3 nM; control media vs. supernatant; P>0.05; Figure 4.2C(i)).  This 
data supports the Ca2+ transient findings with incubated cardiomyocytes.   With 
the incubated cardiomyocyte data there was a parallel increase in the decay 
rate constant of 110.4% of control; (12.2 ± 1.2 vs. 13.4 ± 1.4 s-1; control media 
vs. supernatant; P<0.05; Figure 4.2C(ii)).   
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4.3.1.2 Low [Ca2+]o (0.5 mM) 
The same experiments were also performed with control media and supernatant 
diluted 1 in 4 with 0 mM [Ca2+]o MIKH to lower the [Ca2+]o to 0.5 mM (Figure 
4.2A).  These experiments were performed to ensure that the SR Ca2+ content 
had not reached saturation.  Reduction of [Ca2+]o reduced the Ca2+ transient 
amplitude to 45.9% of that in 1.8 mM [Ca2+]o .  Similar to 1.8 mM [Ca2+]o the Ca2+ 
transient peak was not affected by supernatant; (388.5 ± 23.6 vs. 395.6 ± 24.8 
nM; control media vs. supernatant; P>0.05; Figure 4.2C(i)), nor was the Ca2+ 
transient minimum; (158.4 ± 5.3 vs. 154.3 ± 5.2 nM; control media vs. 
supernatant; P>0.05; Figure 4.2C(i)).  Therefore the Ca2+ transient amplitude 
was also unaffected by supernatant; (230.1 ± 23.5 vs. 242.0 ± 24.8 nM; control 
media vs. supernatant; P>0.05, Figure 4.2C(i)).  However, like the 1.8 mM 
[Ca2+]o, the decay rate constant was significantly increased by supernatant to 
112% of control; (8.5 ± 0.4 vs. 9.5 ± 0.4 s-1; control media vs. supernatant; 
P<0.05; Figure 4.2C(ii)). 
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Figure 4.2: Stimulated Ca2+ transients at low and physiological extracellular Ca2+. 
(A) Protocol used in epifluorescence Ca2+ measurements. (B) Whole protocol traces at (i) low 0.5 
mM [Ca2+]o. and (ii) normal 1.8 mM [Ca2+]o  (C(i)) Mean ± SEM for average of last 12 transients for 
stimulated Ca2+ transient parameters (maximum, minimum and amplitude) normalised to time 
controls for low 0.5 mM [Ca2+]o (n = 8) and normal 1.8 mM [Ca2+]o (n = 12); for control media in the 
first minute (white) and supernatant in the second minute (grey).  (ii) Mean ± SEM for average of 
last 12 transients decay rate constant for both low and normal [Ca2+]o.    
4.3.2 Supernatant Reduces the SR Ca2+ Content 
SR Ca2+ content has a significant influence on Ca2+ transient characteristics.  To 
determine the SR Ca2+ content the amplitude of Ca2+ transient induced by rapid 
application of 10 mM caffeine (20 s) was measured after perfusion of the 
cardiomyocytes with media and then supernatant in the same cell (Figure 4.3A).  
The paired nature of the protocol enabled more accurate determination of small 
changes in SR Ca2+ content between media and supernatant. 
4.3.2.1 Physiological [Ca2+]o (1.8 mM) 
The caffeine-induced Ca2+ transient was measured in media and supernatant and 
normalised to time-control experiments performed in parallel.  Supernatant had 
no significant effect on the minimum [Ca2+]i (152.9 ± 5.4 vs. 170.2 ± 6.1 nM; 
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control media vs. supernatant; P>0.05; Figure 4.3B(i)).  However, supernatant 
significantly reduced the caffeine-induced Ca2+ peak (913.9 ± 44.4 vs. 865.8 ± 
42.0 nM; control media vs. supernatant; P<0.05; Figure 4.3B(i)), resulting in a 
significantly reduced amplitude of 91.7% of the amplitude in control media 
(760.9 ± 42.9 vs. 698.3 ± 39.4 nM; control media vs. supernatant; P<0.05; Figure 
4.3B(i)).  The decay rate constant of the caffeine-induced Ca2+ transient is an 
indicator of sarcolemmal extrusion of Ca2+ as the SR cannot re-accumulate Ca2+ 
in the continued presence of caffeine.  Supernatant did not significantly alter 
the decay rate constant; (1.68 ± 0.08 vs. 1.45 ± 0.07; control media vs. 
supernatant; P<0.05) (Figure 4.3B(ii)). 
4.3.2.2 Low [Ca2+]o (0.5 mM) 
As with the stimulated Ca2+ transient experiments, caffeine was applied at low 
[Ca2+]o.  Similarly with the normal [Ca2+]o supernatant did not significantly alter 
the minimum [Ca2+]i; (155.5 ± 5.5 vs. 150.3 ± 5.3 nM; control media vs. 
supernatant; P>0.05; Figure 4.3B(i)).  However, supernatant did decrease the 
peak of the caffeine-induced Ca2+ transient to 82.7% of control (1114 ± 51.5  vs. 
921.0 ± 42.6 nM; control media vs. supernatant; P<0.05; Figure 4.3B(i)) and the 
amplitude to 80.3% of control (958.7 ± 52.2 vs. 769.4 ± 41.9 nM; control media 
vs. supernatant; P<0.05; Figure 4.3B(i)).  Supernatant did not significantly affect 
the rate constant of decay; (1.95 ± 0.13 vs. 1.78 ± 0.12 s-1; control media vs. 
supernatant; P>0.05, Figure 4.3B(ii)). 
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Figure 4.3: Caffeine-induced Ca2+ transient parameters at low and normal extracellular Ca2+. 
(A) Protocol used in epifluorescence Ca2+ measurements.  (B) Mean ± SEM for caffeine-induced 
Ca2+ transient parameters (maximum, minimum and amplitude) normalised to time controls for low 
0.5 mM [Ca2+]o (n = 8) and normal 1.8 mM [Ca2+]o (n = 12); for control media in the first minute 
(white) and supernatant in the second minute (grey).  (ii) Mean ± SEM for caffeine-induced Ca2+ 
transient decay rate constant for both low and normal [Ca2+]o. 
4.3.3 Myofilament Ca2+ Sensitivity 
An altered stimulated Ca2+ transient decline could be caused by altered Ca2+ 
sensitivity of the myofilaments.  Therefore to examine whether supernatant 
could increase the Ca2+ transient rate of decline via altered Ca2+ sensitivity of 
the myofilaments, experiments were performed to measure cardiomyocyte 
shortening in parallel with [Ca2+]i measurements following the same protocol as 
used to generated the data in Figure 4.2 &Figure 4.3 (Figure 4.4A).  There was 
no significant difference in the fractional shortening percentage (7.77 ± 1.11 vs. 
7.10 ± 1.01%; control media vs. supernatant; P>0.05; Figure 4.4C(i)).  There was 
also no significant difference in the rates of change of cell shortening during 
contraction (223.0 ± 41.6 vs. 240.1 ± 44.8 µm.s-1; control media vs. supernatant; 
P>0.05; Figure 4.4C(ii)), or lengthening during relaxation (179.5 ± 39.8 vs. 164.5 
± 36.5 µm.s-1; control media vs. supernatant; P>0.05; Figure 4.4C(iii)).  At the 
end of diastole the rates of change of [Ca2+]i are minimal, therefore the minimal 
[Ca2+]i and end-diastolic cell length can be used to assess the myofilament Ca2+ 
sensitivity in the intact cell(520).  There was no statistically significant difference 
between end-diastolic [Ca2+]i (160.6 ± 5.3 vs. 165.7 ± 5.5 nM; control media vs. 
supernatant; P>0.05) or end-diastolic cell length (117.8 ± 3.2 vs. 118.7 ± 3.2 µm; 
control media vs. supernatant; P>0.05; Figure 4.4D). 
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Figure 4.4: Fractional shortening of cardiomyocytes. 
(A) Protocol used in parallel shortening and epifluorescence Ca2+ measurements. (B) Example 
shortening traces for (i) control media and (ii) supernatant as ratios of resting cell length (L/L0). (C(i-
iii)) mean ± SEM of fractional shortening % of resting cell length, rate of change of shortening 
(dL/dtS) and rate of change of lengthening (dL/dtL) for media (white) and supernatant (grey) (n = 
11). (D) Plot of mean ± SEM of end-diastolic [Ca2+]i (x axis) and end-diastolic cell length (y axis).  
Fluorescence ratios were 0.512 and 0.528 for media and supernatant respectively (P>0.05). 
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4.3.4 Supernatant Increases Diastolic [Ca2+]i via a Non-SR 
Dependent Route 
In Chapter 3 experiments were conducted with the addition of a β-adrenergic 
agonist (100 nM isoproterenol) to examine the effects under stress.  In these 
experiments the minimum [Ca2+]i was significantly increased to 115% of control 
levels (Figure 3.5).  In order to assess whether supernatant could alter diastolic 
[Ca2+]i in the absence of SR-mediated Ca2+ release or uptake, the higher affinity 
Ca2+ fluorophore Fura-2-AM was utilised in cardiomyocytes where SR function 
was inhibited by the application of both thapsigargin and ryanodine (Figure 4.5).  
In the absence of SR-mediated Ca2+ release, supernatant led to a persistent 
significant elevation of diastolic [Ca2+]i over the 4 min period compared to media 
(Figure 4.5). 
 
Figure 4.5: Diastolic [Ca2+]i measurements with an inhibited SR. 
Fura-2-AM ratio during SR inhibition with thapsigargin and ryanodine in media (open; n = 10) and 
supernatant (grey; n = 11).  Data are normalised to the 60 s time-point.  
4.3.5 Supernatant Does Not Likely Alter the L-Type Ca2+ Channel  
One possible explanation for elevation of diastolic [Ca2+]i could be increased Ca2+ 
influx through the LTCC.  An index of Ca2+ influx through the LTCC is the 
amplitude of the first stimulated Ca2+ transient after application of high 
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concentration caffeine.  Therefore, using the protocol used to generate the data 
in Figure 4.2 &Figure 4.3, the amplitude of the first stimulated Ca2+ transient 
following the application of 10 mM caffeine was measured in 0.5 mM [Ca2+]o and 
1.8 mM [Ca2+]o (Figure 4.6).  Supernatant did not significantly alter the first post-
caffeine Ca2+ transient amplitude in 0.5 mM [Ca2+]o (71.3 ± 6.8 vs. 75.3 ± 7.1 nM; 
control media vs. supernatant; P>0.05; Figure 4.6B(i)) or in 1.8 mM [Ca2+]o (154.4 
± 10.3 vs. 161.5 ± 10.8 nM; control media vs. supernatant; P>0.05; Figure 
4.6B(ii)). 
 
Figure 4.6: First post-caffeine Ca2+ amplitude at low and normal extracellular Ca2+. 
(A) Protocol for epifluorescence Ca2+ measurements, arrows indicate point of the protocol Ca2+ 
transient amplitudes were measured. (B) Mean ± SEM for first post-caffeine Ca2+ transient 
amplitude for media (open) and supernatant (grey) for (i) 0.5 mM [Ca2+]i (n = 8) and (ii) 1.8 mM 
[Ca2+]o (n = 13). 
4.3.6 Supernatant Alteration of SR Function is CaMKII Dependent 
To examine whether CaMKII or PKA are involved in the action of supernatant on 
SR function, inhibitors of these kinases were utilised in cohorts of 
cardiomyocytes incubated in control media or supernatant as described in 
Chapter 3 (section 3.2.3).  The number of cells exhibiting spontaneous 
contractions per min was noted.  The expected increase in spontaneous 
contractile events in supernatant was abolished in the presence of the CaMKII 
inhibitor AIP to 104% of media + AIP levels (P>0.05; Figure 4.7A(i)).  When the 
PKA inhibitor H-89 was used the increase in spontaneous contractile events with 
supernatant was increased as expected to 129% of media + H-89 (P<0.05; Figure 
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4.7A(ii)).  These experiments were performed in conjunction with Ms. Charlotte 
Rossor, a Masters student who was under my supervision at the time and 
presented in her thesis.  
 
Figure 4.7: Percentage change in spontaneous contractile events with AIP or H89. 
Mean ± SEM percentage change in cardiomyocytes with spontaneous contractile events with (i) 
supernatant + AIP (n = 307) vs. media + AIP (n = 121) and (ii) supernatant + H-89 (n = 377) vs. 
media + H-89 (n = 305). 
4.3.7 Supernatant Effects on Ca2+ Handling with CaMKII Inhibition 
Since the increase in spontaneous contractile events expected in supernatant 
was abolished by CaMKII inhibition but not PKA inhibition, further 
epifluorescence Ca2+ measurements were made with the addition of AIP.  A 
separate cohort of cardiomyocytes were incubated with 10 µM AIP for 60 min 
before being loaded into a tissue bath and superfused with media for 1 min 
followed by supernatant for 1 min with 1.8 mM [Ca2+]o .  Parallel time-control 
experiments were also performed in which cardiomyocytes were perfused with 
control media during the second 1 min to which the control media/supernatant 
traces were normalised to control for any alterations in the stimulated Ca2+ 
transients due to time.  When the cardiomyocytes were perfused with 
supernatant and AIP, there was no significant difference in the Ca2+ transient 
amplitude percentage change (97.7 ± 3.2 vs. 104.8 ± 4.6%; supernatant vs. 
supernatant + AIP; P>0.05; Figure 4.8A).  With AIP the significant increase in Ca2+ 
Chapter 4  Investigating the Mechanisms 213 
 
transient decay rate percentage change was reduced to control levels (110.4 ± 
1.2 vs. 96.8 ± 3.2%; supernatant vs. supernatant + AIP; P<0.05; Figure 4.8A).  
The significant reduction in SR Ca2+ content present with supernatant was 
abolished by addition of AIP (91.8 ± 2.1 vs. 100.1 ± 1.3%; supernatant vs. 
supernatant + AIP; P<0.05; Figure 4.8A).  Experiments utilising thapsigargin and 
ryanodine to inhibit SR function were performed using the same protocol as that 
used to generate the data in Figure 4.5.  In contrast with the data shown so far 
for AIP, there was no change in result.  Supernatant + AIP showed the same 
significant elevation in diastolic [Ca2+]i (Figure 4.8B) as supernatant (Figure 4.5).  
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Figure 4.8: Supernatant effects on Ca2+ parameters with AIP. 
(A) Mean ± SEM % change in supernatant ± AIP over control media for stimulated Ca2+ transient 
amplitude, Ca2+ transient decay rate constant and SR Ca2+ content. (B) Diastolic [Ca2+]i 
measurements with inhibited SR in cardiomyocytes pre-incubated with 10 µM AIP for 60 min.  
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4.4 Discussion 
4.4.1 Supernatant Effects on SR Function 
4.4.1.1 SERCA Activity is Increased by Supernatant 
In Chapter 3 the data presented showed an increase in the decay rate constant 
(Figure 3.4) in the cohort of cardiomyocytes perfused with supernatant.  This 
was attributed to a potential increase in SERCA activity (KSERCA) which led to an 
increase in spontaneous Ca2+ release from the SR.  However this was difficult to 
reconcile without a significant change in the SR Ca2+ content.  Therefore paired 
experiments were conducted where the same cardiomyocyte was perfused with 
media followed by supernatant and normalised to time-controls perfused with 
media.  This enabled more accurate assessment of Ca2+ transient parameters and 
SR Ca2+ content.  The paired experiments supported the findings in Chapter 3 
with a significantly increased stimulated Ca2+ transient decay rate constant of 
110.4% of control in 1.8 mM [Ca2+]o, and again in 0.5 mM [Ca2+]o of 111.1% (Figure 
4.2).  As discussed in Chapter 3 a faster rate of stimulated Ca2+ transient decline 
is either explained by faster SR reuptake by SERCA, or faster sarcolemmal 
extrusion predominantly by NCX(158).  Although other Ca2+ extrusion mechanisms 
such as the PMCA and mitochondria do contribute, it is <25% of total Ca2+ 
extrusion(222;223) over almost ten times longer than extrusion by NCX(224).  To rule 
out faster sarcolemmal extrusion a rapidly applied bolus of high concentration 
caffeine can be used to open the RyR and empty the SR of Ca2+.  The decay rate 
constant of the caffeine-induced Ca2+ transient will consist of sarcolemmal Ca2+ 
efflux without any SR contribution in the continued presence of caffeine, which 
can be measured.  No statistically significant difference in caffeine-induced Ca2+ 
transient decay rate was found therefore NCX involvement is unlikely.  In 
addition the caffeine-induced Ca2+ transient decay rate constant (sarcolemmal 
efflux but no SR reuptake) can be subtracted from the stimulated Ca2+ transient 
decay rate constant (sarcolemmal efflux and SR reuptake) to give the SR 
reuptake or KSERCA(506).  When this is performed the KSERCA percentage change is 
114.3 ± 2.2% of media control at 1.8 mM [Ca2+]o which compares well with the 
110.4 ± 1.2% observed when using the rate decay constant of the electrically 
induced transient alone (Figure 4.2C(v)).  The same is true for 0.5 mM [Ca2+]o, 
the subtracted decay rate constant % change is 117.3 ± 2.3% over control media 
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which compares well with 111.1 ± 2.2% over media control when using the rate 
decay constant of the electrically induced transient alone (Figure 4.2D(v)).  
Therefore we can conclude that KSERCA is significantly increased by 10-15% at 1.8 
mM [Ca2+]o and 11-17% in 0.5 mM [Ca2+]o.  
4.4.1.2 SR Ca2+ Content is Reduced by Supernatant 
Chapter 3 demonstrated an increase in Ca2+ frequency which has been attributed 
to increased SERCA stimulation, leading to increased SR Ca2+ accumulation rate 
and subsequent decreased time between spontaneous Ca2+ release events(192;503), 
which was observed (Figure 4.2).  There was also an increase in Ca2+ wave 
velocity, which has been shown to be related to increased SERCA activity(503).  
However, if this were the only effect supernatant had we would expect an 
increase in the SR Ca2+ content from the greater Ca2+ accumulation rate.  This 
was not observed in the data presented in Chapter 3.  When the more sensitive 
paired experiments were conducted, what was observed was in fact a significant 
reduction of the SR Ca2+content of 91.7% at 1.8 mM [Ca2+]o, and 80.3% in 0.5 mM 
[Ca2+]o, by measurement of the caffeine-induced Ca2+ transient amplitude.  
Therefore, the hypothesis is that the supernatant, in addition to the SERCA 
effects, may also enhance SR-mediated Ca2+ leak.  This may explain an increase 
in SERCA activity with concomitant decrease in SR Ca2+ content.  Indeed, it has 
been identified in by Antoons et al. (2006) in the muscle-LIM-protein (MLP) 
knock-out mouse that SERCA activity can be increased without an increase in SR 
Ca2+ content(521).  The same study found that the inhibitory peptide of SERCA, 
phospholamban (PLB) has increased levels of phosphorylation at both the serine-
16 and threonine-17 residues which would enhance SERCA activity(521).   Antoons 
et al. hypothesised that in order for SR Ca2+ content to be unaffected yet SERCA 
activity to be increased, there could be a concomitant increase in diastolic Ca2+ 
leak from the RyR potentially mediated by increased phosphorylation(521).  They 
measured phosphorylation at the PKA phosphorylation site serine-2809 identified 
by Rodriguez et al. (2003)(522) but found only a modest increase attributable to 
increased total RyR therefore hypothesised that CaMKII could be phosphorylating 
the serine-2815 residue(523;524) and may therefore be the mediator(521).  If there is 
a similar mechanism involved with supernatant then there could be dual effects 
on SERCA perhaps via PLB and on the RyR phosphorylation altering the open 
probability (Po).  If the RyR Po is increased then the threshold SR Ca2+ content 
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would be reduced increasing the frequency of Ca2+ waves(192).  Specifically, a 
reduced SR Ca2+ release threshold would mean that less Ca2+ in the SR could 
trigger a spontaneous Ca2+ release.  Therefore spontaneous Ca2+ release or Ca2+ 
waves would increase in frequency due to the lower SR Ca2+ release threshold.  
In heart failure it has been reported that there is an increased Ca2+ leak from 
the RyR caused by hyperphosphorylation of the RyR leading to dissociation of the 
regulatory protein FKBP12.6(276).  However, this hypothesis is controversial as 
phosphorylation of the RyR in different models of heart failure is inconsistent(276-
279;525).  There is evidence to suggest increased diastolic Ca2+ leak from the RyR 
due to phosphorylation by PKA(276;324), CaMKII(277;311) or no phosphorylation(279).  
The fact that AIP can abolish the increase in Ca2+ waves but that H-89 does not, 
suggests the effect observed in the current study may be CaMKII mediated 
phosphorylation, however to confirm this phosphorylation status of the RyR 
would need to be examined.  The increased leak can have the result of a 
reduced SR Ca2+ content and the increased Po can increase Ca2+ wave frequency 
leading to arrhythmias(273;322;526) and can also occur with increased SERCA 
activity(521).  This would not necessarily result in a reduced stimulated Ca2+ 
transient amplitude(527), which supports the results of the current study.  In the 
presence of β-adrenergic stimulation there can be an increase in RyR leak and 
sustained increase in Ca2+ waves(192;320), which supports the data presented in 
Chapter 3 and appears to be modulated by CaMKII but not PKA(320). 
4.4.2 Supernatant Does Not Alter Myofilament Ca2+ Sensitivity 
One explanation for an increased KSERCA is altered myofilament Ca2+ 
sensitivity(517).  During the normal contractile cycle Ca2+ is released from the SR 
into the cytosol and binds to troponin C (TnC) of the myofilaments facilitating 
the hydrolysis of ATP by the myosin ATPase to provide the energy for formation 
of the cross-bridges and the power stroke of the contraction.  In order for the 
myofilaments to relax during diastole when [Ca2+]i reduces the myosin ATPase 
must provide more ATP to break the cross-bridges(148).  Under normal 
circumstances, Ca2+ released from the SR binds to TnC(528).  Therefore a decrease 
in myofilament Ca2+ sensitivity would reduce the Ca2+ buffering capacity of the 
myofilaments and therefore increase the diastolic [Ca2+]i(148).  Decreases in Ca2+ 
buffering would be predicted to increase the available free Ca2+ for the 
stimulated Ca2+ transient as the myofilaments would have a reduced binding 
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capacity(517).  This would result in an increased peak [Ca2+]i and an increased rate 
of Ca2+ transient decay(529;530), which has been shown experimentally with 
exogenous Ca2+ buffers(531).  Alteration of myofilament Ca2+ sensitivity is 
therefore a potential mechanism of the increased KSERCA observed in the current 
study.  With decreased Ca2+ sensitivity of the myofilaments a greater [Ca2+]i 
would be required to induce the same force of contraction or change in 
cardiomyocyte length(148).  Cardiomyocyte length was measured in parallel with 
Ca2+ epifluorescence measurements by edge detection software (Ionoptix) in 
field stimulated cells.  The change in length relative to diastolic cardiomyocyte 
length was calculated and the percentage change in length or fractional 
shortening calculated for media and supernatant normalised to time-controls.  
There was no statistically significant difference, suggesting that supernatant did 
not alter the fraction that cardiomyocytes contract during normal stimulation.  
At end-diastole the rate of change of [Ca2+]i are minimal, thus these values can 
be used to assess myofilaments Ca2+ sensitivity in the intact cell.  No significant 
alteration in myofilaments Ca2+ responsiveness is induced by the supernatant as 
shown in Figure 4.4C suggesting therefore that its contribution to the decline of 
the Ca2+ transient observed is not significant. The supernatant is therefore likely 
to be having an effect on SERCA independent of myofilament Ca2+ sensitivity. 
4.4.3 Effects of Supernatant on Diastolic [Ca2+]i 
Isolated cardiomyocyte experiments where SR-mediated Ca2+ release and uptake 
was inhibited (Figure 4.5) revealed that supernatant elevated [Ca2+]i compared 
with control media.  These experiments do not discriminate between reduced 
Ca2+ efflux and enhanced Ca2+ influx.  However an increased diastolic [Ca2+]i may 
favour spontaneous Ca2+ release from the SR in the form of Ca2+ sparks and 
waves(195) via an increased KSERCA(507).  One potential mechanism for this increase 
in diastolic [Ca2+]i is reduced Ca2+ efflux via reduced NCX activity, the main 
efflux pathway.  This does not appear to be the case in cardiomyocytes exposed 
to supernatant as the decay rate constant of the caffeine-induced Ca2+ was not 
significantly altered (Figure 4.3).  Alternatively, the increase in diastolic [Ca2+]i 
could be a result of increased influx through the LTCC as the inward Ca2+ current 
serves to trigger Ca2+ release from the SR but also to load the cardiomyocyte 
with Ca2+ to balance the sarcolemmal efflux(182).  Under normal circumstances 
the Po of the LTCC during diastole is low (≈10-5) at resting membrane potential (-
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80 mV)(532).  Choi et al. (2000) measured Ca2+ influx and efflux in quiescent rat 
ventricular cardiomyocytes and found a small component of influx sensitive to 
nifedipine, a LTCC blocker(533).  They used a holding potential of -40 mV (more 
positive than resting) but identified that 0.8 µM.l-1.s-1 Ca2+ flux sensitive to 
nifedipine.  As a result, they calculated the Po at resting potential of 0.006. They 
identified that much of the Ca2+ influx in quiescent cardiomyocytes was Ni2+ 
sensitive, a blocker of NCX, and therefore potentially due to NCX activity in 
reverse mode(533).  Ni2+ though lacks specificity so other Ca2+ influx mechanisms 
could not be ruled out(533).  The data in the current study suggests no alteration 
of the NCX due to no significant differences in caffeine-induced Ca2+ transient 
decay.   Schröder et al. identified that β-adrenergic stimulation either β1 or β2 
could increase the Po of the LTCC such that it was activated in physiological 
Tyrodes solution at resting membrane potential(534).  Thus Po can be altered in 
the presence of a β-adrenergic agonist to increase the current through the 
LTCC(532;535;536).  Therefore supernatant could alter the LTCC Po increasing the 
Ca2+ influx during diastole leading to a higher diastolic [Ca2+]i.  To examine 
whether the LTCC current could be altered usually requires electrophysiological 
measurements of the LTCC current.  However, LTCC modulation can be assessed 
indirectly if the amplitude of first Ca2+ transient following a bolus of high 
concentration caffeine (10 mM) is measured.  The principle is that the caffeine 
increases the Po of the RyR to 1 thereby effectively emptying the SR so it will no 
longer contribute to Ca2+ release.  When field stimulation is applied, the change 
in [Ca2+]i will primarily be due to Ca2+ influx through the LTCC(537).  Eisner et al. 
(2000) applied 10 mM caffeine immediately prior to a stimulation protocol that 
effectively emptied the SR of Ca2+ and measured the Ca2+ transients while 
simultaneously measuring the current across the LTCC.  The amplitude of the 
first Ca2+ transient post caffeine was significantly less than the last Ca2+ 
transient but the current across the LTCC was not changed.  This suggests that 
the difference in Ca2+ transient amplitude is due to the initial SR emptying and 
subsequent refilling with Ca2+(537).  Therefore the amplitude of the first post 
caffeine Ca2+ transient was used as an indicator of Ca2+ influx through the LTCC.  
The amplitude of the first post-caffeine Ca2+ transient was not altered with 
perfusion of supernatant compared to control media suggesting that the LTCC is 
not altered (Figure 4.6).  Under some conditions, in some species, there may be 
Ca2+ entry via reverse NCX activity(507), although the data presented in the 
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current study suggests no alteration of NCX activity in the presence of 
supernatant.  There is some evidence to support another method of Ca2+ influx 
independent of the LTCC and NCX reversal but the mechanism remains 
unclear(538). 
4.4.4 Increase in Spontaneous Ca2+ Release Caused by 
Supernatant is Prevented by CaMKII Inhibition 
The supernatant effects on KSERCA and SR Ca2+ content coupled with increased 
spontaneous Ca2+ release support a hypothesis consistent with a potential β-
adrenergic stimulation phenotype.  β-adrenergic stimulation has the effects of; 
i) increased RyR phosphorylation increasing Po(276;539) and SR Ca2+ leak(299;323), ii) 
increased LTCC current(153) via PKA mediated phosphorylation, iii) increased 
KSERCA via phosphorylation of the SERCA inhibitory molecule phospholamban (PLB) 
decreasing SERCA inhibition via PKA activity(239;240;243) and CaMKII 
activity(240;244;245), and finally, iv) altered myofilament Ca2+ sensitivity(148).  
Although the data in the present study did not identify alterations in 
myofilament Ca2+ sensitivity or a detectable increase in LTCC current, the 
potential effects on SERCA and RyR suggest there may be a role for PKA and/or 
CaMKII therefore both PKA and CaMKII were investigated further.  A cohort of 
isolated cardiomyocytes was incubated in control media and supernatant as 
discussed in Chapter 3 (section 3.2.3) with the PKA inhibitor H89.  The 
percentage change in number of cardiomyocytes exhibiting at least one 
spontaneous contractile event in 1 min over media control was calculated.  A 
separate cohort was treated with the CaMKII inhibitor AIP.  H89 did not change 
the increase in spontaneous contractile events observed in supernatant 
suggesting that the increased spontaneous Ca2+ release caused by supernatant 
was not PKA mediated.  However, when cardiomyocytes were treated with AIP 
the increase in contractile events in supernatant was abolished, suggesting the 
effect may be CaMKII mediated.  In a study by Kholhaas et al. (2006) enhanced 
SR Ca2+ leak caused by overexpression of CaMKII was prevented by AIP without 
significantly altering the Ca2+ transient amplitude(321).  
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4.4.5 CaMKII Inhibition Prevents Supernatant Effects on SR 
Function 
4.4.5.1 SERCA Activity Increase in Supernatant Prevented by AIP 
Given the result of CaMKII inhibition on spontaneous contractile events the Ca2+ 
epifluorescence experiments were repeated with AIP at normal [Ca2+]i.  There 
was no change in the peak and [Ca2+]i amplitude of the stimulated Ca2+ transient 
when AIP was added to the supernatant.  In the presence of AIP the increase in 
decay rate constant caused by supernatant was reduced from 110.4% to 104.8% 
of control media.  These data support a hypothesis of CaMKII mediated enhanced 
SERCA activity.  Indeed, it has been shown by Picht et al. (2007) that SR-
localised AIP can inhibit a CaMKII-mediated enhancement of SERCA-mediated 
Ca2+ uptake and inhibit CaMKII-mediated phosphorylation of the RyR reducing 
diastolic Ca2+ leak(540).  Since AIP reduces both SR-mediated spontaneous Ca2+ 
release and KSERCA to the levels of control media in the data presented in this 
chapter, the potential mechanism by which supernatant acts is via enhanced 
CaMKII activity.  
4.4.5.2  SR Ca2+ Content Reduction in Supernatant Prevented by AIP 
The reduced caffeine-induced Ca2+ transient amplitude in supernatant was also 
prevented by AIP.  SR Ca2+ in supernatant with AIP was at 100.1% compared to 
91.7% in control media.  When considered with the concomitant reduction in 
spontaneous Ca2+ release without Ca2+ transient amplitude alteration a 
hypothesis of reduced CaMKII mediated SR Ca2+ leak due to inhibition with AIP 
seems likely and is supported by Kholhaas et al. (2006)(321).  In the SR-AIP 
transgenic mouse of Picht et al. (2007) there was a significant reduction in 
diastolic Ca2+ leak from the SR measured as tetracaine-induced shifts in cytosolic 
Ca2+(540).  Tetracaine-induced shifts work by blocking the RyR thereby preventing 
Ca2+ leak.  When applied in a Na+ and Ca2+ free solution the SR Ca2+ content rises 
and cytosolic Ca2+ declines directly proportionally to the leak(323). 
4.4.6 CaMKII Inhibition Does Not Reduce Diastolic [Ca2+]i 
Interestingly, when the experiments with SR inhibition by thapsigargin and 
ryanodine were repeated, the increase in diastolic [Ca2+]i in supernatant was not 
Chapter 4  Investigating the Mechanisms 222 
 
AIP-sensitive.  The experiments performed in the current study do not 
differentiate between reduced Ca2+ efflux or enhanced Ca2+ influx, but increased 
diastolic [Ca2+]i may favour the production of abnormal SR Ca2+ release via  
CaMKII activation(541).  One potential mechanism for increased diastolic [Ca2+]i is 
reduced NCX activity, the main sarcolemmal extrusion process.  However, the 
data in the current study suggests no effect on NCX function.  Alternatively 
supernatant may have enhanced Ca2+ influx but this is unlikely to be due to the 
LTCC as no difference in first post caffeine Ca2+ transient was apparent and is 
unlikely in quiescent cells(533).  Therefore supernatant may increase diastolic 
[Ca2+]i by another means such as those seen in human brain microvascular 
endothelial cells (HBMECs)(69), an effect potentially mediated by TbCatL action 
on a G-protein coupled receptor (GPCR)-mediated pathway(66).  Further 
investigation in the direction of GPCR targets may reveal a potential 
sarcolemmal target for TbCatL.    
4.4.7 Proposed Mechanism 
Figure 4.9 summarises the proposed mechanism for the SR Ca2+ handling effects 
observed with trypanosome supernatant.    CaMKII inhibition has the effect of 
abolishing the changes in Ca2+ transient decay and SR Ca2+ content that 
supernatant elicits.  The fact that the increase in diastolic [Ca2+]i is not 
prevented by CaMKII inhibition  proposes a hypothesis that; supernatant elevates 
diastolic [Ca2+]i (which could be substantial within sub-cellular compartments) 
that cause CaMKII activation(541), which then increases SR-mediated Ca2+ leak and 
uptake with a net effect being an increase in Ca2+ waves and a reduced SR Ca2+ 
content.   These changes in basal and store-based Ca2+ signalling observed in 
cardiomyocytes parallel those seen in HBMECs exposed to live trypanosomes and 
their culture supernatant(69).  The effect on HBMECs was via a G-protein coupled 
receptor (GPCR) pathway(66).  Activation of this or a similar pathway in 
cardiomyocytes may underlie the supernatant effect on the heart.  Further 
investigation may reveal this sarcolemmal target. 
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Figure 4.9: Proposed mechanism for TbCatL on Ca2+ handling in the ventricular cardiomyocyte 
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5 CHAPTER 5 – Investigating the Cardiovascular 
Effects of Trypanosoma brucei Using an In Vivo 
Infection Model in Rats 
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5.1 Introduction 
5.1.1 Trypanosomiasis and the Heart 
The classical focus of understanding trypanosomiasis has been the neurological 
signs, cardiovascular signs are evident both clinically(51) and histopathologically 
in humans(56;57) and experimentally infected animals(26-28).  The work in the 
preceding chapters demonstrates a direct effect of trypanosomes on the Ca2+ 
dynamics of cardiomyocytes facilitating the abnormal spontaneous diastolic 
release of Ca2+ that can lead to arrhythmias(192).  This has implications not only 
in how HAT manifests in patients but in treatment as well.  The main 
consideration with treatment of HAT is the stage of the disease.  Stage II, once 
neurological signs are evident, signifies that the parasites have traversed the 
blood brain barrier (BBB).  Therefore, treatment strategies for Stage II HAT 
require drugs that cross the BBB.  Several of the drugs have low therapeutic 
margins before adverse reactions are evident(8).  Indeed treatment-induced 
cardiopathy and drug cardiotoxicity has been suspected in cases of sudden death 
in HAT patients(62;542-544), although it should be noted that these reports are 
uncontrolled studies of fewer than 10 patients.  Therefore an understanding of 
the cardiac involvement of African trypanosomiasis may help in; i) the 
development of new drugs and ii) understand and be prepared for cardiotoxicity 
of existing or new drugs.    
There are parallels between the role of induction of Ca2+ fluxes by TbCatL in 
cardiomyocytes and in endothelial cells(69) which also resembles the induction of 
Ca2+ transients with T. cruzi causing American trypanosomiasis (Chagas 
disease)(508).  Therefore understanding the cardiac effects of trypanosomiasis 
may enable the development of drugs that are safer with regard to 
cardiotoxicity.  Interestingly, if TbCatL is a common causative factor in 
alterations in Ca2+ dynamics in both cardiomyocytes and BBB traversal inhibition 
of TbCatL may also reduce BBB traversal. 
5.1.2 Electrocardiographic Findings 
Recent work has begun to look at some of the functional aspects of cardiac 
involvement in HAT.  A detailed study by Blum et al. (2007) assessed the ECGs of 
patients with Stage II T. b. gambiense HAT and compared them to those of 
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healthy controls(51).  They identified a number of differences summarised in 
Table 5.1.  Major changes were defined as low voltage and PR depression which 
occurred at in 71% of HAT patients(51).  They compared this to the frequency of 
histopathological findings on post-mortem examination of 72%(55;56).  The 
repolarisation changes and low voltage were identified at the end of treatment 
which then improved/disappeared 3 months after treatment(51), which they 
attributed to treatment induced/exacerbated inflammation based on anecdotal 
reports(62;542-544) of drug-induced cardiotoxicity.  
Table 5.1: ECG findings in patients with HAT 
 Healthy Controls HAT Patients  
 n %, mean ± SD n %, mean ± SD P value 
PQ 60 163 ± 16.07 ms 59 168 ± 26 ms 0.24 
QRS 60 82 ± 10.97 ms 59 81.6 ± 8.3 ms 0.79 
QTc 60 403 ± 21.01 ms 59 423 ± 3.2 ms <0.001 
Normal (no abnormal findings) 60 65% 59 22% <0.001 
Major changes 60 18% 59 71% <0.001 
Low voltage 60 7% 59 31% <0.001 
AV block I 60 3% 59 8% 0.23 
PR depression 60 0% 59 8% 0.007 
Repolarisation changes 60 5% 59 34% <0.001 
Precordial repolarisation 
changes 
60 2% 59 22% <0.001 
Data from Blum et al. (2007)(51) used with permission. Major changes were defined as; low voltage, 
AV block I, PR depression and repolarisation changes.   
5.1.3   Aims of the Chapter 
Cardiac signs in HAT are usually attributed to perimyocarditis(26-28;51;56;58;61;496).  
However, the data in this thesis offers an alternative explanation for cardiac 
signs at the cellular and ex vivo organ level.  The main aim of this chapter is to 
develop an animal model of trypanosome infection to enable detailed study of 
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electrocardiographic effects of trypanosomes in vivo.  Ultimately, the model 
could be able to be used in future studies to dissect the contribution of a direct 
parasite induced pathology from a systemic immune response and identify 
potential changes in electrocardiographic profile in response to potential drug 
treatments.  In addition, clinical infections of trypanosomiasis are often 
complicated by concomitant infections with other diseases.  For example, Blum 
et al. (2007) found a co-infection rate of 13.3% with malaria which had the 
effect of further prolonging QTc from 419 ± 22 ms in confirmed cases without 
malaria, to 438 ± 29 ms in cases with confirmed malaria(51).  A controlled 
experimental infection model with ECG monitoring should avoid many of the 
complicating factors inherent in patient studies.  
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5.2 Methods 
5.2.1 T. b. brucei Lister 427 Infections 
5.2.1.1 Preparation of Trypanosomes 
Trypanosoma brucei brucei Lister 427 were grown for one passage in mice to 
adapt them to in vivo conditions from being culture adapted.  Lister 427 has 
been grown since the 1960s(545) in media with nutrients in excess thus reducing 
many of the selection pressures normally found in vivo.  Therefore, this passage 
is important to re-adapt the parasites to growth in the mammalian bloodstream 
for in vivo studies.  This step was performed by Mrs. Anne-Marie Donachie, a 
technician from the Wellcome Trust Centre for Molecular Parasitology, 
University of Glasgow.  The parasites were grown in the mice for 2-3 days with 
daily tail venepuncture to check parasitaemia levels.  When parasites reached 1 
x 107 parasites.mL-1 the mice were sacrificed and blood collected in heparin to 
prevent coagulation.  A sample of the blood was counted with a Neubauer 
improved haemocytometer in triplicate.  The parasites were diluted under 
sterile conditions to 1 x 105 parasites in a 200 µL volume of Carter’s balanced 
salt solution (CBSS); 25 mM HEPES, 120 mM NaCl, 5.4 mM KCl, 0.55 mM CaCl2, 0.4 
mM MgSO4, 5.6 mM Na2PO4  and 11.1 mM glucose, pH 7.4.  The 200 µL parasite 
suspension was prepared in a 1 mL syringe for injection.  Matching volumes of 
CBSS were prepared as control injections. 
5.2.1.2 ECG Acquisition 
Adult male Wistar rats (250-300 g) were allowed a 7 day acclimatisation period 
upon delivery to the biological services unit.  Animals were kept at the 
Cardiovascular Research Unit, University of Glasgow in a dedicated room 
licensed under the Specified Animal Pathogens (Scotland) Order 2009 (SAPO).  
Rats were anaesthetised by inhalation of isoflurane gas at 4-5% delivered in 1-1.5 
L.min-1 oxygen in an induction box.  The rats were removed from the box when 
there was loss of the righting reflex.  The animals were maintained on isoflurane 
delivered via facemask.  The gas was reduced based on assessment of the 
animals’ vital parameters to a final plane of anaesthesia at 1-1.5% isoflurane in 1 
L.min-1 O2.  The ECG was recorded via the placement of intradermal electrodes.  
The placement sites on the rat were caudal aspects of the left and right carpi 
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and the medial aspects of left and right crura.  The sites were cleaned with 
chlorhexidine as were the electrode tips.  Appropriate earthing and positioning 
was used to minimise signal noise.  To ensure reproducibility for the same rats 
and between rats, all animals were positioned identically based on an outline 
drawn on a corkboard.  The ECG was recorded for 15 min with an IWX228 
bioamplifier (iWorx, USA).  Rats were then injected via the intraperitoneal route 
with the solutions prepared above (section 5.2.1.1).  The ECG was recorded for a 
further 15 min following the injection before rats were recovered.  See General 
Methods for images of the procedure. 
5.2.1.3 Health Monitoring and Parasitaemia Checks 
Infection with T. brucei Lister 427 can cause anaemia, weight loss and 
immunosuppression.  In some cases the parasitaemia can become fulminant, 
which can be fatal if allowed to persist.  The general health of the animals was 
monitored daily to ensure that welfare was not compromised by the parasite 
infection.  Animals were assessed for lassitude persisting beyond 72 hours, 
weight loss ≥25%, mucous membrane pallor, hunched posture and staring coat.  
In addition, parasitaemia levels were measured daily.  A drop of blood was 
obtained by a small puncture of the lateral tail vein.  The drop of blood 
expressed was smeared to a glass slide and viewed with a 40x objective lens on a 
standard light microscope.  The slide was examined and the number of parasites 
counted and compared to the description of Herbert and Lumsden (1976)(436) and 
described in further detail in section 2.2.1.3.  A parasitaemia level exceeding 
5.0 x 108 parasites.mL-1 for more than two consecutive days was set as a cut-off 
point for the welfare of the animals.  No animal exceeded this level during the 
study.  
5.2.1.4 End ECG and Organ Harvest 
Animals were anaesthetised on the fourth day after infection and the ECG 
recorded for 15 min as described above (section 5.2.1.2).  Following ECG 
acquisition the animals were sacrificed by cervical dislocation while still under 
anaesthesia.  Heart, liver and spleen were removed, mass recorded and 
compared to the tibial length defined as the length from lateral femoral 
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epicondyle proximally to the lateral malleolus distally to control for individual 
size and mass. 
5.2.1.5 In Vivo ECG Data Analysis 
ECG data were collected using the IWX228 bioamplifier and LabScribe 2 software 
(iWorx) at a sampling rate of 2,000 Hz.  The ECG from the last 1 min (to ensure a 
steady state) of each 15 min period was averaged using the advanced ECG 
analysis module of the programme and exported to Origin6.1 (OriginLab) for R-R 
interval and heart rate, P-R interval and QT interval measurement with 
correction for heart rate using the Framingham method(460).  The whole trace 
was manually assessed for arrhythmic events as defined by the Lambeth 
Conventions(437).  Mean ± SEM data for the same animal from day 0 and day 4 
were compared with a paired Student’s T-test.  Comparisons between control 
and infected animals were conducted with a two-sample Student’s T-test.  
P<0.05 was taken to be statistically significant.  
5.2.1.6 Langendorff Perfusion of Ex Vivo Hearts 
The hearts removed from the infected and control rats were immersed in ice-
cold Tyrodes solution; 116 mM NaCl, 20 mM NaHCO3, 0.4 mM Na2HPO4, 1.0 mM 
MgSO4-7H2O and 4.0 mM KCl.  D-glucose was added on the same day as intended 
use to a final concentration of 11 mM.  The solution was bubbled with 95% O2 / 
5% CO2 for 15-20 min to oxygenate and buffer before CaCl2 was added to a 
concentration of 1.8 mM.  Extraneous tissue was carefully dissected away to 
reveal the aorta.  The hearts were blotted dry and quickly weighed before 
cannulation to a Langendorff perfusion apparatus.  The hearts were perfused 
with Tyrodes solution at 10 mL.min-1 and immersed in a water-jacketed chamber 
filled with Tyrodes solution at 37 ºC.  Electrodes were placed in the chamber in 
close approximation with the right atrium for the negative electrode and the 
apex of the left ventricle for the positive electrode and the pseudo-ECG 
recorded.  Hearts were perfused for a period of 15 min steady state followed by 
15 min periods each with the β-adrenergic agonist isoproterenol at 
concentrations of 100 nM, 1 µM, 10 µM and 100 µM. 
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5.2.1.7 Langendorff Data Analysis 
ECG data were collected using the ETH-256 bioamplifier (iWorx) and LabChart 7 
(ADInstruments) software at a sampling rate of 2,000 Hz.  The ECG from the last 
5 min of each 15 min period was averaged using the advanced ECG analysis 
module of the programme and the R-R interval and heart rate, P-R interval and 
the QT interval with correction for heart rate using the Framingham method(460) 
were measured.  Traces were exported to Origin6.1 (OriginLab).  The entirety of 
the traces was manually assessed for arrhythmic events according to the 
Lambeth Conventions(437) and recorded as the frequency min-1.  Mean ± SEM data 
for each isoproterenol concentration were compared to steady state for the 
same animal by paired Student’s T-test.  Comparisons between control and 
infected were performed with a two-sample Student’s T-test.  P<0.05 was taken 
to be statistically significant.  
5.2.2  T. b. brucei TREU 927 Infections 
A limitation of T. b. brucei Lister 427 is that it follows a logarithmic growth 
curve in vivo until the death of the infected host.  This is due to the fact that 
Lister 427 is a ‘monomorphic’ strain of T. b. brucei i.e. it grows in culture as the 
long slender bloodstream form of its lifecycle but has lost the ability to 
differentiate to the short stumpy stage(546).  While this makes 427 a highly useful 
in vitro model organism, it does not provide a robust model of trypanosome in 
vivo infections.  During infections with wild-type ‘pleomorphic’ trypanosomes, as 
parasite numbers increase there is a density-dependent trigger for a proportion 
of the parasites to terminally differentiate to the short stumpy lifecycle stage(11) 
in preparation for transmission to the insect vector(12).  The trigger has not been 
identified but is a secreted factor putatively called ‘stumpy induction factor’ 
(SIF), which increases in concentration with the increase in parasitaemia(11;547).  
The differentiation signal is cAMP-mediated(547) but due to the long-term 
adaptation of 427 to in vitro culture and lack of selection for transmission, and 
therefore differentiation, 427 parasites don not differentiate under this trigger.  
Although SIF remains unidentified much of the regulatory pathways have been 
examined(548;549).  Clinical infections therefore exhibit a cyclical parasitaemia 
that reflects the balance between parasite replication and differentiation, as 
well as the host immune response, such as in cases of T. brucei gambiense 
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infection(10).  A pleomorphic strain of T. b. brucei that results in infections that 
more closely resemble the clinical situation of waxing and waning parasitaemia 
is T. b. brucei TREU 927(550).   
5.2.2.1 Preparation of Trypanosomes 
The 927 parasites were prepared as described for 427 (section 5.2.1.1) by Anne-
Marie Donachie.  Blood taken from infected mice was examined and the 
parasites counted with a haemocytometer. 
5.2.2.2 Telemetry Probe Implantation 
A major limitation of the 15 min ECGs recorded for the 427 infections is the 
short window of observation.  If arrhythmias are occurring at a low frequency, 
then a 15 min ECG may not detect them.  The statistical power is also reduced.  
In addition the animals are under anaesthesia at the time of recording 
introducing potential cardiovascular depressive effects as a result of the use of 
inhalational agents such as isoflurane(551;552).  Therefore the decision was taken 
to implant CA-F40 biopotential recording devices (Data Sciences International) 
into rats to measure the ECG continuously in conscious animals for the duration 
of the study (10-12 days). 
Briefly, adult male Wistar rats (250-300 g) were anaesthetised using an 
inhalational agent for the greater control and least cardio-respiratory depressive 
effects of anaesthetic agents compared with injectable anaesthetics(438) .  The 
inhalational anaesthetic used was isoflurane (Isoflo, Abbot Laboratories, USA) 
delivered in 100% O2.  Animals were anaesthetised by placing them in a pre-filled 
induction box and maintained on a facemask initially with 4% isoflurane at 1.5 
L.min-1 reducing to 1-1.5% during surgery.  Fur was clipped with electric clippers 
over the appropriate surgical sites for probe and lead placements (section 
2.2.2.6).  The clipped areas of skin were cleaned with warmed 10% surgical skin 
disinfectant (Hibiscrub, Ecolab Ltd) and gauze swabs.  The animal was moved to 
the surgical table and positioned in ventral recumbency on a heated pad to 
maintain the animal’s temperature.  Peri-operative analgesia of 5 mg.kg-1 
carprofen (Rimadyl, Pfizer Animal Health) was administered with 5 mL of 0.9% 
sterile saline subcutaneously to maintain fluid balance under anaesthesia.  The 
telemetry device was implanted subcutaneously in the dorsal thoracic region.  
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Tracts were tunnelled under the skin from the implant site to the right pectoral 
and xyphoid regions ventrally where the ECG leads were affixed with 1.5 metric 
nylon suture (Johnson & Johnson).  The surgical incisions were closed with 1.5 
metric polyglactan 910 (Vicryl, Johnson & Johnson).  Further details and 
photographs of the procedure can be found in (section 2.2.2.2).  A proportion of 
these procedures were performed in conjunction with Ms. Charlotte Rossor, a 
Masters student under my supervision. 
5.2.2.3 Trypanosome Infections 
The animals were allowed to recover from the surgical procedure for 1 week 
before they were infected as described for the 427 model in section 5.2.1.1.  
Infection was with 1.0 x 105 T. brucei 927 in 200 µL CBSS via intraperitoneal 
injection.  Control rats were injected with the same volume of CBSS.  Rats were 
monitored daily for clinical signs of infection and parasitaemia levels by 
superficial tail venepuncture. 
5.2.2.4 Data Acquisition and Analysis 
Cages with implanted rats were placed onto receiver pads.  The implanted 
probes were activated magnetically.  Telemetry signals were relayed via a data 
exchange matrix to the computer loaded with the acquisition software 
Dataquest™ OpenART v4.2 (Data Sciences International).  Raw ECG data was 
collected continuously at 2,000 Hz sampling frequency for 2 weeks and saved 
daily.  Files were exported to Ponemah v4.8 (Data Sciences International) for 
analysis.  ECG sections of 30 min were averaged and assessed for R-R interval, 
heart rate, P-R intervals and QT intervals corrected for heart rate using the 
Framingham method.  Longer ECG traces of up to 1 hour were assessed for 
arrhythmias using the Lambeth Conventions as described in section 5.2.1.5. 
5.2.2.5 Organ Harvest and Langendorff Perfusion 
As with the 427 infections, rats were euthanized by cervical dislocation at the 
end of the study (or before if deemed to be suffering according to the clinical 
signs and parasitaemia checks previously described).  The mass of the heart, 
lungs, liver and spleen was recorded and compared to tibial length.  Hearts were 
immersed in ice-cold Tyrodes solution before being cannulated as described in 
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section 5.2.1.6.  The same protocol was employed as the 427 study (section 
5.2.1.6).   
5.3 Results 
5.3.1 In Vivo ECG Parameters for T. b. brucei Lister 427 Infection 
Rats were anaesthetised and their ECGs recorded for the period of 15 min (Day 
0) following infection by intraperitoneal injection with 1 x 105 T. b. brucei Lister 
427 parasites in 200 µL CBSS.  A cohort of rats were injected with 200 µL CBSS 
without parasites as controls.  The animals were maintained and monitored for 4 
days before being anaesthetised again and a final 15 min ECG recorded for each 
animal (Day 4).  Each ECG trace was averaged and heart rate, P-R interval and 
QT intervals determined from the traces.  There was no significant difference in 
the heart rate in the control animals between days 0 and 4 (249 ± 21 vs. 248 ± 21 
bpm; Day 0 vs. Day 4; n = 18; P>0.05; Figure 5.1B(i)), nor was there a significant 
difference in the infected animals (238 ± 19 vs. 226 ± 19; Day 0 vs. Day 4; n = 17; 
P>0.05; Figure 5.1B(i)).  There was no significant difference in P-R interval for 
the control rats (46.6 ± 0.8 vs. 46.4 ± 1.2 ms; Day 0 vs. Day 4; P>0.05; Figure 
5.1B(ii)), nor for the infected rats (46.4 ± 0.6 vs. 45.8 ± 0.8 ms Day 0 vs. Day 4; 
P>0.05; Figure 5.1B(ii)).  The QT changes with heart rate so a correction factor 
is required (QTc).  The correction factor used in the current study is the 
Framingham method.  Blum et al. (2007) identified a prolongation of QTc from 
403 ± 24 ms to 423 ± 21 ms(51).  In the current model no alteration in QT was 
found in the controls between days 0 and 4 (63.3 ± 1.8 vs. 65.7 ± 1.6 ms; Day 0 
vs. Day 4; P>0.05; Figure 5.1B(iii)), and no significant change was found in the 
infected rats either (69.3 ± 3.0 vs. 66.3 ± 3.2 ms; Day 0 vs. Day 4; P>0.05; Figure 
5.1B(iii)).  There was no significant difference in QTc for control (176.6 ± 3.0 vs. 
179.1 ± 2.8 ms; Day 0 vs. Day 4; P>0.05; Figure 5.1B(iv)) or infected animals 
(181.3 ± 3.9 vs. 176.2 ± 3.9 ms; Day 0 vs. Day 4; P>0.05; Figure 5.1B(iv)).  The 
classical end-point of the T wave is the return to the isoelectric point(457).  
However, the T wave tended to approach the isoelectric point asymptotically 
making the true end of T difficult to define.  As described in Chapter 3 (section 
3.2.7) and Rees et al. (1993) the QT90 was also measured for these ECGs(459).  As 
with the standard QT the QT90 was not significantly altered in control (52.4 ± 1.3 
vs. 53.6 ± 1.4 ms; Day 0 vs. Day 4; P>0.05; Figure 5.1B(v)) or infected animals 
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(54.3 ± 2.3 vs. 53.0 ± 2.2 ms; Day 0 vs. Day 4; P>0.05; Figure 5.1B(v)).  When 
corrected for heart rate QTc90 was also unaffected for control (165.7 ± 2.9 vs. 
167.1 ± 2.7; Day 0 vs. Day 4; P>0.05; Figure 5.1B(vi)) and for infected animals 
(166.3 ± 4.1 vs. 162.9 ± 3.4; Day 0 vs. Day 4; P>0.05; Figure 5.1B(vi)). 
5.3.1.1 Arrhythmic Events 
The ECGs were analysed for the occurrence of arrhythmic events as defined by 
the Lambeth Conventions(437).  During the 15 min periods of ECG for both the 
start and end of the study protocol no arrhythmic events were observed.   
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Figure 5.1: In vivo ECG parameters for T. b. brucei Lister 427 infection. 
(A) Protocol used for in vivo T. b. brucei Lister 427 infection model.  ECGs were recorded prior to 
injection with trypanosomes or control vehicle (CBSS).  ECGs were recorded again on day 4 prior 
to sacrifice.  (B(i-vi)) ECG parameters.  QT was corrected for heart rate (QTc) using the 
Framingham method (QTc = QT + 0.154 x (1-RR)).  QT90 was measured from the Q wave to the 
point on the T wave where T amplitude was 10% from the isoelectric point. 
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5.3.2 Ex Vivo Langendorff Perfused Heart Pseudo-ECG 
Parameters for T. b. brucei Lister 427 Infection 
The sympathetic nervous system and β-adrenergic signalling pathway are 
activated in response to both physiological and pathophysiological stresses.  To 
examine the effects of trypanosome infection under β-adrenergic stimulation 
under controlled conditions, a cohort of the hearts were removed from the 
animals and cannulated to a Langendorff perfusion system.  Isoproterenol (ISO) 
was added at increasing doses (100 nM, 1 µM, 10 µM and 100 µM) every 15 min 
(Figure 5.2A).  The raw data for each parameter are shown in Table 5.2 and 
Figure 5.2.   
Table 5.2: T. b. brucei Lister 427 ex vivo Langendorff raw parameters 
ISO 
(µM) 
Heart Rate (bpm) P-R Interval (ms) QTc (Framingham (ms)) 
 Control Infected P value Control Infected P value Control Infected P value 
0 308 ± 26 269 ± 22 0.295 42.3±4.3 39.6±2.5 0.605 195.3±6.8 197.8±3.3 0.750 
0.1 353 ± 25 331 ± 11 0.431 36.1±2.2 34.9±1.7 0.673 195.7±6.0 198.9±3.7 0.665 
1.0 337 ± 10 349 ± 11 0.472 32.2±1.8 36.4±2.6 0.239 197.4±7.0 203.0±3.6 0.502 
10.0 359 ± 10 360 ± 1 0.963 35.9±2.8 37.9±7.9 0.767 199.4±6.2 209.3±0.8 0.343 
100.0 360 ± 14 363 ± 4 0.880 36.5±2.8 37.9±7.3 0.826 201.0±5.8 204.9±2.6 0.685 
 
When normalised to the heart rate at steady state, the control hearts 
demonstrated a slight but not significant increase of 10-17% over steady state 
(1.00 ± 0.08 vs. 1.15 ± 0.08 vs. 1.10 ± 0.03 vs. 1.17 ± 0.03 vs. 1.17 ± 0.05; steady 
state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P>0.05; Figure 5.2B(ii)).  
However, infected hearts demonstrated a significant increase of 23-35% over 
steady state (1.00 ± 0.08 vs. 1.23 ± 0.04 vs. 1.30 ± 0.04 vs. 1.34 ± 0.01 vs. 1.35 ± 
0.02; steady state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P<0.05; Figure 
5.2B(ii)).  For the P-R interval when normalised to steady state, no significant 
differences were observed for control (1.00 ± 0.10 vs. 0.85 ± 0.05 vs. 0.76 ± 0.04 
vs. 0.85 ± 0.07 vs. 0.86 ± 0.07; steady state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 
µM ISO; P>0.05; Figure 5.2C(ii)) or infected hearts (1.00 ± 0.06 vs. 0.88 ± 0.04 vs. 
Chapter 5  Investigating the Effects of T. brucei Using an In Vivo Model 238 
 
0.92 ± 0.07 vs. 0.96 ± 0.2 vs. 0.96 ± 0.2; steady state vs. 100 nM vs. 1 µM vs. 10 
µM vs. 100 µM ISO; P>0.05; Figure 5.2C(ii)).  Finally the QTc was assessed, which 
when normalised to steady state showed no significant differences for control 
(1.00 ± 0.03 vs. 1.00 ± 0.03 vs. 1.01 ± 0.04 vs. 1.02 ± 0.03 vs. 1.03 ± 0.03; steady 
state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P>0.05 Figure 5.2D(ii)) or 
infected hearts (1.00 ± 0.02 vs. 1.01 ± 0.02 vs. 1.03 ± 0.02 vs. 1.06 ± 0.04 vs. 
1.04 ± 0.01; steady state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P>0.05) 
(Figure 5.2D(ii)). 
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Figure 5.2: Ex vivo Langendorff ECG parameters for  T. b. brucei Lister 427 infection. 
(A) Protocol used in Langendorff perfusion experiments.  Increasing concentrations of isoproterenol 
were added every 15 min and the ECG recorded throughout. (B(i)) Raw mean ± SEM for heart rate 
and (ii) normalised to steady state.  (C(i)) Raw mean ± SEM for P-R interval and (ii) normalised to 
steady state.  (D(i)) Raw mean ± SEM for QT interval corrected for heart rate and (ii) normalised to 
steady state. 
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5.3.3 In Vivo ECG Parameters for T. b. brucei TREU 927 Infection 
As discussed in section 5.2.2 a limitation of T. brucei Lister 427 is that it follows 
a logarithmic growth curve in vivo until the death of the infected host as it 
remains as the long slender bloodstream form(546).  Lister 427 has been a useful 
in vitro model of infection due to its ease of culturing (the bloodstream form of 
927, for example cannot be cultured in vitro), but while many of its 
characteristics remain intact for study the loss of pleomorphism in vivo makes it 
harder to assess with infection models.  Therefore, in order to develop a model 
that more closely resembles a clinical infection, a pleomorphic strain was used.  
From the Tritryp genome resource database (www.tritrypdb.org) there are 11 
annotated copies of the TbCatL gene in the genomes of both 427 and 927 with 
no amino acid sequence differences; although trypanosomes are diploid and the 
consensus genome sequences are haploid so allelic differences cannot be 
formally ruled out(139).  A strain of T. b. brucei that exhibits pleomorphism and 
therefore more closely resembles the clinical situation is T. b. brucei TREU 
927(550).   
In the 427 infection model, parasite number increased exponentially over the 4 
day period to a mean peak of 2.51 x 108 ± 1.02 x 108 parasites.mL-1 of blood 
(Figure 5.3A(i)).  In contrast, the parasitaemia in the 927 model follows the 
classical fluctuating pattern.  The 927 infections showed a first peak 
parasitaemia of 3.16 x 107 ± 2.51 x 105 parasites.mL-1 of blood on day 6 before 
returning toward the baseline, followed by a second peak of 3.56 x 107 ± 1.62 x 
107 parasites.mL-1 blood on day 10 (Figure 5.3A(ii)).  
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Figure 5.3: Parasitaemia levels for infection models. 
(A(i)) Parasitaemia levels for T. b. brucei Lister 427 infection model.  Numbers expressed as 
parasites.mL-1 of blood x 108 (n = 21).  (A(ii))  Parasitaemia levels for T. b. brucei TREU 927 
infection model.  Numbers expressed as parasites.mL-1 of blood x 107 (n = 5).  
5.3.3.1 ECG Parameters 
Another limitation of the 427 study (presented in section 2.2) is the length of 
ECG recording.  While a snapshot at the beginning and end will provide 
information on heart rate, P-R and QT intervals, a 15 min window may be too 
short to identify any arrhythmic events.  To account for the snapshot limitation 
biopotential recording telemetry devices were implanted to record the ECG 
continuously for the duration of the study.  The animals could also be kept 
conscious throughout the study as no need for anaesthesia for ECG recording was 
required.  For heart rate there was no significant difference in the control 
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animals but a tendency to decrease over time (404 ± 18 vs. 348 ± 12 bpm; Day 0 
vs. Day 11; n = 5; P>0.05; Figure 5.4B(i)).  However, there was a significant 
increase in heart rate for 927 infected animals (351 ± 22 vs. 413 ± 18 bpm; Day 0 
vs. Day 11; n = 6; P<0.05; Figure 5.4B(i)).  There was no significant difference in 
P-R interval for control (43.2 ± 1.7 vs. 42.6 ± 1.5 ms; Day 0 vs. Day 14; P>0.05; 
Figure 5.4B(ii)) or infected animals (41.5 ± 1.7 vs. 44.1 ± 3.2 ms; Day 0 vs. Day 
14; P>0.05; Figure 5.4B(ii)).  The QT interval was also not significantly altered 
for control (51.2 ± 4.3 vs. 57.5 ± 8.0 ms; Day 0 vs. Day 14; P>0.05; Figure 
5.4B(iii)) or infected animals (58.1 ± 5.9 vs. 61.2 ± 7.3 ms; Day 0 vs. Day 14; 
P>0.05; Figure 5.4B(iii)).  When corrected for heart rate using the Framingham 
method there was no significant difference for control animals (181.9 ± 4.4 vs. 
190.1 ± 11.8 ms; Day 0 vs. Day 14; P>0.05; Figure 5.4B(iv)) or infected animals 
(185.2 ± 7.2 vs. 192.6 ± 6.9 bpm; Day 0 vs. Day 14; P>0.05; Figure 5.4B(iv)). 
5.3.3.2 Arrhythmic Events 
When ECGs were assessed for arrhythmic events, specifically ventricular 
premature complexes, there was no difference in frequency for control animals 
(0.027 ± 0.019 vs. 0.047 ± 0.017 VPC.min-1; Day 0 vs. Day 14; P>0.05; Figure 
5.4B(v)).  However when the infected animal ECGs were assessed there was a 
significant increase of 539% (0.100 ± 0.034 vs. 0.539 ± 0.194 VPC.min-1; Day 0 vs. 
Day 14; P<0.05; Figure 5.4B(v)). 
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Figure 5.4: In vivo ECG parameters for T. b. brucei TREU 927 infection. 
(A) Protocol used for in vivo T. b. brucei TREU 927 infection model.  Biopotential telemetry devices 
were implanted and animals allowed to recover.  ECGs were recorded continuously for the duration 
of the protocol.  Animals were infected with 1 x 10 5 trypanosomes or control vehicle (CBSS) by 
intraperitoneal injection.  (B(i-v)) ECG parameters from average traces taken prior to injection and 
end of the protocol.  QT was corrected for heart rate (QTc) using the Framingham method (QTc = 
QT + 0.154 x (1-RR)).  Arrhythmia frequency was determined from hour long segments of trace 
taken prior to injection and end of the protocol.  
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5.3.4 Ex Vivo Langendorff Perfused Heart Pseudo-ECG 
Parameters for T. b. brucei TREU 927 Infection 
As with the 427 infections the animals were sacrificed at the end of the 
protocol.  The hearts were cannulated onto a Langendorff perfusion apparatus 
and perfused at 10 mL.min-1 with Tyrodes solution with increasing 
concentrations of ISO every 15 min (100 nM, 1 µM, 10 µM and 100 µM) (Figure 
5.5A).  The raw data for each parameter are shown in Table 5.3 and Figure 5.5. 
Table 5.3: T. b. brucei TREU 927 ex vivo Langendorff raw parameters 
ISO 
(µM) 
Heart Rate (bpm) P-R Interval (ms) QTc (Framingham (ms)) 
 Control Infected P value Control Infected P value Control Infected P value 
0 280 ± 16 239 ± 11 0.073 37.4±3.2 39.1±1.7 0.665 203.3±4.9 187.8±12.0 0.265 
0.1 317 ± 4 350 ± 31 0.321 31.1±2.2 37.1±4.3 0.245 206.3±3.2 194.2±2.2 0.015 
1.0 336 ± 18 345 ± 23 0.780 30.0±2.0 37.5±1.9 0.028 206.5±2.8 202.8±2.8 0.451 
10.0 319 ± 5 350 ± 14 0.073 31.1±2.3 38.3±3.5 0.118 209.1±4.3 206.8±2.4 0.655 
100.0 328 ± 20 356 ± 19 0.334 33.2±3.4 39.5±3.9 0.252 209.5±4.4 211.9±2.8 0.657 
 
When normalised to the heart rate at steady state, the infected hearts 
demonstrated a significant increase in rate over the control increase of 13-20% 
over steady state (1.00 ± 0.06 vs. 1.13 ± 0.01 vs. 1.20 ± 0.06 vs. 1.14 ± 0.02 vs. 
1.17 ± 0.07; steady state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P>0.05; 
Figure 5.5B(ii)) compared to an increase of 44-49% over steady state for infected 
hearts (1.00 ± 0.05 vs. 1.47 ± 0.13 vs. 1.44 ± 0.10 vs. 1.46 ± 0.06 vs. 1.49 ± 0.08; 
steady state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P<0.05; Figure 
5.5B(ii)).  When the P-R interval was normalised to steady state, there was a 
significant difference between control and infected hearts.  This difference was 
evident as a reduction in normalised P-R interval for control at 100 nM, 1 µM and 
10 µM ISO of 17-20% over steady state; (1.00 ± 0.09 vs. 0.83 ± 0.06 vs. 0.80 ± 
0.05 vs. 0.83 ± 0.06 vs. 0.89 ± 0.09; steady state vs. 100 nM vs. 1 µM vs. 10 µM 
vs. 100 µM ISO; P<0.05; Figure 5.5C(ii)).  However, infected hearts did not show 
the same decrease (0-5% over steady state).  Therefore, the P-R interval was 
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significantly longer relative to control hearts (1.00 ± 0.04 vs. 0.95 ± 0.11 vs. 0.96 
± 0.05 vs. 0.98 ± 0.09 vs. 1.01 ± 0.1; steady state vs. 100 nM vs. 1 µM vs. 10 µM 
vs. 100 µM ISO; P>0.05; Figure 5.2C(ii)).  Finally the QTc normalised to steady 
state was assessed, which showed no significant changes for control hearts (1.00 
± 0.02 vs. 1.01 ± 0.02 vs. 1.02 ± 0.02 vs. 1.03 ± 0.02 vs. 1.03 ± 0.02; steady state 
vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; P>0.05; Figure 5.5D(ii)).  Infected 
hearts showed an increase of 3-13% over steady state in QTc but this was not 
statistically significant (1.00 ± 0.06 vs. 1.03 ± 0.01 vs. 1.08 ± 0.01 vs. 1.10 ± 0.01 
vs. 1.13 ± 0.01; steady state vs. 100 nM vs. 1 µM vs. 10 µM vs. 100 µM ISO; 
P>0.05; Figure 5.2D(ii)). 
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Figure 5.5: Ex vivo Langendorff ECG parameters for T. b. brucei TREU 927 infection. 
(A) Protocol used in Langendorff perfusion experiments.  Increasing concentrations of isoproterenol 
were added every 15 min and the ECG recorded throughout. (B(i)) Raw mean ± SEM for heart rate 
and (ii) normalised to steady state.  (C(i)) Raw mean ± SEM for P-R interval and (ii) normalised to 
steady state.  (D(i)) Raw mean ± SEM for QT interval corrected for heart rate and (ii) normalised to 
steady state. 
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5.3.5  T. b. brucei TREU 927 Infected Ex Vivo Hearts Show 
Increased Frequency of Arrhythmias in the Presence of 
Isoproterenol 
The pseudo-ECGs from the Langendorff perfused hearts from both models were 
also assessed for the frequency of VPCs during steady state, 100 nM, 1 µM and 10 
µM ISO for both the 427 and 927 models.  There was no significant increase in 
VPC frequency for the 427 model in control hearts (0.35 ± 0.35 vs. 0.1 ± 0.1 vs. 
0.0 ± 0.0 vs. 0.0 ± 0.0 VPC.min-1; steady state vs. 100 nM vs. 1 µM vs. 10 µM ISO; 
n = 4; P>0.05; Figure 5.6B(i)) or the infected hearts (0.0 ± 0.0 vs. 0.45 ± 0.45 vs. 
0.0 ± 0.0 vs. 0.0 ± 0.0 VPC.min-1; steady state vs. 100 nM vs. 1 µM vs. 10 µM ISO; 
n = 4; P>0.05; Figure 5.6B(i)).  Similarly for 927 controls there was no significant 
increase; (0.08 ± 0.08 vs. 0.32 ± 0.23 vs. 0.28 ± 0.15 vs. 0.0 ± 0.0 VPC.min-1; 
steady state vs. 100 nM vs. 1 µM vs. 10 µM ISO; P>0.05; Figure 5.6B(ii)).  
However, infected hearts showed an increase in VPC frequency significant at 1 
µM (0.24 ± 0.16 vs. 5.24 ± 4.99 vs. 5.48 ± 1.83 (P<0.05) vs. 10.4 ± 8.9 VPC.min-1; 
steady state vs. 100 nM vs. 1 µM vs. 10 µM ISO; Figure 5.6B(ii)). 
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Figure 5.6: Arrhythmic events in Langendorff perfused infected and control hearts. 
(A) Protocol used for Langendorff perfusion experiments.  Hearts were perfused at a rate of 10 
mL.min-1 for 15 min steady state followed by 15 min with increasing concentrations of isoproterenol 
(100 nM, 1 µM, and 10 µM). (B) Mean ± SEM for frequency of ventricular premature complexes 
(VPCs) for (i) T. b. brucei Lister 427 and (ii) T. b. brucei TREU 927.  (C-D(i-ii)) Example pseudo-
ECGs from Langendorff perfused heart from 927 infected animal and corresponding model control.  
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5.3.6 Organ Mass Data 
5.3.6.1  T. b. brucei Lister 427 Infection Model 
At sacrifice, on Day 4 post-infection, animals were weighed and organs removed. 
There was no significant difference in body mass between control and infected 
animals (302.7 ± 4.1 vs. 301.0 ± 3.1 g; control (n = 24) vs. infected (n = 21); 
P>0.05; Figure 5.7A(i)).  Heart mass/tibial length ratio was not significantly 
altered (29.3 ± 2.7 vs. 27.8 ± 4.8 mg.mm-1; control vs. infected; P>0.05; Figure 
5.7A(ii)).  Liver mass/tibial length ratio was also not significantly affected, 
although tended to increase (226.5 ± 5.7 vs. 246.2 ± 8.7 mg.mm-1; control vs. 
infected; P>0.05; Figure 5.7A(iii)).  The lung mass/tibial length ratio was not 
significantly altered either (33.1 ± 2.6 vs. 31.4 ± 1.9 mg.mm-1; control vs. 
infected; P>0.05; Figure 5.7A(iv)).  However, spleens were significantly 
increased in mass in infected animals by 199% (13.3 ± 0.4 vs. 26.5 ± 3.4 mg.mm-
1; control vs. infected; P<0.05; Figure 5.7A(v)). 
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Figure 5.7: Organ mass data for T. b. brucei Lister 427 infection model. 
(A(i-v)) Mean ± SEM for body mass and heart, liver, lung and spleen mass to tibial length ratio for 
control (n = 24) and infected (n = 21). (B) Photograph of splenic enlargement. 
 
5.3.6.2 T. b. brucei TREU 927 Infection Model 
As above, organs were weighed and expressed as ratios with the tibial length.  
For the 927 infection model this was on Day 11 post-infection.  Data are 
presented as mean ± SEM.  There was no significant difference in body mass 
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between control and infected animals although infected animals had lost some 
condition by the end of the study (344.0 ± 8.5 vs. 314.7 ± 15.3 g; control (n = 5) 
vs. infected (n = 5); P>0.05; Figure 5.8A(i)).  Heart mass/tibial length ratio was 
not significantly altered (34.1 ± 3.4 vs. 31.8 ± 5.6 mg.mm-1; control vs. infected; 
P>0.05; Figure 5.8A(ii)).  Liver mass/tibial length ratio was also not significantly 
affected (253.3 ± 8.9 vs. 244.7 ± 17.6 mg.mm-1; control vs. infected; P>0.05; 
Figure 5.8A(iii)).  Spleens were significantly increased in mass in infected 
animals by 292% (17.2 ± 1.6 vs. 50.2 ± 7.5 mg.mm-1; control vs. infected; P<0.05; 
Figure 5.8A(iv)).      
 
Figure 5.8: Organ mass data for T. b. brucei TREU 927 infection model. 
(A(i-iv)) Mean ± SEM for body mass and heart, liver and spleen mass to tibial length ratio for 
control (n = 5) and infected (n = 5). 
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5.4 Discussion 
5.4.1 In Vivo ECGs for T. b. brucei Lister 427 Infection 
Given the reported clinical cardiac-related findings in patients with HAT and the 
effects observed and discussed in previous chapters, an experimental infection 
model initially established with cultured Lister 427 trypanosomes was 
conducted.  Adult male Wistar rats were anaesthetised and had their ECG 
recorded before being infected via an intraperitoneal injection of 1.0 x 105 
parasites in 200 µL or equivalent volume of vehicle for controls.  The ECGs were 
recorded again after 4 days.  The ECGs were analysed for P-R and QTc changes 
and occurrence of ventricular arrhythmias that could be associated with 
palpitations.  No significant findings were apparent between the control and 
infected animals, nor were there significant differences between the day 0 and 
day 4 ECG recordings.  Blum et al.(51) attributed their findings of ECG alterations 
in HAT patients to perimyocarditis based on the histological findings of earlier 
studies(55;56;61).  Therefore it is possible the lack of findings in the current model 
is due to the brevity of the infection and subsequent lack of time for 
perimyocarditis to develop(27).  This is perhaps surprising given the increase in 
ventricular arrhythmias observed when ex vivo rat hearts were perfused with 
culture supernatant from in vitro Lister 427 cultures.  The results presented in 
this thesis so far have suggested a direct effect on cardiomyocytes and indeed 
whole hearts independent of an immune/inflammatory response.  A possible 
explanation could be the activity of the secreted TbCatL.  Caffrey et al. (2001) 
showed that TbCatL is present in culture supernatant of T. b. brucei(129) and the 
preceding chapters demonstrate a role for TbCatL in altered Ca2+ dynamics of 
cardiomyocytes.  With the direct application of culture supernatants to isolated 
cardiomyocytes or perfusion through the coronary vessels we know the TbCatL to 
be active and targeted to the tissue of interest.  In an in vivo model, the picture 
is less distinct.  The host will have many proteases (discussed in Chapter 6) and a 
delicate regulatory balance with endogenous inhibitors such as cystatins(553).  
Although information on the host response to TbCatL is scarce there have been 
reports of host inhibitors modulating parasite protease activity in the case of T. 
cruzi infection(554).  A potential future series of experiments would be to 
measure the quantity of TbCatL in the host’s blood by developing a TbCatL-
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specific ELISA and to develop an activity assay to work on the host’s 
blood/serum.     
Four additional reasons may explain the lack of effect observed in vivo using 
Lister 427 cultures despite the occurrence of arrhythmias reported in patients 
with HAT and the ex vivo results presented in this thesis: 
1. The short duration of the 427 in vivo model does not lead to a sufficiently 
large increase in the levels of TbCatL to result in a detectable level of 
arrhythmias in the short time frame measured (particularly given the 
likely role of endogenous inhibitors as discussed above). 
2. The degree of extravasation of the parasite.  It is known that after long-
term infection (weeks) that parasites are seen infiltrating the myocardium 
in both humans(56;496) and animal models(25-28;56).  However, the 427 model 
lasts only 4 days.  Therefore the lack of effect observed with 427 
infection may be due to a lack of sufficient extravasation of the parasite 
due to the brevity of the study.  This in turn may influence the level of 
TbCatL directly in contact with the myocardium.  Myburgh et al. (2013) in 
characterising an in vivo imaging system used Lister 427 as a control for 
vascular leakage following parietal skull thinning surgery i.e. that the 427 
did not extravasate unless there was vascular damage(555). 
3. The amount of TbCatL produced by Lister 427 vs. pleomorphic strains is 
reduced.  Caffrey et al. (2001) demonstrated that short-stumpy form 
trypanosomes produce more TbCatL than long-slender forms(129).  Since 
the 427 strain does not differentiate, then the quantity of TbCatL is likely 
to be reduced and may account for the lack of response observed.  
4. There are also limitations with the assessment of ECG parameters in the 
427 in vivo model.  The length of ECG recording time is sufficient for an 
assessment of ECG parameters such as QTc.  However, if arrhythmic 
events should occur less frequently than the recording time, then the 
events will be missed.   
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5.4.2 Ex Vivo Langendorff Perfused Heart Pseudo-ECGs for T. b. 
brucei Lister 427 Infection 
The sympathetic nervous system and β-adrenergic signalling pathway are 
activated in response to both physiological and pathophysiological stresses.  In 
response to isoproterenol (ISO), cardiomyocytes and ex vivo hearts demonstrated 
enhanced Ca2+ handling effects (i.e. faster Ca2+ transient decline and more Ca2+ 
waves) in response to trypanosome supernatant (Chapter 3).  However, under 
anaesthesia there can be inhibition of the sympathetic nervous system(556;557).  
Anaesthesia may therefore be having the opposite effect, i.e. reducing the 
propensity for arrhythmogenic Ca2+ release and potential VPCs.  To investigate 
the potential importance of the above and also explore the sensitivity of the 
infected hearts to ISO without a systemic autonomic influence, a cohort of 
hearts were removed at the end of the 4 day model and perfused on a 
Langendorff apparatus with increasing concentrations of ISO.  There was a 
significant increase in the heart rate of infected hearts in response to ISO over 
the control hearts.  In addition to the greater metabolic demand in response to 
infection this may indicate a greater sensitivity to β-adrenergic stimulation.   
In response to β-adrenergic stimulation the slope of the pacemaker potential in 
atrial nodal cells is increased leading to a faster rate of depolarisation and 
therefore, more contractions in a given time(558).  This is achieved by activation 
of cAMP, which in turn will interact with ion channels to affect depolarising and 
repolarising currents (If, INa/Ca, ICa T, ICa L and INa(148)).  The activation of PKA by 
cAMP acts to phosphorylate the LTCC(153) (section 1.5), which increases the 
probability and duration of open state leading to increased force of contraction 
in ventricular cardiomyocytes but also increases chronotropy in SA nodal 
cells(558).  Furthermore, PKA phosphorylates the delayed rectifier K+ channels, 
which increases the repolarising outward K+ currents shortening the ventricular 
action potential (section 1.3.3) permitting more excitations.min-1.  The action of 
PKA on PLB(239;240;243) enables faster Ca2+ transient decline via increased SERCA 
activity (as observed in Chapter 3) and faster SR reuptake of Ca2+ enhancing 
cardiac lusitropy enabling more contractions.min-1.  As well as increased β-
adrenergic stimulation via increased sympathetic tone the hormone adrenaline 
acts similarly(558).  During physiological and pathophysiological stress, such as an 
infection, there are increased levels of circulating adrenaline and noradrenaline.  
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Although there was no observed increase in heart rate in vivo, there may be a 
sensitisation effect of β1 adrenergic receptor(559), an alteration in expression of 
β1 adrenergic receptors, or altered phenotypic expression of β-adrenergic 
receptor polymorphisms(560) leading to the increase in heart rate observed in 
response to ISO ex vivo.  However, further work will be required to ascertain 
what is causing the increased responsiveness to ISO in the infected hearts.  
Interestingly, when the heart rate of the ex vivo hearts perfused with 
trypanosome supernatant (Chapter 3) is compared to the infected ex vivo hearts, 
there was no change over their respective controls.  This suggests that any 
effect on heart rate is most likely not due to acute exposure to TbCatL. 
Although there were no other statistically significant differences in the 
measured ECG parameters, there was a tendency for the control P-R interval to 
decrease in response to ISO as may be expected due to increased AV node 
conduction velocity (dromotropic effect)(558).  The P-R interval remained 
unchanged in the infected hearts, which, when interpreted with the slight 
reduction in control, could suggest some prolongation.  P-R interval of >200 ms 
has been reported in 3.7-14% of HAT patients by other studies(61;62), defined as 1st 
degree AV block.  This would suggest that trypanosome infection may alter the 
AV node conduction velocity, which may contribute to the increase in heart rate 
following application of ISO, although further work measuring conduction 
velocity would be required to confirm this hypothesis.  Blum et al. (2007) 
showed some prolongation of P-R interval suggesting 1st degree AV block but this 
was not significant (3% vs. 8% of subjects; control vs. infected; P=0.23)(51) in 
comparison with their other cardiac findings, which suggests that AV node 
conduction is less likely to play a significant role in the cardiac pathology of 
HAT.   
The QTc was not affected, which would support the findings of the ex vivo study 
of supernatant perfused hearts presented in Chapter 3 and a hypothesis of a 
direct effect on the myocardium by trypanosomes independent of an 
immune/inflammatory component.  This is because prolongation of QTc can be 
attributable to an inflammatory infiltrate of the myocardium disrupting the 
tissue leading to altered electrical conductivity(27;57).  The QTc prolongation 
identified by Blum et al. (2007) was ascribed to an inflammatory infiltrate of the 
myocardium(51).  The fact that prolongation of QTc was not observed in the 
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current study suggests that there may not be a significant inflammatory 
infiltrate acting to disrupt the myocardium therefore, any effects observed may 
be directly mediated by the parasites. 
5.4.3 In Vivo ECGs for T. b. brucei TREU 927 Infection   
To more closely approximate a natural infection the strain T. b. brucei TREU 927 
was used.  These parasites do exhibit the ability to differentiate and so are 
pleomorphic, i.e. exist as both short stumpy and long slender forms.  As a result 
the parasites follow the classical cyclical waxing and waning parasitaemia 
phenotype.  Our 927 infection model was sustainable over a longer time period 
(up to 11 days) than the 4 day infection model of 427.  Recognising the 
limitations of the 427 infection model as discussed above, a decision was taken 
to use both the longer term 927 model of infection and to use biopotential 
recording implants to measure the ECGs of the rats continuously.  This would 
allow for a more complete assessment of the occurrence of ventricular 
arrhythmias than the 15 min “snapshot” taken in the 427 model at the 
commencement and termination of the study.  In addition to examining the ECGs 
for arrhythmias, the heart rate, P-R interval and QTc were also measured on Day 
0 and the end of the study.  The normalised heart rate of the infected animals 
was significantly increased suggesting higher sympathetic tone in response to the 
pathophysiological stress the animals were under(558) or indeed increased 
sensitivity to circulating catecholamines as discussed in section 5.3.2).  The P-R 
interval was not significantly altered nor was QTc.  Therefore, further 
investigation with ISO in the same hearts removed from the animals on 
termination and Langendorff perfused was conducted and discussed in section 
5.4.5.  Interestingly, with the longer period of ECG trace it was possible to 
identify the occurrence of ventricular arrhythmias.  There was a significantly 
higher frequency of VPCs in the ECGs of infected animals over controls.  This 
finding supports the data presented so far in this thesis that African 
trypanosomiasis can increase the propensity of arrhythmias.   
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5.4.4 T. b. brucei TREU 927 Infections Exhibit Greater Arrhythmia 
Frequency than Lister 427 Infections 
As discussed above, 927 is a pleomorphic strain of T. b. brucei meaning it 
differentiates to the insect infective short stumpy form.  The overall lower 
parasitaemia of 927 compared with 427 is due to a significant proportion of 927 
parasites terminally differentiating in a density-dependent manner (i.e. self-
regulating growth) whereas 427 will continue to divide resulting in exponential 
growth until the death of the host.  Interestingly, Caffrey et al. (2001) 
demonstrated that short stumpy form trypanosomes produced almost 5 times the 
amount of cathepsin-L than long slender counterparts of the same strain(129).  
Therefore, as 927 infection is producing more stumpy form trypanosomes then it 
is likely that there is significantly more circulating cathepsin-L that may thus 
contribute to more cardiac arrhythmias.  An unpublished finding (Lorna 
MacLean, personal communication) demonstrates that pleomorphic strains of 
trypanosome such as T. b. brucei GVR35 or T. b. rhodesiense IL1825 produce 
greater quantities of cathepsin-L in general than monomorphic 427.  MacLean 
also measured transendothelial migration using an in vitro BBB model and 
identified that the degree of migration correlated with the quantity of 
cathepsin-L expression.  Moreover, T. b. rhodesiense IL1852 expressed an 
increasing amount of cathepsin-L when incubated with the endothelial cells of in 
vitro BBB model depending on time of incubation from 15 min to 30 min and 60 
min.  At the same time-points, there was a corresponding increase in migration 
of parasites across the endothelial cell layer from ~5.0 x 104 parasites.mL-1 at 15 
and 30 min and ~1.8 x 105 parasites.mL-1 at 60 min(561).  During the same time 
GVR35 showed migration at 30 and 60 min of incubation with ~5.0 x 104 
parasites.mL-1 whereas 427 showed no detectable migration during this time 
period(561).  Therefore, this suggests that while all strains and stages of T. brucei 
spp. produce cathepsin-L(129) and therefore data from each is useful, the amount 
produced and correspondingly the transendothelial migration varies with strain 
and stage(69;129;561).  Furthermore, if cathepsin-L can directly affect the Ca2+ 
handling dynamics of the heart and transendothelial migration is linked, then it 
is reasonable to assume that the increased effect of 927 on cardiac arrhythmias 
over 427 could also partly be due to an increase in extravasation of parasites due 
to increased cathepsin-L levels and those same levels could be having a greater 
effect on the heart.  
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5.4.5 Ex Vivo Langendorff Perfused Heart Pseudo-ECGs for T. b. 
brucei TREU 927 Infection 
As with the 427 infection model the animals were terminated at the end of the 
study and the hearts removed.  The hearts were perfused on a Langendorff 
apparatus with increasing concentrations of ISO in Tyrodes and the ECG 
recorded.  As with the 427 data, the 927 data shows a similar pattern.  The 
normalised heart rate increases by a significantly larger margin in the infected 
animals over the controls.  This again suggests increased sensitivity to 
sympathetic and β-adrenergic stimulation (section 5.4.2.).  However, the 
intrinsic heart rate, i.e. the natural rate of the heart prior to addition of any ISO 
but without any neurohumoral input, was not significantly different from that of 
the controls.  In the presence of increasing concentrations of ISO the heart rate 
increased to a greater degree in the infected hearts.  This would suggest (as 
discussed with the ex vivo 427 infected hearts) that there could be increased 
sensitivity, expression or phenotype of β-adrenergic receptors.  In order to 
investigate the hypothesis of altered β-adrenergic response exerted by TbCatL 
effect on intra-cardiomyocyte Ca2+ handling during trypanosome infection, 
experiments involving assessment of the β-signalling receptors/cascade would be 
required(559).  The data presented in the preceding chapters demonstrates 
TbCatL effects on Ca2+ handling that have similarities with increased β-
adrenergic type effects, such as faster Ca2+ transient decay rate that could be 
inhibited by blocking the actions of CaMKII, posing a putative role for altered 
PLB phosphorylation status(240;244;245).  Diastolic Ca2+ leak from the RyR can also 
be attributable to increased β-adrenergic type effects through phosphorylation 
of RyR(299;323), which could also be inhibited by CaMKII blockade.  Since the single 
cellular effects were greater in the presence of trypanosome supernatant over 
control media to a greater degree with ISO, then this may suggest a potentially 
increased sensitivity to β-stimulation.  Therefore, the similarity of the Ca2+ 
handling effects of TbCatL and β-adrenergic stimulation may result in a 
synergistic effect of TbCatL in the presence of ISO in the infected hearts that 
would not be present in the control hearts that are only exposed to ISO. 
Similar to the 427 model there was reduction of P-R interval in the control 
hearts not mirrored by the infected hearts in response to ISO.  The fact that this 
finding has occurred in both independent in vivo models improves the validity of 
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the observation.  The P-R interval was not prolonged as there was no significant 
difference between controls and infected hearts during the steady state period 
and the value of 37.4 – 39.1 ms tallies well with reported values(562;563).  The 
clinical significance of this is unclear.  A recent study evaluated the prognostic 
value of prolonged P-R interval and found no correlation with cardiac or other 
causes of mortality(564) and Blum et al. (2007) recorded their cases of 1st degree 
AV block as rare and not a greater frequency than controls(51).  This suggests that 
changes in P-R interval are less likely to have clinical significance in HAT.   
The QTc was not significantly altered.  A longer term infection model that shows 
a perimyocarditis, as described in post-mortem studies of infected humans(56;57) 
and animals(26-28), may demonstrate the prolongation of QTc described by Blum 
et al. (2007) and isolate this finding as inflammation associated vs. a direct 
effect of the trypanosomes.  As discussed for the 427 infection model the lack of 
prolongation of QTc suggests no significant immune/inflammatory infiltrate 
disrupting the myocardial tissue, therefore supporting a hypothesis of TbCatL 
mediated effects vs. inflammation. 
5.4.6  T. b. brucei TREU 927 Infected Ex Vivo Hearts Show 
Increased Frequency of Arrhythmias 
In response to the increasing concentration of ISO the frequency of VPCs 
increased in the 927 infected hearts compared to controls but not in the 427 
infected hearts.  The 927 data supports the findings presented in this thesis that 
infection with T. b. brucei has the effect of increasing VPC frequency and 
supports the in vivo results above (section 5.3.3.2).  Interestingly, during in vivo 
infections without pharmacological intervention, there is an increase in VPC 
frequency, yet when the same hearts were removed there were no VPCs 
observed without the addition of ISO.  This supports the hypothesis that the 
arrhythmias may in fact be due to a circulating factor produced during 
trypanosome infection.  Once the hearts are removed from the direct influence 
of the circulation then the effect is lost.  If secreted/excreted TbCatL released 
into the circulation has the effect of increasing cardiac arrhythmias, then 
removal of the heart from the circulation and TbCatL may be expected to result 
in fewer arrhythmias ex vivo compared to in vivo.  When ex vivo hearts are 
perfused directly with trypanosome supernatant, which would contain TbCatL, 
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the arrhythmias can be observed.  When ISO is added VPC frequency increases in 
the infected hearts suggesting increased sensitivity to β-adrenergic stimulation 
as discussed above (section 5.4.2), which increases with the increasing ISO 
concentration.   This raises the question that the hearts may be chronically 
affected by the parasite infection compared with the response of healthy hearts 
perfused with supernatant.  Studies utilising field data would be useful to dissect 
the potential direct effects of trypanosomes on the heart from 
immune/inflammatory changes.  Further work would require the use of AIP, a 
CaMKII inhibitor, or a cathepsin-L inhibitor such as K11777, to determine if the in 
vivo effects observed are inhibited in the same way as the single cell effects.  
The lack of VPCs in the 427 model is difficult to reconcile but may be a result of 
a reduced window of observation compared to the continuous telemetry used in 
the 927 model.  In clinical studies a reported frequency of palpitations of 18%(51) 
would equate to 0.72 individual hearts in the 427 Langendorff study.   
5.4.7 Organ Mass 
5.4.7.1 Spleens were enlarged for both models 
Splenomegaly is common finding in both experimental infections of animals(565) 
and upon post-mortem examination of human infections of 
trypanosomiasis(56;496).  Therefore, the finding of splenomegaly in both the 427 
and 927 models is consistent with the literature.  Although histopathology has 
not been performed for the current study the literature reports that 
splenomegaly is due to lymphocytic infiltrates(56;496). 
5.4.7.2 Liver, lungs and heart mass were not changed 
There were no significant differences in the other organ masses.  This suggests 
that there was no significant inflammatory cell infiltrate that could alter the 
gross organ mass as there was with the spleen.  In order to assess a lower level 
of inflammatory cell infiltration the organs will need to be examined 
histologically, which will be performed in future studies.  An indicator of cardiac 
function is lung and liver mass.  If there is left or right sided heart failure 
cardiac output will be reduced.  As a result oedema will begin to pool in the 
liver for right-sided failure and in the lungs for left-sided failure.  The tissue will 
then become oedematous and therefore have greater mass (tissue and oedema).  
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As no change was observed in the current study, there was no clinical 
manifestation of heart failure in any of the infected animals in either model.    
5.4.8 A Role For Cathepsin-L In HAT 
The preceding chapters have demonstrated that TbCatL from T. b. brucei Lister 
427 can elicit effects on SERCA and the RyR mediated by CaMKII.  In vivo the 
situation is more complex.  It is clear from the literature that while there are no 
thus far identified genetic differences (allelic or gene copy number) between 
strain and sub-species’ repertoires of cathepsin-L genes, there are clear 
differences in the levels of cathepsin-L expression.  This seems to be dependent 
on the lifecycle stage of parasite, as well as sub-species and strain.  It appears 
that the largest quantity of cathepsin-L is produced by T. b. rhodesiense(69;129;561) 
and that the pleomorphic strains during the differentiated stumpy form phase 
produce more than long slender form phases or monomorphic strains locked in 
long slender forms(129;561).  Moreover, the larger the quantities of cathepsin-L 
expressed, the greater the degree of transendothelial migration there is in an in 
vitro model(69;561).  Therefore, the studies in this thesis may have 
underestimated the potential direct effects of trypanosomes on cardiac 
function, as clinically derived isolates of T. brucei spp. causing HAT have higher 
TbCatL levels than either T. b. brucei model used in the current study (69;129;561).  
Future studies examining the in vitro and in vivo effects of a range of clinical 
isolates of T. b. rhodesiense and T. b. gambiense, as well as different strains of 
pleomorphic T. b. brucei, may show a more severe phenotype.  Due to the 
inability to maintain bloodstream stages of pleomorphic strains of trypanosome 
in culture, only Lister 427 has been examined in vitro for this study.  The data in 
this chapter demonstrates that infection with trypanosomes can result in 
increased ventricular arrhythmias.  The result is more pronounced when a 
pleomorphic strain of trypanosome is used and can be related through the 
literature to the level of TbCatL expression.  The use of ISO leads to increased 
heart rate and a higher frequency of VPCs ex vivo suggesting a sensitisation 
effect of TbCatL to β-adrenergic stimulation.  The greater frequency of VPCs in 
vivo without ISO (in the 927 infection model) coupled with the ex vivo whole 
heart data from chapter 3 suggests the cardiac arrhythmia phenotype may be 
due to a secreted/excreted factor rather than an immune/inflammatory 
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response.  Therefore, TbCatL is an attractive target for future study and 
development of potential therapeutic strategies to treat HAT.
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6 CHAPTER 6 – The Cardiac Effects of 
Endogenous Extracellular Cathepsin-L  
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6.1 Introduction 
6.1.1 Cathepsins 
The cathepsins are localised within acidic intracellular organelles such as 
lysosomes and endosomes where their primary function is to break down 
unwanted proteins(371-374).  In addition to intracellular protein turnover, 
cathepsins have a wider role in many homoeostatic processes, and have been 
implicated in various diseases discussed in section 1.6.5.1.    The paradigm has 
been that cathepsins are only active at acidic pH, but recent work has shown a 
wider range of active locations and more neutral pH for cathepsins such as 
secretory vesicles(381;382), the cytosol(383-385) and the nucleus(386;387).  Extracellular 
roles for cathepsins have been proposed specifically with regard to extracellular 
matrix (ECM) remodelling(414;566;567).  Under normal physiological conditions the 
cathepsins are primarily intracellular within lysosomes but in pathological 
circumstances such as inflammation and oxidative stress the cathepsins can be 
released to elicit degradative effects on the ECM in cancer, bone and 
cardiovascular tissues(566). 
6.1.2 Cathepsins in the Heart  
Although other cathepsins have been studied in cardiovascular disease such as B, 
K and S(423), cathepsin-L (CatL) is garnering particular attention.  CatL is a 
ubiquitously expressed homoeostatic enzyme involved in many disease 
processes(368).  Within the heart it is known that a basal level appears to be 
necessary, as a CatL knockout mouse model shows a dilated cardiomyopathy 
phenotype(402).  Further evidence in support of the essentiality of basal levels of 
CatL is that a CatL knockout mouse model of myocardial infarction (MI) had 
impaired healing with poorer scar formation and greater cardiac dilatation over 
control mice with MI(424).  However, in patients with cardiovascular disease there 
are reported increases in serum levels of CatL(425;426).  Liu J. et al. (2006) 
examined serum CatL levels in patients with atherosclerosis and demonstrated a 
correlation with the degree of left anterior descending coronary artery stenosis 
and serum CatL(413).  Moreover, Liu Y. et al. (2009) identified that serum levels 
of CatL were significantly increased in patients correlating with severity of 
CHD(425).  They identified CatL was increased significantly from normal levels of 4 
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ng.mL-1 in patients without CHD to 4.7 ng.mL-1 in patients with stable angina 
pectoris, 5.5 ng.mL-1 in patients with unstable angina pectoris and 6.2 ng.mL-1 in 
patients with myocardial infarction(425).  However, while there is a correlation of 
serum CatL and severity of CHD the consequences of elevated levels of CatL 
remain unknown. Cathepsins A and D have previously been studied in the context 
of cardiac ischaemia/reperfusion injury showing increased activity(368;428-431).  For 
example, Linz et al. (2011) identified preserved ventricular wall geometry 
following experimental ischaemia/reperfusion (I/R) injury when CatA was 
inhibited(429).  Decker et al. (1997) visualised the distribution of CatD following 
I/R injury and identified CatD release from cardiomyocyte lysosomes(428).  Tiwari 
et al. (2008) identified that release of CatD during I/R injury correlated with 
myocardial damage with a concomitant increase in lipid peroxides and 
superoxide suggesting a free radical activation by CatD during I/R injury(430).  
CatL on the other hand has been studied with regard to  potential beneficial 
remodelling effects post-MI without reperfusion(424), but despite serum increases 
in CHD little data exists on it with respect to a potential role in I/R injury.  
Inhibition of CatL and CatB has been studied in the context of neuronal 
ischaemia/reperfusion and shows potentially beneficial effects in the initial 24-
48 hours post stroke(366;367).  For example, Anagli et al. (2008) identified that 
cathepsin B and L activity was increased in ischaemic regions of the cerebral 
cortex with a concomitant increase in heat shock proteins, and that inhibition of 
cathepsins B and L resulted in a reduced infarct size by reducing heat shock 
protein levels and serum albumin leakage through the blood brain barrier(366).  
Therefore, inhibition of CatL may have similar effects in cardiac I/R injury.  
Another potential role could be played in reperfusion arrhythmias.  It is well 
known that arrhythmias occur during reperfusion following an ischaemic 
period(568) and is the main cause of sudden cardiac death in humans(569).  
Therefore, given the relationship between arrhythmias and Ca2+ waves, and the 
role TbCatL plays on Ca2+ handling in cardiomyocytes (discussed in Chapters 3 
and 4) it is important to investigate the effects of mammalian cathepsin-L on 
cardiomyocytes Ca2+ handling.  When mammalian CatL is compared to TbCatL 
there is considerable homology between the pre-, pro- and central regions of the 
enzyme(131).  However, a 108 amino acid C-terminal extension distinguishes the 
TbCatL from its mammalian counterpart.  This extension is thought to be 
involved in targeting the enzyme within cells(131).  When the substrate 
Chapter 6  The Effects of Endogenous Extracellular Cathepsin-L 266 
 
specificities of mammalian CatL, and related parasite cathepsin-L-like cysteine 
proteases has been compared, they show essentially the same enzymatic 
activity(570) but have particular amino acid residue preferences at the P2 position 
of the enzyme(131)  where the S2 region of a substrate would bind (Figure 2.19).  
The significance of these minor differences in amino acid residue preference 
with regard to effects on Ca2+ handling remain unexplored.  Work in the lab 
performed by a student, Katrin Nather, and supervised by me identified that 
increased CatL activity could be detected in an ex vivo model of I/R injury 
compared to control hearts (Figure 6.2).  Therefore the potential role of 
increased CatL activity in I/R injury was investigated.  
6.1.3 Ischaemia/Reperfusion Injury and Heart Failure 
6.1.3.1 Ischaemia/Reperfusion Injury 
Coronary heart disease (CHD) is the leading cause of death worldwide with an 
estimated 7 million deaths annually(326).  Coronary heart disease is a narrowing 
and eventual blockage of the coronary arteries supplying the myocardium with 
blood.  The result of blockage is myocardial infarction (MI) creating a region of 
ischaemia distal to the obstruction.  The most effective strategy for reducing the 
size of the infarct and improving clinical outcome is early reperfusion with use 
of thrombolytic therapy or percutaneous coronary intervention (PCI)(327).  
However the process of restoring blood flow can itself be injurious – termed 
myocardial reperfusion injury.  The injury results in death of cardiomyocytes 
that were viable immediately prior to reperfusion(328).  Myocardial reperfusion 
injury consists of four types of dysfunction.  The first is myocardial stunning, a 
persistent mechanical dysfunction despite no irreversible damage and 
restoration of normal coronary flow(329).  This phenomenon is usually reversible 
days to weeks after the initial insult.  The second type is the no-flow 
phenomenon where there is microvascular damage preventing restoration of 
blood flow to the affected region(330).  The third type is reperfusion arrhythmia 
brought about by Ca2+ overload and modulation of the Ca2+ handling proteins 
such as LTCC, RyR, SERCA and NCX(331-337).  The fourth type of cardiac 
dysfunction is termed lethal reperfusion injury(327).  Lethal reperfusion injury is 
thought to have several mediators.  The first is the oxygen paradox where 
reperfusion of the ischaemic tissue results in oxidative stress and release of 
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reactive oxygen species (ROS) and myocardial enzymes(338) including 
cathepsins(339;340).  The second is the Ca2+ paradox where intracellular Ca2+ rises 
secondary to sarcolemmal damage and ROS effects inhibiting SERCA(341-344) and 
increasing Po of the RyR(344-347).  The increase in Ca2+ can overload the 
cardiomyocyte leading to a state of hypercontracture and can overload the 
mitochondria leading to opening of the mitochondrial permeability transition 
pore (MPTP)(328) which causes cell death by uncoupling of oxidative 
phosphorylation and ATP production.  The third is pH paradox where rapid 
reperfusion washes out the lactic acid from anaerobic respiration leading to 
activation of the Na+/H+ exchanger and Na+/HCO3- symporter overwhelming the 
cell’s buffering capacity(348).  The fourth is inflammation; the infarct zone 
attracts neutrophils during the first 24 hours causing vascular plugging, release 
of degradative enzymes and ROS(349).  The role of cathepsins in these processes is 
unclear but initial studies suggest that they have degradative effects(428-431;571).  
It is not understood whether they damage cell membranes or mediate their 
effects through activation of surface receptors.  
6.1.3.2 Heart Failure 
Following a severe myocardial insult such as MI the remaining viable tissue can 
be taxed beyond its means and begin to fail.  Heart failure (HF) is a disease state 
with weakening of myocardial contractility, ultimately resulting in deterioration 
of ventricular pump function.  The characteristic cardiomyocyte features of HF 
are reduced systolic Ca2+ transient amplitude and prolonged Ca2+ transient 
duration(299-302) with a concomitant reduction in the SR Ca2+ content(303-306).  The 
specific mechanisms involved in causing the reduced SR Ca2+ content remain 
unclear and intensely debated.  However, in short, SR Ca2+ leak through the RyR 
is generally accepted as an important pathophysiological mechanism(572;573).  
Other less consistent findings are reductions in SERCA expression/function(279;574-
577) and/or increases in NCX function/expression(225;303;306).  These Ca2+ handling 
proteins are all targets for phosphorylation mediated by PKA and CaMKII and 
current thinking is that modulation of the activity of these proteins is more 
important than expression levels(302).  Given the apparent effects on Ca2+ 
handling proteins potentially mediated by CaMKII by TbCatL, it is possible that 
mammalian extracellular CatL could also directly affect cardiomyocyte Ca2+ 
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handling which could offer some explanation to the pathophysiological 
mechanisms in ischaemic heart disease.  
6.1.4 Aims of the Chapter 
Our evidence suggests that extracellular TbCatL can alter intra-cardiomyocyte 
[Ca2+]i and lead to an increase in the frequency of cardiac arrhythmias.  Another 
disease characterised by altered Ca2+ handling and arrhythmias is 
ischaemia/reperfusion injury, which can occur during treatment by PCI following 
acute MI(327).  The role of mammalian extracellular cathepsin-L (CatL) on 
cardiomyocyte function remains unknown.  This is particularly important given 
that CatL is increased in the serum of individuals with cardiovascular 
disease(425;426).     
The aims of this chapter are to establish: i) the activity of CatL at different pH 
levels, ii) through a preliminary study whether CatL levels are increased in the 
serum of human patients that have undergone reperfusion by PCI, iii) through a 
preliminary study what relationship there may be between severity of ischaemic 
heart disease and CatL serum levels in the human patients and iv) what effect 
CatL has on Ca2+ handling in cardiomyocytes.  The hypothesis is that following 
I/R injury, CatL is released and acts on the myocardium by an as yet unidentified 
target to alter Ca2+ handling in cardiomyocytes, potentially contributing to 
reperfusion arrhythmias and impaired cardiac function.  This hypothesis will be 
tested by measuring the serum CatL levels of patients by ELISA, examining data 
gathered at the Golden Jubilee National Hospital, Glasgow, by magnetic 
resonance imaging and a combination of LASER-scanning confocal microscopy 
and epifluorescence microscopy to dissect the Ca2+ handling dynamics of 
cardiomyocytes.  
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6.2 Methods 
6.2.1 Fluorometric Enzyme Activity Assays 
6.2.1.1 Recombinant Mouse Cathepsin-L 
Recombinant mouse cathepsin-L (R&D Systems) was supplied as 20 µL of a 0.5 
mg.mL-1 solution in 25 mM tris(hydroxymethyl)aminomethane (Tris) and 150 mM 
sodium chloride (NaCl).  The enzyme was in the pro-enzyme form and so 
required activation according to manufacturer’s instructions.  Briefly, an aliquot 
(depending on final volume required for experimentation) of the supplied 
solution was diluted to 10 µg.mL-1 in activation buffer (25 mM sodium acetate 
and 5 mM dithiothreitol (DTT) at a pH of 5.0 in water) and incubated for 90 min 
at 37 ºC.  The activated enzyme was diluted to a concentration of 0.05 ng.µL-1 in 
mouse assay buffer (25 mM 2-(N-morpholino) ethanesulfonic acid (MES) and 5 mM 
DTT) made specifically at pH 6.0, 7.0 and 7.4. 
6.2.1.2 Recombinant Human Cathepsin-L 
Recombinant human cathepsin-L (R&D Systems) was supplied as 36.2 µL of a 
0.279 mg.mL-1 solution of 50 mM sodium acetate and 500 mM NaCl at pH 5.0 (10 
µg quantity).  For activation, the enzyme was diluted to 40 µg.mL-1 in human 
assay buffer (50 mM MES and 5 mM DTT at pH 6.0 in water) at room temperature 
for 15 min.  Activated enzyme was diluted to 0.02 ng.µL-1 in assay buffer (as 
above) at pH 6.0, 7.0 and 7.4 for the activity assay. 
6.2.1.3 Recombinant Cathepsin-L Activity Assays 
Activated enzyme in assay buffer was tested at the recommended pH of 6.0, at 
pH 7.0 and physiological pH 7.4 in triplicate.  Assay buffer at the appropriate pH 
was used as negative control blanks.  An aliquot of the fluorescent substrate Z-
leu-arg-AMC (R&D systems) was diluted in human or mouse assay buffer 
(depending on the enzyme to be tested) to a concentration of 20 µM and 
protected from light.  50µL of 20 µM substrate was added to appropriate wells in 
a black maxisorp 96 well plate (Nunc) followed by 50 µL negative control to the 
control wells. 50 µL activated enzyme was added to the test wells immediately 
prior to the reading time as possible, so that enzyme activity could be read 
immediately.  The plate was read on a spectrophotometer for 30 min at an 
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excitation wavelength of 380 nm and emission wavelength of 460 nm 
corresponding with the properties of the fluorescent moiety of the substrate, 7-
amino-4-methylcoumarin (AMC).  
6.2.1.4 Coronary Effluent Activity Assays 
Coronary effluent samples were collected from Langendorff perfused hearts into 
eppendorfs at a ratio of 50:50 with effluent assay buffer (50 mM sodium acetate, 
2 mM ethylenediaminetetraacetic acid (EDTA) and 2 mM DTT) at pH 5.5.  The 
samples were added last in triplicate to a 96 well plate in 50 µL quantities to 
wells already containing 100 µL effluent assay buffer and 50 µL Z-Leu-Arg-AMC 
substrate and read on a spectrophotometer as above.  Tyrodes solution with 
effluent assay buffer mixed 50:50 was used a negative control with added 
recombinant mouse cathepsin-L as the positive control. 
6.2.1.5 Specific Inhibitor Activity Assays 
Aliquots from the effluent samples with peak activity were tested again with 
specific cathepsin inhibitors to confirm CatL activity was present in the effluent 
samples.  The substrate Z-Leu-Arg-AMC is cleaved by both cathepsins B and L, 
and so specific inhibitors of B and L were used to differentiate between these 
cathepsins.  CA074 was used to inhibit cathepsin-B(578) and CAA0225 was used to 
inhibit CatL(579), both at concentrations of 10 µM.  Both inhibitors permanently 
and competitively bind the active sites of their respective targets preventing 
them from cleaving any substrate(578;579).  Samples were run without any 
inhibitor, with CatL inhibitors ± CA074 and with CA074 only.  The same set of 
conditions was run on the same plate with recombinant mouse CatL.  Inhibitors 
with assay buffer only were used as blanks. 
6.2.2 Cardiomyocyte Isolations 
6.2.2.1 Adult Rat Left Ventricular Cardiomyocyte Isolation 
Adult rat cardiomyocytes were isolated as described in section 2.3.1 and 
resuspended in 1.8 mM Ca2+ MIKH. 
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6.2.2.2 Adult Rabbit Left Ventricular Cardiomyocyte Isolation 
Rabbit cell isolation was performed by Mrs. Aileen Rankin as described in section 
2.3.2.  Cells were then suspended in 1.8 mM Ca2+ MIKH ready for 
experimentation. 
6.2.3 Epifluorescence Measurements of the Field Stimulated Ca2+ 
Transient 
6.2.3.1 Cathepsin-L Activation 
Recombinant mouse CatL was activated prior to experimentation.  Two different 
batches were used during the course of the experiments.  The first required 90 
min activation at a concentration of 10 µg.mL-1 at 37 ºC in activation buffer 
(section 6.2.1.1), the second required overnight activation at 100 µg.mL-1 at 
room temperature in activation buffer according to manufacturer’s 
recommendations (R&D Systems).   
6.2.3.2 Cardiomyocyte Preparation 
Intact cardiomyocytes were incubated with Ca2+ sensitive fluorophore (5 µM 
Fura-2-AM (Biotium Inc., Hayward, CA)) for 10 min.  Cells were then re-
suspended in 1.8 mM Ca2+ MIKH with activated CatL or matching volume of 
activation buffer as vehicle control.  Concentrations tested were 0.68 nM, 2.7 
nM and 5.4 nM.  Cells were incubated at room temperature for 30 min to allow 
enzyme to act and cells to de-esterify the Ca2+ sensitive dye. 
6.2.3.3 Stimulated Calcium Transient Acquisition 
Once the cardiomyocytes were prepared they were loaded into a tissue bath 
with field stimulator (Cell Microcontrols) and superfused with 1.8mM Ca2+ KH 
with CatL or vehicle via gravity fed perfusion pen with active outflow.  Cells 
were field-stimulated (0.5 Hz, 2.0 ms duration, voltage set to 1.5 x threshold) 
for 5 min with a signal generator and stimulator (Digitimer Ltd).  The 
fluorescence ratio (340/380 nm excitation wavelength) was measured with a 
spinning wheel spectrophotometer (Cairn Research UK) at a sampling rate of 5 
kHz. Each cell had background light offset on the photomultiplier tube amplifier 
unit (Cairn Research UK).  Minimum ratio (Rmin) was recorded prior to stimulation 
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and maximum ratio (Rmax) was measured by puncturing the cell membrane with a 
sharp glass micropipette manoeuvred by a micromanipulator (Scientifica). 
6.2.3.4 Sarcoplasmic Reticulum Calcium Content 
Sarcoplasmic reticulum (SR) Ca2+ content was determined by rapid application of 
a bolus of 10mM caffeine via the perfusion pen.  Field-stimulation was stopped 
and the perfusion solution immediately changed using a c-flow pinch valve 
system (Cell Microcontrols). 
6.2.3.5 Calcium Transient Analysis 
Fluorescence ratio was converted to Ca2+ using the following calculation: 
[Ca2+]i = ((Ratio – Rmin)/(Rmax – Ratio)) x (1.2 x 10-6) 
Data were analysed offline and mean [Ca2+]i  obtained from the average 
transient generated from the last 12 transients plotted using Origin (OriginLab) 
software. 
6.2.4 Confocal Imaging of Spontaneous SR-mediated Ca2+ 
Release 
6.2.4.1 Confocal Image Acquisition 
Intact cardiomyocytes isolated as described in (6.2.2) were loaded with Fluo-
3AM Ca2+ sensitive fluorophore for 10 min.  Cells were resuspended and 
incubated in 1.8 mM Ca2+ MIKH with 5.4 nM activated recombinant CatL or 
equivalent volume of vehicle for 30 min as in section 6.2.3.2.  Confocal line-scan 
images of cardiomyocytes were recorded using a LSM 510 confocal system 
(Zeiss).  Fluo-3AM was excited at 488nm (Ar LASER) and measured >515 nm using 
epifluorescence optics of an inverted microscope with a 63 x/1.2 NA water-
immersion objective lens.  Fluorescence was acquired in line-scan mode at 3.07 
ms.line-1 (1 line = 512 pixels); pixel dimension was 0.27 μm.  The scanning LASER 
line was orientated parallel with the long axis of the cell and placed 
approximately equidistant between the outer edge of the cell and the 
nucleus/nuclei to ensure the nuclear area was not included in the scan line.  
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6.2.4.2  Confocal Image Analysis 
Fluorescence data were expressed as the ratio of quiescent fluorescence (F/F0). 
The fluorescence intensity profile was calculated from a 20 pixel band adjacent 
to the point of spontaneous event initiation.  This avoids movement artefact(296).  
Event frequency was calculated as number/time(s).  The event velocity was 
calculated as the gradient of the wave progression across the cell expressed as 
µm.s-1.  Wave decay and amplitude were calculated from the intensity profile 
trace. 
6.2.5 Langendorff Perfusion Global Ischaemia/Reperfusion 
Adult male Wistar rats (250-300 g) were euthanized in accordance with Schedule 
1 of the Animal (Scientific Procedures) Act 1986 and hearts rapidly excised.  
Hearts were cannulated via the aorta in retrograde perfusion.  Tyrodes solution 
at 1.8 mM [Ca2+]o infused with 95% O2 and 5% CO2 was perfused through the 
hearts at 10 mL.min-1.  The perfusion was stopped for a 30 min period of 
ischaemia.  Control hearts (no ischaemia) were perfused continually.  Perfusion 
was restarted and continued for 90 min.  Coronary effluent was collected at 10 
min and immediately prior to ischaemia, and upon reperfusion every minute for 
5 min followed by every 10 min from 10 min.  This technique was in conjunction 
with Katrin Nather, a Masters student under my supervision. 
6.2.6 Enzyme-Linked Immunosorbent Assay of Human Serum 
Samples of serum were obtained from patients presenting to the Golden Jubilee 
National Hospital (GJNH), Clydebank, Glasgow, UK with acute ST segment 
elevation myocardial infarction (STEMI).  Samples were obtained with the 
patient’s written consent and ethical approval from the University of Glasgow 
Ethical Approval Committee.  An arterial blood sample was taken from an 
indwelling catheter inserted on clinical grounds at presentation immediately 
prior to percutaneous coronary intervention (PCI) (section 1.6.4) to reperfuse 
the heart (pre reperfusion sample).  Another arterial sample was taken after 
intervention (immediate post reperfusion sample) as the patient was recovered.  
Blood samples were collected into 5 mL gel separator serum tubes and 
transported to the British Heart Foundation Glasgow Cardiovascular Research 
Centre, University of Glasgow.  The samples were centrifuged at 2,400 g for 15 
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min to separate the serum from the cellular component.  Serum was aspirated 
into 0.5-1.0 mL aliquots and stored at -80 ºC until required.  The quantity of 
cathepsin-L was measured by enzyme-linked immunosorbent assay (ELISA) using 
the manufacturer’s recommended protocol (USCN Life Science Inc.) and 
normalised to the total protein content of the serum determined by 
bicinchoninic acid (BCA) assay.   
6.2.7 Cardiac Magnetic Resonance Imaging 
Patients were invited to return to the GJNH 6 months post primary presentation 
for cardiac magnetic resonance imaging (MRI) with contrast enhancement.  
Contrast enhancement permits visualisation of the blood flow within the tissue 
enabling assessment of infarct size and the area at risk.  The MRI was performed 
by two members of GJNH clinical staff with MRI experience.  Images were 
assessed by clinical staff at GJNH who examined; infarct size, area at risk, 
ejection fraction, left ventricular systolic and diastolic volume indexed to body 
surface area to control for variation in patient size; and the results reported for 
inclusion in this study.  The data was sent to me for correlation with serum CatL 
levels measured by ELISA.  Patient data was tracked by anonymous patient 
identification number. 
6.2.8 Statistical Analysis 
Data are expressed as mean ± SEM.   Statistical comparisons were made by a 
two-sample Student’s T-test on the raw data.  Multiple groups were compared 
with ANOVA.  A significance level of P<0.05 was considered significant. 
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6.3 Results 
6.3.1 Mammalian Cathepsin-L is Active at Physiological pH 
CatL is a lysosomal cysteine protease and therefore usually active at acidic 
pH(368).  The reported optimum pH for CatL is pH 5.5-6.0(371).  However, recent 
findings have identified additional roles for CatL at more physiological pH such 
as in the cytosol(383-385) or extracellular space(580).  To determine if extracellular 
CatL could act on cardiomyocytes at physiological pH enzyme activity assays 
were performed with recombinant mouse CatL at pH 6.0, 7.0 and 7.4.  Figure 
6.1 shows the activity curves (Figure 6.1A) generated when enzyme has been 
incubated with the fluorogenic substrate Z-LR-AMC at 37 ºC and measured at 
excitation and emission wavelengths of 380nm and 460nm respectively on a 
spectrophotometer.    The data show that CatL is active at all tested pH with no 
significant difference; (2.88 x 106 ± 1.07 x 106 vs. 2.82 x 106 ± 1.89 x 105 vs. 2.14 
x 106 ± 5.19 x 106 arbitrary fluorescence units; pH 6.0 vs. pH 7.0 vs. pH 7.4; 
P>0.05, Figure 6.1B).    
 
 Figure 6.1: Fluorometric activity assay of recombinant mouse CatL at different pH. 
(A) Enzyme activity curves for recombinant mouse CatL.  Activity was determined by cleavage of a 
fluorogenic substrate (Z-LR-AMC) measured at wavelengths of 380 nm excitation and 460 nm 
emission on a spectrophotometer.  Neutral and physiological pH values (7.0 and 7.4) were 
compared to optimum pH 6.0 recommended by the manufacturer.  Assay buffer without enzyme at 
each pH was used as a blank and subtracted from the experimental curves.  Activity is present at 
all pH values (n = 5 triplicates). (B) Mean ± SEM for enzyme activity in arbitrary units at 30 min in 
assay buffer at pH 6.0, 7.0 and 7.4. 
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6.3.2 Cathepsin-L Can be Detected in Coronary Effluent from 
Ischaemic Hearts 
In clinical patients with ischaemic heart disease increased serum levels of CatL 
have been described(425;426).  Sun et al. (2010) found increased CatL activity in 
the myocardium of homogenised murine hearts following experimental induction 
of myocardial infarction(424).  However, it is not clear whether CatL is directly 
released by cells within the heart.  Therefore, ex vivo Langendorff perfused rat 
hearts were subjected to 30 min global ischaemia with a control group of hearts 
perfused continuously.  Coronary effluent was collected at time-points pre and 
post ischaemia and CatL activity measured by a fluorometric enzyme activity 
assay.  Perfusion Tyrodes solution with fluorogenic substrate was used as a blank 
and subtracted from the coronary effluent data to give a relative change in 
fluorescence over Tyrodes and substrate alone.  These experiments were 
performed in conjunction with Katrin Nather under my supervision.  CatL activity 
was detected in the coronary effluents following ischaemia (n = 3) compared to 
control hearts (n = 3) that were perfused throughout the protocol.  No activity 
was detected from coronary effluent samples from the period prior to ischaemia 
in either cohort (Figure 6.2A).  Since the fluorogenic substrate is also cleavable 
by CatB that may be present in the effluent samples the activities of both CatB 
and CatL were dissected using the specific inhibitors CA074 (against CatB) and 
CAA0225 (against CatL) at concentrations of 10 µM.  Activity was inhibited by 
79% with CA074 and by 100% with CAA0225 (Figure 6.2B). 
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Figure 6.2: CatL activity in coronary effluent samples from ischaemia/reperfusion hearts 
(A) Mean ± SEM of CatL activity in arbitrary fluorescence units as measured by fluorometric assay 
with Z-LR-AMC substrate for coronary effluent samples.  (Top) Control (n = 3) hearts perfused with 
Tyrodes at 10 mL.min-1 and (Bottom) ischaemia/reperfusion (n = 3) hearts.  Recombinant mouse 
CatL (rmCatL) at 0.68 nM was used as an assay control.  (B) Mean ± SEM of 30 min post 
reperfusion sample ± CatL inhibitor CAA0225 and/or CatB inhibitor CA074.  Blue lines indicate 
period of ischaemia. Time 0 is the first collection immediately after perfusion is restarted. 
6.3.3 Cathepsin-L is Increased in Serum of Human Patients That 
Have Undergone Reperfusion Following Myocardial 
Infarction 
Patients with coronary artery disease have been shown to have increased serum 
levels of CatL(425;426).  However, to our knowledge no-one has measured the 
levels of CatL following reperfusion.  The data from coronary effluent samples in 
rat hearts suggest that there are increased levels of CatL activity following 
reperfusion.  Therefore, as a preliminary study, serum samples were obtained 
from human patients that presented to the GJNH with a diagnosis of STEMI.  
Whole blood samples (~10 mL) were obtained from an indwelling (arterial) 
catheter inserted on clinical grounds from primary PCI by clinical staff at GJNH 
at the following points; pre-reperfusion by PCI and immediately post 
reperfusion.  Thawed serum prepared as described in section 6.2.6 was 
measured by ELISA for CatL levels.  The concentration of CatL was increased 
upon reperfusion (but not significantly) (4.42 ± 0.95 vs. 6.28 ± 1.50 ng.mL-1; pre-
reperfusion vs. immediately post reperfusion; (n = 4); P = 0.11 and 0.14; Figure 
6.3A).  Total serum protein levels in patients can be altered due to hydration 
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status and fluid therapy during the PCI procedure.  Therefore total serum 
protein was measured by BCA assay and the quantity of CatL normalised to the 
total protein.  There was an increase, albeit not statistically significant, in CatL 
in the immediately post-reperfusion serum (0.070 ± 0.012 vs. 0.110 ± 0.025 
ng.mg-1 total protein; pre-reperfusion vs. immediately post reperfusion; P = 0.09 
and 0.14; Figure 6.3B).  
 
Figure 6.3: Serum concentration of CatL in human patients following myocardial infarction 
(A) Mean ± SEM of serum CatL (n = 4) as determined by specific serum ELISA.  (B) Serum CatL 
normalised to total protein determined by BCA protein assay. 
6.3.4 Serum Cathepsin-L Levels Correlate With Severity of 
Cardiac Dysfunction Measured by MRI 
Patients that had undergone PCI for STEMI were invited back to the GJNH 6 
months after initial presentation for follow-up cardiac MRI.  Three of the seven 
patients returned.  Patients were imaged by experienced clinical staff and the 
images were analysed by Dr. David Carrick at the GJNH, who then forwarded the 
data for correlation with the serum CatL levels for the same patients taken 
immediately post reperfusion.  There was a positive correlation of left 
ventricular end systolic volume with serum CatL levels (R = 0.93; P = 0.24; n = 3; 
Figure 6.4A(i)).  Similarly, there was a positive correlation for left ventricular 
end diastolic volume with serum CatL (R = 0.96, P = 0.17; Figure 6.4A(ii)).  There 
were positive correlations for both infarct size (R = 0.96, P = 0.17; Figure 
6.4A(iii)) and the area of myocardium at risk (R = 0.98, P = 0.14; Figure 6.4A(iv)) 
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with serum CatL.  The ejection fraction correlated negatively with serum CatL (R 
= -0.87, P = 0.33; Figure 6.4A(v)).    
 
Figure 6.4: Serum CatL vs. MRI parameters. 
(A(i-v)) Serum CatL level from immediately post reperfusion plotted against left ventricular end 
systolic volume, left ventricular end diastolic volume, infarct size, area at risk and ejection fraction.  
Linear best fit drawn using graphical software programme, Origin6.1 (OriginLab). 
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6.3.5 Cathepsin-L Reduces Stimulated Ca2+ Transient Amplitude 
in Rat Left Ventricular Cardiomyocytes 
Increased serum levels of CatL have been shown to be associated with an 
increased severity of cardiac disease(425).  To examine whether increased levels 
of extracellular CatL could have a detrimental effect on cardiomyocyte Ca2+ 
handling, epifluorescent Ca2+ measurements were conducted with different 
concentrations of CatL.  Concentrations tested were determined from 
pathological values reported in the literature(425;426), the predicted 
concentrations from Figure 6.1 &Figure 6.2 and the concentration of TbCatL 
based on Caffrey et al. (2001)(129).  Isolated rat left ventricular cardiomyocytes 
were incubated for 30 min with CatL (Figure 6.5A) at a concentration of 0.68 nM 
(1:400), 2.70 nM (1:100) and 5.40 nM (1:50) or vehicle control (Figure 6.5B(i-iv)).  
The peak [Ca2+]i was significantly decreased to 82.9%, 62.3% and 56.3% of control 
respectively (552.2 ± 23.7 vs. 458.0 ± 36.8 vs. 344.3 ± 24.2 vs. 310.9 ± 29.2 nM; 
control vs. 0.68, vs. 2.70 vs. 5.40 nM CatL; P<0.05; Figure 6.5C(ii)).  The 
minimum [Ca2+]i was no significantly altered at 0.68 or 2.70 nM CatL (67.5 ± 1.9 
vs. 57.1 ± 2.5 vs. 65.5 ± 2.8 nM; control vs. 0.68, vs. 2.70 nM CatL; P>0.05; 
Figure 6.5C(iii)).  However, the minimum [Ca2+]i was increased to 138.5% of 
control at 5.40 nM CatL (67.5 ± 1.9 vs. 93.5 ± 6.4 nM; control vs. 5.40 nM CatL; 
P<0.05; Figure 6.5C(iii)).  Ca2+ transient amplitude as a result of the reduced 
peak [Ca2+]i was also significantly reduced at all concentrations of CatL to 82.7%, 
57.5% and 44.8% of control respectively (484.8 ± 22.5 vs. 400.9 ± 35.5 vs. 278.8 ± 
23.8 vs. 217.4 ± 26.5 nM; control vs. 0.68, vs. 2.70 vs. 5.40 nM CatL; P<0.05; 
Figure 6.5C(iv)).  In contrast with the data presented in the preceding chapters, 
mammalian CatL decreased the rate constant of decay to 91.3% of control at 
0.68 nM, and significantly to 61.4 % and 36.2% of control, 2.70 and 5.40 nM CatL 
respectively (12.7 ± 0.7 vs. 11.6 ± 0.8 (P>0.05) vs. 7.8 ± 1.2 vs. 4.6 ± 0.4 s-1; 
control vs. 0.68, vs. 2.70 vs. 5.40 nM CatL; P<0.05; Figure 6.5C(v)).  CatL activity 
was measured by fluorometric activity assay in the cardiomyocyte perfusate 
(arbitrary fluorescence units) and correlated with [Ca2+]i amplitude to give an 
inverse linear correlation with r2 = -0.98 ± 0.90 S.D. (Figure 6.5C(vi)).  Activity 
levels were 0.18 ± 0.02 vs. 1.42 ± 0.19 vs. 2.62 ± 0.04 x 104 arbitrary 
fluorescence units normalised to no enzyme control; 0.68, vs. 2.70 vs. 5.40 nM 
CatL; P<0.05 (Figure 6.5C(vi) inset).   
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Figure 6.5: Stimulated Ca2+ transients at different CatL concentrations.  
(A) Protocol used for epifluorescence Ca2+ measurements.  (B) Example Ca2+ transient traces for 
(i) control, (ii) 0.68 nM CatL, (iii) 2.70 nM CatL and (iv) 5.40 nM CatL.  The stimulus mark is shown 
in (i), the frequency was 0.5 Hz. (C(i)) Average Ca2+ transients for the different concentrations, 
(Inset) normalised average transients from (i). (ii - v) Mean ± SEM for Ca2+ transient parameters; 
control (n = 67), 0.68 nM CatL (n = 23), 2.70 nM CatL (n = 22) and 5.40 nM CatL (n = 18).  (vi) Plot 
of the relationship between CatL activity (measured by cleavage of a fluorogenic substrate) (n = 3) 
against Ca2+ transient amplitude. (Inset) Activity level (RFU) for each concentration tested. 
6.3.6 Cathepsin-L Reduces SR Ca2+ Content in Rat Left 
Ventricular Cardiomyocytes 
Ca2+ transient amplitude is related to SR Ca2+ content therefore high 
concentration caffeine (10 mM; 20 s) was applied rapidly to cardiomyocytes at 
the end of the protocol (Figure 6.6A).  The amplitude of the caffeine-induced 
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Ca2+ transient is an indicator of the SR Ca2+ content.  The rate constant of 
decline is an indicator of sarcolemmal Ca2+ efflux.  The caffeine-induced Ca2+ 
transient amplitude was significantly reduced compared to control at all 
concentrations of CatL (100.0 vs. 78.8 ± 5.0 vs. 81.5 ± 5.2 vs. 60.1 ± 8.5% of 
vehicle control; control vs. 0.68, vs. 2.70 vs. 5.40 nM CatL; P<0.05; Figure 
6.6C(i)).  The rate constant of decay was not significantly altered at 0.68 or 2.70 
nM (100.0 vs. 101.7 ± 6.0 vs. 95.0 ± 8.9% of vehicle control; control vs. 0.68, vs. 
2.70 nM CatL; P>0.05; Figure 6.6C(ii)), but was at significantly reduced at 5.40 
nM CatL; (100.0 vs. 78.9 ± 3.9%; control vs. 5.40 nM CatL; P<0.05; Figure 
6.6C(ii)).   
 
Figure 6.6: Caffeine-induced Ca2+ transients at different CatL concentrations.  
(A) Protocol.  (B) Example caffeine-induced Ca2+ transients. (Inset) Normalised caffeine-induced 
Ca2+ transients from (B). (C(i)) Mean ± SEM caffeine-induced Ca2+ transient amplitude as % 
change of vehicle control (ii) Rate constant of decay as % change of vehicle control. 
6.3.7 Cathepsin-L Reduces Stimulated Ca2+ Transient Amplitude 
in Rabbit Left Ventricular Cardiomyocytes 
The Ca2+ handling dynamics of rat left ventricular cardiomyocytes are different 
to that of human ventricular cardiomyocytes(148) (discussed in section 1.4).  In 
the rat Ca2+ transient decline is predominantly due to SERCA mediated reuptake 
to the SR, with reported percentage contributions of 87-92% in the rat(223;224;581) 
vs. 63% in normal human ventricular cardiomyocytes and 58% in failing 
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cardiomyocytes(225).  The other major contributor to the Ca2+ transient decline 
during diastole is sarcolemmal efflux by NCX.  In the rat this constitutes 7-
9%(223;224;581) vs. 37% in normal human cardiomyocytes and 42% in failing 
cardiomyocytes(225).    Therefore, to examine the SR Ca2+ release in an animal 
model with similarities to human cardiomyocyte Ca2+ handling the rabbit was 
used.  The rabbit exhibits similar Ca2+ handling properties with SERCA reuptake 
contributing 70-74% of the Ca2+ transient decline and NCX contributing 23-
28%(257;582).  Therefore epifluorescence Ca2+ measurements were made in rabbit 
left ventricular cardiomyocytes using the same protocol as for the data shown in 
Figure 6.5 (Figure 6.7A).   The concentration of CatL used was 0.68 nM, which 
was identified by activity assays to be the quantity produced in Langendorff 
perfused hearts and is similar to that reported in patients(425) (Figure 6.7B).  In 
comparison with the rat cardiomyocytes, CatL significantly reduced the peak 
[Ca2+]i to 65% of control (399.6 ± 52.4 vs. 260.1 ± 22.4 nM; control vs. CatL; 
P<0.05; Figure 6.7C(ii)).  Minimum [Ca2+]i was not significantly altered (54.1 ± 
4.6 vs. 53.3 ± 4.3 nM; control vs. CatL; P>0.05; Figure 6.7C(iii)).  The reduced 
peak [Ca2+]i led to a significantly reduced [Ca2+]i amplitude of 60% of control 
(345.5 ± 50.9 vs. 206.8 ± 2.0 nM; control vs. CatL; P<0.05; Figure 6.7C(iv)).  The 
decay rate constant was not significantly altered (7.0 ± 0.2 vs. 6.8 ± 0.3 s-1; 
control vs. CatL; P<0.05; Figure 6.7C(v)), which is similar to the result in rat 
cardiomyocytes at 0.68 nM.  
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Figure 6.7: Stimulated Ca2+ transients with CatL in rabbit left ventricular cardiomyocytes.  
(A) Protocol used in epifluorescence Ca2+ measurements.  (B) Example Ca2+ transient traces for (i) 
control and (ii) 0.68 nM CatL.  The stimulus mark is shown in (i), the frequency was 2.0 Hz. (C(i)) 
Average Ca2+ transients taken from last 12 Ca2+ transients for media (grey) and CatL (black). (ii - v) 
Mean ± SEM for stimulated Ca2+ transient parameters for control (n = 29) and 0.68 nM CatL (n = 
25).  
6.3.8 Cathepsin-L Reduces SR Ca2+ Content in Rabbit Left 
Ventricular Cardiomyocytes 
As with the rat cardiomyocyte experiments, the SR Ca2+ content was measured 
from the amplitude of the caffeine-induced Ca2+ transient at the end of the 
protocol (Figure 6.8A).  The caffeine-induced Ca2+ transient amplitude was 
significantly reduced to 49.8% of control; (466.8 ± 121.4 vs. 232.3 ± 29.0 nM; 
control vs. CatL; P<0.05).  The rate constant of decline, an indicator of NCX 
function, was not significantly altered; (1.22 ± 0.11 vs. 1.25 ± 0.10 s-1; control 
vs. CatL; P>0.05) (Figure 6.8C(i-ii)). 
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Figure 6.8: Caffeine-induced Ca2+ transients in rabbit cardiomyocytes with CatL. 
(A) Protocol used for epifluorescence Ca2+ measurements. (B) Example caffeine-induced Ca2+ 
transients for vehicle control (grey) and 0.68 nM CatL (black).  (Inset) Normalised caffeine-induced 
Ca2+ transients from (B). (C(i – ii)) Mean ± SEM for caffeine-induced Ca2+ transient amplitude and 
decay rate constant for control (n = 29) and CatL (n = 25). 
6.3.9 Cathepsin-L Increases Ca2+ Wave Frequency in Resting 
Cardiomyocytes 
Reduced SR Ca2+ content and reduced stimulated Ca2+ transient amplitude can be 
a result of both increased spontaneous Ca2+ release and altered RyR Po lowering 
the Ca2+ release threshold of the SR(192).  We hypothesised this may be the case 
with the trypanosome CatL (discussion Chapter 4).  Therefore, confocal Ca2+ 
imaging experiments to examine diastolic Ca2+ release were performed.  
Recombinant CatL was used at the same concentration as the recombinant 
TbCatL experiments (1:50 dilution; 2.0 nM).  Resting adult rat left ventricular 
cardiomyocytes were loaded with Fluo-3AM Ca2+ sensitive dye and imaged for 30 
s.  F/F0 fluorescence traces were analysed for Ca2+ wave velocity, amplitude and 
decay rate constant.  CatL increased the wave frequency to 136.7% of control 
levels (0.12 ± 0.02 vs. 0.16 ± 0.02 Ca2+ waves.s-1; control vs. CatL; P<0.05; Figure 
6.9A & B(i)).  The Ca2+ wave velocity was not significantly altered (81.4 ± 1.9 vs. 
83.3 ± 2.6 µm.s-1; control vs. CatL; P>0.05; Figure 6.9B(ii)) nor was Ca2+ wave 
amplitude (6.4 ± 0.6 vs. 7.2 ± 1.0 F/F0; control vs. CatL; P>0.05; Figure 
6.9B(iii)).  
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Figure 6.9: Confocal images of unstimulated cardiomyocytes. 
(A) Rat left ventricular cardiomyocytes were incubated with vehicle control or 5.40 nM CatL for 30 
min and then line-scans performed for 30 s. (i - ii) Representative confocal line-scan image and 
corresponding fluorescence trace (F/F0) for control (i) and CatL (ii).  (B(i - iii)) Ca2+ wave 
characteristics for control cardiomyocytes (grey; n = 73) and cardiomyocytes incubated with CatL 
(black; n = 70).  
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6.4 Discussion 
6.4.1 Mammalian Cathepsin-L is Active at Physiological pH 
Cysteine cathepsins have been shown to be localised to the acidic intracellular 
organelles lysosomes where they degrade unwanted proteins(371;373;374).  It has 
been traditionally thought that cathepsins only had limited activity at pH values 
other than their optimal acidic pH values(395;567;583).  However, recent work has 
shown that cathepsins can not only be active in other more neutral cellular 
compartments such as the cytosol(383-385) and nucleus(386;387), but are secreted 
into and function within extracellular spaces(423).  Indeed, extracellular 
cathepsin expression and activity has been identified in failing cardiac 
tissue(421;422;584) and valve tissues(585-587) from humans and animals.  It has been 
proposed by Punturieri et al. (2000) that there is formation of a localised acidic 
environment in the zone of enzyme/substrate contact via expression of H+-
ATPase in monocyte-derived macrophages maintaining the acidic 
environment(588).  However, a study by Lohmuller et al. (2005) used computer 
modelling to predict substrate cleavage specificity and conditions and found that 
CatL could potentially have activity at cytosolic and nuclear pH values(589).  This 
suggests that extracellular CatL could be active in the extracellular environment 
of the heart.  During ischaemia the tissue becomes acidotic from the build up of 
lactic acid from anaerobic respiration(348), which could favour extracellular CatL 
activity.  Mature CatL has been considered as being unstable at neutral and 
alkaline pH with a rate constant of inactivation 17 fold faster at pH 7.4 
compared with pH 7.0 at a temperature of 37 ºC(372).  There is very little 
information in the literature regarding the activity of extracellular CatL and, 
therefore, to determine if mammalian CatL could be active at physiological pH, 
fluorometric activity assays were performed at pH 6.0, 7.0 and 7.4.  
Fluorometric activity assays using recombinant mouse CatL demonstrated 
activity not only at the optimum pH of 5.5-6.0(371), but at pH 7.0 and 7.4 (Figure 
6.1A & B).  The peak rate of activity occurred within the first 5 min but activity 
was present after the 30 min period of measurement at all three measured pH 
values. 
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6.4.2 Cathepsin-L is Detected in Coronary Effluent from 
Ischaemia/Reperfusion Hearts 
CatL is ubiquitously expressed and has been shown to be expressed in 
cardiomyocytes(421;422) and cardiac fibroblasts(421) as well as many other cell 
types(384).  It has also been shown to be secreted into the extracellular 
environment as a pro-enzyme to be activated by other proteases such as 
metalloproteinases in other body tissues, even at neutral pH(590-592).  In cases of 
cardiovascular disease such as myocardial infarction or coronary heart disease 
higher levels of circulating CatL have been identified(413;425;426) and Sun et al. 
found increased levels of CatL activity in homogenised hearts post-MI(424).  
However, it is not clear whether this is resulting from release of CatL from 
tissues associated with the heart, or derives from other organs/systemic 
processes.  To determine if the heart could directly be releasing CatL during 
ischaemia/reperfusion, CatL activity was measured in the coronary effluents 
from ex vivo rat hearts.  The Langendorff perfused hearts were subjected to a 
30 min period of global ischaemia followed by a 90 min period of reperfusion.  
Activity was detected in the effluent samples which, when specifically inhibited 
was shown to be CatL.  Utilisation of an ex vivo model enabled removal of any 
systemic contribution, therefore enabling us to determine that cells within the 
heart were secreting CatL and could contribute to the reported raised serum 
CatL levels in patients(413;425;426).  These results are supported by similar findings 
of raised CatB levels(571) and the serine protease CatD levels(430), as well as CatL 
levels, in ischaemia/reperfusion injury(431).  It remains unclear exactly how or 
where from the CatL is released; whether it is directly secreted during 
reperfusion or if it is released in response to the injury/cell damage.  Several 
studies have examined the effects on the lysosome in response to 
ischaemia/reperfusion injury.  The “lysosomal hypothesis”(593-595), which suggests 
that I/R injury significantly reduces lysosomal integrity and also alters lysosomal 
distribution within cells(339;340), leading to leakage of lysosomal enzymes into the 
cytoplasm and extracellular milieu causing cell necrosis and apoptosis.  Other 
studies report a Ca2+ mediated redistribution and fusion of lysosomes with the 
plasma membranes and subsequent exocytosis of lysosomal cathepsins in skin 
fibroblasts(596) and Chinese hamster ovary cells(597) in response to injury.  Ichihara 
et al. (1987) demonstrated that this same redistribution and exocytosis process 
of lysosomes could be inhibited in ischaemic rat hearts with the LTCC blocker 
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diltiazem, leading to a detectable reduction in CatD (measured in this study), 
and improvement in mechanical function upon reperfusion compared to 
untreated controls(598).  This suggests that cathepsins can be released from cells 
following ischaemia and have potential deleterious consequences.  Therapeutic 
strategies that target inhibition of lysosomal enzyme release or inhibition of the 
enzyme activity following ischaemia could improve recovery.  Therefore, the 
released CatL detected in the coronary effluent could potentially have an effect 
on cardiac function.    
6.4.3 Cathepsin-L is Increased in Serum of Human Patients That 
Have Undergone Reperfusion Following Myocardial 
Infarction 
ELISA has shown that CatL levels are increased in the immediately post-
reperfusion samples, although not statistically significant as only a small number 
have been tested (n = 4).  The quantity of CatL in these MI patients of 6.28 ±  
1.50 ng.mL-1 (Figure 6.3A) corresponds closely to Liu et al. (2009) who report 
levels of 6.1 ± 0.2 ng.mL-1 for acute MI(425).  These data, when interpreted with 
the coronary effluent CatL activity, suggest that CatL could be 
produced/released in the affected region of the heart during ischaemia, which is 
then released into the circulation upon reperfusion.  Studies by Stypmann et al. 
(2002) and Sun et al. (2010) provide evidence to support a beneficial role of 
CatL within the heart(402;424).  Stypmann et al. (2002) examined hearts of a CatL 
gene knockout mouse model and found that there was a dilated cardiomyopathy 
phenotype with interstitial fibrosis and pleomorphic nuclei(402).  They also 
identified that CatL-deficient cardiomyocytes have large fused lysosomes 
containing electron dense heterogeneous material when examined by electron 
microscopy.  Sun et al. (2010), using the same knockout mouse strain, induced 
experimental MI and found greater scar dilatation, wall thinning, reduced left 
ventricular pressure, reduced cardiac output and increase left ventricular 
volume in systole and diastole compared to control wild-type mice that had 
undergone the same MI induction procedure(424).  However, CatL is important for 
protein turnover within cells, activation of MMPs and neovascularisation(599-602), 
all of which would be inhibited in a complete CatL knockout.  Therefore, it 
becomes difficult to determine whether the altered phenotype is a true CatL 
effect or whether it is due to the modulation of other mechanisms.  Moreover, in 
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a full CatL knockout there is likely to be compensatory upregulation of other 
proteases, such as CatB, which may contribute to the detrimental effects rather 
than the lack of CatL(603).  If increased CatL levels were truly beneficial, then 
one would expect increased levels to translate to a correlated improvement of 
clinical signs in patients with cardiovascular disease.  However, the studies that 
report increased CatL do not show improved recovery(425;426).  In fact Liu et al. 
show that CatL is a biomarker for severity of cardiovascular disease(425).  
Although complete absence of CatL seems to be detrimental to cardiac function, 
increased levels of CatL may also be detrimental.  It appears that a fine balance 
of CatL levels is necessary for healthy cardiac function.  Further work with long-
term follow-up CatL measurements correlating with MI recovery in a greater 
number of patients would be interesting to perform.  Sun et al. (2011) suggested 
that CatL promotes fibrosis and therefore limits infarct size(424).  However, the 
long term consequences of fibrosis such as increased arrhythmogenesis, poor 
contraction and reduced lusitropy(604) were not discussed.  Therefore, what may 
be interpreted as a benefit of CatL, may actually be detrimental.  Also of 
interest would be parallel measurements of the endogenous cathepsin inhibitor 
Cystatin C (CysC).  Some studies have shown increases in CysC(605;606) associated 
with increased risk of cardiovascular mortality, while Shi et al. (1999) show 
decreases in CysC in atherosclerosis(417).  If CatL balance is of particular 
importance in ischaemia/reperfusion injury, then there is likely to be a 
contributing component from CysC, although it remains unclear what particular 
role it may play. 
6.4.4 Cathepsin-L Effects on Ca2+ Handling in Rat Left Ventricular 
Cardiomyocytes 
Epifluorescence Ca2+ measurements revealed a significant concentration-
dependent reduction in the stimulated Ca2+ transient amplitude and rate 
constant of decay prolonging the duration of the Ca2+ transient.  There was also 
a significant decrease in the amplitude of caffeine-induced Ca2+ transients 
indicating reduced SR Ca2+ content at all measured concentrations of CatL.  At 
the highest concentrations of CatL (2.70 and 5.40 nM) there was a reduction in 
the rate decay constant of the stimulated Ca2+ transient.  Interestingly, these 
changes in the stimulated Ca2+ transient are similar to those found in models of 
heart failure(299-302), and the reduction in SR Ca2+ content is also recognised in 
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heart failure(303-306).  In heart failure it has been reported that a major factor in 
reduced SR Ca2+ is an increase in Ca2+ leak from the RyR(299).  Other potential 
contributors would be reduced KSERCA and enhanced NCX activity(302).  
6.4.4.1 Ca2+ Transient Amplitude is Reduced in a Concentration Dependent 
Manner by CatL 
Increasing concentrations of CatL showed a strong negative correlation with 
peak [Ca2+]i and consequently [Ca2+]i amplitude. Two explanations for reduced 
stimulated Ca2+ release are; i) failure of RyR activation termed defective 
coupling, and ii) insufficient availability of Ca2+ within the SR(302).  With regard to 
defective coupling, it has been reported that LTCC number (RyR activating 
channels) has been reduced in heart failure(316), but that LTCC activity is 
increased(317).  The reported findings are consistent with an increased level of β-
adrenergic stimulation and subsequent phosphorylation of the LTCC(318).  The 
results with TbCatL suggested no effect on the LTCC but this has not been 
measured with mammalian CatL.  Defective coupling could also occur if there is 
defective interaction between the LTCC and RyR as reported in spontaneously 
hypertensive rats with heart failure(607) and rats with MI(608) i.e. a reduced 
coupling gain of Ca2+ influx and Ca2+ release. With regard to insufficient 
availability of Ca2+ from the SR this was shown to be reduced in the presence of 
CatL and is discussed in section 6.4.4.5. 
6.4.4.2 SERCA Activity is Reduced in a Concentration Dependent Manner by 
CatL 
The decay rate constant of the stimulated Ca2+ transient was significantly 
reduced at the two higher concentrations of CatL.  This shows slower diastolic 
Ca2+ removal, which could be a result of reduced reuptake to the SR by SERCA or 
reduced sarcolemmal efflux.  The application of high concentration caffeine (10 
mM; 20 s) effectively removes SERCA by opening the RyR and emptying the SR of 
Ca2+.  Therefore, to get an indication of KSERCA the decay rate constant of the 
caffeine-induced Ca2+ transient (sarcolemmal efflux) can be subtracted from the 
decay rate constant of the stimulated Ca2+ transient (both SR reuptake and 
sarcolemmal efflux), as conducted by Bode et al. (2011)(506).  KSERCA is reduced 
significantly at 2.70 and 5.40 nM CatL (95.3 ± 6.5 vs. 67.3 ± 11.9 vs. 30.7 ± 3.3% 
of vehicle control; 0.68 vs. 2.70 vs. 5.40 nM CatL).  KSERCA may be reduced in two 
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ways; i) reduced expression(307) or ii) increased inhibition by phospholamban 
(PLB), either by increased quantity in relation to SERCA or altered 
phosphorylation(308).  It has been shown that a decrease in the phosphorylation at 
the PKA dependent site Ser16 occurs in both human(309) and some animal 
models(310) of heart failure.  This is thought to be a result of increased activity of 
the SR-associated phosphatase PP1 which dephosphorylates PLB(310;609) via 
reduced inhibition by the inhibitor I-1(610;611).  The time course for a reduction in 
SERCA expression has been studied in models over the course of several 
weeks(612-615), however, changes in SERCA protein levels can be observed in as 
little as 30 min(616).  Therefore, in 30 min CatL exposed cells it is unclear 
whether there could be an alteration in the phosphorylation status of PLB 
(perhaps via altered phosphatase inhibition), a reduced level of SERCA, or a 
combination of both mechanisms.  The current thinking is that much of the heart 
failure phenotype is due to altered phosphorylation status of Ca2+ handling 
proteins brought about through increased PKA activity through CaMKII 
activation(302), as partial recovery of phosphorylation status results in some 
functional recovery(318;617).  The results presented in the preceding chapters 
suggest that TbCatL could be altering SR-mediated Ca2+ release via CaMKII.  
Therefore, the recombinant mouse CatL may be having effects on similar 
targets.  Further work in future would be required to elucidate the mechanism 
responsible.   
6.4.4.3 Sarcolemmal Extrusion is Reduced at Higher Concentrations of CatL 
NCX function is usually thought to be increased in heart failure(312-315), i.e. more 
Ca2+ extruded from the cytosol reduces the amount available for reuptake by 
SERCA to the SR, but these changes are not consistent(302).  In the present study 
Sarcolemmal extrusion was indirectly assessed by measurement of the decay 
rate constant of the caffeine-induced Ca2+ transient.  At the lower 
concentrations of CatL NCX function was not significantly affected.  However, at 
5.40 nM CatL NCX function was decreased, which is in contrast to many studies 
showing a similar SR-mediated Ca2+ handling phenotype(312-315).  However, during 
ischaemia/reperfusion injury Le et al. (2006) has shown that the time constant 
of decay (τ) (the inverse of rate constant) is increased by about 40%(616), i.e. NCX 
function is decreased.  This is more severe than the NCX effect observed in the 
present study, but the cardiomyocytes examined here were under normal 
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physiological conditions rather than following hypoxic damage.  These results 
suggest that CatL could also have a mild effect on NCX that becomes more 
severe at higher concentrations in addition to the decrease in KSERCA.  However, 
further work would be required to understand this effect more fully. 
6.4.4.4 Diastolic [Ca2+]i is Increased by CatL 
Since KSERCA and NCX activity appear to be decreased in the presence of 5.40 nM 
CatL there should be a rise in the diastolic [Ca2+]i.  This is indeed the case 
(Figure 6.5C(iii)), a finding which parallels those with TbCatL.  At the lower 
concentrations of CatL there was still a significant decrease in KSERCA but no 
significant change in NCX activity or diastolic [Ca2+]i.  It is possible that there 
may be modulation of other Ca2+ extrusion mechanisms.  
6.4.4.5 SR Ca2+ Content is Reduced by CatL 
The significant reduction in caffeine-induced Ca2+ transient amplitude identified 
in the present study is a finding consistent with reduced stimulated Ca2+ 
transient amplitude(303-306).  Reduction in SR Ca2+ content can be a result of; i) 
reduced Ca2+ reuptake or ii) increased Ca2+ leak from the SR through the RyR.  In 
the case of heart failure, SR Ca2+ leak is considered a major contributing factor 
to reduced SR Ca2+ content(319-323).  However, the specific mechanisms are 
contentiously debated at present(276;277;324).  The present study provides evidence 
to support a reduced SR Ca2+ reuptake with the reduced KSERCA but further work 
will be required in future to determine the exact mechanism.  In conjunction 
with SERCA effects there could also be a concomitant leak from the RyR. 
6.4.5 Cathepsin-L Effects on Ca2+ Handling in Rabbit Left 
Ventricular Cardiomyocytes 
Epifluorescence Ca2+ measurements were repeated in rabbit left ventricular 
cardiomyocytes due to the differences in Ca2+ handling properties from 
rodents(257;582).   The data shown in this study suggest that CatL concentrations in 
the region of 0.68 nM are found in both coronary effluents from Langendorff 
perfused hearts that have undergone I/R injury and in the serum of patients that 
have had an MI and subsequent treatment, which correspond with Liu J et al. 
(2006) and Liu Y et al. (2009)(413;425).  Therefore, the epifluorescent Ca2+ imaging 
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experiments were performed with this concentration.  The experiments were 
also performed at a greater stimulation frequency of 2.0 Hz representing a more 
physiological heart rate and hopefully give a better reflection of the potential 
clinical situation.  Figure 6.7 shows a similarly reduced peak [Ca2+]i and [Ca2+]i 
amplitude.  The rate constant of decay was not significantly altered at this 
concentration of CatL.  When compared with the same concentration of CatL in 
rat cardiomyocytes there was also no statistically significant reduction, this was 
only seen at the higher concentrations.  This suggests that KSERCA modulation may 
only be slight in the presence of low concentration CatL vs. higher modulation at 
higher CatL concentrations.  With the significantly reduced Ca2+ transient 
amplitude being observed, this would suggest as discussed above (section 
6.4.4.1) either defective RyR coupling or reduced SR Ca2+ availability(302).  As 
with the rat cardiomyocyte experiments a bolus of high concentration caffeine 
was applied to the rabbit cardiomyocytes at the end of the protocol.  Similarly 
to the results obtained with the rat model, there was a significant reduction in 
the caffeine-induced Ca2+ transient amplitude.  There was no significant change 
in the decay rate constant which is consistent with 0.68 nM CatL in the rat 
cardiomyocyte data.  The reduction in SR Ca2+ content as measured by caffeine-
induced Ca2+ transient amplitude could explain the reduction in stimulated Ca2+ 
transient amplitude(303-306).  Without a significant change in the stimulated Ca2+ 
transient decay rate constant a significant reduction in KSERCA that could explain 
the reduced SR Ca2+ content has little supporting evidence.  A diastolic leak from 
the SR through the RyR may be a more likely explanation. 
6.4.6 Cathepsin-L Increases Ca2+ Wave Frequency in Resting 
Cardiomyocytes 
One measure of diastolic SR Ca2+ “leak” is spontaneous Ca2+ release in the form 
of Ca2+ waves.  Rat left ventricular cardiomyocytes were loaded with Fluo-3 and 
imaged with a LASER-scanning confocal microscope in line-scan mode without 
stimulation.  Since the largest effects on stimulated and caffeine-induced Ca2+ 
transient amplitude and decay were at 5.40 nM CatL, the confocal experiments 
were conducted with the same concentration of CatL.  There was a significant 
increase in the Ca2+ wave frequency.  Increased Ca2+ wave frequency is a 
manifestation of increased Ca2+ leak from the SR(192).  Normally an increase in 
Ca2+ wave frequency occurs when SR Ca2+ content is increased as the release 
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threshold is reached earlier resulting in early release during diastole(192).  
However, it has been reported that in heart failure there can be 
hyperphosphorylation of the RyR resulting in dissociation of FKBP12.6(276).  
FKBP12.6 may act as a diastolic inhibitor of RyR reducing Po and aberrant Ca2+ 
release i.e. stabilising the closed state of the channel(276).  This hypothesis could 
explain a reduced SR Ca2+ content and subsequent reduced stimulated Ca2+ 
transient amplitude and may also lead to reperfusion arrhythmias via 
arrhythmogenic Ca2+ waves(273;322;526;618;619).  However, in heart failure this 
hypothesis remains extremely controversial as findings of RyR phosphorylation in 
different models of heart failure are inconsistent(277-279;525).  The situation with 
TbCatL, as discussed in Chapter 4, suggests a possible CaMKII-mediated effect.  
There is some evidence to suggest that hyperphosphorylation of the RyR at the 
CaMKII site Ser2815 can result in an increase in diastolic Ca2+ leak(280;319).  Other 
suggestions for a similar phenotype in the literature are that RyR activity could 
be enhanced by reactive oxygen species (ROS) or reactive nitrogen species 
(RNS)(620;621).  In the present study the phosphorylation status of the RyR was not 
measured, so whether there is PKA-mediated hyperphosphorylation of RyR as 
proposed by the Marks group(276;324), or whether it is CaMKII-mediated 
hyperphosphorylation as proposed by Bers and colleagues(277;311) or indeed, no 
change in phosphorylation as proposed by Valdivia’s group(279), cannot be 
determined at this time.  Further work assessing the phosphorylation status of 
RyR may help establish by what mechanism CatL is eliciting its effects.  There 
was no significant difference in the velocity or amplitude of the Ca2+ waves 
although both parameters tended to increase. The data presented in Figure 6.9 
is from adult rat cardiomyocytes incubated with 5.40 nM CatL. Ca2+ waves can 
lead to arrhythmias via activation of NCX, triggering an inward electrical current 
through Na+ leading to delayed afterdepolarisations (DAD)(192).  This suggests that 
concentrations of CatL observed in this study and in Liu et al. (2009)(425) could 
play a role in arrhythmias.  Indeed, increased arrhythmia frequency upon 
reperfusion is a hallmark of ischaemia/reperfusion pathology(331-337). 
In the case of reperfusion arrhythmias there is a putative role for ROS(622;623).  It 
has been shown that ROS can increase the Po of the RyR(341;345-347) and that RNS 
stimulated channel activity(624;625).  Interestingly ROS had an inhibitory effect on 
SERCA(342-344;620), which fits the findings of the current study.  The 
Chapter 6  The Effects of Endogenous Extracellular Cathepsin-L 296 
 
cardiomyocytes in the present study were not subjected to ischaemic conditions.  
However, cathepsins can be released by ROS-mediated loss of lysosomal 
integrity(339;340) and ROS can be released through cathepsin-mediated damage to 
mitochondrial membranes(626).  Therefore, one possible explanation for the 
increased Ca2+ wave frequency and decreased KSERCA observed in the present 
study could be increased ROS production brought about by the presence of CatL.  
However, further experiments establishing a potential role for ROS will be 
required. 
6.4.7 Conclusions 
Little is known about the levels of CatL in patients with cardiac I/R injury.  Work 
conducted in our laboratory has demonstrated for the first time that CatL 
proteolytic activity can be detected in coronary effluent samples from hearts 
that have undergone experimental I/R injury, but not in control hearts perfused 
continuously.  The data presented in this thesis shows preliminary findings that 
serum levels of CatL are increased in human patients that have suffered MI and 
undergone therapeutic reperfusion and there may also be a correlation with 
severity of cardiovascular disease.  However, this data is preliminary and will be 
followed up.  The role that increased levels of CatL play in cardiovascular 
disease is not currently known.  However, the work presented in the current 
study demonstrates that recombinant CatL has a concentration dependent effect 
on the SR Ca2+ content, the amplitude of the stimulated Ca2+ transient and SR-
mediated Ca2+ release of rat cardiomyocytes.  The same effects were observed 
in rabbit cardiomyocytes at a CatL concentration of 0.68 nM.  These findings 
suggest that CatL may cause increased SR-mediated Ca2+ leak through the RyR 
resulting in reduced SR Ca2+ content leading to a reduced stimulated Ca2+ 
transient.  Further work will be required to elucidate the potential sarcolemmal 
target for extracellular CatL and the subsequent signalling to result in the 
observed phenotype.  Current work within our laboratory has started to examine 
the effects of the CatL specific inhibitor CAA0225 on cardiac function and infarct 
size in both ex vivo and in vivo models with promising results, therefore, making 
inhibition of CatL an attractive therapeutic target for ischaemic heart disease.  
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7.1 Study Rationale 
The cardiac effects of American trypanosomiasis (Chagas disease) caused by 
Trypanosoma cruzi are widely known and studied in detail.  However, in the 
case of African trypanosomiasis, for both human (human African trypanosomiasis 
(HAT) or ‘sleeping sickness’) and animal (animal African trypanosomiasis (AAT) 
or ‘nagana’) infections, cardiac involvement is often overlooked entirely due to 
the focus on the more overt signs of neurological disturbances (human) or 
anaemia and muscle wastage (animal).  These clinical signs, when looked for, 
are electrocardiogram abnormalities such as a prolonged QT interval, 
repolarisation abnormalities and arrhythmias manifesting as palpitations in 
patients(51), as well as reports of heart failure, ventricular dilatation and sudden 
cardiac death(28;56;57).  Historically, cases of human(56;57) or experimentally 
infected animals(26-28) have been examined post-mortem and evidence of 
perimyocarditis was identified.  Thus any clinical case reports(62;542-544) or 
controlled studies(51;52) have attributed any cardiac involvement to be as a result 
of inflammation of the myocardium in response to parasite infiltration.  However 
reports of cardiac signs and presence of trypanosomes within the myocardium 
without an inflammatory cell infiltrate are harder to reconcile with a hypothesis 
of inflammation alone(26;497).  In the case of Chagas disease, it has been found 
that the T. cruzi parasites and their culture supernatant are capable of inducing 
spontaneous cytosolic Ca2+ transients in isolated cardiomyocytes(508) but no such 
study has been performed in cardiomyocytes exposed to T. brucei spp. and/or 
their culture supernatant.  The most pertinent studies have been performed by 
Grab and colleagues (2006) assessing the ability of T. brucei spp. to cross the 
endothelial cell layer of the blood brain barrier in vitro (69).  They identified that 
T. b. rhodesiense and T. b. brucei were able to traverse the endothelial cell 
layer via induction of Ca2+ fluxes within the endothelial cells facilitating 
alterations in the cytoskeletal components causing the cells to pull apart and 
fenestrate the layer(66;67;69).  They also identified that the trypanosomes induced 
the Ca2+ fluxes by secreting/excreting a cathepsin-L-like cysteine protease 
(TbCatL)(69).  Therefore the rationale for this body of work was that if T. brucei 
could induce Ca2+ fluxes in BBB endothelial cells, and T. cruzi could induce Ca2+ 
fluxes or transients in cardiomyocytes, then we hypothesise that African 
trypanosomes could also affect intra-cardiomyocyte Ca2+ dynamics in the heart.  
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If evidence supported this hypothesis, then some of the observed cardiac clinical 
findings such as arrhythmias and palpitations may in fact be also attributable to 
a direct result of trypanosome-induced Ca2+ fluxes, in addition to solely the 
inflammatory reaction as previously thought.  This would also have potential 
implications in terms of providing new therapeutic targets and treatments.   
7.2 The Effects of T. b. brucei on the Heart at the 
Cardiomyocyte and Whole Organ Level 
Although HAT is caused by T. b. gambiense (West African) or T. b. rhodesiense 
(East African) these subspecies are difficult to use in the lab, both due to their 
infectious nature to humans and also the difficulty in culturing the bloodstream 
form.  However, the broad similarities of the animal infective subspecies T. b. 
brucei and its comparative safety and ease of culture make it an established 
model species of trypanosome.  The most widely used strain of  T. b. brucei used 
is Lister 427(434).  The first step in establishing the effects of T. b. brucei on Ca2+ 
handling in cardiomyocytes was to enzymatically isolate individual 
cardiomyocytes from whole hearts of rats and expose them to cultures of T. b. 
brucei.  The advantage of the rat cardiomyocyte spontaneous contractile assays 
was the basal level of Ca2+ wave activity, such that any potential alteration to 
Ca2+ handling in the cardiomyocytes by trypanosomes or their supernatant could 
be detected without difficulty. Quantification of the result was achieved by 
recording the percentage of cardiomyocytes exhibiting at least one spontaneous 
contraction min-1.  The result was clearly positive and repeatable, and due to its 
simplicity proved a useful technique with which to test hypotheses before 
investigating further with more involved techniques.  To establish whether the 
effect was from the trypanosomes themselves or a secreted/excreted factor, the 
culture supernatant was applied in the same manner as live cultures and the 
cardiomyocytes observed for spontaneous contractile events.  The result was 
replicated and could be abolished by heating the supernatant - adding support 
for the secreted/excreted factor hypothesis.   
The link with the spontaneous contractions and Ca2+ was established with Ca2+ 
sensitive fluorophores and measurements of the Ca2+ fluxes with LASER-scanning 
confocal microscopy and epifluorescence microscopy.  Both these imaging 
techniques are well documented and used as gold standards for cardiomyocyte 
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Ca2+ studies, such that observations made can be rigorously cross-checked with 
published data and any conclusions be drawn robustly.  This enabled 
determination that the contractions were mediated by spontaneous 
sarcoplasmic-reticulum (SR)-mediated Ca2+ release.  The simplicity of the 
cardiomyocyte population assay provided a high throughput means of 
determining through; i) specific cathepsin inhibition, ii) gain of function effect 
with recombinant TbCatL and iii) loss of function effect with RNA interference 
that the cathepsin-L-like cysteine protease TbCatL caused the effect observed.  
Therefore, the same protease that is responsible for inducing Ca2+ fluxes in BBB 
endothelial cells is also responsible for SR-mediated spontaneous Ca2+ release in 
cardiomyocytes. 
However, despite the strong evidence supporting an effect on cardiomyocyte 
Ca2+ dynamics, further work is required to confirm if this is single cell effect 
contributes to the clinical cardiac manifestations reported.  Therefore, the study 
was expanded to incorporate analysis of whole hearts with ECG recording to 
measure the occurrence of potential arrhythmic events.  Ex vivo rat hearts were 
perfused in Langendorff perfusion with trypanosome culture supernatant or 
control media and their ECGs recorded.  SR-mediated spontaneous Ca2+ release 
can lead to whole heart arrhythmia through activation of the Na+/Ca2+ exchanger 
(NCX).  This may cause a delayed after depolarisation (DAD) which can lead to 
an abnormal or ectopic heart beat if the depolarisation propagates to adjacent 
cells.  This will be perceived as a palpitation in individuals.  If the reported 
arrhythmias and palpitations in HAT patients could be due to the effects of 
TbCatL on SR-mediated spontaneous Ca2+ release then whole hearts exposed to 
supernatant may be expected to have an increased frequency of arrhythmias of 
ectopic origin.  Indeed, in a proportion of the hearts perfused with supernatant, 
there were more arrhythmias observed, specifically ventricular premature 
complexes (VPCs).  This correlates well with the published clinical data that 
reports only a proportion of patients exhibit palpitations.   This result also 
supports for the first time the hypothesis of a secreted/excreted factor having a 
direct effect as these hearts are removed from any neurohumoral response or 
inflammatory processes.   
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7.3 The Mechanisms of SR-Mediated Ca2+ Release 
Caused by T. b. brucei 
Following the results of Chapter 3, the aim of the Chapter 4 was to investigate 
the potential mechanisms behind the SR-mediated Ca2+ release observed.  The 
conclusion that TbCatL causes abnormal SR-mediated Ca2+ release as a result of 
stimulation of SERCA required substantiation.  First, the only evidence for this 
conclusion was an accelerated decline of the Ca2+ transient in supernatant 
perfused cardiomyocytes.  If increased spontaneous Ca2+ release was a result of 
increased SERCA activity the SR Ca2+ content would be expected to be higher.  
Therefore, a paired protocol with the same cardiomyocyte being perfused with 
control media followed by supernatant lead to improvement of the accuracy and 
reliability of the epifluorescence experiments.  Furthermore, a parallel set of 
paired protocol experiments using only control media were performed as time 
controls to which the data was normalised.  Application of caffeine after each 
solution within the same cardiomyocyte allowed a more accurate assessment of 
the SR Ca2+ content and NCX function between control media and supernatant.  
This revised protocol identified that the SR Ca2+ content was in fact reduced by 
supernatant and not increased as would be expected with faster Ca2+ transient 
decline from SERCA stimulation.  The decay of the caffeine-induced Ca2+ 
transient was not significantly altered suggesting that NCX function was not 
affected.   
Despite the reduced SR Ca2+ content, the Ca2+ transient decline was still 
significantly faster and calculation of SERCA activity confirmed that SERCA 
stimulation is still the most likely hypothesis.  However, the increased SERCA 
activity may not be the primary effect but a secondary response to a raised 
diastolic [Ca2+]i.  This hypothesis was tested by the inhibition of SR Ca2+ uptake 
with thapsigargin and release with ryanodine.  These experiments revealed that 
in control media diastolic [Ca2+]i reduced over the course of the protocol but 
that in supernatant the diastolic [Ca2+]i failed to decrease, suggesting that higher 
[Ca2+]i may contribute to the SERCA. 
The contribution of myofilament Ca2+ sensitivity and the LTCC to changes in 
SERCA activity and [Ca2+]i were experimentally ruled out.  
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The concomitant reduced SR Ca2+ content (despite an increased SERCA activity) 
and increase in Ca2+ wave frequency suggested that TbCatL may induce diastolic 
Ca2+ leak from the SR via RyR.  This was probably due to an altered SR Ca2+ 
threshold or RyR sensitivity as SR Ca2+ content is reduced.  If both SERCA and the 
RyR are altered by TbCatL, then the effects may be mediated by a common 
secondary messenger.  Both RyR activity and SERCA activity via modified 
inhibition by PLB can be affected by PKA and/or CaMKII, two phosphorylating 
enzymes normally activated with β-adrenergic stimulation.  Therefore PKA and 
CaMKII inhibitors were tested using the high-throughput cardiomyocyte 
population assay.  This identified that the increase in spontaneous contractile 
events could be abolished by CaMKII inhibition but not PKA inhibition.  With this 
information, the triple caffeine protocol and SR inhibition protocols were 
repeated with CaMKII inhibition.  These experiments identified that the Ca2+ 
transient decline was no longer faster and SR Ca2+ content was the same for 
control media and supernatant; therefore, supporting the hypothesis that both 
RyR and SERCA activity were increased by the supernatant.  Interestingly, the 
increase in diastolic [Ca2+]i in the inhibited SR experiments was not prevented by 
CaMKII inhibition. 
Further work in future would be to identify a sarcolemmal target for TbCatL.  In 
the case of T. cruzi the cathepsin-L-like cysteine protease cruzipain targets the 
pertussis toxin sensitive G-protein coupled receptor(508).  For T. brucei spp. in 
the BBB endothelial cell traversal model one suggested target is another G-
protein coupled receptor activated by proteases called protease-activated-
receptor 2 (PAR-2)(66).  Therefore, a similar target may be involved in the cardiac 
effects presented in this thesis.  Preliminary work performed since completion of 
this work has ruled out PAR-2 in the heart, and so another target remains to be 
discovered.  Also worth investigating further are individual channel currents.  
Although the current study did not show any significant effects on NCX there 
may be more subtle differences only identifiable by direct measurements.  The 
NCX can reverse and be a potential source of Ca2+ influx possibly explaining the 
observed increase in diastolic [Ca2+]i without an L-type component.  Although 
often described as less important there are other Ca2+ handling mechanisms in 
the cardiomyocyte that could be further investigated such as the alternative SR 
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Ca2+ release channel the IP3 receptor or the alternative Ca2+ extrusion 
mechanisms like the plasma-membrane Ca2+ ATPase (PMCA).  
7.4 In Vivo Model of Infection and the Cardiac Effects of 
T. b. brucei 
Traditionally much of the focus of research into HAT has been the neurological 
effects and with AAT the anaemia and muscle atrophy.  Therefore in vivo models 
of infection have focused on these signs.  As a result the development of a 
model of infection that enabled examination of the cardiac effects was required.  
Two strains of T. b. brucei were used; Lister 427 and TREU 927.  Although Lister 
427 proved useful for in vitro studies, its inability to differentiate from long-
slender bloodstream form to short-stumpy form resulted in an in vivo model that 
did not last longer than 3-4 days without killing the host.  As a result it was 
deemed that short ECGs from anaesthetised animals over the course of a 4 day 
infection with 427 was a model with limitations.  The 927 strain was a better 
candidate for analysing chronic infections, as it is pleomorphic, i.e. 
differentiates to the short-stumpy form in a density-dependent manner, giving 
rise to fluctuating parasitaemias that mimic natural infections.  This enabled the 
model to be continued for a longer period of time (up to 2 weeks).  Biopotential 
telemetry devices were implanted to record the ECG continuously from 
conscious animals exhibiting normal behaviours.  The result was a more realistic 
model and it showed a significant increase in ventricular arrhythmias.  
Therefore, this may be a useful model in the future testing of cardiovascular 
effects of potential new drugs and testing whether TbCatL inhibition can reduce 
the occurrence of arrhythmias.  Future development of the model would be a 
longer term study extending to the duration of clinical infections lasting several 
weeks to months to estimate to relative contributions of a direct TbCatL effect 
and the traditional immune/inflammatory component.  There is scope to 
combine cardiovascular monitoring with existing infection models of 
trypanosomiasis.  Combination with new techniques such as in vivo imaging 
systems (IVIS) that use trypanosomes modified with either fluorescent proteins 
or reporter proteins such as luciferase enable visualisation of the course and 
distribution of infection including the CNS(555).  Therefore, IVIS combined with 
biopotential recording could help determine if there is a correlation with 
presence of trypanosomes or whether it is the perimyocarditis.  Such a model 
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may also be useful to test new treatment strategies.  For example, if TbCatL is 
responsible for both BBB traversal and cardiac arrhythmias then IVIS with ECG 
telemetry can test both CNS and cardiac response to TbCatL inhibition.  If 
successful, then potentially progression of HAT to Stage II can be prevented 
enabling the less toxic Stage I drugs in current use to be used instead of the 
more toxic Stage II drugs required to cross the BBB.        
7.5 The Cardiac Effects of Endogenous Extracellular 
Cathepsin-L 
The fact that TbCatL is involved in arrhythmogenic Ca2+ handling in 
cardiomyocytes is interesting.  There are many cardiovascular conditions that 
have abnormal Ca2+ dynamics at the centre of their pathophysiology such as 
heart failure and ischaemia/reperfusion injury.  Of particular note is the role 
that cathepsins have in many of these conditions.  In human clinical patients 
with coronary heart disease there is an increase in circulating levels of 
endogenous cathepsin-L.  Since cathepsin-L can be increased in some cardiac 
diseases and TbCatL can elicit arrhythmogenic releases of Ca2+ in African 
trypanosomiasis the hypothesis arose as to whether the characteristic 
arrhythmias of ischaemia/reperfusion can be caused by raised mammalian 
cathepsin-L. 
There is no literature available on the levels of cathepsin-L for 
ischaemia/reperfusion.  Therefore the first step was to identify if cathepsin-L 
activity could be detected in the coronary effluent of ex vivo hearts that had 
undergone ischaemia/reperfusion experimentally on a Langendorff perfusion 
apparatus.  Using an assay based on cleavage of a fluorescent substrate 
cathepsin-L activity was identified in effluents from hearts that had undergone 
the protocol but not in control hearts that were perfused throughout.  In 
addition, a preliminary study revealed that serum samples from human patients 
that had suffered a myocardial infarction (MI) had elevated levels of cathepsin-L 
supporting the ex vivo heart data.  The same patients also had cardiac magnetic 
resonance imaging on their hearts 6 months after initial presentation to assess 
cardiac function and infarct size.  Although the numbers of patients were very 
low, the initial findings showed a strong correlation of post intervention 
cathepsin-L level and subsequent severity of signs at 6 months.  Specifically 
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whole heart fractional shortening reduced as the cathepsin-L level increased and 
infarct size increased with increased cathepsin-L.  These are interesting findings 
that warrant further investigation.   
Given the effects of TbCatL on Ca2+ handling a similar set of experiments to 
Chapter 3 were performed with recombinant mouse cathepsin-L (rmCatL) on rat 
ventricular cardiomyocytes.  LASER-scanning confocal microscopy revealed a 
similar increase in Ca2+ wave frequency with rmCatL to supernatant perfused 
cardiomyocytes suggesting a similar diastolic Ca2+ leak.  Epifluorescence 
experiments identified a reduction in SR Ca2+ content but also a reduction in 
stimulated Ca2+ transient amplitude which differs from the TbCatL response.  
Interestingly when several different concentrations (as reported in a range of 
papers(413;425;426)) of rmCatL were used there was a concentration dependent 
effect on the reduction of Ca2+ transient amplitude and SR Ca2+ content.  The 
reduction was matched in rabbit ventricular cardiomyocytes, which exhibit 
similar Ca2+ handling properties to human ventricular cardiomyocytes.  The 
observed Ca2+ handling phenotype resembles that of cardiomyocytes isolated 
from patients and animal models with heart failure.  Therefore, there may be 
similar mechanisms involved.  No mechanistic studies with mammalian 
cathepsin-L have been performed yet, but this work will be continued focusing 
on Ca2+ handling protein function and quantity as well as potential targets and 
response to specific cathepsin-L inhibition.  In addition the study has since 
further expanded to incorporate both ex vivo and in vivo models.  Initial findings 
are that cardiac function post ischaemia is improved in ex vivo hearts and in vivo 
following pre-treatment with a cathepsin-L inhibitor.  This makes an attractive 
target for potential treatment in patients with ischaemic heart disease and 
following myocardial infarction that could aid in improving survivability. 
7.6 Final Conclusions 
The working hypothesis from Chapters 3 and 4 is that TbCatL acts on a yet to be 
identified sarcolemmal target which results in an elevation of intracellular Ca2+.  
This elevation in [Ca2+]i activates CaMKII which phosphorylates PLB decreasing 
SERCA inhibition and thereby enhancing its activity, and which also 
phosphorylates the RyR increasing its Ca2+ sensitivity and leak (Figure 7.1).  This 
is the first time African trypanosomes have been shown to have a direct effect 
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on the heart independent of an immune/inflammatory response.  Moreover, this 
pathogenic mechanism provides a platform to support future investigations that 
centre on inactivation of the effects of TbCatL via drugs that act on SR/ER-
mediated Ca2+ signalling in order to address the neurological and cardiovascular 
pathology associated with HAT.  Previous studies have shown that arrhythmias 
associated with disrupted SR function can be treated with flecainide and K201 
(JTV-519)(627) and this suggests a potential therapeutic approach for treatment of 
TbCatL induced cardiac dysfunction and other TbCatL mediated pathologies.  
 
Figure 7.1: Proposed mechanism for TbCatL action on cardiomyocyte Ca2+ handling. 
 
In the case of endogenous cathepsin-L the findings are very much in the 
preliminary stages but offers very interesting prospects for future study and 
development.  Increased levels of cathepsin-L appear to have deleterious 
consequences for cardiomyocyte Ca2+ handling resembling the phenotype of 
heart failure.  Hearts that have undergone experimental ischaemia/reperfusion 
injury and patients that have had a myocardial infarction have increased levels 
of cathepsin-L.  Preliminary results from follow-up work show that inhibition of 
cathepsin-L can have a beneficial effect on cardiac function after ischaemia.  
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Therefore cathepsin-L and its inhibition is an attractive target for the treatment 
of ischaemia/reperfusion injury.  
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